








Printed Edition of the Special Issue Published in Toxins
Promising Detoxification Strategies to
Mitigate Mycotoxins in Food and Feed

Promising Detoxification Strategies to
Mitigate Mycotoxins in Food and Feed
Special Issue Editor
Ting Zhou
MDPI • Basel • Beijing • Wuhan • Barcelona • Belgrade
Special Issue Editor
Ting Zhou







This is a reprint of articles from the Special Issue published online in the open access journal Toxins
(ISSN 2072-6651) from 2016 to 2018 (available at: http://www.mdpi.com/journal/toxins/special
issues/promising detoxification)
For citation purposes, cite each article independently as indicated on the article page online and as
indicated below:




Cover image courtesy of Yousef I. Hassan.
Articles in this volume are Open Access and distributed under the Creative Commons Attribution 
(CC BY) license, which allows users to download, copy and build upon published articles even 
for commercial purposes, as long as the author and publisher are properly credited, which ensures 
maximum dissemination and a wider impact of our publications. The book taken as a whole is c© 
2018 MDPI, Basel, Switzerland, distributed under the terms and conditions of the Creative Commons 
license CC BY-NC-ND (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Contents
About the Special Issue Editor . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . ix
Preface to ”Promising Detoxification Strategies to Mitigate Mycotoxins in Food and Feed” . . xi
Yousef I. Hassan and Ting Zhou
Promising Detoxification Strategies to Mitigate Mycotoxins in Food and Feed
Reprinted from: Toxins 2018, 10, 116, doi: 10.3390/toxins10030116 . . . . . . . . . . . . . . . . . . 1
Nina M. Wilson, Nicole McMaster, Dash Gantulga, Cara Soyars, Susan P. McCormick,
Ken Knott, Ryan S. Senger and David G. Schmale
Modification of the Mycotoxin Deoxynivalenol Using Microorganisms Isolated from
Environmental Samples
Reprinted from: Toxins 2017, 9, 141, doi: 10.3390/toxins9040141 . . . . . . . . . . . . . . . . . . . 6
Guanhua Fu, Junfei Ma, Lihong Wang, Xin Yang, Jeruei Liu and Xin Zhao
Effect of Degradation of Zearalenone-Contaminated Feed by Bacillus licheniformis CK1 on
Postweaning Female Piglets
Reprinted from: Toxins 2016, 8, 300, doi: 10.3390/toxins8100300 . . . . . . . . . . . . . . . . . . . 17
Xiangfeng Zheng, Qiya Yang, Hongyin Zhang, Jing Cao, Xiaoyun Zhang and
Maurice Tibiru Apaliya
The Possible Mechanisms Involved in Degradation of Patulin by Pichia caribbica
Reprinted from: Toxins 2016, 8, 289, doi: 10.3390/toxins8100289 . . . . . . . . . . . . . . . . . . . 28
Giuseppe Ianiri, Cristina Pinedo, Alessandra Fratianni, Gianfranco Panfili and
Raffaello Castoria
Patulin Degradation by the Biocontrol Yeast Sporobolomyces sp. Is an Inducible Process
Reprinted from: Toxins 2017, 9, 61, doi: 10.3390/toxins9020061 . . . . . . . . . . . . . . . . . . . . 45
Ye Tian, Yanglan Tan, Na Liu, Zheng Yan, Yucai Liao, Jie Chen, Sarah de Saeger, Hua Yang,
Qiaoyan Zhang and Aibo Wu
Detoxification of Deoxynivalenol via Glycosylation Represents Novel Insights on Antagonistic
Activities of Trichoderma when Confronted with Fusarium graminearum
Reprinted from: Toxins 2016, 8, 335, doi: 10.3390/toxins8110335 . . . . . . . . . . . . . . . . . . . 57
Yan Zhu, Yousef I. Hassan, Dion Lepp, Suqin Shao and Ting Zhou
Strategies and Methodologies for Developing Microbial Detoxification Systems to
Mitigate Mycotoxins
Reprinted from: Toxins 2017, 9, 130, doi: 10.3390/toxins9040130 . . . . . . . . . . . . . . . . . . . 72
Martina Loi, Francesca Fanelli, Vania C. Liuzzi, Antonio F. Logrieco and Giuseppina Mulè
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Denise Gómez-Espinosa, Francisco Javier Cervantes-Aguilar, Juan Carlos Del Rı́o-Garcı́a,
Tania Villarreal-Barajas, Alma Vázquez-Durán and Abraham Méndez-Albores
Ameliorative Effects of Neutral Electrolyzed Water on Growth Performance, Biochemical
Constituents, and Histopathological Changes in Turkey Poults during Aflatoxicosis
Reprinted from: Toxins 2017, 9, 104, doi: 10.3390/toxins9030104 . . . . . . . . . . . . . . . . . . . 210
J. David Ioi, Ting Zhou, Rong Tsao and Massimo F. Marcone
Mitigation of Patulin in Fresh and Processed Foods and Beverages
Reprinted from: Toxins 2017, 9, 157, doi: 10.3390/toxins9050157 . . . . . . . . . . . . . . . . . . . 224
Yousef I. Hassan, Honghui Zhu, Yan Zhu and Ting Zhou
Beyond Ribosomal Binding: The Increased Polarity and Aberrant Molecular Interactions
of 3-epi-deoxynivalenol
Reprinted from: Toxins 2016, 8, 261, doi: 10.3390/toxins8090261 . . . . . . . . . . . . . . . . . . . 242
Rhoda El Khoury, Isaura Caceres, Olivier Puel, Sylviane Bailly, Ali Atoui, Isabelle P. Oswald,
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Preface to ”Promising Detoxification Strategies to
Mitigate Mycotoxins in Food and Feed”
Mycotoxins have been a threat to mankind for thousands of years. Contaminations of mycotoxins
in food and feed are responsible for many different acute and chronic toxicities, including induction
of cancer, mutagenicity, and many other toxic effects ranging from discomfort to death. With
government regulations and routine monitoring of the food value chain, the risks of mycotoxins
entering our food supplies have significantly reduced. However, due to the ubiquitous nature of
mycotoxin producing fungi and our inability to prevent conditions that favor growth and mycotoxin
production of mycotoxigenic fungi, contaminations of agricultural produce with mycotoxins are
still inevitable under the current agri-food production system. On the other hand, mycotoxins are
generally tolerant to common food cooking and processing, thus, the existing food processes are
not effective in mitigating mycotoxins in food and feed. Annual costs related to the occurrence of
mycotoxins in food and feed are continuing to rise, causing the international economy to lose billions
of dollars. Even more challenging, climate change may alter populations of mycotoxigenic fungi and
increase levels of mycotoxins in crop production. Therefore, innovative strategies and techniques are
critically needed to address the worldwide threat of mycotoxins.
One of such innovations is to mitigate mycotoxins by detoxifications, i.e., to inactivate the toxicity
or to reduce the adverse effects of mycotoxins. After several decades of research on mycotoxin
detoxifications, our understanding started to reach a pinnacle. Detoxifications by biological and
enzymatic means have been intensively researched for almost all major mycotoxins, resulting in a
great number of discoveries, technologies and even some commercial products that can be applied to
reduce the adverse effects of mycotoxins. Moreover, advances in food and feed processing techniques,
coupled with state-of-the-art molecular research tools, are leading the way for optimized empirical
and feasible solutions.
This book correlates papers from a Special Issue of the open access journal, Toxins—Promising
Detoxification Strategies to Mitigate Mycotoxins in Food and Feed. The focus of this book is to look
into the most recent advances related to mitigation of mycotoxin contamination in food and feed
through detoxifications. Collectively, the authors have provided many insights in the development
of mycotoxin detoxifications and addressed certain critical challenges in the applications of such
strategies. The book also provides comprehensive strategies with state-of-the-art tools for the future
research and development in the field of mycotoxin detoxifications. It is my hope that this book
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Mycotoxins are secondary fungal metabolites associated with adverse human health and animal
productivity consequences. Annual costs connected with mycotoxin occurrences in food/feed are
continuing to rise. It is estimated that close to five billion dollars are lost yearly in association with
fungal infections and crop contamination with mycotoxins within the North American region alone.
More recent evaluations valued losses associated with aflatoxin (AF) contaminations within the corn
industry to reach as high as US$1.68 billion annually in the United States [1]. Similarly, the U.S. swine
industry was reported to face current losses (in the form of weight gain reduction) due to fumonisins
contamination in dried distillers’ grain and solubles (DDGS) of $9 million annually [2]. This value
represents only those losses attributable to one mycotoxin on one adverse outcome in one species.
In Europe, deoxynivalenol (DON) is typically found in more than 50% of investigated samples [3].
When 18,884 samples collected between 2007 and 2012 from member-states of the European Union
(EU) and Norway were investigated for mycotoxins, DON was found in 44.6%, 43.5%, and 75.2% of
unprocessed grains, food, and feed samples, respectively [4]. The same pattern is also encountered
in North Asia, with DON being the main contaminant (present in 92% of all tested samples) with
average levels of 1154 ppb (part per billion) [5]. The latest multi-city survey conducted in China on the
occurrence of DON in different cereal-based products indicated that more than 80% of the analyzed
samples were positive with DON levels ranging between 0.1 and 2511.7 μg/kg [6].
After more than five decades of continuous mycotoxin-mitigation research, our understanding
started to reach a pinnacle point where biological and enzymatic means can be used to address such
toxins. Moreover, advances in food and feed processing techniques (such as cold atmospheric pressure
plasma, hot air and infrared rays roasting, neutral electrolyzed water, etc.) coupled with state-of-the-art
molecular research tools are leading the way for optimizing empirical and feasible solutions.
In light of the above facts, the focus of this special issue of Toxins was to look into the most recent
advances related to mitigating mycotoxin contamination in food and feed. Multiple recent microbial
and enzymatic investigations are included and many novel and promising techniques for food/feed
applications are covered.
Wilson et al. [7] reported the screening of plant and soil samples for microorganisms capable
of degrading trichothecenes and eventually identified two mixed cultures consistently decreasing
DON levels through oxidation to 3-keto-DON. Another study screened 43 bacterial isolates
and identified Bacillus shackletonii L7, which is capable of reducing aflatoxin B1 (AFB1), AFB2,
and AFM1 [8] where a thermostable-enzyme enriched in the culture’s supernatant was purified
with an estimated molecular mass of 22 kDa. Moreover, a separate study focused on elucidating how
one bio-control agent, Sporobolomyces sp., targets and degrades patulin (PAT), a commonly encountered
mycotoxin that contaminates apple and cider products [9]. The involved mechanism behind this
microorganism’s ability to degrade PAT was shown to be inducible with a rapid degradation of
PAT, especially when the cells of this agent are exposed to low concentrations of PAT ahead of time.
Furthermore, the mechanism(s) behind the degradation of PAT by another yeast isolate, Pichia caribbica,
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was examined. The collected results indicated the involvement of an enzymatic mechanism [10],
while the rigorous proteomics analysis (with two-dimensional gel electrophoresis) revealed the
upregulation of multiple proteins involved in the cellular metabolism and/or stress response which
could be responsible for PAT degradation at the same time.
The presented special issue additionally reported on expanding the current empirical utilization
of innovative mitigation strategies to control mycotoxins in actual farm settings. The use of neutral
electrolyzed water to prevent aflatoxicosis in Turkey poults was among the promising studies
that were shared by Gómez-Espinosa et al. [11]. As reported, alterations of serum biochemical
constituents, enzyme activities, relative organs weights, and morphological changes associated with
AF(s) were all mitigated by using the described neutral electrolyzed water detoxification procedure.
Another novel investigation led by Bosch et al. scrutinized the use of cold atmospheric pressure
plasma for the degradation of multiple mycotoxins including AAL toxin, enniatin A, enniatin B,
fumonisin B1, sterigmatocystin, DON, T2-toxin, and zearalenone (ZEA) [12]. The results reflected
a significant influence of the involved mycotoxin’s structure in addition to the matrix on the overall
degradation rates. The results collectively indicated the suitability of the introduced approach
for the decontamination of mycotoxins in food commodities where mycotoxins are confined to or
enriched on surfaces such as cereal grains. Roasting with the use of infrared or static hot air was
investigated for its ability to decontaminate AFs in hazelnuts [13]. Both traditional static hot-air
roasting and infrared rays roasting methods were effective (85–95% reduction) when temperatures
of 140 ◦C for 40 min were maintained, but infrared rays proved to be slightly better in this regard.
More importantly, the nutritional quality and lipid profile of all tested hazelnut varieties were not
affected after such roasting. Ultraviolet irradiation was also suggested to reduce AF(s) genotoxicity
and carcinogenicity [14]. In order to define the final by-products of this non-specific degradation
method, especially in edible oils, an Ultra Performance Liquid Chromatograph-Thermo Quadrupole
Exactive Focus Mass Spectrometry/Mass Spectrometry (UPLC-TQEF-MS/MS) approach was used.
The obtained high-resolution mass spectra reflected two main products while the toxicological
evaluations conducted using human embryo hepatocytes indicated that these products had much
lower toxicity than the parental compound, AFB1.
The aqueous extract of hyssop, Micromeria graeca, was shown to halt AFB1 production in
Aspergillus flavus. The observed inhibitory effect was attributed to the downregulation of specific
transcripts within the AF biosynthesis pathway [15]. The proposed approach falls well into green
farming practices aiming at reducing the use of fungicides. Similarly, the ability of curcumin to
prevent AFB1 hepatoxicity was reported. The alleviation in the typical symptoms associated with
AFB1-induced hepatotoxicity due to curcumin inclusion/supplementation was attributed mainly to
the pivotal inhibition of CYP450 isozyme-mediated activation of AFB1 to toxic AFBO [16].
The detailed in silico analysis of a laccase (and two different isoforms) capable of degrading AFB1
and AFM1 was reported in this special issue [17]. This interesting investigation helped in pinpointing
the structural differences among the three studied isoforms and highlighting the most suitable isoform
for future protein engineering approaches.
An exciting report about using Bacillus subtilis ANSB060 to ameliorate the negative effects of AFs
in ducks is presented [18]. The bacterium was originally isolated from fish gut and showed the ability to
protect the growth performance of Cherry Valley ducks fed with moldy maize naturally contaminated
with AFs. In a parallel fashion, the ability of Bacillus licheniformis CK1 to protect post-weaning gilts
from ZEA-contaminated feed was demonstrated. The capability of this bacterium to degrade ZEA
was associated with the reported protection mechanism [19]. Finally, the ability of sporoderm-broken
spores of Ganoderma lucidum to enhance the immune function and maintain the growth performance of
broiler chickens exposed to AFB1 was detailed. The results showed that diets contaminated with a low
level of AFB1 can be consumed without any negative consequences as long as they are supplemented
with the sporoderm-broken spores of G. lucidum [20]. Moreover, the introduced treatment was able to
restore the normal levels of IgA and IgG in the serum of chickens exposed to AFB1.
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The enzymatic modifications of DON occupied a considerable part of this issue, particularly
the C3 chemical group modifications. First, Tian et al. suggested that the glycosylation of this
group is part of the self-protection mechanism(s) possessed by multiple Trichoderma strains serving
as antagonists towards Fusarium graminearum growth [21]. Similarly, Hassan et al. [22] explored the
epimerization of the above group (C3) and its influence on the molecular interactions of DON and its
C3 stereoisomer (3-epi-DON) with well-defined enzymes such as Tri101 acetyltransferases to conclude
that the associated changes within the involved –OH group not only influence DON’s toxicity but also
increase the overall polarity of this toxin as well as changing its acetylation patterns [22].
This issue also encompasses some excellent in-depth reviews. The review shared by Loi et al.
covered mycotoxins biotransformation by native and commercial enzymes [23], covering purified
enzymes isolated from bacteria, fungi, and plants with validated potentialities using in vitro and
in vivo methods and setting examples for applications in food, feed, biogas, and biofuel industries.
Zhu et al. brought attention to the most recent strategies and methodologies for developing microbial
detoxification systems to mitigate mycotoxins [24], highlighting the tremendous and unexpected
challenges facing any progress in this regard including the isolation of single colonies harboring the
reported biotransformation activity and the assessment of the cellular toxicity of final biotransformation
by-products. The review prepared by Hojnik et al. was dedicated to explore the use of cold atmospheric
pressure plasma to decontaminate mycotoxins [25], presenting the advantages of this approach
(cost efficiency, ecologically-friendly, negligible influence on food quality and attributes) which may
overcome many weaknesses associated with the conventional/classical methods of inactivation.
Finally, the mitigation of PAT in fresh and processed food commodities including beverages was
discussed by Ioi et al. in a separate review [26] that covered the pre-processing stage (storage conditions,
use of fungicides, and the physical removal of fungi and infected tissues). The review further detailed
the effects of common processing techniques (including pasteurization, filtration, and fermentation) on
PAT and reviewed non-thermal methods (such as high hydrostatic pressure, UV radiation, enzymatic
degradations, and binding to microorganisms) to remove or detoxify PAT.
Overall, we are thrilled to present the above genuine contributions with the diligent work of many
involved teams that collectively aimed at addressing some of the main challenges that remain within
the mycotoxin-mitigation arena using both integrative and innovative approaches. The promising
outcomes of this research focus create a foundation to use recombinant enzymes/proteins for the
detoxification of many agriculturally-important mycotoxins, including AFs, PAT, and DON. Moreover,
the use of innovative processing techniques (such as infrared roasting, non-ionizing radiations,
cold atmospheric pressure plasma, and neutral electrolyzed water) will greatly enhance the safety of
numerous food/feed commodities with diverse physical attributes/chemical compositions.
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Abstract: The trichothecene mycotoxin deoxynivalenol (DON) is a common contaminant of wheat,
barley, and maize. New strategies are needed to reduce or eliminate DON in feed and food products.
Microorganisms from plant and soil samples collected in Blacksburg, VA, USA, were screened by
incubation in a mineral salt media containing 100 μg/mL DON and analysis by gas chromatography
mass spectrometry (GC/MS). Two mixed cultures derived from soil samples consistently decreased
DON levels in assays using DON as the sole carbon source. Nuclear magnetic resonance (NMR)
analysis indicated that 3-keto-4-deoxynivalenol was the major by-product of DON. Via 16S rRNA
sequencing, these mixed cultures, including mostly members of the genera Acinetobacter, Leadbetterella,
and Gemmata, were revealed. Incubation of one of these mixed cultures with wheat samples naturally
contaminated with 7.1 μg/mL DON indicated nearly complete conversion of DON to the less toxic
3-epimer-DON (3-epi-DON). Our work extends previous studies that have demonstrated the potential
for bioprospecting for microorganisms from the environment to remediate or modify mycotoxins for
commercial applications, such as the reduction of mycotoxins in fuel ethanol co-products.
Keywords: mycotoxin; trichothecene; deoxynivalenol; bioprospecting; detoxification; Fusarium
1. Introduction
Mycotoxins are toxic secondary metabolites produced by fungi that are a threat to the health
of humans and domestic animals [1]. This diverse class of compounds can contaminate commercial
foods (e.g., wheat, maize, peanuts, cottonseed, and coffee) and animal feedstocks. Mycotoxins can
be harmful even at small concentrations, creating significant food safety concerns [1,2]. The Food
and Agriculture Organization estimated that approximately 1 billion metric tons of food is lost
each year due to mycotoxin contamination [3]. Economic losses include yield loss from mycotoxin
contamination [4], reduced value of crops [4], loss of animal productivity from health issues related to
mycotoxin consumption [5], and even animal death [6,7].
The trichothecenes are a major class of mycotoxins containing over 150 toxic compounds and are
toxic inhibitors of protein synthesis [8,9]. Trichothecenes are produced by several different fungi in
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the genus Fusarium [9,10]. One of the most economically important trichothecenes is deoxynivalenol
(DON), which contaminates wheat, barley, and maize worldwide [11]. DON causes feed refusal, skin
disorder, diarrhea, reduced growth, and vomiting in domestic animals [12]. Depending on the dose
and exposure time of DON, there is also evidence that DON acts as an immunosuppressive [1]. It is
among the most closely monitored mycotoxins in the US, and DON contaminations have resulted in
estimated annual losses of up to $1.6 billion [13].
While there is structural variety, all trichothecenes share a core structure that includes the C-12,13
epoxide that is important to toxicity and protein inhibition [14,15]. DON is a type B trichothecene
characterized by the presence of a keto group on C-8 [16]. There are mechanisms the fungus Fusarium
implements during the biosynthesis of DON to alter the structure, making it less toxic, e.g., acetylating
the C-3 position [16].
Microbial detoxification of mycotoxins has previously been reported [17,18]. Fuchs et al. [19]
were able to isolate an anaerobic eubacterium that converted DON to de-epoxy-DON. A few years
later, Völkl and colleagues [20] reported that a mixed culture of organisms from soil samples
converted DON to 3-keto-4-deoxynivalenol (3-keto-DON), but they were unable to identify the causal
microorganisms responsible for the modification. The product 3-keto-DON is approximately 90% less
toxic than DON, and represents a suitable detoxified product [21]. Shima et al. [21] discovered a single
organism in aerobic conditions from an environmental sample that converted DON into 3-keto-DON,
and He et al. [22,23] isolated an aerobic organism, from the genus Devosia, converting DON to
3-epimer-DON (3-epi-DON). Ikunaga et al. [24] identified a bacterium from the genus Nocardioides that
converts DON to 3-epi-DON. Recently, He et al. [25] discovered an aerobic culture of microorganisms
converting DON to de-epoxy-DON. The current study extends these prior investigations to a series of
studies to isolate additional microorganisms from the environment that modify and remediate DON.
While others have shown that soil bacteria can detoxify DON, the functional enzyme(s) responsible for
conversion to 3-keto-DON remains elusive. Once the enzymatic mechanism(s) and genetic element(s)
responsible are identified, yeast can be engineered to remediate DON during a fermentation process
involving mycotoxin-contaminated feedstocks.
Based on previous work [21–25], we hypothesized that mixed cultures of microorganisms isolated
from natural soil environments incubated with a mineral salt media using 100 μg/mL DON as
the sole carbon source will detoxify DON. The specific objectives of this research were as follows:
(1) identify microbes isolated from plant and soil samples taken in Blacksburg, VA, that modify DON;
(2) characterize DON metabolites using thin layer chromatography (TLC), gas chromatography mass
spectrometry (GC/MS), and nuclear magnetic resonance (NMR); (3) identify bacterial components
of mixed cultures with DON modification activity; and (4) determine if these microorganisms can
modify DON in naturally contaminated wheat samples. Our work extends previous studies that have
demonstrated the potential for bioprospecting for microbes that modify toxic secondary metabolites
from grains and/or grain products, such as the reduction of mycotoxins in fuel ethanol co-products.
2. Results
2.1. Selection of Microbes in the Presence of High Concentrations of DON
An initial screen of 11 plant and soil environmental samples incubated in mineral media containing
100 μg/mL DON as the sole carbon source identified five cultures in which no DON remained after
7 days. These five mixed culture samples that eliminated DON from the culture media (below the
limit of quantification (<LOQ), which was 0.2 μg/mL) came from soil samples taken from a landscape
plot, vineyard, and peach orchard and from plant samples taken in a small grain field and a vineyard.
With further subculturing, three mixed culture samples had decreased DON levels in the culture
media (Table S1), all of which were derived from the landscape plot. Only two samples from the
landscape plot, Mixed Cultures 1 and 2 (Figure S1), consistently removed/modified DON in the
culture media. Further assays with Mixed Cultures 1 and 2 (Table 1) suggested that the glycerol stocks
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were heterogeneous and likely contained mixtures of culturable and unculturable microbes; four
sample replicates from Mixed Cultures 1 and 2 did not perform the same and had varying amounts of
DON modification based on percentage of DON modified in each culture (Table 1). Mixed Culture 3
replicates did not modify DON and thus were not studied further.
Table 1. DON modification by soil mixed cultures. Four sample replicates from Mixed Culture 1, 2,








Mixed Culture 1-R1 1 0.16 0.16 0.16
Mixed Culture 1-R2 2 2.48 2.72 2.6
Mixed Culture 1-R3 3 3.12 3.04 3.08
Mixed Culture 1-R4 4 2.72 2.68 2.7
Mixed Culture 2-R1 1 <0.2 <0.2 <0.2
Mixed Culture 2-R2 2 4.32 3.8 4.06
Mixed Culture 2-R3 3 <0.2 <0.2 <0.2
Mixed Culture 2-R4 4 <0.2 <0.2 <0.2
Mixed Culture 3-R1 1 3.92 3.8 3.86
Mixed Culture 3-R2 2 3.92 3.76 3.84
Mixed Culture 3-R3 3 4.08 3.8 3.94
Mixed Culture 3-R4 4 3.28 3.64 3.46
Control-R1 1 4.46 4.48 4.47
Control-R2 2 4.48 4.28 4.38
Control-R3 3 3.84 4.04 3.94
2.2. Isolation of Individual DON Modifying Microbes
There were two pure cultures, Pure Cultures 1 and 2 from Table S1, of bacteria that were initially
associated with decreased levels of DON within culture media. Pure Culture 1 originated from the
small grain field, and Pure Culture 2 originated from the landscape plot. Via 16S rRNA sequencing, it
was revealed that Pure Culture 1 was from the genus Achromobacter, and the Pure Culture 2 was from
the genus Pseudomonas. However, additional DON assays indicated that both Pure Cultures 1 and 2
did not consistently modify DON (data not shown). The two pure cultures were inconsistent in their
ability to eliminate DON from culture media, although preparation and culture conditions remained
the same.
2.3. Identification of Mixed Cultures Using 16S Ribosomal Sequencing
Sequencing of 16S of Mixed Cultures 1 and 2, which consistently modified DON, indicated that
they contained mostly members of the genera Acinetobacter, Leadbetterella, and Gemmata (Figure 1).
Mixed Culture 1 consisted of members of the genera Acinetobacter, while Mixed Culture 2 was
composed mostly of the genera Leadbetterella, and Gemmata. Mixed Culture 1-R1 was the only culture
able to modify DON in culture media (Figure 1a). Mixed Culture 1-R1 was composed mostly of the
genera Acinetobacter and Candidatus. Mixed Culture 2-R1, Mixed Culture 2-R3, and Mixed Culture 2-R4
modified DON (Figure 1b). Mixed Culture 2-R2 was unable to modify DON in culture media and was
the only culture that contained a large amount of Burkholderia.
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(a) 
(b) 
Figure 1. 16S rRNA sequencing data for within sample repetitions of (a) Mixed Culture 1 and (b) Mixed
Culture 2. Each plot graph illustrates the major genera represented in each sample in accordance with
number of reads resolved from sequencing. In (a) Mixed Culture 1-R1 was the only culture that was
able to modify DON from the culture media. In (b) Mixed Culture 2-R1, Mixed Culture 2-R3, and
Mixed Culture 2-R4 were able to modify DON from the culture media.
2.4. Thin Layer Chromatography to Identify DON Derivatives
TLC analysis of extracts of Mixed Cultures 1 and 2 showed a DON by-product that was less polar
than DON, 15-ADON, and 3-A-DON (Figure 2). Mixed Cultures 1 and 2 by-products showed similar
properties to 3-keto-DON, which is nonpolar and migrated further up the TLC plate. Mixed Cultures 1
and 2 by-products were also dissimilar to the acetylated versions of DON, 15-A-DON, and 3-A-DON.
The product turned blue with NBP/TEPA, indicating that it contained an epoxide, and had a similar
Rf (retention factor) as 3-keto DON.
 
Figure 2. TLC analysis of DON by-products and controls. Lane 1: Mixed Culture 1; Lane 2: Mixed
Culture 2; Lane 3: DON; Lane 4: 3-keto-DON and DON mixture; Lane 5: 15-A-DON; Lane 6: 3-A-DON:
and Lane 7: De-epoxy-DON.
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2.5. Nuclear Magnetic Resonance to Identify Structure of DON Derivatives
NMR analysis showed that both the DON by-product in both Mixed Culture 1 and Mixed Culture
2 was 3-keto-deoxynivalenol (3-keto-DON) (Table S2). The 3-keto-DON proton closely resembled that
reported by Shima et al. [21].
2.6. DON Assays with Mixed Cultures with Naturally Contaminated Wheat Samples
DON assays using Wheat Sample #13w-7 (41.0 μg/mL) did not show any DON reduction with
Mixed Cultures 1 or 2. DON reduction was observed with Wheat Sample #13-v193 (7.1 μg/mL DON).
In particular, two samples from Mixed Culture 1 (Sample ID 2 and Sample ID 3 in Table 2) showed
nearly complete DON reduction compared to the control. Figure 3 shows a GC/MS chromatogram
overlay of the DON control and Sample ID 2 from Mixed Culture 1, where significant DON reduction
was observed. The DON peak had a retention time of 6.12 min, and the new peak at 6.33 min is
postulated to be 3-epi-DON based on molecular weight and fragmentation. According to He et al. [22],
3-epi-DON is significantly less toxic than DON. However, Ikunaga et al. [24] suggest that 3-epi-DON
may still be just as toxic as DON since the epoxide ring is still present. DON and the postulated
3-epi-DON were detected in SIM mode with a target ion with a mass/charge ratio of 512.3 and had
reference ions at 422.4 and 497.3.
Table 2. Grain culture extracts from naturally contaminated Wheat Sample #13v-193 (7.1 μg/mL
DON) incubated with Mixed Cultures 1 and 2 were analyzed using GC/MS. Two separate assays were
performed at different times with three replicates for Mixed Cultures 1 and 2 and the control. Sample
ID 2 from Mixed Culture 1 in the first assay using Wheat Sample #13v-193 showed significant DON
reduction compared to the negative control (below the limit of quantification, which is 0.20 μg/mL).
Sample ID Culture ID Assay Replicate Starting DON (μg/mL) in Wheat Final DON (μg/mL) in Wheat
1 Mixed Culture 1 1 1 7.10 5.08
2 Mixed Culture 1 1 2 7.10 <0.20
3 Mixed Culture 1 1 3 7.10 0.08
4 Mixed Culture 1 2 1 7.10 7.04
5 Mixed Culture 1 2 2 7.10 7.76
6 Mixed Culture 1 2 3 7.10 5.88
4.3 (mean)
7 Mixed Culture 2 1 1 7.10 4.0
8 Mixed Culture 2 1 2 7.10 6.4
9 Mixed Culture 2 1 3 7.10 3.48
10 Mixed Culture 2 2 1 7.10 7.56
11 Mixed Culture 2 2 2 7.10 7.88
12 Mixed Culture 2 2 3 7.10 7.28
6.1 (mean)
Control Control (no cultures) 7.10 (mean)
Figure 3. GC/MS chromatograph of DON derivatives in scan operating mode from Sample ID 2 in
Table 2 (Mixed Culture 1, Wheat Sample #13w-7, 7.1 μg/mL DON). DON (grey line; retention time of
6.12 min) was modified to 3-epi-DON (black line; retention time of 6.33 min).
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3. Discussion
New strategies are needed to reduce or eliminate DON in feed and food products. DON degrading
activity restricted to anaerobic organisms limits the potential use of these microorganisms for industrial
purposes as feed additives. Aerobic organisms pose their own problems, as many valuable organisms
are unculturable in the lab. Even though culturing aerobic organisms from the environment can
be tedious, Shima et al. [21] discovered Strain E3-39, which can convert DON into 3-keto-DON
under aerobic conditions, and He et al. [25] discovered a microbial culture that converted DON
to de-epoxy-DON. Here, we extend these prior studies by isolating mixed microbial cultures from
the environment that modify DON, characterizing their DON derivatives, and characterizing the
microorganisms present in cultures that modify DON.
Two mixed cultures that consistently decreased DON in cultures, in which DON was the sole
carbon source in a minimal medium, were identified. From these mixed cultures, we were unable to
isolate a pure culture that modified DON consistently in culture media. Several bacteria and fungal
colonies were initially selected and screened for DON modification, but only two bacteria eliminated
DON from cultures containing DON as the sole carbon source. These two bacteria, an Achromobacter
and Pseudomonas species, were not consistent in eliminating DON from cultures. This inconsistency
could be due to the cultures being stored in glycerol stocks at −80 ◦C, since the cold temperatures may
have affected their ability to modify DON. Völkl et al. [20] also were unable to identify a pure organism
from the mixed culture (D107) that consistently modified DON. Isolating pure cultures remains a
challenge, as multiple microorganisms could be responsible for the metabolism or conversion of DON.
According to Shima et al. [19], 3-keto-DON is significantly less toxic than DON. Proton data
from Mixed Cultures 1 and 2 were similar to 3-keto-DON reported by Shima et al. [21]. There is a
discrepancy in the literature regarding proton data for 3-keto-DON reported by Völkl et al. [20]; the
authors appear to have inadvertently switched some of the proton data for DON with the proton data
for 3-keto-DON.
Results from 16S rRNA sequencing of Mixed Cultures 1 and 2, which consistently modified
DON, indicated that they contained mostly members of the genera Acinetobacter, Leadbetterella, and
Gemmata. To our knowledge, these genera have not been reported previously to modify DON in
culture. Strains of Acinetobacter have been associated with the modification of ochratoxin A [26].
He et al. reported Pseudomonas and Achromobacter genera in their microbial culture that converted
DON to de-epoxy-DON; the two pure cultures we isolated that demonstrated activity in DON cultures
could have lost functionality during storage in glycerol stocks at −80 ◦C. Isolating DON modifying
microbes is difficult, in part due to growth and function restrictions since some microbes may be
inhibited by others [27]. Several microorganisms are likely responsible for the conversion of DON to
3-keto-DON, and with additional testing and analysis it may be possible to isolate the specific bacteria
responsible for DON modification.
DON was nearly eliminated in two naturally contaminated samples of wheat (7.1 μg/mL DON)
inoculated with Mixed Culture 1. GC/MS scans of the two samples showed the appearance of a peak
with a similar mass/charge ratio as DON, but different retention times. This was postulated to be the
DON metabolite, 3-epi-DON. A reduction of DON was not observed with the samples contaminated
with a higher concentration of DON (41 μg/mL). The observed differences in the modification of DON
in the assay with DON as the sole carbon source and the assay using naturally contaminated sources
of wheat could be attributed to the naturally contaminated sources of wheat cultures containing
additional carbon sources for the microbes to utilize. He et al. [28] were able to produce 3-epi-DON
with their strain of Devosia with different carbon sources such as corn meal broth and a mixture of
yeast and glucose. 3-Epi-DON may have been produced from our naturally contaminated sources of
wheat, since 3-keto-DON may be further reduced to produce 3-epi-DON [29].
Our work extends previous studies that have demonstrated the potential to use mixed cultures
of microbes to detoxify DON. Future work to assess how microbial assemblages change before,
during, and after screening with DON will highlight what microorganisms are selected for under
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the pressure of DON. Additional work needs to be done to culture specific microorganisms that
are unable to grow under the test conditions to greatly increase the probability of identifying an
organism that can detoxify DON (e.g., the use of the iChip to identify the new antibiotic allowing
scientists to screen for new microbes that are difficult to culture or unculturable with traditional
laboratory practices) [30]. However, the transformation of DON to 3-keto-DON and to 3-epi-DON with
our mixed cultures demonstrates the feasibility of our approach. Future work will aim to elucidate
enzymes responsible for modification of DON as Chang et al. did by modifying ochratoxin A using a
carboxypeptidase enzyme from the species Bacillus amyloliquefaciens ASAG1 [31]. Engineering yeast
that express DON-detoxifying enzymes and/or adding purified enzymes that can convert DON to
less toxic by-products will be of value in the fuel ethanol industry, where such strategies could reduce
mycotoxins in fuel ethanol by-products destined for feed and food [27].
4. Materials and Methods
4.1. Field Collections
Plant and soil samples were collected at Virginia Tech’s Kentland Farm in Blacksburg VA, USA,
on 13 September 2013. Microbial samples were collected from fresh leaves or plant debris, and from
soil samples collected with a soil corer (10 × 1 in. diameter galvanized steel soil sampler, Zoro). Eleven
samples were collected from six different collection sites including a field of oat (Avena sativa), a field
of corn (Zea mays), a landscape plot, a vineyard (Vitis vinifera), a peach orchard (Prunus persica), and an
apple orchard (Malus domestica).
4.2. Selection of Microbes in the Presence of High Concentrations of DON
Plant samples were ground into a fine powder using a coffee grinder (Hamilton Beach, Model
80365, Southern Pines, NC, USA). Soil samples were placed in one-gallon zip lock bags and mixed
thoroughly to displace soil clumps. Aliquots of 0.1 g of each sample were suspended in 1 mL of
mineral salt medium (MM) [32] containing 100 μg/mL of DON as the sole carbon source. A negative
control included 1 mL MM and 100 μg/mL DON without any environmental samples. Cultures were
incubated on a shaker (New Brunswick Scientific Excella E-24 Incubator Shaker, Edison, NJ, USA)
for 7 days at 120 RPM and 28 ◦C. After 7 days, 10 μL of each culture was added to 1 mL of MM and
100 μg/mL of DON and incubated for another 7 days under the same conditions. This process of
subculturing and incubation was repeated four additional times for a total of six weeks.
Resulting cultures were screened for the disappearance of DON using gas chromatography/mass
spectrometry (GC/MS) following standard protocols [33]. Each sample was diluted by adding 100 μL
of culture to 1.9 mL of sterile water before GC/MS analysis; 250 μL of the dilution was added to
1.7 mL of acetonitrile and filtered through Whatman 1 qualitative paper. A 1 mL portion of the
flow through was dried down in a glass tube using compressed air in a nitrogen evaporator set
at 55 ◦C. Dried samples were then derivatized at room temperature with a mixture of 99 μL of
N-trimethylsilylimidazole (TMSI) and 1 μL of trimethylchlorosilane (TMCS) for 20 min. Then, 500 μL
of isooctane containing 0.5 μg/g of mirex (Sigma-Aldrich, St. Louis, MO, USA) was added to the glass
tube and immediately vortexed, followed by an addition of 500 μL of water to quench the reaction.
From the top organic layer, 150 μL was transferred to chromatography vials for GC/MS analysis.
An Agilent 6890/5975 system was used for GC/MS analysis operating in selected ion monitoring
(SIM) mode. An autosampler in splitless mode injected 1 μL of each sample onto an HP-5MS column
(0.25 mm inner-diameter, 0.25 μm film thickness, 30 m length) to detect DON. The inlet temperature
was set at 280 ◦C with a column flow rate of 1.2 mL/min using helium. The initial column temperature
was held at 150 ◦C for 1 min, increased to 280 ◦C at a rate of 30 ◦C/min, and held constant for 3.5 min.
A post-run of 325 ◦C for 2.5 min was used to clean the column. DON was detected in SIM mode at a
mass/charge ratio of 512.3 and had reference ions at 422.4 and 497.3. Mirex (hexachloropentadiene
dimer) was used as an internal standard to check the quantitative precision of the instrument and was
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detected in SIM mode at a mass/charge ratio of 271.8 and had a reference ion of 275.8 [34]. A linear
regression model was used to quantify DON with standards (Romer Labs, Austria and Sigma-Aldrich,
St. Louis, MO, USA) at concentrations of 0.05, 0.10, 0.25, 0.5, 1.0, 2.50, and 5.0 μg/mL. Mycotoxin
values were quantitated using a standard curve ranging from 0.05 to 1.0 μg/mL. Values determined
to be greater than 1.0 μg/mL were quantitated using a curve that included the 2.5 and 5.0 μg/mL
standards. The LOQ for the method was determined to be 0.2 μg/mL, based on standard protocols [33].
All cultures showing decreased levels of DON were transferred to 25% glycerol and stored at −80 ◦C.
Each culture that demonstrated decreased levels of DON were then further analyzed 4X
(quadruplicate) to show consistency of decreased DON in culture assays with 100 μg/mL DON.
A 50 μL sample of the glycerol stocks mentioned above were cultured into four separate tubes of R2A
(Reasoner’s 2A; a medium for culturing slow-growing microorganisms; Sigma-Aldrich) liquid media
for 2 days at 28 ◦C. After incubation, 100 μL of each culture was then added to a new culture tube
containing 1 mL MM and 100 μg/mL DON and allowed to incubate with shaking at 120 RPM at 28 ◦C
for 7 days. Mycotoxin extraction and GC/MS analysis described above was used to determine the
amount of DON in each sample. All samples were made into a 25% glycerol stock and stored at −80 ◦C
for future identification of microbes present.
4.3. Isolation of Individual DON Modifying Microbes
Mixed cultures that resulted in decreased levels of DON were selected and 200 μL of each culture
was plated on solid R2A media and incubated for 7 days at 28 ◦C. After incubation, bacterial and
fungal colonies of different morphologies were randomly selected and cultured in 1 mL of MM and
100 μg/mL DON for 7 days with shaking at 120 RPM at 28 ◦C. GC/MS preparation and analysis as
described above was used to determine the concentration of DON in each sample after incubation.
All pure cultures that demonstrated decreased levels of DON were made into a 25% glycerol stock and
stored at −80 ◦C. Individual microbes that demonstrated decreased levels of DON were sequenced
using 16S primers (27F and 518R bacterial 16S ribosomal primers) at the Biocomplexity Institute at
Virginia Tech (Blacksburg, VA, USA).
4.4. Identification of Mixed Cultures Using 16S Ribosomal Sequencing
To assist in the identification of the microorganisms present in mixed cultures, 100 μL of frozen
stock from the mineral media cultures with 100 μg/mL DON was incubated in 2 mL of R2A liquid
media for 2 days at 28 ◦C. DNA from the mixed cultures was purified using a Thermo Scientific
KingFisher mL nucleic acid purification machine (Thermo Scientific, Waltham, MA, USA) and Qiagen
Puregene Yeast/Bac Kit B (Qiagen, Germantown, MD, USA). Samples of 40 ng/μL suspended in water
were sent to MR DNA Laboratory in Shallowwater, Texas, for a diversity assay with 16S sequencing
using the 27F primer. Illumina sequencing technology was used to generate an average of 20 K reads.
4.5. Thin Layer Chromatography to Identify DON Derivatives
Thin layer chromatography (TLC) was used to detect new DON products in mixed culture
extracts (GC/MS analysis of TMS-derivatized samples run in SIM mode was used to measure the
disappearance of DON). Samples were dried down using compressed air in the fume hood, and
200 μL of acetonitrile was then added and vortexed to ensure the DON derivatives were dissolved.
Each sample was spotted 1 in. from the bottom of a 20 × 20 cm silica gel plate (60-F254, Millipore,
Darmstadt, Germany). The plate was placed in a TLC tank (L × H × W 27.10 cm × 26.5 cm × 7.10 cm)
using 48:92:10 hexane/ethyl acetate/methanol as the solvent. The solvent was allowed to run to
approximately 3 cm away from the top of the plate. The plate was dried in a fume hood, then sprayed
with NBP (nitrobenzylpyridine), heated for 30 min at 100 ◦C, and then lightly sprayed with TEPA
(tetraethylenepentamine). Products that contained an epoxide group were stained blue [35].
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4.6. Nuclear Magnetic Resonance to Identify Structure of DON Derivatives
In order to obtain sufficient product for nuclear magnetic resonance (NMR) analysis, samples were
assayed in 10 mL of MM containing 100 μg/mL DON to produce enough by-product, incubated for one
week with shaking at 28 ◦C, and were subsequently dried down using air. The residue was dissolved in
200 μL of acetonitrile and streaked on TLC plates as described above. Bands were visualized under UV
light, marked with a pencil, and scraped off using a razor blade and placed in a glass vial. Deuterated
chloroform was added to each vial and vortexed. 1H NMR spectra were recorded on a Bruker Avance
II (500 Mhz) equipped with a Prodigy cryoprobe. Chemical shifts were referenced to residual proton
signal of the CDCl3 solvent. MNova 11 was used to analyze the 1H data.
4.7. DON Assays with Mixed Cultures with Naturally Contaminated Wheat
Two wheat (Triticum aestivum) samples naturally infected by Fusarium graminearum and containing
different concentrations of DON were used: Sample #13v-193 (7.1 μg/mL DON) and Sample #13w-7
(41.0 μg/mL DON). GC/MS methods were used to determine the concentrations of DON present
in the samples. Samples were ground to a fine powder using a Stein mill (Steinlite Corp., Atchison,
KS, USA).
To prepare for the assays, 50 μL of the mixed cultures were added to 2 mL of R2A liquid media
and allowed to incubate for 2 days at 120 RPM and 28 ◦C. A 1.0 g sub-sample of each wheat sample
was added to a 125 mL flask topped with a foam stopper (21–26 mm) and autoclaved on a dry cycle.
Under sterile conditions, 4.5 mL of sterile water was added to each flask and 500 μL of each mixed
culture was added to three flasks of each wheat sample, Sample #13v-193 and Sample #13w-7. Negative
controls for each wheat sample were included without any mixed culture and only 5 mL of sterile
water. All flasks were incubated for one week at 180 RPM and 28 ◦C. To analyze DON concentration
after incubation, each sample was dried down in an oven set at 55 ◦C. Each 1.0 g sample was combined
with 8 mL of an 84% (v/v) acetonitrile in DI water to extract DON, sonicated to release any clumps,
then placed on a shaker at 200 RPM overnight at room temperature. The solvent was then cleaned
by passing it through a column consisting of a 1:3 ratio of a 1.5 g mixture of C18 (40 um particle size)
and aluminum oxide (active, neutral, 0.063 to 0.200 mm particle size range). An aliquot of 1 mL of the
eluent was added to a glass test tube, dried and evaporated using a nitrogen evaporator set at 55 ◦C.
Derivatization of samples was performed as described above and GC/MS analysis was performed
operating in scan mode analyzing from 5.7 to 8.8 min; all other parameters of the GC/MS method was
kept the same as described above.
Supplementary Materials: The following are available online at www.mdpi.com/2072-6651/9/4/141/s1,
Table S1: Mixed and pure microbial samples, derived from either soil or plant material, that initially eliminated
DON from cultures containing mineral media and 100 μg/mL of DON as the sole carbon source (GC/MS analysis
indicated a value below the limit of quantification). Not all cultures were consistent at modifying DON in repeated
assays. The percent of time each culture eliminated DON from the culture medium was based on how many
times each culture eliminated DON from the culture over how many times each culture was assayed. Both mixed
culture 1 and mixed culture 2 will modify DON in culture material 77% of the time they are assayed, Figure S1:
GC/MS chromatogram of mixed culture 2 (7.7 min; detected in SIM mode with a target ion with a mass:charge
ratio of 438.2 and reference ions at 318.2 and 303.1) after incubation in mineral media with 100 μg/mL of DON as
the sole carbon source. DON is represented by the peak at 6.1 min. The DON incubated with mixed culture 2 was
below the limit of detection of 0.20 μg/mL. Table S2: Proton data collected with a Bruker, Avance II, 500 MHz
NMR for mixed culture 1 and DON. Proton data for 3-keto-DON was produced by Shima et al. [19]. Comparison
of proton data for mixed culture 1 products with DON and 3-keto-DON confirm that mixed culture 1 contained
3-keto-DON. Proton data for mixed culture 2 was similar to mixed culture 1 (data not reported).
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Abstract: Zearalenone (ZEA), an estrogenic mycotoxin, is mainly produced by Fusarium fungi.
In this study, Bacillus licheniformis CK1 isolated from soil with the capability of degrading ZEA was
evaluated for its efficacy in reducing the adverse effects of ZEA in piglets. The gilts were fed one of
the following three diets for 14 days: a basic diet for the control group; the basic diet supplemented
with ZEA-contaminated basic diet for the treatment 1 (T1) group; and the basic diet supplemented
with fermented ZEA-contaminated basic diet by CK1 for the treatment 2 (T2) group. The actual
ZEA contents (analyzed) were 0, 1.20 ± 0.11, 0.47 ± 0.22 mg/kg for the control, T1, and T2 diets,
respectively. The results showed that the T1 group had significantly increased the size of vulva and
the relative weight of reproductive organs compared to the control group at the end of the trial.
The T1 group significantly decreased the concentration of the luteinizing hormone (LH) compared
with the control and T2 groups. Expression of ERβ was significantly up-regulated in the T2 group
compared with the control. In addition, expression of ERβ was not different between the control and
the T1 group. In summary, our results suggest that Bacillus licheniformis CK1 could detoxify ZEA in
feed and reduce the adverse effects of ZEA in the gilts.
Keywords: Bacillus licheniformis CK1; zearalenone (ZEA); serum hormones; estrogen receptor (ER);
post-weaning female piglets
1. Introduction
Mycotoxins are toxic secondary metabolites produced by a range of fungi, especially from
Fusarium, Aspergillus, and Penicillium genera [1]. Mycotoxins pose great risks to the health of animals
as well as humans. The ingestion of mycotoxin-contaminated feed by animals results in mycotoxin
accumulation in different organs or tissues, endangering animal health or entering into the food chain
through meat, milk, or eggs [2]. Humans get directly exposed to mycotoxins as a result of eating
contaminated crops, or indirectly exposed by consuming contaminated animal products. In addition,
the absorption of mycotoxins can be via respiratory or dermal exposure [3–5]. Over 400 mycotoxins
have been identified, but thousands of mycotoxins may exist [6]. The number of mycotoxins could
be changed according to a newly proposed definition of mycotoxins [7]. The new definition states
that something is a mycotoxin if and only if it is a secondary metabolite produced by microfungi,
posing a health hazard to human and vertebrate animal species by exerting a toxic activity on human
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or vertebrate animal cells in vitro with 50% effectiveness levels <1000 μM [7]. Of these, zearalenone
(ZEA) is one of the most important mycotoxins for its global incidence and toxicity [8].
Zearalenone—a phenolic resorcyclic acid lactone—has good thermal stability and low solubility
in water, but is highly soluble in organic solvents. Zearalenone is particularly toxic to the reproductive
system, resulting in uterine enlargement, alterations to the reproductive tract, reduced litter size,
increased embryo lethal resorption, decreased fertility, and changed progesterone (PRG) and estradiol
(E2) plasma levels in laboratory animals [9]. ZEA and 17β-estradiol have similar structures,
and both competitively bind to estrogen receptors (ERs). ZEA can activate the transcription of
estrogen-responsive genes [10,11]. The estrogenic effects of ZEA are particularly pronounced in the
reproductive system of pigs [12].
The Food and Agriculture Organization of the United Nations (FAO) has estimated that
approximately 25% of the world’s agricultural products are contaminated with mycotoxins, resulting in
significant economic loss due to their impact on human health, trade, and animal productivity [13].
Streit et al. analyzed 13,578 samples of feed and feed raw materials for contamination with ZEA
from all over the world over a period of eight years (January 2004–December 2011), and found that
36% of samples were positive for ZEA [14]. Among the positive samples, the average concentration
and the maximum concentration were up to 101 μg/kg and 26,728 μg/kg, respectively [14]. Thus,
detoxification strategies for contaminated feeds for animals are needed to reduce or eliminate the toxic
effects of ZEA in order to improve food safety, prevent economic losses, and reclaim contaminated
products. Numerous physical and chemical detoxification methods have been tried, including chemical,
physical, and biological approaches. Among them, biological transformations (including the use of
microorganisms to breakdown ZEA) are the least studied and may provide an effective means to
manage this mycotoxin. Microorganisms in the Bacillus genus are considered as probiotics and have
been shown to effectively degrade ZEA in vitro. For example, Tinyiro et al. found that B. subtilis 168
and B. natto were efficient in the removal of more than 75% of ZEA from the liquid medium [15],
whereas Cho et al. reported that a B. subtilis strain degraded 99% of ZEA in the liquid medium [16].
Moreover, Yi et al. isolated a strain of Bacillus licheniformis CK1 from soil samples and found that this
strain was capable of degrading ZEA [17]. However, there was limited investigation on feeding animals
with microbiologically-detoxified diets [18]. Therefore, the purpose of this study was investigate effects
of Bacillus licheniformis CK1 on growth performance, vulva size, relative weights of organs, and serum
hormone of female piglets fed feed contaminated with ZEA. In addition, we also evaluated the
expression of the estrogen receptors in the vagina, uterus, and ovary of the piglets.
2. Results
2.1. Growth Performance
In the seven-day adaption period, there was no significant difference in the average daily
feed intake (ADFI), average daily gain (ADG), or feed efficiency (FE, feed intake/gain) among the
three groups. Similarly, during the 14-day feeding period, treatments T1 and T2 exhibited no negative
effect on the ADFI, ADG, or FE in comparison with the control (Table 1).
Table 1. Growth performance of piglets fed different diets.
Groups Average Daily Feed Intake (kg) Average Day Gain (kg) Feed Conversion Rate
Control 0.71 ± 0.01 0.40 ± 0.08 1.73 ± 0.09
T1 0.68 ± 0.02 0.42 ± 0.05 1.63 ± 0.05
T2 0.63 ± 0.04 0.39 ± 0.06 1.65 ± 0.09
p value 0.289 0.463 0.713
Control group: the basal diet; T1 group: Zearalenone-contaminated diet; T2 group: fermented ZEA-contaminated
basic diet by Bacillus licheniformis CK1. Values are expressed in mean ± S.E. (standard error, n = 6).
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2.2. Vulva Size
Figure 1 shows changes in vulva size in the piglets in the three groups of piglets. There was no
significant difference in the vulva size among the three groups at the beginning of the trial (d1). At the
end of the trial (d15), the size of the vulva was significantly increased in the T1 group, but not in the
T2 group, in comparison with the control (p < 0.05). The vulvae of the piglets in the T1 group were
slightly red and swollen. On the other hand, no obvious change was observed in the control and T2
groups (Figure 2).
Figure 1. Effects of different diets on the vulva size of female piglets. a, b Values followed by
different superscript letters differ significantly (p < 0.05, n = 6). Control group: the basal diet;
T1 group: zearalenone (ZEA)-contaminated diet; T2 group: fermented ZEA-contaminated basic diet by
Bacillus licheniformis CK1.
Figure 2. The representative vulva of piglets at the end of the study. (Control group) the basal diet;
(T1 group) zearalenone-contaminated diet; (T2 group) fermented ZEA-contaminated basic diet by
Bacillus licheniformis CK1.
2.3. Organ Weight
The relative organ weight was calculated as the weight of the organs divided by the body
weight (g/kg). As shown in Table 2, the relative weight of the liver was significantly lower in piglets
in the T1 group compared with the control (p < 0.05), while there was no significant difference between
the T2 group and the control (p > 0.05). Piglets in the T2 group had significantly increased kidney
weight, in contrast with the control and the T1 groups (p < 0.05). The T1 group and the T2 group
had significantly heavier reproductive organs than the control (p < 0.05), but the relative weights of
reproductive organs in T1 and T2 groups were not different (p > 0.05). For the other organs (heart,
spleen, and lung), there were no differences among the three diet groups (p > 0.05).
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Table 2. Relative weight of organs in weaned piglets fed different diets.
Group
Relative Weight (g/kg)
Heart Liver Spleen Lung Kidney
Reproductive
Organs
Control 4.98 ± 0.24 27.51 ± 1.08 a 2.09 ± 0.30 11.68 ± 0.77 5.32 ± 0.28 a 0.47 ± 0.04 a
T1 4.87 ± 0.10 24.33 ± 0.85 b 1.79 ± 0.07 10.38 ± 0.20 5.24 ± 0.26 a 0.66 ± 0.06 b
T2 5.00 ± 0.17 25.53 ± 0.76 ab 2.04 ± 0.19 11.16 ± 0.42 6.80 ± 0.52 b 0.63 ± 0.04 b
p value 0.888 0.048 0.559 0.243 0.015 0.006
Control group: the basal diet; T1 group: zearalenone-contaminated diet; T2 group: fermented ZEA-
contaminated basic diet by Bacillus licheniformis CK1. Values are expressed in mean ± S.E. (n = 6). a, b Means
with different superscripts within same column differ significantly (p < 0.05).
2.4. The Level of Serum Hormones
The levels of serum hormones at the end of the test period are presented in Table 3. No significant
differences were found in the level of follicle stimulating hormone (FSH), estradiol (E2), prolactin
(PRL), progesterone (PRG) and testosterone (T) among the three treatments (p > 0.05). On the other
hand, the T1 diet significantly decreased the concentration of luteinizing hormone (LH) in comparison
with the control (p < 0.05). The T2 diet ameliorated the effect of ZEA and the levels of LH in the control
and T2 groups were similar.
















Control 13.33 ± 0.56 8.68 ± 0.11 a 21.27 ± 1.18 12.64 ± 0.48 0.80 ± 0.14 32.07 ± 2.97
T1 12.55 ± 0.56 8.02 ± 0.12 b 24.38 ± 1.01 12.60 ± 0.72 0.91 ± 0.2 31.85 ± 3.59
T2 12.76 ± 0.26 8.70 ± 0.13 a 23.32 ± 1.57 11.09 ± 0.42 1.13 ± 0.32 31.85 ± 0.96
p value 0.521 0.002 0.256 0.124 0.635 0.998
Control group: the basal diet; T1 group: zearalenone-contaminated diet; T2 group: fermented ZEA-
contaminated basic diet by Bacillus licheniformis CK1. Values are expressed in mean ± S.E. (n = 6). a, b Means
with different superscripts within same column differ significantly (p < 0.05).
2.5. Estrogen Receptor α (ERα) and Estrogen Receptor β (ERβ) mRNA Expression
As shown in Figure 3, mRNA expression of ERα and ERβ (two subtypes of estrogen receptor) was
quantified in the reproductive organs by real-time quantitative polymerase chain reaction (RT-qPCR).
No significant difference in ERα mRNA expression was found in the uterus and ovary among the
three treatments, while the T2 group significantly decreased the mRNA expression of ERα in vagina
(p < 0.05) in comparison with the control and the T1 group. The mRNA abundance of ERβ in the
uterus, vagina, and ovary was significantly higher in gilts on the T1 diet. Meanwhile, ERβ mRNA
expression in the uterus, vagina, and ovary in the T2 group was not significantly different from those
in the control group.
Figure 3. Cont.
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Figure 3. Effects of different diets on the mRNA expression of estrogen receptor α (ERα) ((A) vagina,
(C) uterus, and (E) ovary) and estrogen receptor β (ERβ) ((B) vagina, (D) uterus, and (F) ovary)
in the reproductive organs of female weaned piglets. Control group: the basal diet; T1 group:
zearalenone-contaminated diet; T2 group: fermented ZEA-contaminated basic diet by Bacillus
licheniformis CK1. a, b Different letters in each panel indicate significant differences (p < 0.05, n = 6).
3. Discussion
Zearalenone (ZEA) activates estrogen receptors and induces functional and morphological
alteration in reproductive organs. The susceptibility to the adverse effect of ZEA is species–dependent,
and pigs—especially prepubertal gilts—are very sensitive to ZEA due to its high alpha-hydroxylation
activity and low glucuronidation activity [19]. ZEA is a substrate for α and β hydroxysteroid
dehydrogenases, which convert ZEA into two stereoisomeric metabolites, α-zearalenol and
β-zearalenol. Alpha-hydroxylation results in an increase in estrogenic potency as compared to the
parent compound and beta-hydroxylation product [20]. The glucuronidation conjugates metabolites of
ZEA hydroxylation and eliminates them through urine and bile fluid. Pigs have a rather low activity
of glucuronidation [21].
Bacillus licheniformis (B. licheniformis) CK1 efficiently degraded ZEA in the basal diet.
The concentration of ZEA in diets offered to the T2 group was reduced to 0.47 mg/kg from 1.20 mg/kg
in the T1 group due to degradation by B. licheniformis CK1. The reduction of ZEA from 1.20
to 0.47 mg/kg in feed relieved red and swollen symptoms in the vulva of the piglets, and significantly
decreased the vulva size of the piglets. Jiang et al. [22] reported the vulva size and relative weight
of genital organs, liver, and kidney increased linearly in a ZEA-dose-dependent manner, indicating
that the estrogenic effects are stronger with increasing concentration of ZEA. Thus, decreasing the
concentration of ZEA in feeds could reduce the estrogenic effects of ZEA in the gilts. In addition, it has
been previously shown that B. licheniformis CK1 decreased more than 98% of ZEA in ZEA-contaminated
corn meal medium and was non-hemolytic, non-enterotoxin producing, and displayed high levels of
extracellular xylanase, cellulase, and protease activities [17]. The presence of interfering substance in
the basal diet might explain the lower efficiency of B. licheniformis CK1 to degrade ZEA in the current
study, in comparison with the study of Yi et al. [17].
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Whether B. licheniformis CK1 could reduce the adverse effects of ZEA for piglets was investigated
in the feeding trial. Our results showed that feeding the ZEA-contaminated diet (T1 group) significantly
increased the vulva size of gilts. In addition, organ weights were used as an index of estrogenic
response to ZEA, especially for reproductive organs. In our study, we observed that the relative
weight of reproductive organs in the T1 group was significantly increased compared to the control
group. Our results are in agreement with previous reports. Oliver et al. reported that gilts fed
ZEA-contaminated diets significantly increased vulva width and length compared with control [23].
Similarly, the vulva width, length, and area of piglets linearly increased as ZEA levels increased [24].
In addition, the relative weight of genital organs was also increased in female piglets supplemented
with 1.05 mg/kg ZEA [24]. While there was no significant difference between T1 and T2 groups for
the relative weight of genital organs, the T2 group significantly reduced the vulvar swelling of piglets
in this study, implying that B. licheniformis CK1 can effectively alleviate the estrogen acting on the
vulva of postweaning piglets caused by ZEA. Others have reported similar effects by using adsorbent
materials or chemicals to deal with ZEA contaminations. Jiang et al. reported that clay enterosorbent
at the levels of 5 or 10 g/kg was able to reduce the estrogenic effect of ZEA on vulvar swelling in
postweaning female pigs [25]. Moreover, Denli et al. demonstrated that activated diatomaceous
clay could effectively spare the estrogenic effect of ZEA on uterus and ovaries in rats and pigs [26].
The addition of a modified calcium montmorillonite alleviated some of the reproductive effects of ZEA
on the relative weight of genital organs in postweaning piglets [24,27].
ZEA and its metabolites can be regarded as endocrine disruptors that change hormonal activity
at the pre-receptor level. In the current study, ZEA decreased the level of luteinizing hormone
(LH) in post-weaning gilts, but had no influence on the level of follicle stimulating hormone (FSH),
estradiol (E2), prolactin (PRL), progesterone (PRG), or testosterone (T). Wang et al. observed that ZEA
decreased the levels of E2 and LH in pre-pubertal gilts, but had no effect on the level of FSH [28].
Other researchers also reported that serum LH in gilts was significantly decreased by adding ZEA in
feeds [29,30]. The gilts in the T2 group had similar LH concentrations to those in the control group,
indicating that B. licheniformis CK1 has a protective effect on ZEA toxicosis symptoms in piglets.
ZEA and some of its metabolites have been shown to competitively bind to estrogen receptors
(ERα and ERβ) in a number of in vitro and in vivo systems [31]. Therefore, we also investigated the
mRNA expression level of estrogen receptors in different tissues of piglets among the three groups.
In the present study, ERβ expression was significantly increased in the uterus, vagina, and ovary of
gilts in the T1 group compared with the control group, whereas ERα was not significantly different.
Our results are in agreement with a previous study by Oliver et al. [23]. ERβ could directly bind and
accelerate the expression of adipogenic genes, enhancing triglyceride concentrations in ERβ-positive
cells [32]. Thus, increasing the size and weight of the reproductive organs in our study—at least in
part—could result from altering the expression of ERβ and the subsequent expression of other genes.
Contrary to our results, Dong et al. found that the expression of ERα was significantly increased in the
uterus of goats by ZEA, while the expression of ERβ was not changed [33]. The different results could
be due to the species difference. Expression of ERβ in vagina, uterus, and ovary in the T2 group was
similar to those in the control group, but was significantly lower than that in vagina of the T1 group.
In our study, the average daily feed intake (ADFI), average daily gain (ADG), and feed efficiency
(FE) of the piglets were not different among the three groups. Likewise, Jiang et al. reported that there
was no obvious difference in the growth performance of gilts between the control diet and the diet with
ZEA concentration in the range of 1.1 to 3.2 mg/kg. Another study also showed that average daily
feed intake did not differ between gilts consuming the control and zearalenone diets, which resulted
in similar feed efficiency [23].
During the microbial transformation of ZEA, both estrogenic and non-estrogenic intermediates
and by-products can be produced—for example, estrogenic α-zearalenol and β-zearalenol [34–36].
Certainly, some microbes could degrade ZEA to non-estrogenic products. For example, Clonostachys
rosea IFO 7063 was effectively capable of converting ZEA to a non-estrogenic compound,
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1-(3,5-dihydroxy-phenyl)-10′-hydroxy-1′E-undecene-6′-one, determined by 2D NMR spectroscopy [37].
The yeast strain Trichosporon mycotoxinivorans was also able to decarboxylate ZEA [38] and produce
a compound identified as (5S)-5-({2,4-dihydroxy-6-[(1E)-5-hydroxypent-1-en-1-yl]benzoyl}oxy)
hexanoic acid via NMR spectroscopy [39]. In addition, although the degradation product was not
clear, Kriszt et al. [40] reported non-pathogenic Rhodococcus pyridinivorans K408 degraded 87.21% ZEA
and reduced 81.75% of estrogenic effects. Our results supported that B. licheniformis CK1 degraded
ZEA and reduced its estrogenic effects, possibly because ZEA was converted to non-estrogenic or less
estrogenic compounds.
In conclusion, B. licheniformis CK1 could degrade the ZEA in feed and alleviated the adverse effect
of ZEA for piglets. Our results support the notion that microbiological detoxification is suitable for the
decontamination of mycotoxins in feed with high efficiency, strong specificity, and no environmental
pollution [41].
4. Materials and Methods
4.1. Strains and Chemicals
Bacillus licheniformis CK1 was isolated from the National Taiwan University [17]. Purified
zearalenone (ZEA), acetonitrile, and methanol (HPLC (high-performance liquid chromatography)
grade) were purchased from Sigma-Aldrich (St. Louis, MO, USA). All other chemicals used were of
analytical grade.
4.2. Preparation of the Experimental Diets
ZEA (47 mg) was dissolved in acetic ether and then mixed with talcum powder. A ZEA premix
was prepared by blending ZEA-contaminated talcum powder with 3 kg of the basic diet (Table 4).
We prepared two batches of ZEA premixes. One was used in mixing with the basic diet as treatment 1
(T1), which was calculated for a ZEA concentration of 1 mg/kg. The other was used for fermentation
by Bacillus licheniformis CK1 to degrade ZEA before mixing with the basic diet as treatment 2 (T2).
Table 4. Ingredients and compositions of the basic diet.
Ingredients Percentage, % Nutrients Analyzed Values
Corn 53.00 Gross energy (MJ/kg) 17.12
Wheat middling 5.00 Crude protein (%) 19.40
Whey powder 6.50 Calcium (%) 0.84
Soybean oil 2.50 Total phosphorus (%) 0.73
Soybean meal 24.76 Lysine (%) 1.36
Fish meal 5.50 Methionine (%) 0.46
L-Lysine HCl 0.30 Sulfur amino acid (%) 0.79
DL-Methionine 0.10 Threonine (%) 0.90
L-Threonine 0.04 Tryptophan (%) 0.25
Calcium phosphate 0.80 - -
Limestone, pulverized 0.30 - -
Sodium chloride 0.20 - -
Premix 1 1.00 - -
Total 100 - -
1 Supplied per kg of diet: vitamin A, 3300 IU; vitamin D3, 330 IU; vitamin E, 24 IU; vitamin K3, 0.75 mg;
vitamin B1, 1.50 mg; vitamin B2, 5.25 mg; vitamin B6, 2.25 mg; vitamin B12, 0.02625 mg; pantothenic acid,
15.00 mg; niacin, 22.5 mg; biotin, 0.075 mg; folic acid, 0.45 mg; Mn, 6.00 mg; Fe, 150 mg; Zn, 150 mg; Cu, 9.00 mg;
I, 0.21 mg; Se, 0.45 mg.
For the fermentation, batches of 300 g of autoclaved ZEA-contaminated feed were mixed with
2700 mL sterilized water in a 5 L fermentor. The mixture was inoculated with 1% of an overnight
bacterial culture of Bacillus licheniformis CK1 and incubated at 37 ◦C, 300 rpm for 36 h. The fermented
23
Toxins 2016, 8, 300
feed was poured into a basin. To absorb water, the basic diet was gradually added. The mixture was
dried at room temperature. A total of 3 kg ZEA-contaminated feed were fermented.
All diets were prepared at the same time and stored in covered containers before feeding.
4.3. Determination of ZEA in Feed by HPLC
The concentration of ZEA in feed was determined by high-performance liquid chromatography
(HPLC) performed on HPLC instrument including a LC-20AT delivery system (Shimadzu, Kyoto,
Japan), a CBM-20A system controller (Shimadzu, Kyoto, Japan), a SIL-20A autosampler (Shimadzu,
Kyoto, Japan), a RF-10AXL fluorescence detector (Shimadzu, Kyoto, Japan), and an Ascentis C18
HPLC column (Sigma-Aldrich, Bellefonte, PA, USA; 5 μm particle size, L × I.D. 250 mm × 4.6 mm).
The injection volume for quantifying ZEA was 20 μL. The mobile phase consisted of methanol:water
80:20 (v/v) at a flow rate of 0.5 mL·min−1. The detector was set at excitation and emission wavelengths
of 225 nm and 465 nm, respectively. A standard curve was established by analyzing six ZEA standard
solutions (0.125, 0.25, 0.5, 1, 2, 5 μg/mL), and each concentration was determined in triplicate.
The linear regression equation of the standard curve showed an R2 value >0.99. Before the HPLC
analysis, ZEN in the feed was extracted and cleaned up using the Romer Mycosep 226 column (Romer
Labs Inc., Union, MO, USA) according to the manufacturer′s instructions. The levels of ZEA in feeds
were calculated by using the linear regression equation of the standard curve.
4.4. Experimental Design and Animals
A total of 18 post-weaning female piglets (Landrace × Yorkshire × Duroc) weaned at d30 with
an average body weight (BW) of 8.19 ± 0.32 (mean ± SE) kg were used in this study. The animal
protocols used in this work were evaluated and approved by Institutional Animal Care and Use
Committee of Northwest A&F University (Identification code: NWAFAC2014, Date of approval:
16 August 2014). Gilts were randomly allocated to three treatments, with six gilts in each group
according to BW. All animals were on the basic diet during a 7 day adaptation period after weaning.
The nutrient concentrations of the basic diet met or exceeded minimal requirements according to
the National Research Council (NRC) [42]. Pigs were fed the basic diet (control), treatment 1 diet
(T1), or treatment 2 (T2) diet during a 14 day test period. The actual ZEA contents (analyzed) were 0,
1.20 ± 0.11, 0.47 ± 0.22 mg/kg for the control, T1, and T2 groups, respectively.
During a 14 day test period, animals were housed individually in metal pens on the Northwest
A&F University farm. Throughout the study, animals had free access to feed and water, and room
temperature was 26–28 ◦C. Body weights were measured weekly. Feed intake of each treatment was
recorded daily. Vulva length and width were measured on d1, d8, and d15 after treatments started
to determine the dietary ZEA estrogenic effects, and the vulva area was calculated approximately as
a diamond shape ((vulva length × vulva width)/2) according to Jiang et al. [25].
4.5. Sample Collection
Pigs were fasted for 12 h at the end of the experimental period. Blood samples of approximately
10 mL were collected from the jugular vein of all animals into non-heparinized tubes, incubated at
37 ◦C for 2 h, centrifuged at 1500 × g for 10 min at room temperature, and the serum was separated and
stored in 1.5 mL Eppendorf tubes at −20 ◦C for hormone analyses (described below). After collection
of blood samples, piglets were immediately euthanized and genital organs (ovary + cornu uteri +
vagina − vestibule), liver, kidney, heart, lung, and spleen were isolated, weighed, and examined for
gross lesions. Samples of uterus, vagina, and ovary tissue were kept at −80 ◦C until extraction of total
RNA for expression of the ERα and ERβ. Organ weights were expressed on a relative body weight
basis (g/kg).
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4.6. Serum Hormone Analysis
Serum samples were analyzed for follicle stimulating hormone (FSH), luteinizing hormone
(LH), estradiol (E2), prolactin (PRL), progesterone (PRG), and Testosterone (T) using commercial
radioimmunoassay kits obtained from Tianjin Jiuding medical bioengineering CO., Ltd. (Tianjin,
China). All the samples were determined by the Yangling Demonstration Zone Hospital (Yangling,
Shaanxi, China).
4.7. Total RNA Extraction and Real-Time Quantitative RT-PCR (qRT-PCR)
Total RNA was extracted from frozen tissues using a total RNA Kit from Omega (Norcross, GA,
USA), according to the manufacturer’s instructions. The purity of total RNA was ascertained by the
A260/A280, and the integrity of total RNA was checked by agarose gel electrophoresis. Total RNA
for each sample was converted into cDNA using TaKaRa PrimeScriptTM RT Reagent Kit (TaKaRa
Biotechnology CO., Ltd., Dalian, China) according to the manufacturer’s instructions and used for
real-time quantitative polymerase chain reaction (RT-qPCR).
A SYBR® Premix Ex Taq kit (TaKaRa Biotechnology CO., Ltd., Dalian, China) was used to measure
mRNA expression of estrogen receptor genes (ERα and ERβ) with glyceraldehyde-3-phosphate
dehydrogenase (GAPDH) as an endogenous control. Pig-specific primers were designed from
published GenBank sequences (Table 5). All of the PCR reactions were performed in triplicate.
The relative gene expression levels were determined using the 2−ΔΔCt method [43].
Table 5. Nucleotide sequences of primers for quantitative real-time polymerase chain reaction (qRT-PCR).












Data were analyzed through ANOVA and Duncan’s multiple range tests using SPSS 16.0
statistical software (SPSS 16.0 Inc., Chicago, IL, USA, 2008). The values are expressed as mean
± S.E. Differences were considered significant at p < 0.05.
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Abstract: In this work, we examined the mechanisms involved in the degradation of patulin by
Pichia caribbica. Our results indicate that cell-free filtrate of P. caribbica reduced patutlin content.
The heat-killed cells could not degrade patulin. However, the live cells significantly reduced the
concentration of the patulin. In furtherance to this, it was observed that patulin was not detected
in the broken yeast cells and cell wall. The addition of cycloheximide to the P. caribbica cells
decreased the capacity of degradation of patulin. Proteomics analyses revealed that patulin treatment
resulted in an upregulated protein which was involved in metabolism and stress response processes.
Our results suggested that the mechanism of degradation of patulin by P. caribbica was not absorption;
the presence of patulin can induce P. caribbica to produce associated intracellular and extracellular
enzymes, both of which have the ability to degrade patulin. The result provides a new possible
method that used the enzymes produced by yeast to detoxify patulin in food and feed.
Keywords: mycotoxin; patulin; biodegradation; Pichia caribbica; proteomics; intracellular and
extracellular enzymes
1. Introduction
Phytosanitation is critical in food safety in the globalized agribusiness, where fresh fruits have
been considered as promising natural food. The Food and Agricultural Organization (FAO) estimated
that 25% of the world’s crops are contaminated with mycotoxins, and Aspergillus, Penicillium, and
Fusarium genera were incriminated [1–3]. Patulin (4-hydroxy-4H-furo [3,2c] pyran, 2[6H]-one) one of
these mycotoxins is an unsaturated heterocyclic lactone produced by certain fungi species (Penicillium,
Aspergillus, and Byssochlamys). Patulin is the most common mycotoxin found in apples and its derived
products [4]. Penicillium expansum is the most common fungus that causes blue mold and patulin
contamination in stored apples [5]. Patulin was first isolated from Aspergillus clavatus and studied in the
early 1940s [6,7]. Patulin contamination is a world-wide problem including, Portugal [8,9], Belgium [10],
India [11], Northeast China [12]. Patulin has been demonstrated to induce oxidative stress and causes
DNA strands to break in HepG2 cells. Oxidative damage in human cells can lead to mutagenic [13],
carcinogenic [14], immunotoxic [15], neurotoxic [16], genotoxic, and teratogenic [17,18] effects.
Traditionally, to control blue mold and patulin contamination in apples, synthetic fungicides are
usually relied upon. However, the development of fungicide resistance by pathogens and the public’s
concern over the presence of chemical residues in food have prompted an urgent need for alternative
control with good efficacy, and little or no toxicity to the non-target organisms [19]. In recent years,
biological control using antagonistic yeasts has emerged as a promising method to reduce synthetic
fungicides [20]. In view of this, many researches have shown that some antagonist yeasts could directly
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inhibit the production of patulin. Through almost 30 years of research, dozens of yeasts, including
Pichia caribbica [21], Rhodotorula glutinis [22], Pichia ohmeri [23], Rhodosporidium kratochvilovae [24],
Gluconobacter oxydans [25], and several others have been shown to degrade patulin, and inhibited the
growth of P. expansum. Coelho et al. [26] reported that patulin concentration of 223 μg was decreased
over 83% by P. ohmeri 158 cells when incubated at 25 ◦C for two days at a humidity >99. Also, R. glutinis
and Cryptococcus laurentii degraded patulin in vivo and significantly reduced the accumulation of
patulin in apples [22]. Zhu et al. [27] reported that the yeast Rhodosporidium paludigenum reduced the
patulin content in apples.
However, the mechanism(s) of action of yeasts is/are insufficient and remain poorly understood.
A study by Coelho, Celli, Ono, Wosiacki, Hoffmann, Pagnocca, and Hirooka [26] showed that
antagonistic yeast cells incubated with PAT decreased its contamination through two mechanisms:
(1) PAT adsorption at the yeast cell wall, and (2) PAT absorption into yeast cells. Zhu et al. [28] pointed
out that, when dead and live cells of Rhodosporidium paludigenum were incubated with patulin for three
days, 51% of the patulin was absorbed by the dead cells while no patulin was detected in the viable
yeast cells.
Genome-wide analysis of the model yeast Saccharomyces cerevisiae exposed to patulin indicated that
there were upregulated genes which showed proteasome activity, metabolism of sulfur amino acids,
and stress responses [29]. Ianiri et al. [30] reported that patulin was degraded by Sporobolomyces sp.
strain IAM 13481 and two kinds of mesostate were produced. To determine the genes responsible
for the degradation, 3000 mutants were instructed by T-DNA insertion, and some were proven to
be sensitive to patulin. The genes which include YCK2, PAC2, DAL5, and VPS8 were annotated to
Saccharomyces cerevisiae. Ianiri et al. [31] described a transcriptomic approach based on RNAseq to
study the changes of gene expression in Sporobolomyces sp. exposed to patulin. In their study, the
upregulated Sporobolomyces genes were those involved in metabolic processes, oxidation-reduction,
and transport processes. The patulin decreased the expression of genes involved in the processes of
protein synthesis, modification, cell division, and cell cycle. The results provide a comprehensive
analysis to identify potential mechanisms and enzymes that are involved in patulin degradation.
However, there were no genes and enzymes found to be responsible for the patulin degradation.
In vitro test indicated that P. caribbica can degrade patulin directly [21]. However, the mechanism
of degradation of patulin by the P. caribbica is unknown. Therefore, in the present study, we investigated
the possible mechanisms involved in degradation of patulin by Pichia caribbica and provided a
comprehensive analysis of the genes and enzymes that are involved in patulin degradation.
2. Results
2.1. Effect of Cell-Free Filtrate of P. caribbica on Patulin Degradation
The findings revealed that the cell-free filtrate of P. caribbica reduced the patulin concentration
compared to the control (CK) during all the tested time, Figure 1. This demonstrates that that the
cell-free filtrate significantly affected the patulin content. The patulin content was reduced from
18.8 μg/mL at 0 h to 11.4 μg/mL at 12 h after incubation, however, after 12 h the degradation declined
steadily throughout the entire duration.
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Figure 1. Efficacy of cell-free filtrate of P. caribbica on the degradation of patulin. The x axis represents
the time after the addition of patulin (h: hour), the y axis represents the concentration of the patulin
in the medium. CK: NYDB + patulin, Supernatant: P. caribbica cultuered in NYDB medium + patulin.
Results are presented as means ± SD of triplicate experiments. The data at the same time were analyzed
by the t test. The significant difference was assessed at the level p < 0.05.
2.2. Effect of Viable and Heat-Killed P. caribbica Cells on Patulin Degradation
The assay demonstrated that compared to the control, the dead yeast cells could not degrade the
patulin, while the live yeast cells significantly reduced the patulin level throughout the 36 h inoculation
period, Figure 2. The live P. caribbica cells decreased the patulin concentration to 1.4 μg/mL at 36 h of
incubation. However, the patulin concentration of the control and the heat-killed cells were 13.7 μg/mL
and 12.7 μg/mL at 36 h after incubation, respectively.
Figure 2. Efficacy of viable and heat-killed P. caribbica cells on degradation of patulin. The x axis
represents the time after the addition of patulin (h: hour), the y axis represents the concentration of the
patulin in the medium. Results are presented as means ± SD of triplicate experiments. The data at the
same time were analyzed by the analysis of variance (ANOVA) in the statistical program SPSS/PC
version 17.0. The significant difference was assessed at the level p < 0.05.
2.3. Degradation of Patulin by P. caribbica Was Inhibited by Cycloheximide
The results on the treatment without cycloheximide (P. caribbica alone) decreased the patulin
level completely after 36 h of incubation, Figure 3. However, the cycloheximide that was added to
the patulin at the beginning of the experiment decreased slightly and declined steadily. The patulin
content in which the cycloheximide was added at after 6 h of incubation followed a similar trend with
that of the control.
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Figure 3. Effects of cycloheximide on degradation of patulin by P. caribbica. The x axis represents the
time after the addition of patulin (h: hour), the y axis represents the concentration of the patulin in the
medium. Results are presented as means ± SD of triplicate experiments. The data at the same time
were analyzed by the analysis of variance (ANOVA) in the statistical program SPSS/PC version 17.0.
The significant difference was assessed at the level p < 0.05.
2.4. Effect of P. caribbica’s Supernatant on Patulin Degradation
The supernatant of P. caribbica significantly reduced the patulin content, regardless of whether the
yeast cells were filtered after 6 h or not, Figure 4. The supernatant without yeast cells had no effect on
patulin degradation. Henceforth, no significant difference was observed between the two treatments.
Figure 4. Efficacy of cell-free filtrate of P. caribbica which was induced 6 h by patulin on degradation
of patulin. The x axis represents the time after the addition of patulin (h: hour), the y axis represents
the concentration of the patulin in the medium. Results are presented as means ± SD of triplicate
experiments. The data at the same time were analyzed by the t test. The significant difference was
assessed at the level p < 0.05.
2.5. Effect of Intracellular Enzymes of P. caribbica on Patulin Degradation
The results on the intracellular enzymes demonstrates that the intracellular enzymes obtained
from the P. caribbica that were incubated in the NYDB did not exhibit degradation effect. The patulin
content remained at a high level of 8.3 μg/mL at 24 h after incubation, Figure 5C,D. However,
the intracellular enzymes from P. caribbica incubated in the NYDB and amended with the patulin
degraded the patulin to 0.25 μg/mL at 24 h after incubation, Figure 5B,D.
31













































































































































































































































































































































Toxins 2016, 8, 289
2.6. Identification of Differentially Expressed Proteins
Proteins were identified by means of peptide mass fingerprints (PMF). MASCOT was used to
search protein database of Viridiplantae. More than 150 protein spots were detected in each gel after
ignoring very faint spots and spots with undefined shapes and areas using Image Master 2D Elite
software, Figure 6A. Protein was extracted from P. caribbica, harvested at 24 h after incubation in NYDB,
Figure 6A, and NYDB amended with patulin, Figure 6B. A total of 53 differentially expressed proteins
were identified from the P. caribbica harvested from the NYDB amended with patulin. Out of the
53 proteins, 18 proteins were upregulated and 35 proteins were downregulated. Our test focused on
27 of them, Table 1. The differentially expressed proteins were classified with GO analysis, Figure 6C.
Most of the differentially expressed proteins were related to basic metabolism such as isocitrate lyase
activity, citrate (Si)-synthase activity, acetyl-CoA hydrolase activity, phosphomannomutase activity,
and phosphopyruvate hydratase activity, Figure 6C. This indicated that the basic metabolism of
P. caribbica was activated by patulin. The responses of P. caribbica to patulin are complex, as the
differentially expressed proteins were involved in multiple metabolic pathways. Heat-shock protein
70 and Heat-shock protein SSB1 under the category of stress response may be related to the yeast cell’s
stress response to the patulin, Figure 6C.
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Figure 6. Two-dimensional pattern of intracellular proteins of P. caribbica after cultivation for 24 h in
NYDB and NYDB amended with patulin. (A): Protein extracted from P. caribbica which was harvested
from NYDB at 24 h after incubation; (B): Protein extracted from P. caribbica which was harvested
from NYDB amended with patulin at 24 h after incubation; (C): Gene ontology (GO) analysis of the
differentially expressed proteins of P. caribbica when treated with patulin.
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3. Discussion
Patulin is a worldwide food mycotoxin which is present in a variety of fruit products. In recent
years, attempts have been made to reduce the mycotoxin content in fruits and their derived
products [32]. In view of this, biodegradation of mycotoxins has taken center stage for many researchers.
Some antagonistic yeast strains used in biological control of fruits do not only control pathogens in the
storage period, but also reduce patulin and other mycotoxins directly. Our research team found that
the degradation of patulin treated with P. caribbica was higher than that of the control at all the tested
time, which showed that P. caribbica can degrade patulin directly [21], but the degradation mechanisms
are unknown. In this paper, we investigated the possible mechanisms involved in degradation of
patulin by antagonistic yeast using P. caribbica as the model organism.
The cell-free filtrate of P. caribbica decreased the concentrations of the patulin at all tested times
indicating that P. caribbica might have produced certain intracellular enzymes which degraded
the patulin. These results are similar to the degradation of OTA by the cell-free supernatant of
Bacillus subtilis CW 14 [33]. The functions of these enzymes were, however, short-lived as the
degradation declined after 12 h. Moreover, the patulin may have reacted with sulfhydryl containing
amino acids or proteins, thereby decreasing its concentration [17].
Co-incubation of heat-killed and live cells of P. caribbica with patulin respectively showed that
the inactive yeasts could not reduce the concentration of the patulin, while the live cells significantly
reduced the concentration of the patulin (Figure 2). This finding is in line with Dong et al. [34] who
reported that the live yeast Kodameae ohmeri could degrade patulin. In addition, significant differences
in the reduction of patulin content was observed between viable and heat-killed cells. The results
showed that the degradation of patulin requires the presence of live yeast cells.
Fifty-one percent of patulin was absorbed by dead yeast cells of R. paludigenum [28]. However,
the test on the role of P. caribbica in patulin absorption indicated that patulin was not detected in the
broken yeast cells and the cell wall. These results showed that there are other mechanisms of patulin
reduction other than absorption by the yeast cells.
The test on the effects of cycloheximide on P. caribbica degradation of patulin, demonstrated
that the P. caribbica without the cycloheximide decreased the patulin concentration throughout the
entire duration of the experiment and after 36 h the patulin could not be detected. On the contrary,
P. caribbica containing the cycloheximide decreased the patulin concentration sharply during the first
12 h. These results are in agreement with the findings of Zhang et al. [35] who used cycloheximide
combined with S. cerevisiae to degrade ZEN at time 0 h, while addition of cycloheximide at 12 h
significantly slowed down degradation. Moreover, cycloheximide inhibits protein (enzymes) synthesis
in eukaryotes. These results suggest that enzymes produced by antagonistic yeasts play an important
role in degradation of patulin.
As reported, the process of patulin degradation is an enzymatic reaction [22,24,34]. This confirmed
our findings in which the supernatant from the P. caribbica degraded the patulin regardless of whether
the yeast cells were filtered out or not. This is an indication that the yeast may have synthesized some
extracellular enzymes in the supernatant which was involved in the degradation.
Additionally, Folger [36] reported that patulin can be degraded by yeast protein extract.
R. paludigenum was observed to have degraded patulin through the activities of its intracellular
enzymes, and the enzymes were induced by the patulin [28]. In this way, the intracellular enzymes of
P. caribbica alone and the P. caribbica induced with patulin were extracted and their ability to degrade
patulin was confirmed. Our results showed that the intracellular enzymes of the P. caribbica induced
with patulin contained the enzymes which were responsible for the degradation of patulin.
Ianiri, Idnurm, Wright, Durán-Patrón, Mannina, Ferracane, Ritieni, and Castoria [30] in their
quest to determine the relevant genes responsible for patulin degradation used A. tumefaciens T-DNA
delivery system. They isolated 13 mutants which were affected in patulin degradation, some
exhibited hypersensitivity to patulin. However, the slow patulin degradation observed for the mutants
was proven not to be the inactivation of genes encoding enzymes directly involved in the patulin
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degradation pathway, but to the loss of functions of genes involved in resistance to patulin-induced
stresses. No degradation pathway was found. In this study, the differentially expressed proteins
of P. caribbica induced by the patulin showed that the basic metabolic proteins of P. caribbica were
affected. Response patterns of P. caribbica to patulin are complex, as the differentially abundant
proteins were involved in multiple metabolic pathways. The cytoplasm of eukaryotic cells, whether
chemical, thermal, or in the form of misfolded or aggregated protein, triggers a complex biological
response referred to as the heat shock response [37–40]. Hsp70 is a molecular chaperone belonging to
heat-shock protein family. It is a stress-inducible member, in contrast to Hsc70 expressed constitutively.
Hsp70 plays an important role in the folding and assembling of newly synthesized proteins, refolding of
misfolded proteins, aggregation of proteins, and membrane translocation of organelles. It also secretes
proteins and controls the activities of regulatory proteins [41–44]. The more concentration indicated that
Hsp70 was produced during the degradation of patulin by P. caribbica. Phosphomannomutase (PMM,
EC 5.4.2.8), catalyzing the interconversion between mannose-6-phosphate and mannose-1-phosphate,
is an essential and conserved enzyme in eukaryotic organisms [45,46]. Mannose-1-phosphate is
necessary for synthesizing the vital cellular metabolite GDP-mannose, which plays a crucial role in the
formation of polysaccharide chains required for the glycosylation of protein and lipid molecules [47,48].
The mannan oligosaccharide is composed of mannose and glucose oligosaccharides, one of the main
active ingredients of the cell wall of yeasts. It can absorb mycotoxins. So PMM may be an important
enzyme in the degradation of patulin by P. caribbica. Most of the differentially expressed proteins
are related to basic metabolism, such as acetyl-CoA hydrolase, isocitrate lyase, citrate synthase, and
enolase 1.
4. Conclusions
In conclusion, the degradation of patulin by P. caribbica is an enzyme catalytic process, and these
enzymes were induced by patulin. In the future, we will focus on the identification of these enzymes
which are involved in patulin degradation and the degradation products of the patulin.
5. Materials and Methods
5.1. Antagonist and Growth Conditions
P. caribbica was isolated from soils of an unsprayed orchard (the central shoal of Yangtze River,
Zhenjiang, Jiangsu Province, China) by our research team. Sequence analysis of the 5.8 S internal
transcribed spacer (ITS) ribosomal DNA (rDNA) region of the yeast found that it was P. caribbica [49,50].
P. caribbica has been shown to be safe in animal testing, such as physiological, acute toxicity and
Ames test [51]. P. caribbica isolates were maintained at 4 ◦C on nutrient yeast dextrose agar medium
(NYDA-0.8% nutrient broth, 0.5% yeast extract, 1% glucose and 2% agar) (Sangon Biotech, Shanghai,
China). Liquid cultures of the yeast were grown in 250-mL Erlenmeyer flasks containing 50 mL of
nutrient yeast dextrose broth (NYDB) which had been inoculated with a loop of the culture. Flasks were
incubated on a rotary shaker at 190 rpm for 48 h at 28 ◦C. Following incubation, cells were centrifuged
at 6000× g for 10 min and washed twice with sterile distilled water. Cell pellets were re-suspended in
sterile distilled water and adjusted to an initial concentration before being adjusted to the concentration
required for different experiments.
5.2. Preparation of Stock Standard Solutions of Patulin
The patulin (Sigma-Aldrich, St. Louis, MO, USA) was prepared in accordance with the method
described by MacDonald et al. [52], with some modifications. The patulin standard working solution
(20 μg/mL) was diluted 10-fold with acetate buffer (pH 4.0). The samples were filtered through
a 0.22 μm Wondadisc NY organic filter (SHIMADZU, Kyoto, Japan), and subjected to HPLC analysis.
A standard curve of the patulin (μg/mL) was generated.
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5.3. HPLC-UV Analysis of Patulin
Agilent 1100 series system (Agilent, Santa Clara, CA, USA) was used to analysis the patulin.
The analytical column used was Zorbax, SB-C18 250 × 4.6 mm 5 μm (Agilent, Santa Clara, CA, USA).
The mobile phase composed of water and CAN (9:1, v/v) that was set at 1 mL/min. The UV detection
was performed at 276 nm. Data collection and subsequent processing were performed using Gilson
Unipoint software 5.0 (Gilson, Inc, Middleton, WI, USA).
5.4. Efficacy of Cell-Free Culture Filtrate of P. caribbica on the Detoxification of Patulin
One milliliter culture medium of P. caribbica (1 × 108 cells/mL) was added to 50 mL NYDB in
250-mL Erlenmeyer flasks. Flasks were incubated on a rotary shaker at 180 rpm at 28 ◦C for 20 h.
Following incubation, cells were centrifuged at 6000× g for 10 min. Then cell suspensions were
filtered through micro pore (0.22 μm) to obtain the cell-free filtrate. Twenty-five mL cell-free filtrate of
P. caribbica and NYDB medium (control) were each added into 150-mL Erlenmeyer flasks containing
patulin at the concentration of 20 μg/mL, respectively. Samples were taken every 6 h and centrifuged
at 7000× g for 5 min. The supernatants were filtered through a 0.22 μm filter and HPLC analysis was
performed to determine the patulin contents. Every group had three replicates and the experiment
was replicated twice.
5.5. Efficacy of Viable and Heat-Killed P. caribbica Cells on the Reduction of Patulin
The yeasts cells were inactivated in water at 100 ◦C for 15 min. Two mL of the live P. caribbica
(1 × 108 cells/mL), the heat-killed cells, and sterile distilled water (control) were added to 25 mL
NYDB containing 20 μg/mL of patulin in 150 mL Erlenmeyer flasks, respectively. Samples were taken
at every 6 h, centrifuged at 7000× g for 5 min. The supernatants were filtered through a 0.22 μm
filter, and subjected to HPLC analysis. Every group had three replicates and the experiment was
replicated twice.
5.6. Absorption of Patulin by P. caribbica Cells
One milliliter suspension of P. caribbica (1 × 108 cells/mL) was added to 25 mL NYDB and
20 μg/mL of patulin in 150 mL Erlenmeyer flasks. The samples were incubated in a rotary shaker
at 180 rpm for 20 h at 28 ◦C. Following incubation, cells were centrifuged at 6000× g for 10 min
and washed twice with sterile distilled water to remove the patulin in the supernatant. The yeasts
were sonicated at 1000 hz for 20 min. Fifteen mL of ethyl acetate was added to broken yeast cells,
vortexed for 60 s and the upper layer was transferred into a separate funnel (125 mL). This step
was repeated thrice and then 5 mL of 1.4% (w/v) Na2CO3 was added to the ethyl acetate layer and
vigorously mixed for 2 min. The upper ethyl acetate layer was dried in a vacuum at 40 ◦C in a rotary
evaporator. Soon after, 1 mL acetate buffer (0.2 mol/L, pH 4) was added and vortexed until it dissolved
completely. The sample was filtered through a 0.22 μm Wondadisc NY organic filter (SHIMADZU,
Kyoto, Japan), and analyzed in HPLC machine. Every group had three replicates and the experiment
was replicated twice.
5.7. Effects of Cycloheximide on Degradation of Patulin by P. caribbica
One milliliter suspension of P. caribbica (1 × 108 cells/mL) was added to 25 mL NYDB and
20 μg/mL of patulin in 150 mL Erlenmeyer flasks. Treatments were as follows: (1) 5 μg/mL
cycloheximide with patulin; (2) Addition of patulin into cycloheximide after 6 h; (3) only patulin
(Control). Samples were taken at every 6 h, and centrifuged at 7000× g for 5 min. The supernatants
were filtered through a 0.22 μm filter, and subjected to HPLC analysis to determine the patulin content.
Every group had three replicates and the experiment was replicated twice.
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5.8. Effects of P. caribbica Supernatant on Patulin Degradation
Two milliliter suspension of P. caribbica (1 × 108 cells/mL) was added to 25 mL NYDB and
20 μg/mL of patulin. After incubating for 6 h, one group was filtered twice through 0.22 μm filter to
remove all the cells and the group was not filtered. Samples were taken every 6 h and centrifuged at
7000× g for 5 min. The supernatants were filtered through a 0.22 μm filter and analyzed using HPLC.
Every group had three replicates and the experiment was replicated twice.
5.9. Degradation of Patulin by Intracellular Enzymes
P. caribbica (108 cells/mL) was incubated in NYDB and NYDB containing 20 μg/mL patulin in
a rotary shaker at 180 rpm at 28 ◦C. After 20 h of incubation, the supernatants and the cells were
centrifuged. The cells were washed with phosphate buffer (50 mM, pH 7.0) thrice. The wet cells
were quickly ground in mortar using pestle with liquid nitrogen added and then suspended in 10 mL
phosphate buffer. After 30 min in ice, the samples were centrifuged at 13,000× g for 10 min at 4 ◦C and
the supernatant was collected. Afterwards, 100 μg of patulin was added to 5 mL of the yeast cells was
amended with the patulin and those that were not amended. Every group had three replicates and the
experiment was replicated twice.
5.10. Protein Sample Preparation
Liquid cultures of the yeasts were grown in NYDB and NYDB + 20 μg/mL patulin as described
above under the section Antagonist and Growth Conditions’. The protein samples were prepared as
described by Li et al. [53] with some modifications. After 24 h, the yeast cells were harvested from the
NYDB and the NYDB + patulin, and centrifuged at 10,000× g for 10 min (4 ◦C). The cells were washed
with cold distilled water each time after centrifugation to remove residual medium. Subsequently,
the samples (yeast cells) were ground into fine powder with a mortar and pestle. The powder was
transferred into a 50-mL tube. Thereafter, 10 mL TE buffer (10 mM Tris-HCL, pH 8.0, 1 mM EDTA, and
1 mM PMSF), 50 μg of RNase A and 200 μg of DNase I was added and incubated at 4 ◦C for 30 min.
The samples were centrifuged at 11,000× g for 20 min (4 ◦C), then the supernatant was added to two
volumes of 20% TCA/acetone (−20 ◦C pre-cooled at least 30 min), vortexed, and incubated at −20 ◦C
for 12–16 h. Following incubation, the sample was centrifuged at 11,000× g for 20 min (4 ◦C) and
the supernatant was discarded. The pellets were centrifuged at 11,000× g for 5 min (4 ◦C), washed
with acetone (−20 ◦C pre-cooled). The pellets were air-dried at room temperature to remove residual
acetone. Then solubilized in lysis buffer containing 2 M thiourea, 7 M urea, 4% (w/v) CHAPS, 65 mM
DTT, 0.2% (w/v) Bio-Lyte (Bio-Rad, Hercules, CA, USA). Protein samples were kept at −80 ◦C until
use. The protein concentration was determined according to Bradford’s method using bovine serum
albumin as standard [54].
5.11. 2-DE and Image Analysis
Two-dimensional electrophoresis (2-DE) and image analysis were performed as described by
Wang et al. [55]. The first dimension electrophoresis was carried out on a 17-cm IPG strip (pH 3–10,
Bio-Rad, Hercules, CA, USA). The strip was rehydrated for 1 h in the rehydration solution containing
2 M thiourea, 7 M urea, 4% (w/v) CHAPS, 65 mM DTT, 0. 2% (w/v) Bio-Lyte, and about 400 μg
sample protein in a re-swelling trough. The rehydrated strip was then subjected to electrophoresis
in the first dimension. After isoelectric focusing, the strip was equilibrated in two steps in the
SDS equilibration stock solution consisting 50 mM Tris-HCl buffer, 6 M urea, 20% (v/v) glycerol
and 2% (w/v) SDS supplemented with 2% (w/v) DTT, and 2.5% (w/v) iodoacetamide, respectively.
The second dimension was run on a 12.5% polyacrylamide gel using the Multiphor system (Amersham
Biosciences, Amersham, UK). The conditions were 1 W per strip for 1 h followed by 15 W per strip until
bromophenol blue reached 0.5 cm above the bottom. To estimate the molecular weights of the protein
spots, marker proteins were also separated together with the P. caribbica proteins. After electrophoresis,
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gels were visualized by Coomassie Blue stain. The stained gels were scanned and analyzed using
PDQuest software (version 7.4, Bio-Rad, Hercules, CA, USA). Proteins that increased two-fold at one
point after treatment, as well as exhibited the same expression pattern among the replicates, were
considered as significant and reproducible change proteins. The proteins were subsequently identified.
At least three biological replicates were performed for each treatment.
5.12. Protein In-Gel Digestion and Identification
Differentially expressed protein spots were excised from the gel and were washed twice by
distilled H2O, then destained with 50 mM NH4CO3/CAN solution. Afterwards, they were washed
with 25 mM NH4CO3, 50% CAN until the gels became white, then vacuum drained for 5 min. Two μL
trypsin (10 μg/μL) (Sigma–Aldrich, St. Louis, MO, USA) was incubated at 4 ◦C for 30 min, then 10 μL
25 mM NH4CO3 was added. The gels were incubated overnight at 37 ◦C. The supernatant was collected
for MS analysis [56]. Proteins were identified by MALDI-TOF/TOF and database query. The peptide
solution was analyzed using MALDI TOF/TOF mass spectrometer (Ultraflex III, Bruker-Daltonics,
Bremen, Germany). MS/MS spectra were analyzed using the FlexAnalysis 3.0 (Bruker Daltonics
GmbH, Bremen, Germany). The resulting monoisotopic peptide masses were queried against the
protein database in NCBInr using MASCOT version 2.3 software (Matrix Science, Franklin, UK) with
the following search parameters: all entries, trypsin, up to one missed cleavage, carbamidomethyl (C),
oxidation (M), and Gln-Pyro-glu, peptide tolerance 0.3 Dal, mass value MH+, and monoisotopic [37].
5.13. Statistical Analysis
The data were analyzed by the analysis of variance (ANOVA) in the statistical program SPSS/PC
version 17.0, (SPSS Inc. Chicago, IL, USA) and the Duncan’s multiple range test was used for means
separation. In addition, when the group of the data was two, the independent samples t test was
applied for means separation. The statistical significance was assessed at the level p < 0.05.
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Abstract: Patulin is a mycotoxin produced by Penicillium expansum and a common contaminant
of pome fruits and their derived products worldwide. It is considered to be mutagenic,
genotoxic, immunotoxic, teratogenic and cytotoxic, and the development of strategies to reduce
this contamination is an active field of research. We previously reported that Sporobolomyces sp.
is able to degrade patulin and convert it into the breakdown products desoxypatulinic acid and
ascladiol, both of which were found to be less toxic than patulin. The specific aim of this study was
the evaluation of the triggering of the mechanisms involved in patulin resistance and degradation by
Sporobolomyces sp. Cells pre-incubated in the presence of a low patulin concentration showed a higher
resistance to patulin toxicity and a faster kinetics of degradation. Similarly, patulin degradation
was faster when crude intracellular protein extracts of Sporobolomyces sp. were prepared from cells
pre-treated with the mycotoxin, indicating the induction of the mechanisms involved in the resistance
and degradation of the mycotoxin by Sporobolomyces sp. This study contributes to the understanding
of the mechanisms of patulin resistance and degradation by Sporobolomyces sp., which is an essential
prerequisite for developing an industrial approach aiming at the production of patulin-free products.
Keywords: Sporobolomyces sp. IAM 13481; microbial patulin degradation; desoxypatulinic acid; ascladiol
1. Introduction
Mycotoxins are secondary metabolites produced by fungi belonging to several genera, such as
Aspergillus, Penicillium, and Alternaria. Besides their economical importance due to crops infection
and product losses, their toxic secondary metabolites represent a health risk to humans and animals.
The maximum content of some mycotoxins in harvested commodities and derived products has been
established by national and international organizations, and the reduction of mycotoxin contamination
is an important research focus.
Patulin (PAT) is a toxic fungal metabolite produced mainly by species of Penicillium and Aspergillus.
P. expansum, the causative agent of the blue mould disease of stored apples, is the main PAT producer
and its infections result in PAT contamination of apples, pears, and their derived products [1].
The carcinogenic risk of PAT is classified in group 3 by the International Agency for Research on
Cancer [2], and this has led to the establishment of a maximum tolerable daily intake for PAT of
0.4 mg/kg body weight/day [3]. Moreover, although there are legislative regulations in Europe and
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USA that set the highest tolerable levels of PAT in fruit-based products and juices at 50 μg/kg, and for
baby food at 10 μg/kg (EC Regulation 1881/2006), recent surveys in Europe and USA revealed that
PAT contamination is still a common issue [4–6].
The mechanisms of PAT toxicity and its effects on living cells have been long investigated [1,7].
Patulin was found to have antibacterial and antifungal activities [7]. In mammals, the primary target
organs of PAT toxicity are the gastrointestinal tract, kidney, liver and the immune system. Continued
exposure to high concentrations of PAT may include mutagenicity, genotoxicity, embryotoxicity,
immunotoxicity and neurotoxicity [1,7,8].
The ecological role of PAT has not been fully elucidated, and it is likely to help in competition
against other microbes that PAT-producing fungi encounter in their niche. Mutation in the gene
encoding enzymes involved in PAT biosynthesis [7,9] has allowed to investigate the role of PAT in the
pathogenicity of P. expansum, which is still controversial and it seems to be dependent on factors of the
host fruits [10–13].
Limiting P. expansum infections in postharvest settings is crucial to prevent PAT accumulation.
The use of chemical fungicides is still the most effective approach. However, ethical, technical and
health issues, foster an increasing demand for alternative methods to reduce the use of chemicals,
and the use of biocontrol agents and/or controlled atmosphere are very promising strategies [6].
Moreover, their combination with tools aiming at the detoxification of PAT has the potential to
further reduce PAT contamination, thus providing safer fruit juices; an important focus because their
contamination poses a major risk for children, who consume great quantities of fruit juices.
The influence of biocontrol agents (BCAs) that are effective against P. expansum on PAT
accumulation is an emerging and attractive field of study, and major findings have been elegantly
reviewed [14]. The ability of PAT degradation seems to be a widespread feature of the Pucciniomycotina
red yeasts. We found that Sporobolomyces sp. IAM 13481 was able to convert PAT to DPA and ascladiols,
with (E) ascladiol being a transient metabolite, and DPA and (Z) ascladiol the two final breakdown
products [15]. In the red yeast BCAs Rhodotorula kratochvilovae and R. paludigenum, DPA was found
as the major PAT degradation products [16–18], although at least in the case of R. kratochvilovae,
the isomers (E) and (Z) of ascladiol were found as transient products (our unpublished data). Using
Sporobolomyces sp. IAM 13481 as a model, we explored the molecular mechanisms involved in PAT
degradation by Pucciniomycotina yeasts through a random insertional mutagenesis approach based on
Agrobacterium tumefaciens-mediated transformation (AMT) [15]) as well as a transcriptomic approach
based on RNAseq analysis of yeast cells grown in the presence and absence of this mycotoxin [19].
Our data indicated that PAT toxicity is exerted through the generation of ROS (reactive oxygen
species), which leads to cellular damage but also function as signalling molecules that activate cellular
components required for oxidative stress resistance and PAT degradation. Based on these findings,
in the present work, we investigated whether the biochemical mechanisms that lead to PAT resistance
and degradation in Sporobolomyces sp. IAM13481 can be induced by exposition to low doses of
this mycotoxin.
2. Results
2.1. Pre-Treatment of Sporobolomyces sp. IAM 13481 Cells with Patulin Induces Mechanisms Involved in Its
Resistance and Degradation
Sporobolomyces sp. IAM 13481 is able to degrade in vitro the mycotoxin PAT under aerobic
conditions. The products of PAT degradation have been identified as (E)-ascladiol, (Z)-ascladiol
and desoxypatulinic acid (DPA); (E)-ascladiol is a transient or less stable product, while DPA and
(Z)-ascladiol are the final metabolites of PAT degradation [15] (Figure 1).
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Figure 1. Chemical structures of patulin and its breakdown products (E) and (Z) ascladiol,
and desoxypatulinic acid (DPA).
In the present work, the induction of the mechanisms that underlie PAT resistance and degradation
by Sporobolomyces sp. IAM 13481 was assessed by incubating pretreated cells (PC, cells preincubated in
the presence of 15 μg/mL of PAT) and non-preincubated cells (NPC, cells incubated in the absence of
PAT) in the presence of two different concentrations of PAT, 50 and 100 μg/mL.
In Figure 2 the growth curves of NPC and PC of Sporobolomyces sp. IAM 13481 in the absence
and in the presence of 50 and 100 μg/mL of PAT are reported. While in LiBa without PAT the growth
kinetics of NPC and PC followed a similar trend, there were clear differences between their growth
in the presence of the mycotoxin. In particular, with 50 μg/mL of PAT, PC suffered from the initial
toxicity of PAT only partially and reached the highest OD595 value after 3 days of incubation, whereas
the growth of NPC was characterized by a 1-day lag phase followed by exponential growth until the
fourth day of incubation. In the presence of 100 μg/mL of PAT, there were more marked differences
between the growth of PC and NPC, with PC showing a 1-day lag phase followed by active growth
until the fourth day of incubation, a trend that reflected that of NPC grown with PAT 50 μg/mL,
and NPC characterized by a 4-day lag phase followed by exponential growth until the seventh day
of incubation.
Figure 2. Growth curves of Sporobolomyces sp. IAM 13481 cells that were preincubated (PC, black lines)
and non-preincubated (NPC, grey lines) with PAT in the presence (50 and 100 μg/mL) or in the absence
(i.e., LiBa alone) of the mycotoxin. Values are expressed as OD595 and represent the means ± standard
deviation (n = 9).
In accordance with our previous report [15], the kinetics of PAT degradation reflected the
growth curves both for PC and NPC. As reported in Figure 3, with 50 μg/mL of PAT, after 24 h
of incubation there was a significant difference between the PAT recovery of PC and NPC, with values
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of 33.40 ± 2.16 μg/mL and 43.91 ± 0.11 μg/mL, respectively (Figure 3A–C). At the same time
point, PC produced 2.73 ± 0.14 μg/mL of (E)-ascladiol, 0.62 ± 0.15 μg/mL of (Z)-ascladiol and
1.09 ± 0.04 μg/mL of DPA (Figure 3A), while only traces of (E)-ascladiol were detected for NPC
(Figure 3B). Also, at 48 h of incubation there was a significant difference in PAT reduction by
Sporobolomyces PC and NPC (Figure 3C). PC led to a complete degradation of 50 μg/mL of PAT after
three days of incubation, in correspondence of which they produced 6.90 ± 1.56 μg/mL of (E)-ascladiol,
4.47 ± 1.04 μg/mL of (Z)-ascladiol and 5.70 ± 0.04 μg/mL of DPA. In the same culture, at the fourth
day of incubation, the (E)-ascladiol decreased to 3.75 ± 1.27 μg/mL, whereas the (Z)-ascladiol and DPA
increased respectively to 5.09 ± 1.61 μg/mL and 6.06 ± 1.43 μg/mL, the highest values achieved; at the
last time points, the amount of the breakdown products slightly decreased (Figure 3A) probably due
to their instability or other unknown enzymatic activities. In NPC of Sporobolomyces, after four days of
incubation, PAT was almost totally degraded (PAT was only 1.81 ± 2.52 μg/mL), and this paralleled
the production of 5.36 ± 3.44 μg/mL of (E)-ascladiol, 4.70 ± 1.75 μg/mL of (Z)-ascladiol and
5.15 ± 1.30 μg/mL of DPA; at the fifth day, the (E)-ascladiol decreased, while (Z)-ascladiol and DPA
slightly increased (Figure 3B).
Figure 3. Time course of PAT decrease (full line) and onset of breakdown products (dotted lines) of
Sporobolomyces PC (A) and NPC (B) grown in the presence of 50 μg/mL of mycotoxin. PAT is patulin,
(E)-ascl and (Z)-ascl are (E)-ascladiol and (Z)-ascladiol, respectively. Values are expressed as μg/mL and
represent the means ± standard deviation (n = 9, three measurements in three experiments); (C) Fate
of 50 μg/mL of PAT in the presence of Sporobolomyces PC and NPC. Asterisk indicates significant
differences (p < 0.05) when analyzed by Student’s t test.
With 100 μg/mL of PAT (Figure 4), PC of Sporobolomyces started to degrade the mycotoxin since
the first day of incubation (PAT recovery of 89.18 ± 0.38 μg/mL), and this paralleled the production
of about 2 μg/mL of (E)-ascladiol and DPA, and traces of (Z)-ascladiol (Figure 4A). At the third
day of incubation, more than 50% of PAT was degraded, and the highest production of (E)-ascladiol
(8.00 ± 0.35 μg/mL) was also achieved, which, as expected, decreased to 1.54 ± 0.41 μg/mL on the last
day of incubation. PAT was completely degraded after four days of incubation, and, at the same time
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point, the amount of the final breakdown products (Z)-ascladiol and DPA were 6.91 ± 1.75 μg/mL and
8.64 ± 0.55 μg/mL, respectively. Even though no more PAT was present in the medium, the amounts
of these two degradation products still increased to reach the highest values at the sixth day of
incubation, 11.00 ± 1.66 μg/mL and 11.34 ± 0.44 μg/mL for (Z)-ascladiol and DPA, respectively
(Figure 4A). For NPC instead (Figure 4B), a considerable PAT reduction of about 40% was observed
only at the fifth day of incubation, and at the same time point, (E)-ascladiol reached its production peak
(4.42 ± 0.62 μg/mL) and decreased in the following days, while the amounts of (Z)-ascladiol and DPA
were still low (traces for (Z)-ascladiol and 2.99 ± 0.11 μg/mL for DPA). PAT was completely degraded
at six days of incubation, and at the seventh day there was the highest production of (Z)-ascladiol and
DPA (12.36 ± 1.49 μg/mL and 13.36 ± 0.96 μg/mL, respectively) (Figure 4B). As shown in Figure 4C,
after 1, 3, 4 and 5 days of incubation, there were highly significant differences between the degradation
of 100 μg/mL of PAT by PC and NPC. With 200 μg/mL of PAT, there were even more remarkable
differences between PC and NPC of Sporobolomyces, and when there was a lower initial concentration
of cells (i.e., 1 × 105 CFU/mL), only PC were able to grow and degrade PAT, whereas NPC did not
(data not shown).
Figure 4. Time course of PAT decrease (full line) and onset of breakdown products (dotted lines) of
Sporobolomyces PC (A) and NPC (B) grown in the presence of 100 μg/mL of PAT. PAT is patulin, (E)-ascl
and (Z)-ascl are (E)-ascladiol and (Z)-ascladiol, respectively. Values are expressed as μg/mL and
represent the means ± standard deviation (n = 9, three measurements in three experiments); (C) Fate
of 100 μg/mL of PAT in the presence of Sporobolomyces PC and NPC. Symbols indicate significant
differences for p < 0.05 (*), p < 0.01 (**), and p < 0.001 (***) when analyzed by Student’s t test.
2.2. Intracellular Extracts from Sporobolomyces sp. Cells Preincubated with Patulin Degrade the Mycotoxin
More Rapidly Than Extracts from Non-Preincubated Cells
Intracellular extracts from PC (EPC, induced extracts) were obtained from Sporobolomyces sp.
cells in their active phase of PAT degradation, which was monitored by TLC analysis as described
in Section 5.5; intracellular extracts from non-preincubated cells (ENPC) were obtained from
Sporobolomyces sp. cells grown in LiBa medium without PAT when the growth reached the same
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OD595 as the culture with PAT. Using this rationale, cells for intracellular extracts were expected
to be at the same metabolic stage, with the only difference being the presence or the absence of
the mycotoxin.
In Figure 5A,B, the fate of 30 and 50 μg/mL of PAT in the presence of EPC and ENPC of
Sporobolomyces sp, respectively, is reported. With 30 μg/mL of PAT, even after 30 min of incubation,
there was a significant difference between EPC and ENPC, with a PAT recovery of 16.09 ± 0.13 μg/mL
and 27.68 ± 1.30 μg/mL, respectively; from 60 min to 360 min (6 h) of incubation; the differences
in PAT recovery between EPC and ENPC were still significant, and in both cases only traces of
mycotoxin were found after 1440 min (24 h) of incubation (Figure 5A). When 50 μg/mL of mycotoxin
was used, significant differences between the PAT recovery in the presence of EPC and ENPC were
found after 60 and 90 min of incubation, and since then they were progressively lower until only
traces of mycotoxin were found after 1440 min of incubation (Figure 5B). At both concentrations used
(30 μg/mL and 50 μg/mL), no PAT decrease was observed when incubated in the presence of boiled
ENPC and EPC.
Figure 5. Fate of 30 μg/mL (A) and 50 μg/mL (B) of PAT in the presence of induced
intracellular extracts (EPC, black lines) and non-induced intracellular extracts (ENPC, grey lines)
of Sporobolomyces. Values are expressed as μg/mL and represent the means ± standard deviation (n = 9,
three measurements in three experiments). Symbols indicate significant differences for p < 0.05 (*)
when analyzed by Student’s t test.
3. Discussion
PAT is a worldwide mycotoxin that represents an economic challenge to pome fruit food industries
and a health hazard to consumers. The reduction of PAT contamination through the use of beneficial
microbes has been known for long time and it is still an active field of research [14].
Pucciniomycotina red yeasts have emerged amongst the microbes that exhibit an elevated tolerance
to PAT toxicity and have a constitutive arsenal to breakdown the PAT molecule. Previous research
showed that the red yeast Sporobolomyces sp. IAM 13481 used in the present study is able to
degrade PAT in vitro by forming desoxypatulinic acid (DPA) and (Z)-ascladiol as the final products
of degradation, whereas (E)-ascladiol is only formed as a transient product [15]. The red yeasts
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Rhodotorula kratochvilovae LS11 and R. paludigenum (originally classified as Rhodosporidium but renamed
following recent taxonomy analysis [20]) are also able to degrade the mycotoxin PAT, but only DPA was
found as a final product of degradation [17,18]; at least for R. kratochvilovae LS11, both ascladiol isomers
were detected as transient products (our unpublished data). We also found that several other red yeast
species degrade PAT in a similar manner to Sporobolomyces or Rhodotorula (our unpublished data).
Therefore, it seems likely that Pucciniomycotina red yeasts degrade PAT through two different
pathways, and their regulation differs between the species under examination. The hypothesis of the
two distinct pathways is supported by the chemical structures of DPA and ascladiol, as they derive from
the breakage of bonds that are located in separate ends of the PAT molecule (Figure 1). Interestingly,
the production of DPA has been described only in red yeasts, whereas ascadiol was found following
PAT degradation both by yeasts (i.e., Saccharomyces cerevisiae) and bacteria (Gluconobacter oxydans and
Lactobacillus plantarum [21–23]). This suggests that while the ascladiol-forming degradation pathway is
likely to be conserved across fungi and bacteria, the DPA-forming pathway has independently evolved
in the red yeast group within the Pucciniomycotina. The importance of these mechanisms of degradation
is supported by the low toxicity of the PAT breakdown products: DPA is less toxic to different
microorganisms, to human lymphocytes and hepatocytes, as well as to Arabidopsis thaliana [17,18,24,25];
ascladiol was originally reported as retaining a quarter of the toxicity displayed by PAT [26], and a more
recent investigation demonstrated that it is not toxic to the porcine intestinal tissue [27].
Noteworthy, the sum of the breakdown products was found to be less than the initial concentration
of PAT. Although there is evidence of adsorption of PAT on the yeast cell wall [28], this phenomenon
does not occur in Sporobolomyces sp. [15], R. paludigenum [17] and R. kratochvilovae [18], indicating that
beside the ascladiol- and DPA- forming degradation pathways, in red yeasts part of the mycotoxin
is probably transformed in other compounds that can enter other metabolic pathways for energy or
other cellular functions, or might be internalized in the cell and/or in organelles.
In the present work, we further examined the response of Sporobolomyces to PAT and demonstrated
that the resistance to and/or degradation of the mycotoxin by Sporobolomyces sp. IAM 13481
are inducible processes. In particular, Sporobolomyces cells that were pretreated (PC) with a low
concentration of PAT showed a faster growth (Figure 2) and a faster kinetics of PAT degradation
compared to Sporobolomyces cells that were not preincubated with PAT (NPC) (Figures 3 and 4),
with differences being more evident when high concentrations of PAT (100 or 200 μg/mL versus
50 μg/mL) were used after the preincubation. Counts of viable Sporobolomyces cells after 1 day of
incubation revealed that with 50 μg/mL of PAT, the growth of PC and NPC increased in a similar
manner (5.3 × 107 CFU/mL and 4.0 × 107 CFU/mL, respectively) compared to the initial cellular
concentration (i.e., 1 × 107 CFU/mL). Conversely, in the presence of 100 μg/mL and 200 μg/mL of
PAT, the growth of NPC dropped respectively to 1.7 × 105 and 4.3 × 103 CFU/mL, with that of PC
being instead 1.2 × 107 and 6.4 × 105 CFU/mL, respectively. Taken together, these data indicate that
Sporobolomyces PC have the highest tolerance to the initial stresses caused by PAT toxicity and this
resulted in a faster growth and degradation of the mycotoxin. This is also demonstrated by the similar
growth (Figure 2) and kinetics of PAT degradation of Sporobolomyces NPC incubated with 50 μg/mL of
mycotoxin (Figure 3B) and Sporobolomyces PC incubated with 100 μg/mL of mycotoxin (Figure 4A).
Similar results were also obtained for R. kratochvilovae LS11 (our unpublished data) and S. cerevisiae [29].
Based on our recent RNAseq study performed with Sporobolomyces sp. IAM 13481 incubated in the
presence or absence of 5 μg/mL and 50 μg/mL of PAT [19], it is likely that the pre-incubation step
with the mycotoxin induces the earlier activation of (i) genes encoding proteins involved in response
to oxidative and other stresses related to PAT cytotoxicity; (ii) antioxidants systems (glutathione
and thioredoxin) essential for restoring the cellular redox homeostasis; (iii) export and detoxification
proteins that are predicted to be involved in PAT efflux and PAT degradation. Therefore, Sporobolomyces
PC cells are already in an active/alert stage that enables them to better counteract the stronger toxicity
impact due to the use of higher PAT concentrations. Other data that corroborate this interpretation of
the obtained results come from our screening of T-DNA insertional mutants of Sporobolomyces sp. IAM
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13481; we found that the inactivation of genes involved in the resistance to oxidative, genotoxic and
other stresses caused by PAT resulted in an increased sensitivity of the mutants to the mycotoxin as
compared to the wild type strain [15].
A caveat of using intact cells of Sporobolomyces sp. IAM 13481 consisted in the difficulty in
evaluating the induction of mechanisms involved in the direct degradation of the PAT, which might
be hidden by the multiplicity of resistance mechanisms activated in response to the mycotoxin.
Therefore, with the rationale to focus only on the degradation mechanisms and excluding those of
resistance, the fate of PAT was also tested in the presence of intracellular proteins extracted from
Sporobolomyces sp. IAM 13481 cells grown in the presence (EPC) and in the absence of PAT (ENPC).
Results presented in Figure 5A,B showed that EPC degrades PAT more promptly as compared to
ENPC, although in all cases there were no differences in the length of the degradation period as only
traces of PAT were detected after 24 h of incubation (1440 min). Corroborating data obtained for
R. kratochvilovae LS11 (our unpublished data), R. paludigenum [17] and S. cerevisiae [29], our results
confirm that PAT degradation is an enzyme-mediated mechanism and that the synthesis of the relevant
enzyme(s) is likely induced by PAT treatment, further suggesting that PAT metabolization is itself
a mechanism of resistance that contributes to overcoming PAT toxicity together with the activation
of defense mechanisms described above. Several genes encoding for enzymes specifically involved
in PAT degradation have been predicted [19], and they include a glucose–methanol–choline (GMC)
oxidoreductase, a protein subunit of aromatic ring-opening dioxygenase, the vacuolar proteins Env9
and Ycf1, and several short and medium chain dehydrogenases. Their target mutagenesis is in
progress to elucidate their role in the hydrolysis of the mycotoxin, and to allow the identification of
the cellular and molecular components that control their expression. Last but not least, the evaluation
of the biocontrol activity of these mutants against P. expansum will help to understand whether
PAT degradation is also an additional mechanism of action used by the biocontrol agents to
counteract postharvest pathogens, since some recent reports point to PAT as a factor involved in
the virulence/aggressiveness of P. expansum, at least on some cultivars of apples [13].
4. Conclusions
In conclusion, in the present study, we used the model organism Sporobolomyces sp. IAM 13481
to evaluate the induction of mechanisms of PAT resistance and degradation; the induction step was
performed by pretreating Sporobolomyces cells with a low concentration of PAT. Our results suggest
that intact yeast cells were appropriate for the evaluation of the mechanisms of PAT resistance and
degradation together, while the use of intracellular extracts allowed to evaluate more specifically the
mechanisms of PAT degradation. We found that the mechanisms that control both PAT resistance and
degradation can be induced by pretreatment with the mycotoxin, and that both processes are related
to each other and overall, they contribute both to reduce PAT concentration and mitigate its toxicity.
These results contribute to the achievements of long-term goals, namely the production of the enzymes
responsible for PAT detoxification that could be the base for detoxification processes of products and
juices derived from pome fruits.
5. Materials and Methods
5.1. Strain Used in This Study
The red yeast Sporobolomyces sp. strain IAM 13481 was used in this study. This strain was routinely
cultivated on yeast peptone dextrose (YPD: Yeast extract 10 g/L, Peptone 20 g/L, Glucose 20 g/L,
Agar 20 g/L).
5.2. Patulin
Commercial standards of PAT were purchased from Sigma-Aldrich (Milan, Italy) and from A.G.
Scientific, Inc. (San Diego, CA, USA). PAT was dissolved in ethyl acetate and stored at −20 ◦C.
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For experiments, the appropriate aliquots of PAT were withdrawn and the ethyl acetate evaporated
under nitrogen stream. The dry PAT was subsequently resuspended at the desired concentrations in
working solutions that were LiBa medium (LiBa, 10.0 g of D-glucose, 2.0 g of L-asparagine, 1.0 g of
KH2PO4, 0.5 g of MgSO4·7H2O, 0.01 mg of FeSO4·7H2O, 8.7 mg of ZnSO4·7H2O, 3.0 mg of MnSO4·H2O,
0.1 mg of Biotin, and 0.1 mg of Thiamine, per Liter) [30] for assays with intact cells, or in buffer
potassium phosphate 0.1 M pH 6 [31] for assays with intracellular extracts. The PAT working solutions
were filter-sterilized (0.2 μm) prior to use.
5.3. Patulin Degradation Assays with PC and NPC of Sporobolomyces sp. IAM 13481
Analysis of PAT persistence in the presence of PC and NPC of Sporobolomyces sp. was performed
as previously reported [15] with minor modifications. Cells of Sporobolomyces sp. were grown overnight
in LiBa medium in the absence and in the presence of 15 μg/mL of PAT. Cultures were centrifuged
for 5 min at 4000 rpm, the cells were resuspended in LiBa, and their concentration was adjusted to
1 × 107 CFU/mL. Three millilitres of this suspension was incubated at 24 ◦C in sterile 25 mL-flasks in
the presence of 50 and 100 μg/mL of PAT. Yeasts growth was monitored on a daily basis by reading
OD at 595 nm in a microplate Reader (Bio-Rad Laboratories, Hercules, CA, USA) [32], and at the same
time points, the time-course of PAT degradation was assessed by means of HPLC analysis in the same
samples as described in Section 5.5. Data from the experiments were pooled since they were similar in
the three repetitions.
5.4. Patulin Degradation Assays Using Intracellular Protein Extracts Obtained from PC and NPC of
Sporobolomyces sp. IAM 13481
In order to obtain induced intracellular extracts of Sporobolomyces sp. IAM 13481, an overnight
culture of yeast cells was diluted to 1 × 107 CFU/mL, inoculated in LiBa medium with 15 μg/mL of
PAT and incubated on a rotary shaker at 24 ◦C. The yeast growth was monitored by reading the OD at
595 nm, and the degradation of PAT and the onset of breakdown products were monitored by TLC
analysis as previously described [15,16]. When the intensity decrease of the PAT spot paralleled the
onset of the degradation products, achieved at OD595 of ~0.25, intracellular proteins were extracted as
described below. Non-pretreated intracellular samples were extracted from Sporobolomyces sp. cells
grown in LiBa (same initial concentration as in PC) without PAT until the OD595 value reached the
same value as the culture grown in the presence of the mycotoxin.
Cells were collected by centrifugation for 10 min at 4000 rpm and then lyophilized. Five hundred
milligrams of lyophilized pellets was resuspended with lysis buffer [buffer potassium phosphate
50 mM pH 6 + phenylmethylsulfonyl fluoride (PMSF) 1 mM], 300 mg of acid-washed glass beads was
added and the samples vortexed for 1 min. Samples were kept in liquid nitrogen for 1 additional min,
then thawed and subsequently centrifuged at 10,000 rpm for 5 min at 4 ◦C. Supernatants were kept
on ice. This lysis step was repeated five times, at the end of which all the supernatants of the same
sample were pooled. In order to eliminate residual pellet, the supernatants were filtered with 0.45 μm
and 0.25 μm filters (Barloworld Scientific, Stone, Staffordshire, UK). Sodium azide (0.02% w/v) was
added and the samples were dialyzed (dialysis tubes with cutoff 12,000 Da) in water (pH 6) for 24 h
with three changes. Samples were lyophilized, suspended in buffer phosphate 50 mM pH 6 (without
PMSF) and the intracellular proteins concentration was quantified using the Bradford assay (Bio-Rad)
according to the manufacturer’s instructions, with the BSA used as reference.
PAT degradation assays were carried out in 50 mL falcon tubes each containing 3 mL of incubation
mixture. Tubes were kept on a rotary shaker at 160 rpm and 24 ◦C. Amounts of 30 and 50 μg/mL
of PAT were added to phosphate buffer 50 mM pH 6 containing 0.4 mg/mL of intracellular extracts.
Controls were PAT in buffer phosphate, and PAT incubated in the presence of boiled intracellular
extracts. PAT fate was assessed by HPLC analysis according to the same conditions as those described
above after 30 min, 60 min, 90 min, 6 h (360 min), 24 h (1440 min) and 48 h (2880 min). At each
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time point, 100 μL of each suspension was withdrawn, extracted twice with ethyl acetate, dried and
resuspended with buffer phosphate 50 mM pH 6 for HPLC analysis.
5.5. TLC and HPLC Analyses
TLC qualitative analysis and HPLC quantitative analyses were performed as previously
reported [15,16,18].
For TLC analysis, samples were pooled, centrifuged at 14,000 rpm for 5 min for pelleting the cells,
and the supernatant was extracted twice with ethyl acetate adjusted to pH 2. Extracted samples were
dried under a nitrogen stream, resuspended in 10 μL of ethyl acetate and loaded on aluminium-backed
silica gel 60 F254 plates (EMD Chemicals, Gibbstown, NJ, USA). Chromatography was performed
at room temperature in glass tanks by using toluene/ethyl acetate/formic acid 5:4:1 (v/v/v) as the
solvent system. After development, plates were dried, observed and photographed under UV light
(λ = 254 nm).
Quantitative analysis of PAT and breakdown products formed by Sporobolomyces sp. IAM13481
was performed by HPLC based on MacDonald et al. [33] with slight modifications. Three samples per
time point were centrifuged and filter-sterilized to remove cells, then injected for analysis. The HPLC
apparatus was a Dionex (Sunnyvale, CA, USA) analytical system consisting of a P680 solvent delivery
system and a 20 μL injector loop (Rheodyne, Cotati). The UVD170 detector (Dionex, Sunnyvale, CA,
USA) set at 276 nm was connected to a data integration system (Dionex Chromeleon Version 6.6).
Data from the experiments were pooled, since they were similar in the three repetitions, and expressed
as μg/mL of patulin, desoxypatulinic acid and ascladiols ± standard deviation (n = 9).
5.6. Statistical Analysis
Patulin persistance in the biodegradation assays carried out using intact Sporobolomyces PC
and NPC and their intracellular extracts (EPC and ENPC) was analyzed by Student’s t test using
the software GraphPad Prism 7.00 for Mac (La Jolla, CA, USA), and differences were considered
statistically significant when p-value was lower than 0.05.
Acknowledgments: This research was supported by PRIN 2008—prot. 2008JKH2MM—“Exploitation of genes
and proteins from different biological sources for limiting patulin contamination caused by the pathogenic fungus
Penicillium expansum” (to Raffaello Castoria) and by a grant from the Dottorato di Ricerca in Difesa e Qualità delle
Produzioni Agro-alimentari e Forestali (to Giuseppe Ianiri). This research was also partly supported by a grant
from MINECO (AGL2015-65684-C2-1-R) (to Cristina Pinedo).
Author Contributions: G.I. and R.C. conceived and designed the experiments; G.I. and C.P. performed the
experiments; G.I., C.P. and A.F. analyzed the data; R.C. and G.P. contributed reagents/materials/analysis tools;
G.I. and R.C. wrote the paper. All the authors read and approved the final version of the manuscript.
Conflicts of Interest: The authors declare no conflict of interest. The founding sponsors had no role in the design
of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, and in the
decision to publish the results.
References
1. Moake, M.M.; Padilla-Zakour, O.I.; Worobo, R.W. Comprehensive review of patulin control methods in
foods. Compr. Rev. Food Sci. Food Saf. 2005, 1, 8–21. [CrossRef]
2. IARC. Some naturally occurring and synthetic food components, furocoumarins and ultraviolet radiation.
In IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Humans; IARC: Lyon, France, 1986;
Volume 40, pp. 83–98.
3. WHO. World Health Organization, 44th Report of the Joint FAO/WHO Expert Committee on Food Additives;
Technical Report Series; WHO: Geneva, Switzerland, 1995; Volume 859.
4. Harris, K.L.; Bobe, G.; Bourquin, L.D. Patulin surveillance in apple cider and juice marketed in michigan.
J. Food Prot. 2009, 72, 1255–1261. [CrossRef] [PubMed]
5. Ritieni, A. Patulin in italian commercial apple products. J. Agric. Food Chem. 2003, 51, 6086–6090. [CrossRef]
[PubMed]
54
Toxins 2017, 9, 61
6. Morales, H.; Marín, S.; Ramos, A.J.; Sanchis, V. Influence of post-harvest technologies applied during cold
storage of apples in Penicillium expansum growth and patulin accumulation: A review. Food Control 2010, 21,
953–962. [CrossRef]
7. Puel, O.; Galtier, P.; Oswald, I.P. Biosynthesis and toxicological effects of patulin. Toxins 2010, 2, 613–631.
[CrossRef] [PubMed]
8. Glaser, N.; Stopper, H. Patulin: Mechanism of genotoxicity. Food Chem. Toxicol. 2012, 50, 1796–1801.
[CrossRef] [PubMed]
9. Tannous, J.; El Khoury, R.; Snini, S.P.; Lippi, Y.; El Khoury, A.; Atoui, A.; Lteif, R.; Oswald, I.P.; Puel, O.
Sequencing, physical organization and kinetic expression of the patulin biosynthetic gene cluster from
Penicillium expansum. Int. J. Food Microbiol. 2014, 189, 51–60. [CrossRef] [PubMed]
10. Sanzani, S.M.; Reverberi, M.; Punelli, M.; Ippolito, A.; Fanelli, C. Study on the role of patulin on pathogenicity
and virulence of Penicillium expansum. Int. J. Food Microbiol. 2012, 153, 323–331. [CrossRef] [PubMed]
11. Ballester, A.R.; Marcet-Houben, M.; Levin, E.; Sela, N.; Selma-Lázaro, C.; Carmona, L.; Wisniewski, M.;
Droby, S.; González-Candelas, L.; Gabaldón, T. Genome, transcriptome, and functional analyses of
Penicillium expansum provide new insights into secondary metabolism and pathogenicity. Mol. Plant
Microbe Interact. 2015, 28, 232–248. [CrossRef] [PubMed]
12. Li, B.; Zong, Y.; Du, Z.; Chen, Y.; Zhang, Z.; Qin, G.; Zhao, W.; Tian, S. Genomic characterization reveals
insights into patulin biosynthesis and pathogenicity in Penicillium species. Mol. Plant Microbe Interact. 2015,
28, 635–647. [CrossRef] [PubMed]
13. Snini, S.P.; Tannous, J.; Heuillard, P.; Bailly, S.; Lippi, Y.; Zehraoui, E.; Barreau, C.; Oswald, I.P.; Puel, O. Patulin
is a cultivar-dependent aggressiveness factor favouring the colonization of apples by Penicillium expansum.
Mol. Plant Pathol. 2016, 17, 920–930. [CrossRef] [PubMed]
14. Mahunu, G.K.; Zhang, H.; Yang, Q.; Li, C.; Zheng, X. Biological control of patulin by antagonistic yeast:
A case study and possible model. Crit. Rev. Microbiol. 2016, 42, 643–655. [CrossRef] [PubMed]
15. Ianiri, G.; Idnurm, A.; Wright, S.A.; Durán-Patrón, R.; Mannina, L.; Ferracane, R.; Ritieni, A.; Castoria, R.
Searching for genes responsible for patulin degradation in a biocontrol yeast provides insight into the basis
for resistance to this mycotoxin. Appl. Environ. Microbiol. 2013, 79, 3101–3115. [CrossRef] [PubMed]
16. Castoria, R.; Morena, V.; Caputo, L.; Panfili, G.; De Curtis, F.; De Cicco, V. Effect of the biocontrol yeast
Rhodotorula glutinis strain LS11 on patulin accumulation in stored apples. Phytopathology 2005, 95, 1271–1278.
[CrossRef] [PubMed]
17. Zhu, R.; Feussner, K.; Wu, T.; Yan, F.; Karlovsky, P.; Zheng, X. Detoxification of mycotoxin patulin by the
yeast Rhodosporidium paludigenum. Food Chem. 2015, 179, 1–5. [CrossRef] [PubMed]
18. Castoria, R.; Mannina, L.; Durán-Patrón, R.; Maffei, F.; Sobolev, A.P.; De Felice, D.V.; Pinedo-Rivilla, C.;
Ritieni, A.; Ferracane, R.; Wright, S.A. Conversion of the mycotoxin patulin to the less toxic desoxypatulinic
acid by the biocontrol yeast Rhodosporidium kratochvilovae strain LS11. J. Agric. Food Chem. 2011, 59,
11571–11578. [CrossRef] [PubMed]
19. Ianiri, G.; Idnurm, A.; Castoria, R. Transcriptomic responses of the basidiomycete yeast Sporobolomyces sp. to
the mycotoxin patulin. BMC Genom. 2016, 17, 210. [CrossRef] [PubMed]
20. Wang, Q.M.; Yurkov, A.M.; Göker, M.; Lumbsch, H.T.; Leavitt, S.D.; Groenewald, M.; Theelen, B.; Liu, X.Z.;
Boekhout, T.; Bai, F.Y. Phylogenetic classification of yeasts and related taxa within Pucciniomycotina.
Stud. Mycol. 2015, 81, 149–189. [CrossRef] [PubMed]
21. Moss, M.O.; Long, M.T. Fate of patulin in the presence of the yeast Saccharomyces cerevisiae. Food Addit. Contam.
2002, 19, 387–399. [CrossRef] [PubMed]
22. Ricelli, A.; Baruzzi, F.; Solfrizzo, M.; Morea, M.; Fanizzi, F.P. Biotransformation of patulin by Gluconobacter
oxydans. Appl. Environ. Microbiol. 2007, 73, 785–792. [CrossRef] [PubMed]
23. Hawar, S.; Vevers, W.; Karieb, S.; Ali, B.K.; Billington, R.; Beal, J. Biotransformation of patulin to
hydroascladiol by Lactobacillus plantarum. Food Control 2013, 34, 502–508. [CrossRef]
24. Scott, P.M.; Kennedy, B.; Walbeek, W.V. Desoxypatulinic acid from a patulin-producing strain of Penicillium
patulum. Experientia 1972, 28, 1252. [CrossRef] [PubMed]
25. Wright, S.A.; De Felice, D.V.; Ianiri, G.; Pinedo-Rivilla, C.; De Curtis, F.; Castoria, R. Two rapid assays for
screening of patulin biodegradation. Int. J. Environ. Sci. Technol. 2014, 11, 1387–1398. [CrossRef]
26. Suzuki, T.; Takeda, M.; Tanabe, H. A new mycotoxin produced by Aspergillus clavatus. Chem. Pharm. Bull.
1971, 19, 1786–1788. [CrossRef] [PubMed]
55
Toxins 2017, 9, 61
27. Maidana, L.; Gerez, J.R.; El Khoury, R.; Pinho, F.; Puel, O.; Oswald, I.P.; Bracarense, A.P. Effects of patulin
and ascladiol on porcine intestinal mucosa: An ex vivo approach. Food Chem. Toxicol. 2016, 98, 189–194.
[CrossRef] [PubMed]
28. Guo, C.; Yue, T.; Hatab, S.; Yuan, Y. Ability of inactivated yeast powder to adsorb patulin from apple juice.
J. Food Prot. 2012, 75, 585–590. [CrossRef] [PubMed]
29. Sumbu, Z.L.; Thonart, P.; Bechet, J. Action of patulin on a yeast. Appl. Environ. Microbiol. 1983, 45, 110–115.
[PubMed]
30. Lilly, V.G.; Barnett, H.L. Physiology of the Fungi; McGraw-Hill: New York, NY, USA, 1951.
31. Sambrook, J.; Fritsch, E.F.; Maniatis, T. Molecular Cloning: A Laboratory Manual; Cold Spring Harbor
Laboratory: Cold Spring Harbor, NY, USA, 1989.
32. López-García, B.; González-Candelas, L.; Pérez-Payá, E.; Marcos, J.F. Identification and characterization of
a hexapeptide with activity against phytopathogenic fungi that cause postharvest decay in fruits. Mol. Plant
Microbe Interact. 2000, 13, 837–846. [CrossRef] [PubMed]
33. MacDonald, S.; Long, M.; Gilbert, J.; Felgueiras, I. Liquid chromatographic method for determination of
patulin in clear and cloudy apple juices and apple puree: Collaborative study. J. AOAC Int. 2000, 83,
1387–1394. [PubMed]
© 2017 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access
article distributed under the terms and conditions of the Creative Commons Attribution




Detoxification of Deoxynivalenol via Glycosylation
Represents Novel Insights on Antagonistic Activities
of Trichoderma when Confronted with
Fusarium graminearum
Ye Tian 1, Yanglan Tan 1, Na Liu 1, Zheng Yan 1, Yucai Liao 2, Jie Chen 3, Sarah de Saeger 4,
Hua Yang 5, Qiaoyan Zhang 5 and Aibo Wu 1,*
1 SIBS-UGENT-SJTU Joint Laboratory of Mycotoxin Research, Key Laboratory of Food Safety Research,
Institute for Nutritional Sciences, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences,
University of Chinese Academy of Sciences, 294 Taiyuan Road, Shanghai 200031, China;
tianye@sibs.ac.cn (Y.T.); yltan@sibs.ac.cn (Y.T.); liuna@sibs.ac.cn (N.L.); zyan@sibs.ac.cn (Z.Y.)
2 College of Plant Science and Technology, Huazhong Agricultural University, Wuhan 430070, China;
yucailiao@mail.hzau.edu.cn
3 Department of Resources and Environment Sciences, School of Agriculture and Biology,
Shanghai Jiaotong University, 800 Dongchuan Road, Shanghai 200240, China; jiechen59@sjtu.edu.cn
4 Laboratory of Food Analysis, Department of Bioanalysis, Faculty of Pharmaceutical Sciences,
Ghent University, Ottergemsesteenweg 460, B-9000 Ghent, Belgium; Sarah.DeSaeger@UGent.be
5 State Key Laboratory Breeding Base for Zhejiang Sustainable Pest and Disease Control,
Institute of Quality and Standard for Agro-Products, Zhejiang Academy of Agricultural Sciences,
Hangzhou 310021, China; yanghua806@hotmail.com (H.Y.); yanyan0014@163.com (Q.Z.)
* Correspondence: abwu@sibs.ac.cn; Tel.: +86-21-5492-0716
Academic Editor: Ting Zhou
Received: 22 September 2016; Accepted: 10 November 2016; Published: 15 November 2016
Abstract: Deoxynivalenol (DON) is a mycotoxin mainly produced by the Fusarium graminearum
complex, which are important phytopathogens that can infect crops and lead to a serious disease
called Fusarium head blight (FHB). As the most common B type trichothecene mycotoxin, DON
has toxic effects on animals and humans, which poses a risk to food security. Thus, efforts have
been devoted to control DON contamination in different ways. Management of DON production
by Trichoderma strains as a biological control-based strategy has drawn great attention recently.
In our study, eight selected Trichoderma strains were evaluated for their antagonistic activities on
F. graminearum by dual culture on potato dextrose agar (PDA) medium. As potential antagonists,
Trichoderma strains showed prominent inhibitory effects on mycelial growth and mycotoxin
production of F. graminearum. In addition, the modified mycotoxin deoxynivalenol-3-glucoside
(D3G), which was once regarded as a detoxification product of DON in plant defense, was detected
when Trichoderma were confronted with F. graminearum. The occurrence of D3G in F. graminearum
and Trichoderma interaction was reported for the first time, and these findings provide evidence that
Trichoderma strains possess a self-protection mechanism as plants to detoxify DON into D3G when
competing with F. graminearum.
Keywords: mycotoxin; toxigenic Fusarium; biological control; Trichoderma; modified mycotoxin
1. Introduction
Mycotoxins are toxic secondary metabolites that are produced by toxigenic molds, and may
contaminate different cereal grains [1]. Deoxynivalenol (DON), also known as vomitoxin, is mainly
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produced by the Fusarium graminearum species that can infect crops and cause devastating diseases
called Fusarium head blight (FHB) or scab [2]. DON is an inhibitor of protein, DNA, and RNA
synthesis at the molecular level, and exerts toxic potential to plants, animals, and humans [3].
The functions of DON in interactions of F. graminearum and other organisms have been studied
before. As a crucial secondary metabolite in development of F. graminearum, DON is beneficial for
Fusarium to deal with a complex environment and compete with other organisms [4,5]. Fusarium
may utilize DON to disrupt plant defense system in the infection process. DON is regarded as a
virulence factor when infecting plants, and it can facilitate disease spread in infected plant tissues.
Genetic studies have proved that DON non-producing Fusarium mutants showed less virulence on
crops than wild-type strains [6]. On the other hand, plants usually have the self-defense mechanisms
to cope with mycotoxins, such as conjugating them with endogenous metabolites to less toxic products.
An important detoxification process reducing the toxicity of DON in plants is glycosylation catalyzed
by a special kind of glycosyltransferases [7], and a common detoxification product of DON in this
reaction is deoxynivalenol-3-glucoside (D3G) (Figure 1). This conjugated mycotoxin was originally
termed as a masked mycotoxin, because its structure has been changed and it may escape routine
detection by conventional analytical methods [8].
Figure 1. Chemical structures of deoxynivalenol (DON), deoxynivalenol-3-glucoside (D3G), and
acetylated derivatives of DON: 3-acetyl-deoxynivalenol (3-ADON) and 15-acetyl-deoxynivalenol
(15-ADON).
The pathogens causing FHB are also capable of producing 3-acetyl-deoxynivalenol (3-ADON)
or 15-acetyl-deoxynivalenol (15-ADON), which are commonly-detected acetylated derivatives of
DON in contaminated grains or food commodities [2]. Both DON and ADONs belong to B-type
trichothecene mycotoxins (Figure 1) characterized by a keto-group at position C-8 in their molecule
structures [2]. The epoxide group is considered as a key factor determining the toxicity of trichothecene
mycotoxins [9], and ADONs also possess toxic effects [10,11]. In order to protect consumers, DON and
its acetylated types have all been included in the group provisional maximum tolerable daily intake
(PMTDI) according to the maximum tolerated levels of DON in food enacted by the Joint FAO/WHO
Expert Committee on Food Additives (JECFA) [10].
To reduce the risks caused by DON contamination in the food chain, plenty of measures, including
selection of resistant cultivars, application of fungicide, and biological control agents (BCAs), have
been studied and used to control DON-producing pathogens [12,13]. Among these mentioned
strategies, biological control emerging as a green approach has captured significant attention recently.
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Natural fungicides, antagonistic microorganisms, and detoxification enzymes are the most-concerned
functional BCAs to control DON contamination [14]. Antagonistic microorganisms could inhibit the
development and mycotoxin production of toxigenic pathogens. Trichoderma strains, Bacillus strains,
Clonostachys rosea, and Cladosporium cladosporioides are promising antagonistic microorganisms to
manage DON contamination [15,16]. Among them, Trichoderma strains have been widely investigated
and applied as beneficial BCAs in agriculture. They can protect crops against plant pathogens
environment-friendly, and biological control activity of Trichoderma is mainly due to antibiotic
production to inhibit the growth of pathogens, substrate competition to restrict colony areas of
pathogens, and the ability to activate plant defense responses against pathogens [17,18].
The aim of our work was to study the potential antagonistic activities of selected Trichoderma
strains for management of F. graminearum by dual culture assay. We assessed the anti-growth
activity of the different Trichoderma strains on F. graminearum. Meanwhile, DON and its acetylated or
glycosylated forms were monitored to evaluate the anti-toxigenic activity of antagonists. Interestingly,
the modified mycotoxin D3G, which was previously regarded as a detoxification product in plant
defense against DON-producing Fusarium [7], was detected when F. graminearum was co-cultured with
Trichoderma strains. To our knowledge, this is the first time that it has been reported that the D3G is a
detoxification product of Trichoderma when in competition with F. graminearum, which may provide
new understandings on the interaction of antagonistic microbes and toxigenic Fusarium.
2. Results
2.1. Impact of Trichoderma Strains on Growth of F. graminearum 5035 in Dual Culture
Trichoderma is recognized as a non-pathogenic genus majorly found in soil and plants, and has
been widely studied due to its biological control-related characteristics [19]. In our antagonistic assay,
the growth rates of selected Trichoderma strains were much faster than that of F. graminearum 5035
(Figure 2A). The mycelia of tested fungi began to contact two days after incubation. The faster growth
rate made Trichoderma quickly occupy the living space and surround the colony of Fusarium, and then
Trichoderma effectively suppressed the mycelial growth of Fusarium. The inhibition rate of Trichoderma
on mycelial growth of Fusarium ranged from 73% to 77% (Figure 2B). For the pathogen, it was hard to
overgrow antagonists for further extension on PDA medium.
Moreover, we observed the colony morphology of Fusarium when alone or in the presence
of antagonists after incubation (Figure 3), finding that four Trichoderma strains including
T. longibranchiatum GIM 3.534, T. harzianum Q710613, T. atroviride Q710251 and T. asperellum Q710682
were able to overgrow and sporulate on the colony of F. graminearum 5035, and the mycelia of Fusarium
in these combinations were relatively flat, while the mycelia of Fusarium in other combinations were
much denser. These signs demonstrated that the four Trichoderma strains capable of overgrowing the
pathogen were more effective in inhibiting the mycelia spread of Fusarium on PDA medium.
Trichoderma strains have a stronger capacity to occupy living space and take up nutrients than
other microbes [20]. It seems that growth suppression is the major inhibition pattern of Trichoderma
when in competition with pathogens.
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Figure 2. Growth rate (cm/day) of F. graminearum 5035 and Trichoderma strains (A). From left to right:
the growth rate of F. graminearum 5035, T. harzianum JF309, T. harzianum GIM3.442, T. koningii GIM3.137,
T. longibranchiatum GIM3.534, T. harzianum Q710613, T. atroviride Q710251, T. asperellum Q710682,
and T. virens Q710925, respectively. Inhibition rate (%) of Trichoderma strains on mycelial growth of
F. graminearum 5035 in dual culture (B). From left to right: F. graminearum 5035 grew against T. harzianum
JF309, T. harzianum GIM3.442, T. koningii GIM3.137, T. longibranchiatum GIM3.534, T. harzianum Q710613,
T. atroviride Q710251, T. asperellum Q710682, and T. virens Q710925, respectively. Data were from two
independent experiments and shown as the mean ± SEM. Bars with different letters were significantly
different according Tukey’s Test (α < 0.05) following one-way ANOVA (analysis of variance) analysis.
Figure 3. Cont.
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Figure 3. Colony morphology of F. graminearum 5035 in dual culture tests after incubation on the
potato dextrose agar (PDA) medium. F. graminearum 5035 grew alone (A); F. graminearum 5035 grew
against T. harzianum JF309 (B); T. harzianum GIM3.442 (C); T. koningii GIM3.137 (D); T. longibranchiatum
GIM3.534 (E); T. harzianum Q710613 (F); T. atroviride Q710251 (G); T. asperellum Q710682 (H); and
T. virens Q710925 (I).
2.2. Effect of Trichoderma Strains on Mycotoxin Production of F. graminearum 5035 in Dual Culture
DON-producing Fusarium could infect crops in field and subsequently cause DON accumulation
in cereal grains. Prevention before harvest is an important strategy to manage DON contamination,
and antagonistic Trichoderma strains are promising BCAs to achieve this goal [21]. Matarese et al. has
revealed that a Trichoderma gamsii strain 6085 could strongly reduce DON production of Fusarium
on rice medium [17]. In order to accurately reveal the effect of Trichoderma strains on mycotoxin
production of F. graminearum, DON and ADONs were all monitored by a liquid chromatography
tandem mass spectrometry (LC-MS/MS) method in our work.
The data showed that F. graminearum 5035 was able to produce 57 μg/g DON and 20 μg/g
15-ADON on PDA medium when alone, indicating that the tested F. graminearum was a 15-ADON
producer mainly producing DON and 15-ADON [2]. When F. graminearum 5035 was co-cultured with
Trichoderma, the amount of DON produced by F. graminearum reduced significantly due to the strong
antagonistic action of Trichoderma. When in the presence of T. harzianum Q710613, T. atroviride Q710251
and T. asperellum Q710682, the amount of DON produced by F. graminearum 5035 decreased more than
90% compared with the control. In the presence of other Trichoderma strains, the inhibition rate of DON
production ranged from 70% to 88% (Figure 4A). With regard to 15-ADON, the antagonists seemed to
exhibit stronger inhibition capacity: the inhibition rate of 15-ADON production ranged from 86% to
98% (Figure 4B). In consideration of the non-ignorable toxicity of ADONs [22], DON and its acetylated
forms should be all monitored when assessing the anti-toxigenic activity of antagonistic microbes.
Figure 4. Cont.
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Figure 4. Mycotoxin production (DON and 15-ADON) of F. graminearum 5035 when alone or
against different Trichoderma strains. From left to right: F. graminearum 5035 grew alone, and grew
against T. harzianum JF309, T. harzianum GIM3.442, T. koningii GIM3.137, T. longibranchiatum GIM3.534,
T. harzianum Q710613, T. atroviride Q710251, T. asperellum Q710682 and T. virens Q710925 (A,B). Data
were from two independent experiments and shown as the mean ± SEM. Bars with different letters
were significantly different according Tukey’s Test (α < 0.05) following one-way ANOVA analysis.
2.3. Occurrence of Modified Mycotoxin D3G in Dual Culture of Trichoderma and F. graminearum
Modified mycotoxin D3G is the most prevalent detoxification product of DON in self-defense of
plants, and detoxification via glycosylation is very general in plants. However, this biotransformation
process is unusual in microbes [23]. A previous study has emphasized that DON production of
F. graminearum could not reduce the biomass of Trichoderma when in competition [24]. Therefore,
we speculated that Trichoderma strains were very likely to possess some underlying detoxification
mechanisms against DON-producing F. graminearum. In order to verify whether Trichoderma strains
could detoxify DON via glycosylation when confronted with F. graminearum, D3G was monitored in
our work.
Based on our LC-MS/MS method, the glycosylation form of DON (D3G), was detected when
F. graminearum 5035 was co-cultured with Trichoderma strains, while there was no D3G detected in
the control group (Figure 5). Glycosylation of DON catalyzed by UDP-glucosyltransferases (UGTs)
is a well-known detoxification process in plants, and the first UGT capable of transforming DON to
D3G was identified from Arabidopsis thaliana [7]. However, no studies have reported the occurrence of
modified mycotoxin D3G in interactions between microbes so far. In order to confirm the presence
of D3G in the co-culture of Trichoderma and F. graminearum, prepared samples of dual culture assay
were analyzed by liquid chromatography high resolution mass spectrometry (LC-HRMS). Shown
as in Figure S1, the MS/MS spectra of the precursor ion (m/z 517.1927, [M + Ac]−) in samples of
the dual culture test were in good agreement with the MS/MS spectra of D3G standard. The key
fragments m/z 427.16, 457.17, 409.15, 277.11, 247.10 for [D3G + Ac]− were also observed in the previous
study [25]. These results provided evidences for the existence of D3G in dual cultures of Trichoderma and
DON-producing Fusarium. The occurrence of D3G in Trichoderma and Fusarium interaction indicated
that D3G was a detoxification product in self-defense of Trichoderma against DON-producing Fusarium.
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Figure 5. Selected reaction monitoring (SRM) chromatograms of D3G in samples of dual culture test:
F. graminearum 5035 grew against T. harzianum JF309 (B); T. harzianum GIM3.442 (C); T. koningii GIM3.137
(D); T. longibranchiatum GIM3.534 (E); T. harzianum Q710613 (F); T. atroviride Q710251 (G); T. asperellum
Q710682 (H); and T. virens Q710925 (I). Red line (m/z 517.1 > m/z 427.4) and blue line (m/z 517.1 >
m/z 457.4) show the SRM traces of D3G. There was no D3G detected when F. graminearum 5035 grew
alone on PDA medium (A).
Our preliminary results provide evidence that Trichoderma strains not only possess the strong
inhibitory action on F. graminearum, but also possess the detoxification capability to glycosylate DON
when competing with F. graminearum. All of these advantageous features make Trichoderma strains
promising BCAs against plant disease in agriculture.
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2.4. A Significant Difference in D3G/DON Ratios of Trichoderma Strains when Confronted with
F. graminearum 5035
Previous studies regarding pathogen and plant interactions have illustrated that D3G/DON
ratios of various wheat lines can be regarded as their resistance indicators against FHB [8,26,27].
Similarly, D3G/DON ratios of different Trichoderma strains used in this study may also be related to
their resistance to Fusarium. In our work, we assessed the D3G/DON ratios of tested Trichoderma
strains when dual cultured with DON-producing F. graminearum 5035. Interestingly, the D3G/DON
ratios of different Trichoderma strains that might reflect their resistance to Fusarium were significantly
different (Figure 6). T. harzianum Q710613, T. atroviride Q710251 and T. asperellum Q710682 showed
relatively higher ratios that exceeded 20%, while D3G/DON ratios of other Trichoderma strains were
relatively lower, which were in the range of 4% to 12%. It seems that DON-resistant antagonists
have more potential in further investigation and application, because recent studies have showed
that over-expression of UGT genes capable of detoxifying DON into D3G in crops could improve
their resistance against Fusarium [28,29], and the reported functional UGT genes were all derived from
plants. Thus, our data revealed that Trichoderma might be a potential source to seek efficient UGT genes,
which can be expressed to detoxify DON directly or be genetically-engineered in crops to improve
their resistance against FHB causal agents [30].
Figure 6. D3G/DON ratios of different Trichoderma strains when confronted with F. graminearum 5035
in dual culture. F. graminearum 5035 grew against T. harzianum JF309, T. harzianum GIM3.442, T. koningii
GIM3.137, T. longibranchiatum GIM3.534, T. harzianum Q710613, T. atroviride Q710251, T. asperellum
Q710682; and T. virens Q710925, respectively. Data were from two independent experiments and shown
as the mean ± SEM. Bars with different letters were significantly different according Tukey’s Test
(α < 0.05) following one-way ANOVA analysis.
Understanding the mechanisms of the antagonistic action of BCAs on pathogens is essential
for searching potential Trichoderma strains to manage plant disease. Lutz et al. suggested that the
role of DON in competitiveness of F. graminearum was a negative signal, which down-regulated one
chitinase gene (nag1) involved in biological control activity of an antagonistic T. atroviride strain [31].
However, our study provided evidence for a new role of DON in the competition of Trichoderma and
Fusarium: DON not only modulated biological-control related genes of Trichoderma, but also induced
Trichoderma self-defense related genes to detoxify mycotoxin DON. The responses of Trichoderma to
DON-producing F. graminearum 5035 were different according to the D3G/DON ratios, which may
represent their resistance against DON-producing pathogens, and this hypothesis needs to be validated
in future work. Generally, the metabolic fate of DON in Trichoderma needs more detailed study to
present new antagonistic mechanisms of Trichoderma.
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3. Discussion
FHB caused by F. graminearum species could reduce the yield and quality of cereal grains around
the world, and DON contamination in the food chain leads to deleterious effects on the health of
animals and humans [12]. Biological control of F. graminearum and mycotoxin DON contamination
would be an important part in integrated FHB management, which may avoid negative effects and
minimize environmental impacts caused by conventional approaches [15]. Application of Trichoderma
strains on crops or crop residuals to inhibit the development and DON production of Fusarium is an
available biological-based strategy. As potential BCAs, Trichoderma strains are capable of producing
a large number of enzymes and secondary metabolites, which are effective components against
pathogens and play an important role in the antagonistic action of Trichoderma [32]. Hydrolytic
enzymes (such as chitinase and proteases) and antibiotics (such as polyketides and terpenes) derived
from Trichoderma act as “weapons” against pathogens when in competition [32]. In addition, the
potential UGTs inactivating DON in Trichoderma strains, act as “shields” to protect themselves against
DON-producing pathogens. For Trichoderma, “weapons” and “shields” are all significant agents
for control of Fusarium. For plants, glycosylation of DON catalyzed by the UGTs is an effective
defense strategy to resist pathogens [27], and our present study indicates that Trichoderma also have a
defense capacity to detoxify DON as plants when against DON-producing Fusarium. Our findings are
supported by the detection of modified mycotoxin D3G in a dual culture of Trichoderma and Fusarium.
Suzuki et al. have already elucidated that D3G exhibited extremely low toxicity to yeast and algae,
indicating that detoxification via glycosylation may not be exclusive to plants [33]. Moreover, our
data confirmed that glycosylation of DON was a self-defense process for Trichoderma as well, which
is in accordance with a previous study of Suzuki et al. A novel understanding on the role of DON
in the competitiveness of Fusarium would promote deeper investigation of the interaction between
antagonists and toxigenic Fusarium species.
The metabolism of mycotoxins in plants has been studied previously. Plants have the
detoxification metabolic systems to counter phytotoxic compounds. Mycotoxins can be conjugated
to endogenous metabolites by plants, generating modified mycotoxins with decreased toxicity [27].
In plants, detoxification of mycotoxins usually includes three phases. In phase I, mycotoxins are
oxidized or hydrolyzed to generate some active sites for the next reaction. In phase II, low-toxic or
non-toxic metabolites are formed by conjugating some hydrophilic molecules, such as sugars or amino
acids, and D3G is the major metabolite of DON in this phase. Finally, the metabolites from phase II are
irreversibly transported to a vacuole or accumulated in the cell wall in phase III [8]. Glycosylation
catalyzed by UGTs is a major process of phase II in detoxification reactions of plants [33]. A recent
study has clearly validated that over-expressing such UGT genes able to detoxify DON in Brachypodium
could confer increased resistance to Fusarium [34]. Glycosyltransferases are a series of enzymes that
can catalyze the formation of a glycosidic bond by transferring sugars to substrates, such as plant
secondary metabolites and mycotoxins. Identification of the UGTs inactivating DON into D3G is
rather complex because UGTs are encoded by a large family: more than 100 putative gene members
in plants [35]. To date, some induced functional UGT genes during the DON-producing Fusarium
infection process have been studied and identified in different plants [28,34–38]. However, little is
known about such UGTs possessing DON-detoxification ability in Trichoderma strains. According to
previous studies, Trichoderma can produce non-phytotoxic trichothecenes, such as trichodermin and
harzianum [18,39], but the mechanism of DON metabolism in Trichoderma strains is unclear. Taken
together, the studies on identifying these specific UGT genes from Trichoderma strains by transcriptome
analysis of Trichoderma and DON-producing Fusarium interaction should be conducted in the future.
The details about the endogenous self-protection mechanism against DON in Trichoderma strains
needs further investigation and interpretation after the detoxification UGT genes from Trichoderma
are identified. On the other hand, other detoxification products of DON have been identified in plant
detoxification processes, such as DON-sulfates, DON-15-glucoside, and DON-glutathione [25,40,41].
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Seeking and identifying other modified mycotoxins generated from Trichoderma and Fusarium are also
essential to reveal the mycotoxin detoxification mechanism of Trichoderma.
4. Conclusions
In the present study, eight Trichoderma strains were selected to evaluate their antagonistic activities
against F. graminearum by dual culture assay. Results suggested that T. harzianum Q710613, T. atroviride
Q710251, and T. asperellum Q710682 were more effective antagonists to control the pathogen, not
only because of the efficacy in inhibiting mycelia spread and mycotoxin production, but also because
of the relatively higher D3G/DON ratios that may reflect their resistance to Fusarium. In addition,
the occurrence of modified mycotoxin D3G in a dual culture of Fusarium and Trichoderma provides new
insights into antagonistic activities of Trichoderma.
5. Materials and Methods
5.1. Standards and Chemicals
The mycotoxin standards of DON, D3G, 3-ADON, and 15-ADON were purchased from
Sigma-Aldrich (St. Louis, MO, USA). Methanol and acetonitrile (ACN) were all high performance
liquid chromatography(HPLC) grade, and obtained from Merck (Darmstadt, Germany). Other
solvents and chemicals of HPLC or analytical grade were provided by Aladdin (Shanghai, China).
Ultrapure water (18.2 MΩ·cm) was obtained from Millipore (Bedford, MA, USA), and used throughout
the experiments.
5.2. Fungal Strains and Culture Medium
A total of eight Trichoderma strains and one F. graminearum strain were used in the present study
(Table 1). F. graminearum 5035 was from the Huazhong Agricultural University [42]. T. harzianum
JF309 was isolated from Lentinus edodes in our lab. T. harzianum GIM3.442, T. koningii GIM3.137,
and T. longibranchiatum GIM3.534 were purchased from the Microbial Culture Collection Center
of Guangdong Institute of Microbiology (GIMCC). T. harzianum Q710613, T. atroviride Q710251,
T. asperellum Q710682, and T. virens Q710925 were from the Center for Culture Collection of Trichoderma
(CCCT), Shanghai Jiaotong University (SJTU). All of the fungal strains were maintained as spore
suspensions in 30% glycerol at −80 ◦C. Before the start of antagonistic assay, the fungal strains were
grown on PDA medium at 25 ◦C for five days for activation.
Table 1. The information of the fungal strains used in this study.
Strain Code Strain Source
5035 Fusarium graminearum Huazhong Agricultural University, China
JF309 Trichoderma harzianum Isolated from Lentinus edodes in our lab
GIM3.442 Trichoderma harzianum GIMCC, China
GIM3.137 Trichoderma koningii GIMCC, China
GIM3.534 Trichoderma longibranchiatum GIMCC, China
Q710613 Trichoderma harzianum CCCT, SJTU, China
Q710251 Trichoderma atroviride CCCT, SJTU, China
Q710682 Trichoderma asperellum CCCT, SJTU, China
Q710925 Trichoderma virens CCCT, SJTU, China
GIMCC: Microbial Culture Collection Center of Guangdong Institute of Microbiology; CCCT, SJTU: Center for
Culture Collection of Trichoderma, Shanghai Jiaotong University.
5.3. Antagonistic Activities of Trichoderma on Growth and Mycotoxin Production of F. graminearum
The antagonistic activities of the chosen Trichoderma strains on F. graminearum were assessed by
dual culture assay according to Matarese et al. [17] with minor modifications. In short, 6 mm-diameter
mycelial discs of tested Trichoderma and Fusarium strains were removed from the edge of actively-
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growing colonies, and then the mycelial discs (Fusarium and Trichoderma combinations) were placed
at a distance of 45 mm on a 90 mm-diameter Petri dish containing 20 mL PDA medium. Meanwhile,
a mycelial disc of F. graminearum 5035 was placed with an agar disc on the dish as the control.
The pathogen-antagonist combinations and the controls were all set up in three biological replicates,
and incubated at 25 ◦C for 14 days. The mycelial growth rates (cm/day) of Trichoderma strains and
F. graminearum were recorded before their mycelia began to interact. After incubation, the radii of
Fusarium colonies facing the antagonists were measured and used for calculation of the inhibition
rate [32]. The inhibition rate of Trichoderma on mycelial growth of tested F. graminearum was calculated
based on the following formula: I = (C − T)/C × 100, where I is the inhibition rate (%), C is the growth
radius of pathogen when alone, and T is the growth radius of the pathogen when co-cultured with
antagonists [32].
5.4. Fusarium Mycotoxin Extraction and Preparation
After incubation, the PDA medium containing mycelia of tested fungi strains in Petri dish was
dried until a constant weight, and then the sample was ground into a homogenized powder for
preparation as described previously [43].
The homogenized powder was weighed and put into a 50 mL centrifuge tube, and then 10 mL of
ACN/water (84/16, v/v) solution was added. The mixture was shaken for 5 min, and then subjected
to ultrasonication for 30 min. Next the mixture was centrifuged at 3200× g for 30 min. Then 2 mL of
supernatant was transferred into a centrifuge tube, followed by adding 150 mg of MgSO4. The mixture
was vortexed for 30 s, and centrifuged at 3200× g for 30 min. Thereafter, the remaining supernatant
was moved into a new tube, and evaporated to dryness by a stream of nitrogen gas at 40 ◦C. At last, the
residue was redissolved with 1 mL of water containing 5 mM ammonium acetate. After redissolution,
the mixture was passed through a 0.22-μm filter, and then injected into LC-MS/MS for analysis.
5.5. Mycotoxin Determination by LC-MS/MS
Mycotoxin concentrations were determined according to a published method with minor
modifications [43]. Briefly, chromatographic separation was performed on an Agilent Extend—C18
column (100 mm × 4.6 mm, 3.5 μm) at 30 ◦C using a Thermo Scientific Accela 1250 UPLC system
(Thermo Fisher Scientific, San Jose, CA, USA). The mobile phase consisted of water containing 5 mM
ammonium acetate (A) and methanol (B), and a gradient elution program was as follows: 0 min 15% B,
1 min 15% B, 6.5 min 90% B, 8.5 min 90% B, 9 min 15% B, 12 min 15% B. The injection volume was
10 μL and the flow rate was 0.35 mL/min.
MS/MS analysis was carried out using a Thermo Scientific TSQ VantageTM (Thermo Fisher
Scientific, San Jose, CA, USA) triple stage quadrupole mass spectrometer in both positive and negative
electrospray ionization (ESI+/ESI−) modes. The ionization source parameters were set as follows:
interface voltage of 3.5 kV (ESI+) or 3.0 kV (ESI−); desolvation line (DL) temperature of 250 ◦C;
nebulizing gas (N2) and drying gas (N2) pressure of 30 psi (207 kPa) and 20 psi (138 kPa), respectively;
heat block temperature of 350 ◦C. A series of standard solutions of analytes (10–1000 ng/mL) were
used for calibration to absolutely quantify the targeted mycotoxins in the samples, and the quantitation
and identification of target mycotoxins were performed in selected reaction monitoring (SRM) mode.
The MS/MS parameters of detected mycotoxins were summarized in Table 2. All data acquisition
and processing were achieved with Xcalibur™ Software (2.2, Thermo Fisher Scientific, San Jose, CA,
USA, 2011).
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DON 355.1 [M + Ac]− 5.04 265.0 a 17 247.2 b 18
D3G 517.1 [M + Ac]− 4.89 427.4 a 22 457.4 b 14
3-ADON 397.1 [M + Ac]− 6.54 307.1 a 16 173.1 b 15
15-ADON 356.1 [M + NH4]+ 6.52 321.0 a 15 137.0 b 12
a Ion for quantification; b Ion for identification.
5.6. LC-HRMS Analysis of D3G
LC–HRMS analysis of the fragmentation pattern of D3G was conducted on a UHPLC system
(1290 series, Agilent Technologies, Santa Clara, CA, USA) coupled to a quadruple time-of-flight
(Q-TOF) mass spectrometer (Agilent 6550 iFunnel Q-TOF, Agilent Technologies, Santa Clara, CA, USA).
Chromatographic separation was performed on an Agilent Extend—C18 column (100 mm × 4.6 mm,
3.5 μm) at 30 ◦C. The mobile phase consisted of water containing 5 mM ammonium acetate (A) and
methanol (B), and a gradient elution program was as follows: 0 min 15% B, 1 min 15% B, 6.5 min
90% B, 8.5 min 90% B, 9 min 15% B, and 12 min 15% B. The flow rate was 0.35 mL/min and the sample
injection volume was 5 μL.
To confirm the presence of D3G in samples of dual culture test, the negative precursor ion
m/z 517.1927 (theoretical mass of [D3G + Ac]− based on molecular formula) was ionized in an
electrospray ionization (ESI) source and mass isolated by quadruple mass filter, following by
collision-induced dissociation (CID) with the collision energy of −20 eV and, finally, the fragments
and the remaining precursor were detected in the TOF tube. The parameters of high resolution mass
spectrometer were set as follows: sheath gas (N2) temperature, 300 ◦C; dry gas (N2) temperature,
170 ◦C; sheath gas flow, 12 L/min; dry gas flow, 16 L/min; capillary voltage, 3.0 kV in negative
mode; nozzle voltage, 0 V; fragmentor, 175 V; and nebulizer pressure, 40 psi (276 kPa). Data analysis
was achieved with Agilent software MassHunter B.06.00 (Agilent Technologies, Santa Clara, CA,
USA, 2012).
5.7. Statistical Analysis
Data were subjected to one-way ANOVA (analysis of variance) analysis followed by Tukey’s
multiple comparisons test using Graphpad Prism 5.0 (GraphPad Software, San Diego, CA, USA, 2007).
All data were shown as the mean ± standard error of the mean (SEM), and p < 0.05 was considered to
be significantly different.
Supplementary Materials: The following are available online at www.mdpi.com/2072-6651/8/11/335/s1,
Figure S1: Tandem mass spectra of the precursor ion (m/z 517.1927, [M + Ac]−) in negative mode. (A) Product ion
spectra of the D3G standard (1000 ng/mL); (B–I) product ion spectra of the precursor ion (m/z 517.1927) with the
same chromatographic retention time as the D3G standard in samples of dual culture test: F. graminearum 5035 grew
against T. harzianum JF309 (B); T. harzianum GIM3.442 (C); T. koningii GIM3.137 (D); T. longibranchiatum GIM3.534
(E); T. harzianum Q710613 (F); T. atroviride Q710251 (G); T. asperellum Q710682 (H); and T. virens Q710925 (I).
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Abstract: Mycotoxins, the secondary metabolites of mycotoxigenic fungi, have been found in almost
all agricultural commodities worldwide, causing enormous economic losses in livestock production
and severe human health problems. Compared to traditional physical adsorption and chemical
reactions, interest in biological detoxification methods that are environmentally sound, safe and
highly efficient has seen a significant increase in recent years. However, researchers in this field
have been facing tremendous unexpected challenges and are eager to find solutions. This review
summarizes and assesses the research strategies and methodologies in each phase of the development
of microbiological solutions for mycotoxin mitigation. These include screening of functional microbial
consortia from natural samples, isolation and identification of single colonies with biotransformation
activity, investigation of the physiological characteristics of isolated strains, identification and
assessment of the toxicities of biotransformation products, purification of functional enzymes and
the application of mycotoxin decontamination to feed/food production. A full understanding
and appropriate application of this tool box should be helpful towards the development of novel
microbiological solutions on mycotoxin detoxification.
Keywords: mycotoxin; detoxification; biodegradation; biotransformation; enzyme; microorganism
identification
1. Introduction
Over the past several decades, research interest in the mitigation of mycotoxins, the toxic
secondary metabolites produced by specific fungi, has continuously increased due to concerns over
human and animal health, economic losses and food safety and security [1]. Important mycotoxins
include aflatoxin B1 (AFB1), aflatoxin G1 (AFG1), ochratoxin A (OTA), deoxynivalenol (DON), nivalenol
(NIV), fumonisin (FUM), zearalenone (ZEA), patulin (PAT) and citrinin (CIT), which are mainly
produced by the fungal genera Aspergillus, Fusarium and Penicillium. It has been estimated that the
economic costs of crop losses from major mycotoxins (aflatoxins, fumonisins and deoxynivalenol) in
the United States are as great as $932 million per year, in addition to mitigation costs of $466 million
and livestock costs of $6 million [2]. In Europe, although no data regarding economic losses caused by
mycotoxins are available, the direct and indirect losses due to a wheat epidemic in 1998 in Hungary
were estimated at 100 million euros [3]. Moreover, severe human health effects can result from the
exposure of mycotoxins through either ingestion, absorption or inhalation routes [4]. In 2015, the Rapid
Alert System for Food and Feed (RASFF) reported 475 notifications in Europe on mycotoxin exposure
in food, most related to the presence of aflatoxins [5].
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Pre-harvest control of mycotoxin production and post-harvest mitigation of contamination are the
main strategies to limit mycotoxins in food and feed. Good agricultural practices (GAPs), including
crop rotation, soil management, choice of varieties and correct fungicide use, have been recommended
by the European Commission (EC) to prevent the contamination of Fusarium toxins in cereals [6].
Strategies for post-harvest mitigation can be categorized as chemical, physical and biological. Chemical
strategies use acids, bases, oxidizing agents, aldehydes or bisulfite gases to change the structure of
mycotoxins, which has led to increased public concerns over the chemical residues in food and feed.
Furthermore, negative effects on the nutrition and palatability of food and feed may result from
chemical treatments [7–9]. For physical strategies, the application of adsorption agents has become
popular since the European Union (EU) allowed substrates that suppress or reduce the absorption,
promote the excretion of mycotoxins or modify their mode of action to be used as feed additives [10].
However, the efficacy of adsorption agents in reducing mycotoxin contamination is variable, and most
of the commercial binding agents presented no sufficient effect against DON [11]. Compared with
chemical and physical approaches, biological detoxification methods, which biotransform mycotoxins
into less toxic metabolites, are generally more specific, efficient and environmentally friendly.
As more and more researchers enter the field of biodetoxification, guidance is needed on the
various approaches and methodologies that may be employed. In this paper, we aim to review
the entire process of the discovery and development of biological mitigation systems, focusing on
the strategies and methodologies at each research stage from initial microorganism screening to
final application. Although the methods in the steps of enrichment, isolation, strain identification,
chemical analysis, mycotoxin biotransformation, toxicity evaluation and enzyme extraction were
developed based on specific mycotoxins and detoxifying microorganisms, the approaches used should
be generally applied to studies seeking microbial-based solutions for mycotoxin mitigation.
2. Workflow
An integrated research program on the microbial detoxification of mycotoxins is expected to
proceed through up to five stages. First, mycotoxin-biotransforming microorganisms (MBMs) or
consortia should be obtained and identified from either environmental sources or be screened from
a group of previously-identified candidates. Secondly, the efficacy and influencing factors on the
detoxification activities of the selected microorganisms, as well as the biotransformation products
should be investigated and identified. In the third stage, safety assessments of both functional strains
and biotransformation products should be performed. Biotransformation may not necessarily result
in a less toxic secondary product, so the reduced toxicity of the biotransformation products must
also be confirmed. In the fourth, and potentially most difficult, stage, the enzymes responsible for
the biotransformation are isolated, identified and/or cloned and expressed. Finally, the feasibility of
mycotoxin-detoxifying applications in food and feed should be validated. The complete workflow is
outlined in Figure 1. It should be noted that it is not necessary to endure all five stages in an individual
research project. For example, studies on the detoxification activities of known strains would not
require the first screening stage. Furthermore, the isolation of the enzymes may be optional if the
functional microorganisms are to be used in the application.
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Figure 1. Workflow of research on microbial detoxifications of mycotoxins.
3. Strategies and Methodologies
3.1. Sources of Microorganisms
Undoubtedly, the successful isolation of MBMs is one of the critical steps of the whole research
project. A careful selection of environmental sources more likely to harbor MBMs should increase the
probability of finding functional microorganisms. Previous studies have isolated microorganisms from
a range of environmental [12–29], plant [30–38] and animal [39–48] sources.
The existence of MBMs was initially hypothesized based on the fact that chemically-stable
mycotoxins do not accumulate in agricultural soil [25,30,46]. Soil is therefore a likely reservoir for
functional MBMs, in particular that on which crops susceptible to mycotoxigenic fungi have been
grown previously. In addition, nearby aqueous environments to agricultural soil have also been used
for the successful isolation of DON-degrading bacteria [15].
Rumen fluid and intestinal contents are hosts to a diverse microbiota, which not only
contribute to host metabolism, but have also been shown in some cases to have biotransformation
activities. This is partly demonstrated by the reduced sensitivity of ruminants to mycotoxins and
in particular to trichothecenes [40,41]. Some early studies reported that the rumen microbiota has
the capability to transform a wide range of mycotoxins, including OTA, ZEA, DON, T-2 toxin and
diacetoxyscirpenol [40,42]. In addition, chicken large intestinal contents have been shown to harbor
functional bacteria with DON deepoxidation activity [39,43].
From a practical standpoint, it is advantageous to isolate MBMs from an environment similar to
that to which they will be applied, as they will then be more likely to grow and express detoxification
activities during application. For example, Bacillus subtilis strain UTBSP1, isolated from mature
pistachio nut fruits in Iran, showed AFB1 biotransformation activity in this agriculture crop [38].
Similarly, the patulin in apple juice was degraded into less toxic E- and Z-ascladiol by Gluconobacter oxydans,
a bacterium isolated from rotten apple puree [37].
In contrast to screening microbes in a particular environment, an alternative strategy is to focus
on only a certain taxonomic group [19,35,45,49] or already available strains [50–53]. These strains
may possess specific properties to facilitate isolation or provide additional benefits to commercial
applications. For instance, Bacillus spp. have been targeted due to their tolerance of adverse
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environmental conditions, application as probiotics, antimicrobial activities and the production of
insect toxins and extracellular enzymes [19,35,45,47]. Petchkongkaew et al. (2008) [35] screened for
Bacillus spp. from Thai fermented soybean using Gram-staining and the API 50CH system, and they
isolated three strains with highly efficient AFB1 and OTA biotransformation capabilities. Lactic acid
bacteria (LAB) are also good candidates for mycotoxin biotransforming bacteria since their additional
probiotic properties promote their application in food and feed. Pediococcus parvulus UTAD 473 was
selected from a collection of 19 LAB strains and has the ability to biotransform 90% of OTA to the
less toxic OTα [53]. An isolated CIT biotransforming bacterium, Moraxella sp. MB1, has the particular
benefit of being able to perform detoxification in solvent environment, as it belongs to the class of
organic solvent-tolerant microorganisms (OSTMs) [50]. Rodriguez et al. (2011) [51] considered strains
belonging to Rhodococcus, Pseudomonas and Brevibacterium, which have the capability to biotransform
aromatic compounds, to have a higher potential to degrade mycotoxins. The authors successfully
obtained Brevibacterium casei RM101 and Brevibacterium linens DSM 20425T, which can completely
biotransform OTA at concentrations up to 40 μg/mL [51].
3.2. Enrichment
Due to the complexity of microbial communities obtained from environmental or animal
sources, screening may fall into a “trial-and-error” phase, leading to high costs of labour and
consumables. Enrichment of particular microorganism taxa, by either enhancing the growth of
potentially functional strains or supressing unwanted ones, is therefore used to reduce the diversity of
the microbial consortium.
Enrichment strategies vary based on sources of microbiota, the mycotoxins to be targeted and
possible biotransformation pathways (Table 1). Media used for enrichment may be classified into three
categories: nutrient medium, minimal medium and sole carbon source medium. The latter normally
contains the salt medium with or without vitamin mixtures as the medium base and supplemented
with the specific mycotoxin or related compounds as a sole carbon source.
The application of selective pressures encountered in the environments of plant materials
contaminated with mycotoxigenic fungi is an effective strategy to screen for functional microbes. In this
way, the potential functional strains may become predominant, which aids in further isolation. He et al.
(2016) [12] hypothesized that DON-biotransforming microorganisms would have the ability to tolerate
and grow in the presence of DON-producing Fusarium graminearum and using this approach eventually
isolated Devosia mutans 17-2-E-8, a new bacterial species that detoxifies DON into 3-epi-DON with high
efficiency. An in situ plant enrichment (isPE) strategy has been developed to screen functional strains
on wheat heads that were artificially contaminated with DON and grown in situ for one month. This
approach yielded 17 colonies with DON-biotransformation activities among 60 colonies examined [32].
In order to screen for biotransforming bacteria in the chicken intestinal tract, in vivo enrichment was
performed by feeding the chickens moldy wheat contaminated with DON (10 mg/kg), which was
shown to improve the activities of the digesta contents in biotransforming DON [43].
Another well-known and effective enrichment strategy that has been widely employed involves
the use of a specific mycotoxin as a sole carbon source in a basal mineral medium. It has been reported
that DON, ZEA, PAT and CIT can be utilized as a sole carbon source and ultimately biotransformed
by a number of microbial strains [13,15,18,23,24,26,27,29,32,41,54]. Due to the high cost and toxicity
of many pure mycotoxins, chemically-related compounds may be substituted as the sole carbon
source when screening for potential MBMs [25,46,55,56]. One successful application of this strategy
involved the use of coumarin as a surrogate for AFB1, which shares the basic structure of this extremely
toxic mycotoxin, but is a much safer and less expensive alternative [25,46]. Guan et al. (2008) [46]
first developed this strategy to isolate 25 single colonies grown in medium supplemented with
coumarin as the sole carbon source, which were all shown to have AFB1 biotransformation activities
(between 9.18% and 82.50%), as determined by HPLC, indicating the highly selective and accurate
nature of this method.
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Individual or combinations of antibiotics can also be used as a selective factor to inhibit the
growth of unwanted microorganisms according to the different antimicrobial spectra [14,28,43].
Yu et al. (2010) [43] investigated the growth and DON-biotransformation activity of a bacterial culture
treated with different combinations of 10 antibiotics, at various concentrations, demonstrating that
one combination of virginiamycin (20 μg/mL), lincomycin (60 μg/mL) and salinomycin (5 μg/mL)
significantly reduced microbial growth, without a loss of biotransforming activity.
Heat treatment is another effective method to enrich for heat-resistant strains, such as
Bacillus spp. [14,19]. In order to enrich for desirable Bacillus strains with mycotoxin biotransforming
activities, samples were treated at 80 ◦C for 15 min to inactive non-thermophiles [19,45].
The changes that occur in a microbial community following enrichment, such as the anticipated
dominance of functional microbes and the decrease in the population diversity, are often difficult to
track using traditional microbiological approaches. Fortunately, a number of molecular techniques,
such as polymerase chain reaction with denaturing gradient gel electrophoresis (PCR-DGGE), terminal
restriction fragment length polymorphism (T-RFLP) or 16S rRNA gene sequencing, can be applied to
assess the microbial diversity and guide the screening process [14,17,43]. By monitoring the number
of bands in PCR-DGGE bacterial profiles, Yu et al. (2010) [43] were able to show a reduction in the
diversity of a microbial community with DON-biotransformation activity following several rounds
of antibiotics and medium-based selection. Guided by PCR-DGGE, 10 positive isolates were finally
obtained from 196 single colonies, which is more efficient than traditional blind screenings.
3.3. Isolation of Single Colonies
Once an enriched microflora containing MBMs is obtained, further screening to isolate single
active colonies can be performed. Traditional plating methods have been widely used for this
purpose. In order to selectively support the growth of potential MBMs, mycotoxins or mycotoxin-like
compounds have also been introduced as sole carbon sources [26,27,31,34,46,54,58,62] or used to apply
selective pressure in media containing another carbon source [47,60], as mentioned above. A summary
of the various media, isolation strategies and isolated functional strains is given in Table 1.
Due to the physiological characteristics of the potential MBMs, they may be difficult to culture
under the conditions used in the laboratory [63]. Efforts such as extending the incubation time,
choosing media with inorganic nitrogen sources and changing the solidifying agent in the media, have
been adopted to improve culturability [13,14,32,57]. The use of longer incubation times (i.e., >5 days)
could help in the isolation of slow-growing bacteria, which are prone to suppression by more
predominant bacteria [13,14]. In regard to the media-solidifying agent, it was reported that gellan
gum, rather than agar, better supported the growth of soil-based bacteria [64]. Ito et al. (2012) [32]
isolated a DON-biotransforming strain, Marmoricola sp. MIM116, from 1/3 R2A-gellan gum media
and also observed better growth of the strain in media containing gellan gum as the solidification
agent as compared with agar.
The mycotoxin biotransformation activities of isolated microbes are typically detected by chemical
analysis methods, such as TLC, HPLC and LC-MS, which will be discussed further below. Some rapid
detection methods have also been developed [34,50,62]. The basic concepts for these methods were
originally based on the Kirby–Bauer disc plate diffusion assay. Devi et al. (2006) [50] examined six
marine bacteria belonging to Moraxella spp. using the disc plate diffusion assay with 50 μg/disk of
CIT. A strain showing high tolerance to mycotoxin was selected and examined for biotransformation
activity. In another study screening for MBMs, a sterile filter paper disk inoculated with a culture
was incubated on a nutrient agar plate coated with 0.4 mL of AFB1 (10 μg/mL). Another successful
application involved visualizing single colonies able to biotransform AFB1 through the disappearance
in fluorescence surrounding the colony, which is contributed by the coumarin ring structure in AFB1,
indicating the degradation of AFB1 [34]. Similarly, this method has been applied to screening single
strains with OTA biotransformation activity, which indicated that none of the strains had the ability to
break the isocoumarin ring of OTA [62].
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3.4. Identification of Functional Microorganisms
Microbial isolates capable of biotransforming mycotoxins may be identified and further
characterized based on genome sequence information, which can range from the analysis of a single
marker gene to entire genomes. The most commonly-used marker gene for bacterial identification
and phylogenetic analysis is the 16S small ribosomal RNA subunit gene (rDNA) [65], which can be
used to characterize both individual isolates and complex microbiota, though other conserved genes,
such as rpoA, may also be used [66]. Several characteristics make the 16S gene well suited: it is present
among all bacteria; it contains regions of a conserved sequence that allow for the design of universal
PCR primers, but is also interspersed with regions of variability sufficient to discern phylogenetic
relationships often to the genus and, occasionally, the species, level [67–69]. Furthermore, several
databases of high-quality full-length 16S rDNA sequences and taxonomical assignments have been
developed, such as SILVA [70], the Ribosomal Database Project (RDP) [71] and GreenGenes [72], and
many bioinformatics tools are available for processing the sequence data. Many universal 16S primers
are available in the literature, and several systematic comparisons have been carried out to evaluate
their performance in terms of taxonomic coverage and discriminatory power [73–75].
The general workflow for taxonomic classification of a single isolate involves amplification of
the 16S gene region, cloning of the amplicon and subsequent sequencing by the Sanger method.
The taxonomy is then assigned by comparison of the sequence against one of the established reference
databases (e.g., SILVA, RDP or GreenGenes), in which the taxonomy has already been established.
Next-generation DNA sequencing (NGS) technologies now allow for the taxonomic classification
of complex microbiota by sequencing of the rDNA gene en masse, with the added benefit that the
rDNA amplicons can be sequenced directly without the need for a cloning step. This approach
may be useful during different stages of the isolation process to examine mixed cultures capable of
biotransformation and to identify candidate bacteria that might possess activity. Illumina technology
is currently the highest throughput and most cost-effective method for microbiota sequencing and can
sequence rDNA amplicons up to ~600 bp in length, which is generally adequate for classification to
the genus level. Several open-source bioinformatic pipelines, including QIIME [76] and mothur [77],
are freely available, which will cluster the rDNA reads into operational taxonomic units (OTUs),
assign taxonomy and perform various diversity analyses. It is important to consider several technical
factors that could lead to systematic biases in the final community composition, including the choice of
universal primers, as mentioned above, as well as the DNA extraction method, which should extract
DNA equally from all members of the population [78,79].
A drawback of rDNA-based phylogenetic analysis is that, due to the relatively high conservation
of this gene, its resolution is limited and cannot be used to distinguish between different strains.
A wide range of other molecular typing techniques is available for strain-level typing, which typically
infer sequence variability based on DNA fragment length polymorphisms. These methods generate
electrophoretic DNA banding patterns from genomic DNA either through restriction enzyme digestion,
(e.g., restriction fragment polymorphism (RFLP), pulsed field gel electrophoresis (PFGE)), PCR
amplification (e.g., rapid amplification of polymorphic DNA (RAPD), repetitive sequencing-based
PCR (REP-PCR), Multiple-locus variable number tandem repeat analysis (MLVA), Denaturing gradient
gel electrophoresis (DGGE)) or a combination of both (e.g., amplified fragment length polymorphism
(AFLP)) [80]. Additionally, strain-level sequence-based typing methods, such as multi-locus sequence
typing (MLST), use several conserved marker genes to phylogenetically classify members of the same
species; however, for these methods, a complete genome sequence is first required to develop the assay.
The most definitive phylogenetic resolution, of course, is achieved by whole genome sequencing of the
isolate, which is now becoming routine due to the reduced cost made possible by NGS.
Although phylogenetic analysis is a useful tool for the identification of functional strains,
traditional morphological and biochemical characterization is still necessary to confirm the physiological
characteristics of the isolates. These may include light [18,54], phase contrast, bright field [59] and electron
microscopy [12,16,57] to determine cell size, shape and Gram-stain type. Biochemical tests, such as
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carbon source utilization, enzyme activity and chemical sensitivities [18,19,27,33,38,45,46,50,58,59,81],
as well as commercial identification systems, such as BIOLOG or API® strips, may also be used for
the identification of MBMs [12,21,35,60]. In addition, fatty acid and ribosomal protein profiles may be
determined using gas chromatographic analysis of fatty acid methyl esters (GC-FAME) and matrix
assisted laser desorption/ionization-time of flight (MALDI-TOF) techniques, respectively [12,59].
A safety assessment must be performed to exclude potential pathogens, which may produce
extracellular toxins that could contaminate food and feed. Bacillus spp. with mycotoxin biotransformation
activities have been more sought after, due to their perceived probiotic properties. However,
some species, such as Bacillus cereus, are known toxin producers, and even species outside the
Bacillus cereus group have been reported to produce related enterotoxins [82]. Yi et al. (2011) [21], using
two commercial immunoassay kits, evaluated the enterotoxin-producing ability of Bacillus licheniformis
CK1 by assaying for the Hbl and Nhe enterotoxins, which are produced by Bacillus cereus.
It is recommended to check the functional strains against the U.S. Food and Drug Administration
(FDA) Generally Recognized as Safe (GRAS) list and European Food Safety Authority (EFSA) Qualified
Presumption of Safety (QPS) list. Biological agents belonging to GRAS are exempt from premarket
review and FDA approval. Similarly, biological agents included in the QPS list usually undergo
a simplified assessment by the EFSA [83,84].
The identified MBMs are suggested to be registered and deposited in a microorganism collection
organization for further research or patent procedures. Those governmental or private non-profit
organizations include the Agriculture Research Service Culture Collection (NRRL), the International
Depositary Authority of Canada (IDAC), Deutsche Sammlung von Mikroorganismen und Zellkulturen
(DSMZ) and the American Type Culture Collection (ATCC).
3.5. Physiological Characterization of Mycotoxin Biotransformation Activity
In this stage, the isolated microorganisms should be investigated to verify the biotransformation
activity by determining the efficiency correlation with cell growth, influencing factors and the position
of active substrates. A time course showing a decrease in mycotoxin levels combined with an increase
in biotransformation products provides clear evidence of the biotransformation activity of the isolated
strain [12,14,30,37,53,61,85–87]. The efficiency of biotransformation can be measured based on the
relationship between mycotoxin decrease and cell growth. The mycotoxin biotransformation rate
(Equation (1)) may be calculated as follows [15,32]:
Mycotoxin Biotransformation rate =
amount of transformation (μg)
amount of dry cell (mg)× time (hour) (1)
Knowledge of intrinsic and extrinsic factors that influence the biotransformation is beneficial to
understanding the mechanisms of enzymatic biotransformation and for developing and optimizing
the detoxification conditions in the complex food/feed matrix. A number of studies have evaluated intrinsic
factors, including carbon source [26,34], nitrogen source [26,34,88], vitamins [26], metals ions [12,34,46,89–93],
enzyme inhibitors and promoters [52,89–94], initial concentration of mycotoxins [93,95], initial
concentration of cells [53,95] and initial pH value [12,14,17,26,31,34,41,46,54,60,88,89,95,96], as well as
extrinsic factors, including temperature [12,14,17,25,26,31,34,38,41,46,52,54,60,88,89,95,96], aeriation
(shaking rate) [26], oxygen preference [14], as well as pre-incubation [26] and incubation time [34,97].
The experimental designs and optimized biotransformation conditions are summarized in Table 2.
In addition to the investigation of single factors, researchers have also looked for optimized
conditions for multiple variables using mathematic models. One example is the optimization of
AFB1 biotransformation based on six parameters (temperature, pH, liquid volume, inoculum size,
agitation speed and incubation time) using a Plackett–Burman design followed by a response surface
methodology (RSM) based on a central composite design (CCD). The degradation efficiency reached
95.8% based on the predicted parameters from the mathematic model [97]. Other methods, such as
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the orthogonal method and one-factor-at-a-time method, were also useful for screening of optimized
biotransformation conditions [26,34].






AFB1 U.I. a Starch (4.0%) [34]
CIT U.I. Glucose (1.2%) [26]
Nitrogen source
AFB1 U.I. Yeast extract (0.5%) [88]; tryptone (0.5%) [34]
CIT U.I. Peptone (0.3%) [26]
Vitamins CIT U.I. Vitamin C (100 μg/mL) [26]
Metals ions
DON 3-epi-DON Minerals added in the corn steep liquor andpeptone [12]
ZEA U.I. Zn2+, Mn2+, Ca2+, Mg2+ (10 mmol/L) [89]
AFB1 U.I.
Mg2+, Cu2+ (10 mmol/L) [46]; Ca2+, Mg2+
(10 mmol/L) [90–92]; Mn2+, Cu2+
(10 mmol/L) [25]; Mg2+, Zn2+, Cu2+, Mn2+
(10 mmol/L) [93]
Enzyme inhibitor/enhancer
ZEA U.I. Reverse effect: chelating agents of EDTA,OPT (10 mmol/L) [89]
AFB1 U.I.
Reverse effect: chelating agents of EDTA,
OPT (10 mmol/L) [90–92]
OTA OTα Reverse effect: chelating agents of EDTA(10 mmol/L), OPT (1 mmol/L) [52]
AFB1 U.I. Tween 80, Triton X-100 (0.05%) [93]
AFB1 U.I.
NADPH (0.2 mmol/L), NaIO4
(3 mmol/L) [94]
Concentration of mycotoxins
AFB1 U.I. 0.5 μg/mL [93]
OTA U.I. a 0.1 μg/mL [95]
Concentration of cells
OTA U.I. 108 CFU/mL [95]
OTA OTα 109 CFU/mL [53]
Initial pH
DON 3-epi-DON pH = 7 [12]
DON DOM-1 pH = 6.5–7 [14]; pH = 5–10 [17]
ZEA U.I. pH = 7–8 [89]; pH = 4.5 [41]
AFB1 U.I.
pH = 5–6 [96]; pH = 6–7 [31,34,88];
pH = 8 [46]
PAT E- and Z-ascladiol pH = 3–6 [60]
PAT U.I. pH = 3–5 [54]
CIT U.I. pH = 7 [26]
OTA U.I. pH = 4 [95]
Temperature
DON 3-epi-DON 20–35 ◦C [12]
DON DOM-1 20–35 ◦C [14]; 20–37 ◦C [17]
ZEA U.I. 30–37 ◦C [41]; 42 ◦C [89]
AFB1 U.I. 30–37 ◦C [31,34,46,88,96]
PAT E- and Z-ascladiol 35 ◦C [60]
PAT U.I. 37 ◦C [54]
CIT U.I. 37 ◦C [26]
OTA OTα 25–35 ◦C [52]
OTA U.I. 28 ◦C [95]
Shaking rate CIT U.I. 200 RPM [26]
Oxygen preference DON DOM-1 Aerobic condition [14]
Concentration of mycotoxins OTA U.I. 0.1 μg/mL [95]
Pre-incubation time CIT U.I. 36–48 h [26]
a U.I. means unidentified.
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As an observed decrease in the amount of mycotoxin may result from absorption rather than
biotransformation, identification of the daughter compound(s) is necessary to confirm biotransformation
activities. The most direct evidence to support biotransformation is the observation of new product(s)
in parallel with a decrease in the amount of the original mycotoxin. In some cases, however,
the biotransformation product is not detectable through chemical analysis methods, and indirect
methods must therefore be adopted to distinguish between adsorption and biotransformation.
The involvement of an enzymatic reaction, rather than simple binding, is evidenced by the loss
of biotransformation activity following heat or acid-inactivation of cells or in an extracellular
extract treated with enzyme inactivating agents, such as proteinase K, SDS or EDTA [12,15,19,98,99].
Furthermore, the subcellular location of active components responsible for biotransformation can be
identified by comparing activities in the whole cell culture, extracellular extract (by centrifugation)
and cytoplasmic extract (by cell lysis) [25,27,34,45,50,59,88,99].
3.6. Identification of Mycotoxins and Their Biotransformation Products
To determine the mycotoxin content in a sample, chromatographic techniques are most commonly
adopted. Based on the properties of the sample matrices and the mycotoxin itself, a solvent can be
chosen for extraction followed by a range of different clean-up procedures. For example, DON was
extracted from mouldy corn with 84% acetonitrile (acetonitrile/water 84:16, v/v) on a rocking platform
at 60 RPM for two hours at room temperature [100] before HPLC analysis. ZEA was usually recovered
by a mixture of water and methanol (50:50) [18,41] before HPLC analysis. Solvent extraction can be
performed under regular shaking conditions or more efficiently with the aid of an ultrasonicator [18].
Table 3 summarizes the solvents used during the extraction of various mycotoxins and can be used as
a baseline to choose appropriate extraction solvents for the analysis of mycotoxins.
Table 3. Analytical methods for the detection and identification of mycotoxins and their
biotransforming products.






LC-MS [48,101,102]; ELISA [32];
HSCCC [101]; NMR [102]
3-epi-DON 50% methanol [12];ethyl acetate [13]
HPLC [12,13,15]; LC-MS [102];
NMR [13,102]
DOM-1 (deepoxy DON) 84% acetonitrile [100];50% methanol [48]
HPLC [100]; LC-MS [14,48];
GC-MS [17]; MS [43]







LC-MS [23,89,98]; ELISA [24]
1-(3,5-dihydroxy-phenyl)-
10′-hydroxy-1′E-undecene-6′-one Chloroform [22] TLC, MS, NMR [22]
ZEA-sulfate 60% methanol [36] LC-MS [36]
ZEA-4-O-β-glucoside TLC, MS, NMR, IR [103]
α-ZAL, β-ZAL, α-ZOL,
β-ZOL, ZAN, 8′(S)-hydroxyzearalenone,
ZEA-2,4-bis(methyl ether), ZEA-2-methyl ether
50% chloroform [104] TLC, MS, NMR, IR [104]
ZEN-4-O-sulfate 33% chloroform:methanol(9:1) [105] MS, NMR, infrared [105]
ZOM-1 ((5S)-5-({2,4-dihydroxy-6-[(1E)-5-
hydroxypent-1-en-1-yl]benzoyl}oxy)hexanoic acid) Ethyl acetate [106] HPLC, LC-MS, NMR [106]
α-ZOL, α-ZOL-S, ZEA-14-sulfate, ZEA-16-sulfate,
ZEA-14-Glc, ZEA-16-Glc 50% acetonitrile [107] LC-MS [107]
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Table 3. Cont.







TLC [38,96,109]; ESMS [109];
LC-MS [38,96,109]; HR-FTMS [96];
ELISA [34]
AFB2 Chloroform [25] HPLC [25]
AFG1
60% methanol [108];
50% methanol [45] HPLC [45,108]
AFM1
Chloroform [25];
50% methanol [45] HPLC [25,45]
AFD1, AFD2, AFD3 Chloroform [111] TLC, HPLC, GC-MS, FT-IR [111]
PAT Ethyl acetate [54,60,99] TLC [85]; HPLC([37,54,60,85];LC-MS [99]; NMR [85]
DPA (desoxypatulinic acid) Ethyl acetate [99] HPLC [112]; LC-MS [99];NMR [112]
E- and Z-ascladiol Ethyl acetate [60,85] TLC [85]; HPLC [37,60,85];LC-MS [37,60]; NMR [37,85]
CIT Acetone:ethyl acetate(1:1) [27]; ethyl acetate [50] TLC(C04); HPLC [26,27]
Decarboxycitrinin Ethyl acetate [50] MS, NMR [50]
FUB1
TLC [28]; HPLC [28]; GC-MS[28];
LC-MS [113,114]
Heptadecanone, isononadecene,
octadecenal, eicosane GC-MS [28]
Hydrolyzed FUB1 LC-MS [113,114]





TLC [52,61]; HPLC [33,51–53,61]
OTα Methanol [51];dichloromethane [52]; HPLC[51,52]; LC-MS [51]
L-β-phenylalanine Methanol [51] HPLC [51]
The strategy for the identification of unknown mycotoxin biotransformation products will be very
different from the determination of known mycotoxins in a sample due to the unknown properties of
the products. Thus, the sample needs to be subjected to both polar and non-polar solvent extraction
and the formation of new compounds identified by comparing the chromatographs of samples
before and after biotransformation. Initial identification of the biotransformation products is usually
performed using LC/MS, while final identification requires the peaks to be purified at milligram levels
and subjected to NMR analysis. For example, the DON biotransformation product 3-epi-DON by
D. mutans 17-2-E-8 was purified from bacterial culture following centrifugation, filtration, freeze-drying
and high-speed countercurrent chromatography. The purified 3-epi-DON was then subjected to 1D
and 2D NMR, and the structure was then identified [102]. Metabolomic strategies have started
gaining recognition for the identification of new products resulting from microbial biotransformation.
With the progress in metabolomics and its related tools and software, the identification of novel
biotransformation mycotoxin products will become easier and faster.
3.7. Evaluation of Toxicity of Biotransforming Product
While many studies report novel structural/chemical modifications that render mycotoxins
less toxic [116–119], the final use of any biological detoxification method is dependent on providing
empirical evidence for this claim. Furthermore, some country/state regulatory agencies have set up
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rigid parameters for the assessment of the safety and efficacy of any developed detoxification product,
which need to be addressed accordingly before the registration of that product. A very clear example is
the EU regulations regarding the additives for use in animal nutrition and the establishment of a new
functional group of feed additives (No. 1831/2003 and No. 386/2009).
Different in vitro and in vivo [120–122] approaches were suggested in the past to test for changes
in toxicity (Table 4), each with a unique set of advantages and challenges [123,124]. The adopted
system should take into consideration: (a) the nature of the tested mycotoxin as screening carcinogens
for example with long-term exposure studies is different from screening estrogenic toxins; (b) host
suitability and selection since mono-gastric animals for example show higher sensitivity towards
certain toxins (such as DON) in comparison to other livestock; (c) the solubility and stability of
final biotransformation products (the reduced solubility and stability of 3-keto-DON for example
necessitates using organic solvents for storing and diluting this metabolite that might interfere with
assay outcomes in certain cases.); and finally, (d) the route of exposure; even though the oral route is
the main contamination means, symptoms might also develop in animals due to inhalation of grain
dust (as the case of aflatoxins for example) [125,126]. Generally speaking, a host highly ranked within
the evolutionary tree is more sensitive toward mycotoxins; hence, bacterial hosts are the least preferred
for evaluating the bio-toxicity of mycotoxins.
Table 4. Models and methodologies of toxicity evaluation of mycotoxins and their biotransforming products.
Mycotoxins Biotransforming Products Model Methodologies Reference
DON
3-epi-DON Caco-2 cells Evaluation of metabolic activity byan MTT cell proliferation assay [127]
3-epi-DON 3T3 cells
Evaluation of DNA synthesis
activity by a cell proliferation ELISA
employing BrdU incorporation
[127]
3-epi-DON Female B6C3F1 mice
Evaluation of effects on body
weight gain, relative organ weights,
food consumption, hematology and
clinical chemistry
[127]
DOM-1 Swine kidney cells Evaluation of metabolic activity byan MTT cell proliferation assay [44]
DOM-1 Chickenlymphocytes
Evaluation of DNA synthesis
activity by a cell proliferation ELISA
employing BrdU incorporation
[56]
DOM-1 Starter pigs Evaluation of effects on growthperformance and serum metabolites [100]
3-keto-DON Mouse spleenlymphocytes
Evaluation of immunosuppressive




Evaluation of estrogenic activity by
a WST cell proliferation assay [22]





Evaluation of estrogenic activity by







Evaluation of relative binding
affinity by an estrogen receptor
binding assay
[104]
ZOM-1 Yeast YZRM7 Evaluation of estrogenic activity bya sensitive yeast assay [106]
ZOM-1 Human estrogenreceptor-α
Evaluation of estrogenic activity by
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Table 4. Cont.
Mycotoxins Biotransforming Products Model Methodologies Reference
ZEA
U.I. a Pre-pubertalfemale gilts





U.I. Yeast BLYES Evaluation of estrogenic activity bya sensitive yeast assay [130]
U.I. Pre-pubertalfemale rats
Evaluation of estrogenic activity by
an immature uterotrophic assay [130]
AFB1
AFD1, AFD2, AFD3 Hela cells
Evaluation of cytotoxicity by
an MTT cell proliferation assay [111]
U.I. L929 cells Evaluation of cytotoxicity byan MTT cell proliferation assay [108]
U.I. Salmonellatyphimurium TA100
Evaluation of mutagenicity by
an Ames assay [109]
U.I. Artemia salina Evaluation of toxicity by an insectlarvae survival assay [31]
PAT
DPA Escherichia coli Evaluation of microbial toxicity [99]
DPA Seeds ofArabidopsis thaliana Evaluation of phytotoxicity [99]
DPA Human hepatocytesLO2
Evaluation of cytotoxicity by
an MTT cell proliferation assay [99]
DPA Human lymphocytes Evaluation of cytotoxicity bya trypan blue cell proliferation assay [112]
CIT U.I. Bacillus subtilis TISTR Evaluation of microbial toxicity [27]
OTA
U.I. HepG2 cells Evaluation of cytotoxicity byan MTT cell proliferation assay [95]
OTα Zebrafish(Danio rerio) embryo Evaluation of teratogenicity [131]
a U.I. means unidentified.
The high costs of raising and keeping large animals and strict guidelines for using animals in
research [132,133] are other factors to consider when performing preliminary toxicity evaluations.
In some cases, the use of primary and secondary cell lines derived from different hosts (mainly
porcine/canine) [134–138] may be warranted to replace actual animals. Specific cell lines may be
more or less suitable for testing certain toxins. For example, He et al. (2015) [127] used heterogeneous
human epithelial colorectal adenocarcinoma (Caco-2) cells and mouse embryonic fibroblast (3T3)
cells to assess cell viability and DNA synthesis, respectively, and thereby to illustrate the diminished
toxicity of 3-epi-DON. Recently, mouse models have been gaining more attention and becoming
feasible routes for bio-potency testing. He et al. (2015) [127] followed the above cell culture assays by
exposing B6C3F1 mice to DON and 3-epi-DON treatments for 14 consecutive days, demonstrating that
toxin-induced lesions were only observed in the adrenal glands, thymus, stomach, spleen and colon of
the DON-group, but not 3-epi-DON. Some alternative approaches for using large animals in toxicity
testing have been devised recently. For example, explants of specific and more sensitive tissues were
developed by the Oswald group using pig jejunal explants to investigate the toxicity of deepoxy-DON
and 3-epi-DON [139,140].
Another primary challenge for toxicity testing is the purification of enough starting
materials/metabolites with which to proceed. The optimum range to start with can span milligram to
gram quantities, based on the selected host, assay and testing approach. In some cases, the development
of a large-scale preparative purification of the final biotransformation metabolite(s) is unavoidable
in order to proceed with the toxicity testing. He et al. (2015) [102] applied a refined high-speed
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counter-current chromatography protocol to scale up the purification of 3-epi-DON from D. mutans
17-2-E-8 bacterial cultures before toxicity assessment.
The stability of the final biotransformation products used in toxicity bio-assays is another
factor that should be considered. Conjugation-based modifications (acetylation, glycosylation,
phosphorylation) are usually more difficult to address as the attached groups can be hydrolyzed
or cleaved under the implemented experimental conditions. Compounds with chemically-active
groups, such as ketones [141,142] (3-keto-deoxynivalenol for example), are another example of unstable
modifications that can give misleading results, as such reactive groups seek the simultaneous reduction
to more thermodynamically-stable alcohols (DON or 3-epi-DON) in aqueous solutions with the
possibility of reverting back to the original toxins (DON in the above example).
Beyond showing a reduction in the toxicity of the final biotransformation product(s), the mechanism
of this reduction must also be determined [143,144]. For example, the reduction in DON toxicity
due to C3 carbon epimerization was attributed to attenuated binding of 3-epi-DON within the
ribosomal peptidyl transferase center [139,140], in addition to increased polarity of 3-epi-DON and
decreased molecular interactions with different cellular targets, such as Fusarium graminearum Tri101
acetyltransferase [145]. Similar results were also obtained for deepoxy-DON when transformed
anaerobically by strain BBSH 797 [139,140]. This mechanistic information is pivotal for predicting how
the final biotransformation product(s) will behave under different scenarios and usage conditions, such
as under unfavorable pH conditions, or in the presence of metabolizing bacteria in the animal intestinal
tract. Some of the modifications that were promising in early stages (conjugation-based modifications
such as acetylation/glycosylation) were subsequently found to be incompatible with practical
agricultural and industrial applications as they give rise to so-called masked mycotoxins [146,147],
where the modifying chemical groups are easily cleaved or hydrolyzed by intestinal bacteria [148–152].
3.8. Genes and Enzymes
One of the ultimate goals for mycotoxin mitigation strategies is to establish the conditions
needed for efficient practical usage [9]. In many agricultural and industrial applications, the use
of whole bacterial cells, for instance through incorporation into fermentation matrixes (especially if
they belong to the lactic acid group), might be the most feasible approach to mitigation [153,154].
This also reduces the costs associated with enzyme(s) purification and the need to incorporate any
co-factors/co-substrates into the final enzymatic reactions. The above scenario is not always possible
due to either processing conditions that do not favor the use of microorganisms (human food chain
applications) or the presence of natural consortium that outcompete the active strain(s). In such cases,
the use of pure enzyme preparations is unavoidable.
The identification of functional genes and the purification of detoxification enzyme(s) is a laborious
and time-consuming process that involves working expertise in the fields of microbiology, analytical
and synthetic chemistry, molecular biology, enzymology, genomics and bioinformatics. For detailed
information regarding such a process and the involved procedures, the readers are referred to other
recently published in-depth reviews [9,155–157].
After the responsible enzyme(s) are identified, a second stage of troubleshooting and optimization
is initiated to deliver workable enzymatic mixtures that are suitable for the chosen application. Many
native enzymes are not stable under certain processing conditions (pH, temperature, presence of
inhibitors) or require specific expensive co-factors, such as NADP(H), to function. Such properties
can sometimes be manipulated to make these enzymes more industry friendly through targeted
protein-engineering [158,159]. The enantioselective epoxidation of styrene by two-component
monooxygenases offers a good example of efficient enzyme engineering that was preformed recently.
A fusion protein was generated by joining the C-terminus of StyA epoxidase with the N-terminus of
the StyB reductase. Furthermore, the above fusion protein was cloned into a single-vector expression
system to couple the epoxidation function to NADH oxidation, thereby enhancing the overall
catalytic function of the system. The observed positive changes in the catalytic mechanism were
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attributed in part to an increased flavin-binding affinity of the StyB reductase associated with its
N-terminal extension [160]. In a similar optimization, the NADP(H) dependence of hyperthermophilic
6-phosphogluconate dehydrogenase was engineered to favor the less expensive NAD(H) cofactor for
a promising industrial application in bio-batteries [161].
3.9. Feasibility of Commercial Application
From the application point of view, there are many additional challenges to overcome in order
to achieve success. These obstacles include the validation of detoxification activities in food/feed
materials, the industrial-scale production and marketing authorization based on the extensive
assessment. Unlike ideal in vitro conditions, many factors such as poor nutrient availability, lower
pH, natural temperature, interactions with the microbiota and complicated structures of food/feed
materials may become hurdles for successful application. For example, the ensiling procedure for
production of silage, an important fodder for ruminants, generates an anaerobic environment with
acidic pH, high carbon/nitrogen ratio and low nutrient availability, which inhibits most MBMs that
grow well and present detoxification activities in media [162]. During the large-scale production
of MBMs, the difficulties to maintain the activity may appear as the media and fermentation
conditions vary from those in the laboratory. From an economical point of view, the media used
in industrial-scale fermentation processes are usually produced from less expensive and more readily
available materials, as opposed to the costly synthetic or semi-synthetic media used in laboratory-scale
fermentation. Moreover, the downstream processing steps, such as freeze-drying, spray-drying or
preparing a direct-fed microbial (DFM) product, may also influence the detoxification activities. Thus,
the optimization and validation of mycotoxin detoxification activities should eventually be performed
under conditions of commercial-scale production. In addition, any negative or uncertain effects,
such as nutrient/palatability loss and safety of biotransformation agents, must also be considered.
Finally, the manufacturer should obtain marketing authority before they may claim their products as
anti-mycotoxin additives. In Europe, for example, the dossier of anti-mycotoxin additives registration
must include the mycotoxin specificity, the species specificity, the efficacy and the safety. The marketing
authority in EU member states is issued by the EC based on positive evaluation by the EFSA [163].
For these reasons, the successful commercial application of microbial detoxification has been limited.
To our knowledge, Biomin® BBSH 797 is the sole microorganism product that has obtained market
authority in the EU. The product has the capacity of biotransforming DON to harmless products and
was approved as a pig feed additive in 2013. Recently, the EFSA published a positive scientific opinion
on the safety and efficacy of Biomin® BBSH 797 for application in poultry feed. FUMzyme®, a purified
enzyme isolated from the fumonisin-degrading soil bacteria Sphingopyxis sp. MTA 144, is the only
enzyme product for mycotoxin detoxification that has been approved by the EC [164–166].
The feasibility of commercial applications has been evaluated in a number of research papers and
granted patents [8,9]. One of the essential considerations at this stage is to validate the detoxification
activity of MBMs in the complex food/feed matrices to which they will be applied, such as corn,
wheat, barley, DGGS, peanut meal, pistachio nut, rice straw, apple juice, apple puree and grape
must [13,20,32,37–39,47,53,54,100,108,110,167]. The typical procedure includes preparation of samples
with either spiked or naturally-contaminated mycotoxins, incubation of samples with the MBMs under
natural conditions, followed by extraction and chemical analysis of mycotoxins and their metabolites.
Ito et al. (2012) verified a decrease in DON in 1000 kernels of wheat and barley grain by applying
Marmoricola sp. MIM116. The authors also investigated spreading agents and selected 0.01% Tween 80
for its advantages in facilitating cell growth and DON reduction [32]. Gluconobacter oxydans, a bacterium
isolated from PAT-contaminated apples, has been reported to degrade 96% of PAT (800 μg/mL) to
ascladiols in apple juice. However, a full evaluation of the quality attributes of apple juice, the toxicity
of ascladiol and safety assessment of the MBM is needed before any industrial applications of such
a microorganism [37].
87
Toxins 2017, 9, 130
Since the principle detrimental effect of mycotoxin contamination is the decreased growth
of livestock, another consideration for the application of MBMs is the effect of detoxified feed
on livestock performance. A two by two factorial design is recommended for these studies.
Specifically, the experimental samples should be catalogued into four groups including positive
mycotoxin-free control, negative mycotoxin-exposed control, mycotoxin-free with detoxifying agents
and mycotoxin-exposed with detoxifying agents. The strength of this design is that it not only verifies
the detoxification activity, but also ensures that the bio-availability of essential feed ingredients is not
impaired by the detoxifying agent [168]. Li et al. (2011) [100] designed an animal trial to evaluate the
growth performance of swine, a DON-sensitive livestock, fed a diet detoxified by the isolate Bacillus sp.
LS100. Compared to pigs fed a diet with Fusarium-infected corn with DON, the daily feed consumption,
daily weight gain and feed efficiency of pigs fed the LS100-detoxified diet were significantly improved
by 45%, 82% and 32%, respectively. These results demonstrate that microbially-detoxified feed can be
used in the livestock industry to reduce the effects of DON toxicity, while not conferring significant
negative effects on the nutrition and palatability of the feed.
In addition to reducing mycotoxin contamination through biotransformation, some detoxification
strategies have introduced specific microorganisms with additional benefits to commercial applications.
For example, Bacillus subtilis ANSB01G may be delivered as spores, which have the ability to tolerate
the gut environment. In addition, this strain produces antimicrobial compounds against common
bacterial pathogens such as Escherichia coli, Salmonella typhimurium and Staphylococcus aureus, which
could improve the growth of livestock [19]. In another study, a Bacillus licheniformis strain was shown
to have higher xylanase, CMCase and protease activities, which may enhance the digestibility of
nutrients in feed [21]. Another potential advantage of detoxifying microorganisms is that certain such
microorganisms may possess antifungal activity, inhibiting the growth of mycotoxin-producing fungi
and further reducing mycotoxin contaminations [33,35,47,95].
4. Conclusions and Research Trends
The biological detoxification of mycotoxins is an attractive and environmentally-friendly
alternative to the chemical and physical decontamination methods explored extensively over the past
three decades [169]. The recently-reported examples, coupled with the emergence of some efficient
commercialized biological/enzymatic agents, highlight the promise of this approach to address the
safety of animal feed and human food [170,171].
The introduction of state-of-the-art research tools, such as next-generation sequencing,
recombinant-enzyme overexpression and robust HPLC-MS/MS systems, combined with our enhanced
understanding of the actual mechanisms underlying the diminished toxicity of final biotransformation
products [140,146,172], will immensely aid in the identification [12], optimization and usage [170,171]
of such naturally-derived alternatives. It is anticipated that these novel approaches will form the basis
for sustainable long-term solutions to the ever-growing problem of mycotoxins in the coming years.
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Abstract: Worldwide mycotoxins contamination has a significant impact on animal and human health,
and leads to economic losses accounted for billions of dollars annually. Since the application of
pre- and post- harvest strategies, including chemical or physical removal, are not sufficiently effective,
biological transformation is considered the most promising yet challenging approach to reduce
mycotoxins accumulation. Although several microorganisms were reported to degrade mycotoxins,
only a few enzymes have been identified, purified and characterized for this activity. This review
focuses on the biotransformation of mycotoxins performed with purified enzymes isolated from
bacteria, fungi and plants, whose activity was validated in in vitro and in vivo assays, including
patented ones and commercial preparations. Furthermore, we will present some applications
for detoxifying enzymes in food, feed, biogas and biofuel industries, describing their limitation
and potentialities.
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1. Introduction
Mycotoxins are secondary toxic metabolites produced by filamentous fungi mainly belonging to
Fusarium, Aspergillus and Penicillium genera. They infect cereals, seeds and fruits both in the field and
during storage, and can be found as common contaminants in food and feed supply chains [1,2].
Mycotoxins poisoning of staple food commodities has a significant impact on worldwide health,
especially in developing countries [3,4]. Both animals and humans may develop acute and chronic
mycotoxicosis, depending on several factors, which include the type of mycotoxin, the amount
and the duration of the exposure, etc. Mycotoxins can be classified as hepatotoxins, nephrotoxins,
neurotoxins, immunotoxins and so forth, based on the organ they affect [1]. Main target tissues
include gastrointestinal and breathing apparatus, endocrine, exocrine, reproductive, nervous and
immune system [5,6]. Aflatoxin B1 (AFB1) is the most toxic mycotoxin and has been classified in
group 1, carcinogenic to humans, by the International Agency of Research on Cancer (IARC) in
2002 [7]. Other mycotoxins, such as aflatoxin M1 (AFM1), ochratoxin A (OTA) and fumonisin B1 (FB1),
are classified within group 2B, thus possibly carcinogenic to humans, due to the limited availability of
their toxicological data [7–9].
Synergistic and additive effects of different mycotoxins have been documented; however,
the worsening and toxic outcome of multiple exposure cannot be predicted by summing up the
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individual toxicities. Furthermore, the mechanisms of interactions among toxins are still poorly
understood [10]. In rats FB1 synergistically promotes liver lesions, hepatocyte dysplasia and, by long
term exposure, tumors initiated by AFB1 [11]. AFB1 also acts synergistically with zearalenone (ZEN)
in decreasing egg production, feed intake, feed conversion ratio and eggshell strength in birds [12].
In vitro cytotoxicity of AFM1 on Caco-2 cells is greatly enhanced by the presence of OTA, ZEN and/or
α-zearalenol (α-ZEL), which often co-contaminate milk and infant formulas [13]. OTA and citrinin
have often been reported to act in a synergistic mode in relation to their cytotoxic [14–17] and genotoxic
effects [18].
Global trade significantly contributes to mycotoxin spread. The economic losses associated with
mycotoxin contamination in commodities account for billions of dollars annually [19]. They can be
categorized into direct and indirect losses: direct losses are related to lowered crop yields, reduction of
animal performance and costs derived from diseases for livestock producers; indirect losses are very
challenging to quantify, and are linked to the increased use of fungicide, the reduction of the marketable
value of the commodities, the management, health-care, veterinary-care costs, and investments in the
development of reducing strategies and in research programs.
Mycotoxins levels are regulated in many countries worldwide. The European Union has implemented
the most extensive and detailed food regulation for mycotoxins within the Commission Regulation
(EC) No. 1881/2006 [20], which set mycotoxins maximum levels discriminating among food products
and consumers (e.g., adults or infants). Indicative levels in cereals and cereals products [21] have
been established for the trichothecenes T-2 and HT-2 toxins (T-2, HT-2). A scientific opinion on
their toxicity was released in 2001 by the European Commission Scientific Committee on Food
(SCF) [22], highlighting the need for further studies on the occurrence, daily intake, analytical methods
development and induced hematotoxicity and immunotoxicity. However, for other so-called emerging
mycotoxins (e.g., enniatins, beauvericin, fusaric acid and moniliformin), whose increasing occurrence
has been clearly evidenced, maximum levels have not been yet established. This delay exists since
certified analytical methods for their determination, complete surveys on their occurrence and defined
scientific opinions on their toxic effect and health associated risks are still being developed [21,23].
Mycotoxin contamination can be prevented in the field through the application of good agricultural
practices (GAPs), such as the choice of resistant varieties, harvesting at the right time, crop rotation,
and the use of fungicides [20,24]. Nevertheless, pre-harvest strategies are not completely effective,
and fungal contamination of raw materials can lead to mycotoxin accumulation during storage.
Furthermore, mycotoxins are extremely stable and resistant to the commonly used physical and
chemical treatments of food and feed processing.
Since the application of GAPs, proper storage and risk management procedures might only
mitigate mycotoxin occurrence, the development of alternative strategies to reduce mycotoxins
contamination is considered a relevant, innovative, urgent, yet challenging research topic.
In this review, we will briefly present the current methods to reduce mycotoxins contaminations in
food and feed, and then we will focus on the biotransformation of mycotoxins performed with purified
enzymes isolated from bacteria, fungi and plants, whose activity was validated in in vitro and in vivo
assays, including patented ones and commercial preparations. We will also describe enzyme potential
applications and limitations in food, feed and bioenergy in compliance with the European Regulation.
Methods for Mycotoxins Reduction
Current methods to reduce mycotoxin contamination in food and feed can be classified into
physical, chemical and biological. It must be underlined that EU regulation does not authorize any
detoxification methods for those commodities, intended for food production, exceeding mycotoxins
limit levels [20].
(1) Physical methods comprise the mechanical removal of highly contaminated fractions from raw
materials (by sorting, cleaning, milling, dehulling), the application of heat, the irradiation and the use of
adsorbents, which is still limited to feed production [25]. The latter approach is considered promising,
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although some possible negative drawbacks related to unspecific binding of essential nutrients and
antibiotics exist. In addition, these adsorbents have diversified efficacy towards different classes of
mycotoxins, with trichothecenes being the most difficult to target. Furthermore, since co-occurrence
is much more common than individual contamination, complementary reduction strategies should
be implemented.
Recently, the application of unconventional strategies such as cold plasma [26–28],
photoirradiation [29,30] and microwave treatments [31] have been proposed and/or introduced
in food processing, as sterilization or degrading methods. Nevertheless, the partial knowledge about
degradation products (DPs) and the nutritional/organoleptic changes induced by these treatments
still confine their application.
(2) Chemical methods such as ammoniation [32], acid treatments [33], alkaline hydrolysis [34],
peroxidation [35], ozonation [36], and the use of bisulphites [37] have been tested, but their application
in food and feed is limited due to their potential toxicity, poor efficacy, high costs and negative effects
on the quality of raw materials.
(3) Biological methods consist of the use of microorganisms or enzymes, which are able to metabolize,
destroy or deactivate toxins into stable, less toxic, up to harmless compounds [38]. Biological agents
and their enzymes allow a specific, most likely irreversible, environmental friendly and effective
approach, with minor impact on food sensory and nutritional quality with respect to chemical ones.
2. Mycotoxin Biotransformation by Enzymes
Mycotoxin biotransformation is defined as “the degradation of mycotoxins into non-toxic
metabolites by using bacteria/fungi or enzymes” [39]. The possibility to use living microorganisms as
whole cell biocatalysts for mycotoxins degradation has cost advantages. This represents a valid strategy,
especially if multi step reactions are required, or if the microorganism is already implemented within
industrial processes [40,41]. On the other hand, in case of high levels of mycotoxins contamination, the
growth and physiology of such microorganisms might be altered or inhibited, thus requiring longer
time for adaptation before achieving satisfactory decontamination levels.
The majority of the research papers which describes microbial degrading activity, rarely
discriminates between physical adsorption and enzymatic degradation. This greatly complicates
the identification of DPs and the evaluation of their toxicity. This knowledge is relevant in the
evaluation of biotrasforming enzymes, especially since not every reaction leads to a real detoxification.
Indeed, the metabolized mycotoxin can acquire greater toxic properties than the parent compound.
This is the case, for example, of ZEN biotransformation performed in vivo by yeasts, which reduce the
toxin to α-ZEL, actually more estrogenic than ZEN [42].
The identification and characterization of a degrading enzyme (DE) can be challenging and
time consuming, but it is a necessary step to understand the mechanism of degradation, towards its
optimization and the development of mycotoxins reducing methods. Enzymes guarantee reproducible
and homogeneous performances, with ease-of-handling, no risks of contamination and no safety
concerns for operators compared to the use of living microorganisms.
Screening microbial population from different mycotoxin-contaminated environment is an
efficient, fast and promising strategy to discover degrading microbes and activities [43–45], which could
be enhanced by coupling advanced approaches, such as metagenomics or functional metagenomics.
In addition, genetic engineering enables to clone and express heterologous enzymes in bacterial,
yeast, fungal and plant cells for massive, less expensive and less laborious productions. If
no structural-functional data are available, enzyme efficiency, stability and tolerance to organic
solvents can also be improved by computational approaches, aiming at targeted or combinatorial
semi-rational mutagenesis.
Many enzymes have been reported to remove or reduce mycotoxin contamination both in vitro
and in real matrices. Nonetheless, their application in feed is very limited, due to the lack of information
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about the potential toxic effects of generated products and their influence on nutritional quality of feed.
These data are mandatory to be authorized as possible biotransforming agent in Europe [39].
Very few commercial biotransforming feed additives are available: Mycofix®, FUMzyme®,
Biomin® BBSH 797 and Biomin® MTV (Biomin Holding GmbH, Getzersdorf, Austria) are some
examples, but only FUMzyme® exploits a purified enzyme, an esterase, to perform fumonisin
degradation. Below we will discuss in details the biotransformation of the main mycotoxins by
native and commercial enzymes.
2.1. Aflatoxins
The term aflatoxins (AFs) includes more than 20 fungal secondary metabolites produced by
fungi belonging to Aspergillus genus [1]. They are classified into two main groups according to their
chemical structure. The difurocoumarocyclopentenone group includes AFB1, aflatoxin B2, aflatoxin
B2a, AFM1, aflatoxin M2, aflatoxin Q1 (AFQ1), and aflatoxicol (AFL), while the difurocoumarolactone
group comprises aflatoxin G1, aflatoxin G2 and aflatoxin G2a (Figure 1).
Figure 1. Chemical structure and features of ciclopentenone (A) and difurocoumarolactone (B) aflatoxin
(AF) series. Coloured bonds indicate reactive groups involved in AFs toxicity. The double bond leading
to 8,9-epoxide upon metabolic activation is indicated in red, while the lactone bond is indicated in blue.
Tables show substituent groups and saturation of the C8-C9 bond in different AF analogues.
While AFs of the B and G series co-occur in cereals and their derived products, fruits, oilseeds,
nuts, tobacco and spices, AFM1 AFM2, AFL and AFQ1 are detected in food as carry-over products of
AFB1 contaminated feeds. In vivo AFB1 is readily metabolized through hydroxylation (to AFM1 or, to
a lesser extent, to AFQ1) or reduction (to AFL).
AFs are difuranocoumarin derivatives composed by two furan rings, linked together to a coumarin
moiety. Furofuran and cumarin rings are arranged in a planar configuration which is responsible for
conjugation leading to the typical AFs fluorescence.
The furofuran ring has been recognized as responsible for the toxic and carcinogenic activity upon
metabolic activation of the C8-C9 double bond to 8–9 epoxide [9] (Figure 1).
The epoxidation is a crucial reaction for AFs carcinogenicity, since it allows the binding to
N7-guanine and the subsequent G to T transversions in the DNA molecule [46]. Activated AFs are
also able to form schiff bases with cellular and microsomal proteins (via methionine, histidine and
lysine), thus leading to acute toxicity [47]. The lactone ring also plays a role in AFs toxicity and
carcinogenicity: upon ammoniation it is hydrolyzed, forming aflatoxin D1 (AFD1) which still retains
101
Toxins 2017, 9, 111
the 8,9-dihydrofuran double bond; AFD1 lacks the strong in vivo DNA binding activity of AFB1,
demonstrating that DNA alkylation depends upon both difuranocumarin and lactone moieties [48].
Several authors addressed lactone hydrolysis, reduction or addition reactions as possible mechanisms
of degradation, since the putative hydrolyzed products showed greatly reduced mutagenic activity
in vitro [49,50].
Table 1 summarizes the purified enzymes identified as capable of degrading AFs, and their
main features. Although direct comparison is not possible, since the enzymes and the experimental
conditions used by the authors are not equivalent, reaction parameters and AFs concentrations
are indicated.
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Most of these enzymes are comprised in the oxidoreductase (EC 1) group. The first identified
was the AF oxidase enzyme (AFO) isolated from the edible fungus Armillariella tabescens by Liu and
colleagues in 1998 [51]. AFO is an oxygen dependent reductase, releasing H2O2 as by product [51,60].
One mg/mL of enriched preparation and 30 min of incubation at 28 ˝C were needed to completely
degrade 150 ng of AFB1. AFO did not affect AFB1 fluorescence properties, indicating that the
conjugation system, between the coumarin moiety and the lactone ring, was not disrupted by the
degrading reaction. The mechanism proposed by the authors consisted of the enzymatic cleavage
of the bisfuran ring. This hypothesis, although not yet experimentally verified, is in agreement
with the reduced mutagenicity, toxicity and genotoxicity of the DPs and with their differential pulse
voltammetry response similar to furofuran analogs [61,62]. Products of AFO treatment were found to
exert neither liver toxicity in rats, nor mutagenicity activity on Salmonella typhimurium TA98, and not
to be genotoxic to chicken embryos [61].
Three different peroxidases (EC 1.11.1.7) were also reported to possess AFB1 degrading capabilities.
They were extracted and purified from horseradish (Armoracia rusticana) [52], Phanerochaete sordida
YK-624 [63] and Pleurotus ostreatus [56]. The horseradish peroxidase was tested in vitro towards AFB1,
which was reduced by 42% after 1h with 0.2 U/mL of enzyme. Similar results were also obtained in
real matrix: AFB1 was reduced by 41% in artificially spiked groundnut [64]. A lowered toxicity of the
DPs was also registered by inhibition growth assay on Bacillus megaterium [51]. The two manganese
peroxidases (MnPs) from the two different white rot fungi were studied [56,63] in in vitro assays with
similar reaction conditions, allowing a direct comparison. They were tested towards 0.3 μg/mL of
AFB1, achieving 86% reduction after 24 h of incubation, and up to 90% after 48 h by using the MnP from
P. sordida YK-624 and the one from P. ostreatus respectively. Wang and colleagues [63] also registered
69.2% reduction of mutagenicity of DPs compared to AFB1, based on the umu test performed on
Salmonella typhimurium TA1535 and on S9 liver homogenate. According to Proton Nuclear Magnetic
Resonance (1H-NMR) and high resolution electrospray ionization mass spectrometry (HR-ESI-MS)
analysis, the authors hypothesized that MnP treatment converted AFB1 to AFB1-8,9-dihydrodiol.
Laccases (EC 1.10.3.2) (LCs) have been intensively used in bioremediation [65] and were recently
proposed for ZEN and AFs biotransformation [59,66,67].
Alberts and colleagues [53] made as firsts a decisive step towards the correlation between
AFs degradation and LCs activity. The authors used different LCs, including native LCs from
representatives of Peniophora genus and P. ostreatus, one commercial LC from Trametes versicolor, and
one recombinant LC from Aspergillus niger. By treatment with 1 U/mL of the commercial preparation
AFB1 (1.4 μg/mL) was reduced by 87.34% after 3 days of incubation at 30 ˝C. DPs were not identified,
but proved to be less mutagenic than the parent compound. However, none of the preparations used
by the authors was purified to homogeneity. The commercial product from T. versicolor was indeed
an enriched preparation, which included additional proteins and different laccase isoforms [68]; thus,
an unambiguous assignment of the degrading activity to a specific LCs would be improper.
Recently the effectiveness of purified LCs towards AFs and ZEN was acknowledged [58,67,68].
Pure LCs from P. pulmonarius and P. eryngii were used by Loi and colleagues [58,59] towards both AFB1
and AFM1. The authors performed in vitro and in matrix tests with 1 μg/mL of AFB1 and 0.05 μg/mL
for AFM1. Interestingly, they reported that, while LC alone is poorly able to degrade these toxins, the
addition of a redox mediator at 10 mM concentration increased the degrading percentages from 23%
up to 90% for AFB1, and up to 100% for AFM1 after 72 h [58,59].
The laccase-mediator approach patented by Novozymes in 2008 [54], consisted of the use of
LCs, preferably from Streptomyces coelicolor, and methylsyringate as mediator. In this case, AFB1 was
completely removed after 24 h of incubation with 0.1 mg/mL of enzyme and 0.2 mM of mediator at
37 ˝C.
Members of the reductase family have also been studied for AFs degrading capabilities. Among
these, the F420H2-dependent reductases (EC 1.5.8.), isolated from Mycobacterium smegmatis, were tested
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towards AFB1, AFB2, AFG1 and AFG2; no details were provided in relation to efficacy and assay
conditions [55].
Besides oxidases above described, Guan et al. [69] identified the myxobacteria aflatoxin DE
(MADE), isolated from Myxococcus fulvus, which was further characterized in 2011 [57]. Pure MADE
(100 U/mL) was tested towards 0.1 μg/mL each of AFG1 and AFM1, achieving 98 and 97% of
degradation after 48 h of incubation. No further details about the nature of the enzyme, nor about the
DPs were given.
2.2. Ochratoxin A
OTA is a phenylalanine-dihydroisocoumarine derivative, composed of a 7-carboxy-5-chloro-8-
hydroxy-3,4-dihydro-3-R-methylisocoumarin (ochratoxin α—OTα) moiety and a L-β-phenylalanine
molecule (Phe), which are linked at the 7-carboxy group by an amide bond (Figure 2).
Figure 2. Chemical structures of (A) ochratoxin A and (B) its degradation products, ochratoxin-α and
phenylalanine. The amide bond hydrolyzed by the main degrading pathway is indicated in red.
Due to its structural analogy to the amino acid Phe, the toxin can competitively inhibit tRNA
phenylalanine synthetases and, consequently, block protein synthesis [70]. Furthermore, OTA causes
the formation of DNA adducts, indirect oxidative DNA damage and activates a network of interacting
epigenetic mechanisms [71,72].
The main OTA detoxification pathway consists in the hydrolysis of the amide bond between
the isocoumarin residue and phenylalanine, resulting in the formation of Phe and OTα (Figure 2).
The former is considered to be a non-toxic compound, with a 10-times shorter elimination half-life
than OTA [73].
Numerous enzymes were hypothesized to hydrolyze the OTA amide bond, but only few of them
were isolated and characterized [74].
Two classes of carboxypeptidases (EC 3.4) have been associated with OTA degradation:
carboxypeptidase A (CPA) and carboxypeptidase Y (CPY) class. CPA uses one zinc ion within the
protein for hydrolysis (EC 3.4.24), while CPY is a serine-type carboxypeptidase (EC 3.4.16) and does
not contain any zinc ion in its active site. The first peptidase reported as able to hydrolyze OTA was a
CPA isolated from bovine pancreas, which resulted able to perform the degrading reaction with a Km
value of 1.5 ˆ 10´4 M at 25 ˝C [75]. A CPY isolated from Saccharomyces cerevisiae was demonstrated to
hydrolyze OTA with optimum at pH 5.6 and 37 ˝C; its specific activity was very low considering that
only 52% of OTA was converted into OTα after five days of incubation [74]. The same enzyme was
efficiently immobilized on electroactive surfaces in order to develop a biosensor system for the direct
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detection of OTA in olive oil, with promising results [76]. Many carboxypeptidases have high optimal
reaction temperatures (30 ˝C or higher); this might not hamper detoxifying applications for food and
feed [25].
Other enzymes are also able to perform OTA hydrolysis, such as lipases (EC 3.1), amidases (EC 3.5)
and several commercial proteases (EC 3.4) [77–79].
By screening different commercial hydrolases, a lipase preparation from Aspergillus niger (Amano
A) was shown to hydrolyze OTA into OTα and Phe. Single-step purification, by anion exchange
chromatography, allowed the isolation of the pure protein. The lipase nature of the enzyme was
confirmed by assaying the cleavage of p-nitrophenyl palmitate. The purified enzyme resulted able
to completely hydrolyze 50 μg of OTA into OTα after 120 min of incubation, in 1 ml of reaction
mixture [77].
Several commercial proteases were also reported to hydrolyze OTA to OTα, such as Protease A
from A. niger and pancreatin from porcine pancreas. These enzymes showed a significant hydrolytic
activity at pH 7.5, which resulted in the cleavage of 87.3% and 43.4% of 1 μg of OTA respectively, after
25 h of incubation in 1 ml reaction mixture [78].
Finally, an amidase and the feed or food additive comprising it, capable of degrading OTA, were
patented by Dalsgaard et al. in 2010 [79]. The protein, named amidase 2, is encoded by an open reading
frame of A. niger. The degrading assay was performed in 300 μL of reaction mixture, containing
160 ng/mL amidase 2 and 50 μg/mL of OTA. This enzyme was able to reduce OTA concentration
by 83%. Amidase 2 was tested also in some food preparations. The patented additive decreased
OTA content, from 47 ppb to undetectable level (<2 ppb), after 2.5 h-incubation in contaminated milk.
Similarly, OTA concentration in corn flour was reduced from 38 ppm to less than 2 ppb after 20 h
of incubation.
2.3. Fumonisins
Fumonisins are a group of mycotoxins associated with several mycotoxicoses, including equine
leukoencephalomalacia, porcine pulmonary edema and experimental kidney and liver cancer in
rats [80]. Chemically, fumonisins are diesters of propane-1,2,3-tricarboxylic acid and similar long-chain
aminopolyol backbones. Structurally they resemble the sphingoid bases sphinganine (SA) and
sphingosine (SO), with tricarboxylic acid groups added at the C14 and C15 positions (Figure 3). This
structural similarity is responsible for the fumonisin mechanism of action. It was described to act by
disturbing the sphingolipids metabolism, by inhibiting the enzyme ceramide synthase, and leading to
accumulation of sphinganine in cells and tissues [81–83].
Figure 3. Type B fumonisins chemical structure. The ester bonds hydrolyzed by the main degrading
pathways, leading to the formation of HFB1 and the two tricarballylic acid moieties, are indicated in
red. The table shows substituent groups of different fumonisin analogues.
There are at least 28 different forms of fumonisins, designated as A-series, B-series, C-series, and
P-series [84]. The B-series (FB) is the most abundant and important with respect to toxicity.
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Pre-harvest strategies to reduce fumonisins contamination are based on the bio-control of the
spread of fumonisin-producing fungi. Post-harvest methods include the application of natural clay
adsorbents during food processing. While they do not lead to a real detoxification of fumonisin [85,86],
different microorganisms were reported to transform these class of mycotoxins. Among them, only
few enzymes have been identified, molecularly and biochemically characterized, and patented.
FB1 was reported to be degraded by the consecutive action of a carboxylesterase (EC 3.1.1) [87]
and an aminotransferase (EC 2.6.1) [88,89] (Table 2).
By the deesterification action of the carboxylesterase, the two tricarballylic acid moieties are
released, resulting in hydrolyzed FB1 (HFB1), also known as aminopentol 1 (AP1). After the oxidative
deamination, HFB1 is converted to N-acetyl HFB1 and 2-oxo-12,16-dimethyl-3,5,10,14,15-icosanepentol
hemiketal [88]. The action of these enzymes, isolated from Sphingomonas sp. ATCC 55552 [90],
was worldwide patented in 1994 [89].
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The same degrading activity was shown by Sphingopyxis sp. MTA144, isolated from composted
earth [92]. In this strain the two key DEs were identified within a gene cluster: fumD, encoding a type
B carboxylesterase, and fumI, encoding an aminotransferase [80,93,94]. The authors also demonstrated
the degrading activities of the two recombinant enzymes by in vitro assays. The first enzyme, encoded
by fumD, was able to catalyze the complete deesterification of FB1 (3.34 μg/mL) to HFB1 within
15 min. The oxygen independent aminotransferase, encoded by fumI, was shown to deaminate
HFB1 (8.9 μg/mL), in presence of pyruvate and pyridoxal phosphate, within 44 h. Furthermore,
the authors described the additional genes located in this putative degrading cluster identified by
genome walking (NCBI Accession n. FJ426269). The cluster includes one transporter, one permease,
dehydrogenases, and transcriptional regulators and was U.S. patented by Moll et al. within the
“Method for the production of an additive for the enzymatic decomposition of mycotoxins, additive
and use thereof” [95].
The esterase (EC 3.1.1.87) from Sphingopyxis sp. MTA144, produced by a genetically modified
strain of Komagataella pastoris (formerly Pichia pastoris), has been included in a patented formulation,
FUMzyme® (Biomin Holding GmbH, Getzersdorf, Austria). This enzyme-based feed additive, whose
safety and efficacy has been recently evaluated by EFSA [91], is intended to degrade fumonisins found
as contaminants in feeds for growing pigs. The esterase partially degrades FB1 and related fumonisins
by cleavage of the diester bonds and release of the tricarballylic acid.
2.4. Trichothecenes
Trichothecenes are a large group of sesquiterpenoid metabolites sharing a common core structure
comprised in a rigid tetracyclic ring (Figure 4). To date, more than 190 trichothecenes and derivatives
have been described [96,97].
 
Figure 4. Chemical structure of trichothecenes. Groups responsible for trichothecenes toxicity are
highlighted in red (epoxide) and blue (substituent groups, see the text for further details). The table
shows substituent groups of different trichothecene analogues.
Their synthesis starts with the formation of trichodiene via the cyclization of farnesyl pyrophosphate.
Trichodiene then undergoes a series of oxygenation, cyclizations, isomerization and esterification
needed for the bioactivation of the molecule [98].
Trichothecenes are classified into 4 groups according to the functional groups associated to the
core molecule: type A trichothecenes (e.g., T-2 and HT-2) do not contain a carbonyl group at the C-8
position; type B trichothecenes (mainly represented by deoxynivalenol (DON) and nivalenol (NIV)
contain a carbonyl group at the C-8 position; trichothecenes of type C (e.g., crotocin and baccharin)
have an additional epoxy ring between C-7 and C-8, or between C-9 and C-10; trichothecenes of type D
(e.g., satratoxin and roridin), contain a macrocyclic ring between C-4 and C-15 (Figure 4).
The results of trichothecenes exposure on eukaryotic cells was reviewed by Rocha et al. [99], while
T-2 and HT-2 toxicity data were reported to EFSA in 2010 by Schuhmacher-Wolz and colleagues [100].
Trichothecenes are not degraded during normal food processing, they are stable at neutral and acidic
pH and, consequently, they are not hydrolyzed in the stomach after ingestion [99].
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Type A trichothecenes arise special interest, being more toxic than the other food-borne
trichothecenes [101]. Among the effects exerted by T-2 and HT-2 toxins several studies reported
the inhibition of DNA, RNA and protein synthesis, and apoptotic effects in mammalian cell cultures
in vitro and ex vivo [22,102].
T-2 is rapidly metabolized to HT-2 in the gut. Data indicate that these toxins induce acute toxic
effects with similar severity. For these reasons, the toxicity of T-2 in vivo is considered to include that
of HT-2 [102]. Type B trichothecene have a relatively low toxicity compared to type A trichothecene,
but it varies depending on the species and the cell type. The general toxic mechanism of trichothecenes
is induced by the interference with protein synthesis, through 60S ribosome binding, leading to
translation inhibition [103].
The 12,13-epoxy ring is the most important structural determinant of trichothecenes toxicity.
In addition, the presence of hydroxyl or acetyl groups at appropriate positions on the trichothecene
core [104], the presence of substituents on C15 and C4 [105,106], and of the side groups, are implicated
in defining the degree of toxicity [107]. Both acetylation and de-acetylation may reduce toxicity of
trichothecenes, as well as epimerization, oxidation [108–110].
Trichothecenes are noticeably stable molecules under different treatments, including both thermal
and chemical ones. Several microorganisms, isolated from disparate complex environments, such as
rumen or soil, have been reported to degrade trichothecenes into de-acetylated and/or de-epoxidated
products [25]. However, the majority of the studies focused on this topic never achieved the
identification of the enzymes responsible for the biotransformation. Nevertheless, considering the
reaction products, acetylase, deacetylase or de-epoxidase activities are surely involved in the process.
In addition, hydroxylation and glycosylation of trichothecenes generate less toxic derivatives [111].
In this case, these compounds might undergo reverse reaction in the digestive tract of humans and
animals, limiting the use of these enzymes at least in feed-related applications.
Recently, the bacterial cytochrome P450 system (EC 1.14) from Sphingomonas sp. strain KSM1, was
reconstructed in vitro and demonstrated to hydroxylate DON, NIV and 3-acetyl DON [112] (Table 3).
The system includes the cytP450, encoded by the gene ddnA, and the endogenous redox partners.
The DON catabolic product, 16-HDON, is used by the Sphingomonas strain as a carbon source, and was
shown to exert a reduced phytotoxicity to wheat.
Poppengberger et al. [113] identified a UDP-glycosyltransferase from Arabidopsis thaliana
(the deoxynivalenol-glucosyl-transferase DOGT1) able to catalyze the transfer of glucose from
UDP-glucose to the hydroxyl group at C3 of DON forming 3-O-glucopyranosyl-4-DON. The
overexpression of this enzyme in A. thaliana enhanced DON resistance. The reaction products were
identified by in vitro assays, using the enzyme purified from recombinant Escherichia coli cells.
Commercial products containing biotransformant agents have already been developed and
patented. As an example, Biomin® BBSH 797 includes a pure culture of Eubacterium BBSH 797
isolated from bovine rumen fluid; it is capable of converting DON into DOM-1 and with de-epoxydase
activity towards NIV, T-2, tetraol, scirpentriol, and HT-2. Nevertheless, purified enzymes with specific
trichothecenes degrading activity have not been yet reported.
However, the recent increasing of microorganisms isolated from trichothecenes contaminated
environments and capable of transforming this class of toxins led to the assumption that this goal will
not be so distant [109,110,114].
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2.5. Zearalenone
ZEN is a resorcylic acid lactone, nonsteroidal yet estrogenic mycotoxin, which binds to mammalian
estrogen receptors (ER), although with lower affinity than the natural estrogens 17β-estradiol, estriol
and estrone [115]. From a structural point of view, ZEN resembles the 17-βestradiol, and this similarity
is responsible for its estrogenic potential and ER binding capacity (Figure 5).
 
Figure 5. Chemical and structural analogies between zearalenone (A) and 17β-estradiol (B). The main
chemical groups interacting with the estrogen receptors and responsible for zearalenone toxicity are
highlighted in red (see the text for further details).
In vivo ZEN undergoes reduction to α-ZEL and β-zearalenol (β-ZEL), with the first being more
estrogenic than the parent compound [116]. A further reduction leads to the formation of α- and
β-zearalanol (α-ZAL, β-ZAL), which are both less estrogenic than ZEN.
ZEN estrogenicity is greatly enhanced by the reduction of the 61-ketone group and of the
11-21double bond, while it is reduced by the methylation of the hydroxyls in C4 and C2. The OH group
in 61of α and β-ZEL resembles that of C3 in estradiol. This group strongly interacts with ER, while the
saturation of the 11-21double bond increases the flexibility of the molecule. This allows ZEN and/or
ZEL to undergo some slight conformational changes, effective at adapting the molecules to the binding
pocket of the receptor. Hydroxyl groups in C4 and C2 also contribute to the binding, with the first
being more important than the latter in increasing ZEN estrogenic potential [116] (Figure 5).
ZEN and derivatives detoxification strategies aim at disrupting their estrogenic activity. Among
the reported ZEN metabolizing reactions, lactone ring cleavage, catalyzed by esterases, is the
prevalent detoxification method described so far. Since the resulting hydroxyketones spontaneously
decarboxylate, the reaction is irreversible.
A lactonohydrolase (EC 3.1.1) from the fungus Clonostachys rosea has been identified as capable
of degrading ZEN. The enzyme was purified to homogeneity, and its gene (namely zhd101) was
cloned and characterized by heterologous expression in E. coli BL21 and S. cerevisiae INVSc1 [117,118]
(Table 4). The recombinant protein was proved to completely degrade 2 μg/mL of ZEN in in vitro
assays, although with minimal yeast mediated conversion of ZEN to β-zearalenol. Zhd101 gene and
transformants carrying lactonohydrolase gene were patented in 2002 [119].
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Besides the above-mentioned activity towards AFs, laccases are also able to degrade ZEN.
Novozyme patented the laccase-mediator degradation of ZEN in 2007 [120], using Streptomyces coelicolor
LC and, preferably, phenotiazin-10-propionic acid or methylsyringate as redox mediators. By using
this system, ZEN was completely removed by 0.1 mg/mL of LC and 0.2 mM of mediator at 37 ˝C,
within 24 h. Laccase degrading capabilities were also studied by Banu and colleagues [67] using one
LC-enriched Trametes versicolor preparation. Reactions, containing 6.2 ˆ 10´4 μg/mL of ZEN, were
incubated with 0.4 mg/mL of laccase for 4 h at 30 ˝C, achieving a maximum of 81.7% of degradation.
Another ZEN degrading oxidoreductase is a 2-Cys peroxiredoxin (Prx) (EC 1.11.1.15) extracted
from Acinetobacter sp. SM04 [121,122]. Prxs are peroxidases containing redox-active cysteine, which
can be oxidized to cystine by using H2O2 as cofactor. Prx degraded up to 95% of ZEN (20 μg/mL)
in in vitro assays, when added with 20mM H2O2; nearly 90% of the toxin was instead degraded in
contaminated corn sample (ZEN levels of nearly 1000 μg/mL), treated for 6 h at 30 ˝C with purified
recombinant Prx, plus 0.09% (mass fraction, mol/mol) H2O2. Toxicity bioassays were also performed.
The proliferative effect on MCF-7 cells by ZEN-DPs was reduced by 75%. Altalhi and colleagues [123]
identified a 5.5 kb gene fragment from Pseudomonas putida pZEA-1, which encodes for DE(s) not yet
characterized. E. coli DH5 cells, expressing the 5.5 kb gene fragment, were able to reduce 100 μg/mL
of ZEN by 85% after 72 h, while no degradation was observed by wild type cells. ZEN DPs were also
shown to possess a marked reduced toxicity on Artemia salina larvae.
3. Potentialities and Limitations of Mycotoxin Degrading Enzymes in Food, Feed, and Bioenergy
The use of enzymes in the food, feed, biogas and biofuel industries is not new, as biocatalysts
have been increasingly used in the last 30 years. They allowed reducing the employment of hazardous
chemicals, to use mild working conditions, to increase specificity, to speed up a process or to simply
create new products.
Enzyme biotechnological applications are widespread: the dairy industry has a long story of
protease use for cheese manufacturing, while bakery employs laccase and transglutaminase to achieve
doughs strengthening; phytases are used in non-ruminant animal nutrition for the degradation of
phytic acid, which interferes with mineral absorption; pretreatment of lignocellulosic biomass for
bioethanol production can be achieved using a cocktail of cellulases (endoglucanase, EC 3.2.1.4,
exoglucanase, EC 3.2.1.91 and cellobiohydrolase, EC 3.2.1.21) instead of employing acid or alkali
treatments [124,125].
Mandatory requirements for enzyme application in large scale industry are (a) safety; (b) effectiveness;
(c) low cost of production and purification for both enzyme and cofactors, if needed; d) stability to
wide ranges of temperature, pH and organic solvents, and thus compatibility to productive processes.
All those characteristics make the enzyme use advantageous from both technological and economic
points of view. Native enzymes usually do not respond to each distinctive requirement of a perfect
industrial enzyme, but these features can be achieved via molecular engineering and structure-function
modifications by targeted or random mutagenesis.
The most important limitation related to the application of mycotoxin DEs in real matrices is
represented by the reduced effectiveness of the process due to matrix effects. The physicochemical
properties of food, such as the moisture and fat content, acidity, texture etc., greatly influence the
success of the detoxification process. Moreover, inhibitory compounds may be present in raw materials
and mycotoxins can occur in masked forms in plant tissues [126]; thus, their bioavailability for the
enzyme catalysis may be further reduced. These implications might require pretreatments, additional
time and costs, which must be taken into account in the development of industrial applications.
Despite these limitations, the potentialities of enzyme use in food and feed industries remain
widespread. Their application is versatile, since they can be used both in free or immobilized form
and easily applied to well established industrial processes (fermentations, ripening, brewing or cheese
manufacturing, feed and bioenergy production).
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Moreover, DEs can be heterologously expressed by industrial microorganisms, such as lactic acid
bacteria or yeasts, to perform in situ bioremediation. New smart and edible packaging with enzymes
are also under study [127].
3.1. Food
The European Community established the last regulation on food enzymes in 2008 [128].
This regulation covers “enzymes added to food to perform a technological function in the manufacture,
processing, preparation, treatment, packaging, transport or storage of such food, including enzymes
used as processing aids”. All enzymes are submitted to this regulation as processing aids, with the
exception of lysozyme and invertase, considered as additives.
Article 6 states that necessary conditions to authorize a food enzyme are that (i) its use does not
pose a safety concern for the health of the consumer; (ii) it responds to a technological need that cannot
be achieved by other economically and technologically practicable means; and (iii) it does not mislead
the consumer.
Only recently, acceptability criteria for detoxification treatments, including biotransformation,
have been set for commodities intended for animal nutrition [38].
Some of the enzyme recognized to have mycotoxins degrading capabilities have been proposed
and studied for applications in food industry, even if thought for other purposes.
Laccases have been studied for their introduction in bakery and dairy as crosslinking agent,
in brewing, wine and fruit juice production as clarifying agent and polyphenol remover [129–131].
Peroxidases have also been studied for their crosslinking activity in bakery and dairy industry, but the
use of H2O2 as cofactor limits their real application in food.
Amano enzyme Inc. (United Kingdom) requested EFSA to perform a scientific risk assessment on
one laccase from Trametes hirsuta, currently in progress.
The employment of DEs in the food industry, especially in immobilized forms, is not unrealistic.
Still, it must overcome the gap of knowledge related to the effects that these enzymes exert on the
nutritional and organoleptic qualities of raw materials, as well as fill a legislative void, which, so far,
does not foresee the possibility of detoxifying treatments for food.
3.2. Feed
Enzyme use in animal diets has a long history, starting from the 1920s, when a commercial enzyme
preparation, produced by Aspergillus orizae, known as Protozyme, was applied in poultry diets [132].
Phytases, proteases, α-galactosidases, glucanases, xylanases, α-amylases, and polygalacturonases
are commercially available and increasingly used in animal nutrition, with huge benefits in terms of
nutritional value and micronutrients availability [133].
For authorizing their use in feed, EFSA requires solid supporting information about production,
safety, efficacy and non-interference with the nutritional and organoleptic quality of the feed [134].
However, to become a commercial reality, an effective and safe DE must be formulated in order to
guarantee its stability and efficacy during storage, and to ensure detoxification once released in the
animal digestive tract.
There are two ways to apply a DE to feed: (a) as stabilized by a suitable formulation for becoming
a feed additive or (b) used in a detoxifying process for contaminated raw materials intended for feed.
(a) During feed production enzymes are usually added before pelleting, in premixes with other
additives (such as vitamins), or after pelleting as a liquid application. The most convenient approach is
to introduce them as protected in formulations before pelleting: indeed, in this condition enzymes are
less exposed to high moisture content and high temperature [135], thus preventing their inactivation.
High temperature protection is usually achieved by coating. Its challenging development has to
succeed in both stabilizing the enzyme during feed processing, and in fast dissolving in the animal gut,
thus releasing the active enzyme. To this aim new coated and tough (CT) granulated coatings have been
developed by different companies (Novozymes®, Bagsvaerd, Denmark; DSM™, The Netherlands).
116
Toxins 2017, 9, 111
Within the CT granulates, enzymes are enclosed in a core matrix of minerals and carbohydrates.
The outer layer can consist of vegetable oil, kaolin, and calcium carbonate, which are readily degraded
upon ingestion [136]. On 5 May 2014 Biomin® (Holding GmbH) received the first-ever EFSA positive
opinion, for using a purified enzyme in feed. This is an esterase, embodied in a 10% maltodextrin
matrix and spray dried, capable of biotransforming fumonisins.
(b) The development of a detoxifying application at industrial scale should allow the treatment of
highly contaminated batches, with significant reduction of mycotoxin under the limits imposed by the
current regulation. The achieved detoxification could result worthless in case of residual contamination
by toxigenic fungi, if long term storage of the treated material is expected.
Free enzymes can be delivered in the feed productive process both in liquid and in solid forms
(some prior wetting in dissolving feeders might be needed), through pumps, and mixed with the raw
material, usually through a vertically mounted, shaft-driven impeller. This mode of application well
fits a batch type process.
The major limitation of this approach is the difficulty to achieve a homogenous enzyme delivery
throughout the entire material. In addition, the enzyme must target hot spots of contamination, typical
of the distribution of toxigenic fungi and associated mycotoxins.
Among the environmental parameters that should be well set to preserve enzyme catalytic
properties, moisture is by far the most critical. A high water content can increase enzyme activity,
but simultaneously trigger fungal spread.
Immobilized enzymes encounter the same limitations, but they present the advantage of allowing
the setup of continual processes, enzyme reuse and costs reduction.
3.3. Bioenergy
In biofuel production, enzymes are used to break down complex carbohydrates and to release
ready fermentable sugars from cheap raw materials. Cellulose hydrolysis preceding fermentation is
usually performed with cellulases, cellobiohydrolases and endoglucanases [137]. Pre-treatment of
lignocellulosic biomasses prior to saccharification by laccases is under study, both to degrade lignin
and to detoxify phenolic inhibitory compounds in bioethanol production [138,139]. The same biomass
breakdown is realized during biogas production, especially in maize-feeded biogas plants, to adapt
and accommodate raw materials and to enhance their suitability for the activity of methanogenic
microorganisms [140,141]. In this case, the mixture may include cellulose, hemicellulose, pectin
and starch DEs, but also proteins able to breakdown long chain fatty acids, whose accumulation is
responsible for the decrease of the process stability.
Despite these applications, no enzymes have been yet developed to reduce mycotoxin level in
maize silage, plants or any other substrate used for bioenergy production. Their content, which
mirrors fungal contamination in raw materials, affects the efficiency of the anaerobic digestion and
ethanol/methane accumulation: indeed, fungal metabolites, including mycotoxins, act as antimicrobial
or inhibitory compounds, or lead to excessive foam formation [142].
Storm et al. [143] recently reviewed fungal and mycotoxin contamination in maize feeding biogas
plants. The authors assessed that pre-harvest contamination of grass and maize by Fusarium spp.,
Aspergillus spp. and Alternaria spp. can lead to DON, ZEN, FBs and AFs accumulation, but with
concentration usually lower than regulatory limits. Salati et al. [144] reported that the addition of AFB1
in a lab scale anaerobic digestion trials did not affect biogas production. In a recent conference abstract
presented by De Gelder et al. [145] the authors evaluated the biodegradability of mycotoxins during
anaerobic digestion. They performed lab scale degradation tests with digestate spiked with different
mycotoxins. After 30 days of mesophilic and thermophilic digestion, each tested mycotoxin resulted
absent in the final products, suggesting the activation of some adsorption/detoxification mechanism
during the fermentation. The adsorption mechanism appears the most probable, since (1) as discussed
in previous paragraphs mycotoxins are greatly stable and (2) they strongly bind to soil clay minerals
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and organic matter present in the reactors. However, no experiment has been performed in real biogas
plants under conventional operating conditions.
Recent studies demonstrated that the addition of enzymes directly into biogas reactors has no
significant effect on biogas process [146], since the enzymes are quickly degraded [147]. This obviously
might require a continuous addition, and thus increases costs in comparison to raw materials
pre-treatment. The development of enzymatic formulates able to couple biomass breakdown and
mycotoxin degrading activity could allow the simultaneous increase of biogas yield and the safe
utilization of byproducts, for which mycotoxins levels are not yet regulated.
The fate of mycotoxins during biofuel production has been only recently investigated.
Dzuman et al. [148], performed a study on five different batches of the ethanol–distiller’s grains
and soluble (DDGS) production process. They reported a significant increase of deoxynivalenol and its
glycosylated form, DON-3-glucoside, during the first part of fermentation, when hydrolytic enzymes
were added. After yeast addition, total DON content rapidly decreased. They observed an opposite
trend for FB1, since yeast addition contributed to its increase. The same results were discussed by
Wu and Munkvold [149], who estimated that mycotoxins are concentrated up to three times in DDGS
compared to the feeding grain.
Despite these data, the second generation of bioethanol industry is not greatly concerned
by mycotoxin contamination since: (a) less susceptible commodities can be used as raw material;
(b) mycotoxins occurrence in bioethanol byproducts is not yet regulated neither in Europe or in U.S.
and (c) the growth and productivity of highly tolerant fermenting yeasts are only slightly influenced
by mycotoxin contamination [150,151].
The re-use of contaminated biomasses for renewable energy production is raising great interest
both for economic and environmental reasons. However, more detailed studies should evaluate side
effects not sufficiently considered, since by-products use for animal nutrition in Europe, Canada and
U.S. [152–155] is increasing.
Sosa et al. [156] performed a preliminary economic analysis evaluating the feasibility of using
fumonisin highly contaminated corns as feedstock for ethanol production. The authors calculated
that the advantages deriving from the lower price of contaminated raw materials is balanced by the
increase of the operating costs and the decrease of the final ethanol production by the fermenter. Thus,
the performance of the process must be optimized, using process alternatives (e.g., both microfiltration
and pervaporation membranes) coupled by the introduction of ethanol tolerant yeast strains, in order
to effectively increase the economic value of the process.
DDGS are considered valuable by-products, thanks to the low carbon-nitrogen ratio and their
high proteins and micronutrients content [157]. However, their utilization should be responsibly
addressed, since ecological outcomes of mycotoxin contaminated fertilizers and health effects are still
poorly investigated.
As for biogas production, the implementation of DEs for biofuel application has not been
developed. Still, it benefits of less limitations than those encountered by the food and feed industries.
Cloning DEs in industrial hosts could ideally allow to simultaneously perform detoxification and
fermentation of contaminated biomasses.
4. Conclusions and Future Perspectives
Within this review we gave a global view of the identified mycotoxins DEs, their mechanisms,
their current and possible application in food, feed, biogas and biofuel industries. We also presented
patented commercial preparations used by feed industries.
Although this paper is focused on the main mycotoxins, for which a high level of contamination
and health implications have driven the majority of economic and research efforts, the discovery of
novel DEs is becoming an interesting and stimulating topic also in relation to other mycotoxins.
Several patents have been deposited, mostly in U.S. and China, describing microorganisms and
methods to degrade minor mycotoxins, such as patulin [158], beauvericin [159] and moniliformin [160]
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in plants, maize or grains. These patents are mainly related to microorganisms or crude extracts
preparation, and no enzymes have been yet characterized as responsible for the degrading activity.
It should not be excluded that enzymes efficient towards minor mycotoxins could be effective
towards structurally similar main ones.
In addition to the previously described ones, another challenge related to the application of DEs,
is represented by mycotoxins co-occurrence, which should require the simultaneous use, and thus
optimization, of different preparations and protocols. To overcome this barrier, the combination of
different strategies, such as adsorbents mixture, binding microorganisms and enzymes, suitable for the
inclusion within the same procedure, should be considered.
In the optimization process, great potentialities are ascribed to structural modelling and design
of experiments (DOE) technologies. These approaches are able to identify structural determinants
responsible for the degradation mechanism and to improve substrate-enzyme affinity by setting the
conditions, which maximize enzyme efficiency. In combination with targeted mutagenesis methods,
they strongly reduce lab-optimization processes and accelerate the industrial scale up.
Transcriptional analysis of degrading microorganisms [161] has recently led to the identification
of a DE from the novel Acinetobacter sp. neg-1 species, described by Fanelli et al. [162] as capable of
degrading OTA. This high-throughput approach, as other advanced Next Generation Sequencing
technologies, such as functional metagenomic, could give a huge contribution in the identification
of similar classes of DEs from complex and unexplored environments, such as contaminated soils,
water or rumen. The advantage of these approaches is represented by the possibility to investigate
non-culturable organisms, as well as those living in complex environmental niches, hardly analyzable
under laboratory conditions.
The application of DEs could be simplified by the biotechnological advances in the field of
immobilization and encapsulation techniques. Finally, an interesting perspective is represented by the
development of transgenic crops able to counteract mycotoxins formation in the field. EU does not
authorize the genetic modification of plants as a breeding technique. In contrast, the U.S. have 20 years
of history of genetically engineered crops: herbicide-tolerant and insect-resistant crops were introduced
in 1996 and today more than 90% of the corn cultivated in the U.S. is genetically modified [163].
Syngenta patented trichothecene-resistant transgenic plants bearing the Fusarium graminearum
Tri101 gene [164], which encodes for a 3-O-acetyltransferase [165,166], which catalyzes the transfer of
an acetate to the C3 position of trichothecenes. The company performed field trials, in Canada, the
U.S., Argentina, and three European countries [108], proving that the development of self-defending
crops is already achievable.
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CPA carboxypeptidase A
CPY carboxypeptidase Y
CT coated and tough
DDGS distiller’s grains and soluble
DE degrading enzyme
DOE Design of experiments
DON deoxynivalenol
DPs degradation products
EDC endocrine disrupting chemical
EFSA European Food Safety Authority
ER estrogen receptors
FB1 fumonisin B1
GAPs Good Agricultural Practices
HFB hydrolyzed FB1
HR-ESI-MS High Resolution electrospray ionization mass spectrometry
HT-2 HT-2 toxin
IARC International Agency of Research on Cancer
LCs laccases
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Abstract: Mycotoxins are secondary metabolites of fungi that contaminate food and feed, and are
involved in a series of foodborne illnesses and disorders in humans and animals. The mitigation
of mycotoxin content via enzymatic degradation is a strategy to ensure safer food and feed, and to
address the forthcoming issues in view of the global trade and sustainability. Nevertheless, the search
for active enzymes is still challenging and time-consuming. The in silico analysis may strongly
support the research by providing the evidence-based hierarchization of enzymes for a rational
design of more effective experimental trials. The present work dealt with the degradation of aflatoxin
B1 and M1 by laccase enzymes from Trametes versicolor. The enzymes–substrate interaction for various
enzyme isoforms was investigated through 3D molecular modeling techniques. Structural differences
among the isoforms have been pinpointed, which may cause different patterns of interaction
between aflatoxin B1 and M1. The possible formation of different products of degradation can
be argued accordingly. Moreover, the laccase gamma isoform was identified as the most suitable for
protein engineering aimed at ameliorating the substrate specificity. Overall, 3D modeling proved
to be an effective analytical tool to assess the enzyme–substrate interaction and provided a solid
foothold for supporting the search of degrading enzyme at the early stage.
Keywords: aflatoxins; biotransformation; enzymatic detoxification; laccase; mild technologies;
food safety; mycotoxins mitigation
1. Introduction
Mycotoxins are low-molecular weight molecules produced as secondary metabolites by several
species of fungi. They may enter the feed and food production chains worldwide upon the infection of
crops and commodities intended for animal and human consumption. The contamination of food and
feed by mycotoxins poses major concerns for the public health and welfare as the dietary exposure may
cause disorders, dysfunctions and alterations of physiological states in both humans and animals [1,2].
Many countries have adopted regulations to reduce the possible dietary intake, thereby preserving
the health of animals and consumers (for Europe: EC No 1881/2006, EU No 165/2010, EU No 105/2010).
However, the allowed levels of contamination are not harmonized among countries, and this may
cause trade frictions at the global level. De facto, the management of risks related to foodborne
mycotoxins must consider several factors and have to reach controversial socio-economical tradeoffs,
being primarily influenced by the availability of a secure food supply. The developing areas
are the most damaged in terms of health and international exchanges as the contamination
levels commonly found in traded commodities do not often comply with those enforced by
industrialized countries, also considering that low-income countries lack regulatory actions and
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monitoring plans. As an example, the restrictions of the European Regulation cause huge economic
losses to Africa, unreasonably exceeding the limits to effectively safeguard the public health in the
European countries, as commented by the past Secretary-General of the United Nations, Kofi Annan [3].
On this basis, the mitigation of mycotoxin content in food and feed is a critical foothold to address
the forthcoming challenges in view of the sustainability and global trade. On the one side, the reduction
of contamination levels in food and feed can effectively ameliorate the health and welfare of both
humans and animals. On the other side, the implementation of cost-effective strategies for recovering
contaminated food and raw materials after spoilage may concretely allow the weaker markets to
reenter the global trade. In this scenario, the development of affordable and straightforward strategies
for mitigating mycotoxin content is definitely a major task for the scientific research.
A wide number of strategies for the control and mitigation of mycotoxins content in food and feed
are currently under consideration. For instance, the strategies of biocontrol with non-toxigenic fungi,
conventional breeding and genetic engineering are promising methodologies aimed at preventing
the accumulation of mycotoxins on the field at the pre-harvest level [4]. Instead, food processing,
physical methods (e.g., irradiation and adsorption) and microbial/biochemical transformation of
mycotoxins to non- or less toxic compounds may act post-harvest on raw material or intermediate
products [4]. The main advantage of the latter approach on the former is the possible application
to low- or non-compliant food batches to reduce and/or reuse wastes. Among these, the enzymatic
transformation seems to be the most promising tool for the mitigation in situ [5].
The high-throughput search and optimization of effective enzymes to be used for mitigation is
thus of primary interest, even though highly challenging and time-consuming. Typically, the first steps
in the conventional large-scale research process of active enzymes inevitably include the coarse-grained
selection of candidate enzymes, which drastically depends on the realistic affordability of proteins
in sufficient amounts and/or in the active forms. Commonly, this hardly complies with the rational
criteria of exclusion in terms of possible effectiveness. However, the search of putative active enzymes
in the early steps can be effectively boosted in a straightforward and cost-effective manner by using
screening procedures in silico. Indeed, the upstream use of computational approaches to screen the
libraries of candidate enzymes may support a wide-ranging and evidence-based selection of those
enzymes to be investigated experimentally. In particular, the use of the 3D modeling by means of the
computational estimate of the interaction at the enzymes binding site deepens the structural aspects
underlying the enzyme–substrate interaction and succeeds in identifying substrates (e.g., ref. [6,7]).
Hence, it can be a reliable tool for providing the rational and evidence-based hierarchization of enzymes
on the basis of the computed capability to allow a favorable arrangement of substrates.
In this framework, the present study addressed the enzymatic degradation of aflatoxins (AFs)
by laccase enzymes from Trametes versicolor. AFs are difuranocoumarin derivatives produced by
Asperigillus sect. Flavi that can be found as contaminants primarily in cereals, maize, oilseeds and
nuts [8]. AFs are mutagenic, genotoxic and carcinogenic compounds that cause both acute and
chronic health effects [9]. Among the 20 AFs identified so far, aflatoxin B1 (AFB1) is the most
widespread and harmful in terms of both acute and chronic toxicity [10], while aflatoxin M1
(AFM1)—its major hepatic metabolite in mammals—raises concern as it can be found in milk and
dairy products [11]. In recent years, severe outbreaks related to aflatoxin contamination in feed have
been reported in Europe, mainly in the Mediterranean and Balkan areas [12]. Besides health concerns,
these events caused significant losses in terms of veterinary costs and managing of incompliant feed
and milk batches.
Laccases are multi-copper containing enzymes capable of performing one electron oxidation
of a broad range of substrates [13]. The laccase enzymes from T. versicolor have been identified as
a promising route for the low-cost and effective reduction of AFB1 content [14,15], while the use of
these enzymes has been never considered before to degrade AFM1. Moreover, the strategies commonly
rely on the use of mixtures of the various laccase isoforms. The relative activity of the various isoforms
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and the structural aspects of aflatoxin interaction have not been elucidated yet, making the design of
rational strategies based on selected isoforms difficult.
As a proof of concept, the present work aimed at modeling the interaction of AFB1 and
AFM1 (Figure 1) with three out four laccase isoforms from T. versicolor (namely, the beta,
delta and gamma isoforms) in order to find out possible differences among the enzymes in terms of
pocket–ligand recognition. The complementarity of both AFB1 and AFM1 towards the various catalytic
sites has been assessed using a previously validated structure-based molecular modeling workflow
based on docking simulation and rescoring procedures. The pharmacophoric analysis of catalytic
sites and the comparison of structures and sequences of the various isoforms have been done to better
understand the basis of the enzymes–substrates interaction at a molecular level.
Figure 1. Chemical structure of aflatoxin B1 (A) and aflatoxin M1 (B).
2. Results
2.1. Sequence Analysis and Pocket Anatomy
Laccases from T. versicolor show a globular structure with approximate dimensions of 70 × 50 × 50 Å
with a topology consisting mainly of antiparallel β-barrels [16]. The overall amino acids sequence
alignment of the laccase enzymes (from here on referred to as models) revealed that the delta and
gamma isoforms showed, respectively, 71.6% and 71.8% of the identity with the beta isoform, and 77%
between themselves (Figure 2A).
Concerning the primary structure, the sequence alignment revealed that the binding site
of the beta and delta isoforms appeared fairly comparable to each other (12 residues out of 16
are conserved). Instead, the gamma model showed a higher divergence mainly due to the presence
of an extend loop with five and four additional residues in respect to the beta and delta isoforms,
respectively (Figure 2A,D).
The pharmacophoric analysis of the various binding site environments revealed that all the
pockets appeared prevalently hydrophobic, as the hydrophobic environment turned out to exceed
in extension the hydrophilic one, with a limited capability to receive polar groups, wherein H-bond
donors groups were found to be more energetically favored than the H-bond acceptor ones
(Figure 2B–D). In addition, concerning the distribution of the polarity of the space available for ligands,
the binding sites of beta and delta isoforms were found to be more similar to each other, while the site
of the gamma isoform was found to be less hydrophobic with a more extended volume energetically
able to receive H-bond donor groups.
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Figure 2. The sequence alignment (A) and pharmacophoric analysis of beta (B), gamma (C) and delta
(D) laccase isoforms from T. versicolor. In the sequence alignment (box A), dots represent matching
residues while dashes indicate gaps (red spots in the gap fraction blue bar). Residues of the binding
site are highlighted in yellow while the green box indicates an extended region of the gamma isoform
lining the catalytic site. The overall 3D structure of the beta isoform is also reported to provide
localization of the binding site (colored in yellow). In the pharmacophoric analysis (boxes B, C and D),
white, red, and blue contours identify regions sterically and energetically favorable for hydrophobic,
H-bond acceptor, and H-bond donor groups, respectively. Spheres indicate Cu ions. The green box
indicates the extended region of the gamma isoform.
2.2. Assessment of Procedure Reliability
The in silico investigation of AF-laccase interactions relied on the assessment of pocket–substrate
complementarity through the coupling of docking simulation to calculate the binding architecture
with re-scoring procedures using the HINT (Hydropathic INTeractions) scoring function for the
careful estimation of the energetic contributions of the binding event (see Section 5 for further details).
Such a procedure already proved to be an effective strategy for investigating the protein–ligand
complex formation and the biological activity of chemicals, [17,18], and succeeded in identifying
enzymes substrates as well [6]. However, the case-by-case assessment of procedural performances is
required to prove the fit-for-purpose reliability among the diverse case studies [19].
Therefore, in the present work, the two benchmark laccase substrates ABTS
(2,2′-azino-di-(3-ethylbenzothiazoline)-6-sulfonic acid) and 2,6-dimethoxyphenol [20] have been
chosen to assess the case-specific reliability of the computational procedure. Specifically, the procedure
has been validated assessing the capability to properly rank the reference compounds in accordance
with the experimental data from the literature, and for the capability to reproduce the 3D binding
architecture observed in the crystallographic structures available so far. The Km values indicate the
enzymes affinity for substrates. Thus, the Kms have been chosen among the various biochemical
parameters for the comparison with the computed scores since the HINT scoring may correlate the
pocket–ligand affinity proportionally [6,21–25].
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ABTS showed a clearly defined rank of Kms among the various isoforms, with the following order:
88 μM in beta < 359 μM in gamma < 2262 μM in delta [26]. As shown in Table 1, the computational
ranking of ABTS among the various laccase isoforms was consistent with that observed experimentally.
Table 1. Comparison of experimental affinity and HINT (Hydrophatic INTeractions) scores of ABTS
(2,2′-azino-di-(3-ethylbenzothiazoline)-6-sulfonic acid) within the various laccase isoforms.




1 As reported by Christensen and co-workers [26].
Moreover, while the beta isoform wild type shows a higher affinity for ABTS than for
2,6-dimethoxyphenol, previous studies demonstrated that the D206A mutation at the level of binding
site causes the inversion of ranking [20,27]. As reported in Table 2, the computational ranking of ABTS
and 2,6-dimethoxyphenol within both the mutated and wild type enzyme was consistent with that
observed experimentally.
Table 2. Comparison of experimental affinity and HINT scores of ABTS and 2,6-dimethoxyphenol









Beta wild type 2 430 1 500
Beta D206A 1 495 2 203
1 As reported by Madzak and co-workers [20].
In order to assess the reliability of the procedure in predicting the binding architectures,
the computed pose of ABTS within the beta isoform was compared with the crystallographic
one within the orthologous laccase enzyme from Bacillus subtilis, as no structures of laccases from
T. versicolor are available so far. They can be consistently compared as orthology allows taking the
functional conservation in different species for granted (i.e., the catalytic reaction and the overall
organization of substrates in this case) [28]. It should be kept in mind that laccase enzymes catalyze
the one-electron oxidation of substrates involving a Cu ion (at the so-called Cu T1 site), coupled to the
four-electron reduction of molecular oxygen to water at the tri-nuclear Cu cluster [27]. The catalytic
histidine lining the binding site, which may interact with substrates, mediates the electron transfer.
For a proper transfer, the distance of the electron–donor regions of substrates from the receiving
histidine cannot exceed the 5 Å [26]. The inspection of the crystallographic pose of ABTS revealed
that the electron–donor region occupies the deepest region of the binding site, closely arranged to the
catalytic histidine, while sulfonic acid groups protrude outside. Therefore, the geometric reliability
of the in silico procedure was established by assessing the capability to properly reproduce such
binding architecture. As showed in Figure 3, the overall computed organization of ABTS turned out to
be consistent with the crystallographic pose and the arrangement of the electron–donor region has
been correctly predicted as well, being posed within the 5 Å needed for undergoing the reaction [27].
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Figure 3. Binding architecture of ABTS. Proteins are represented in cartoon and surface, ABTS and
residues of binding sites are represented in sticks. Cu at the T1 site is represented by the red sphere and
the catalytic histidine is colored in red. ABTS electron donor region is highlighted with the yellow box,
while interatomic distances are indicated by yellow dashed lines. (A) calculated surface interaction
with beta laccase from T. versicolor; (B) crystallographic surface interaction with CotA laccase from
Bacillus subtilis [29]; (C) detail of binding architecture with beta laccase from T. versicolor; and (D) detail
of binding architecture with CotA laccase from B. subtilis [29].
2.3. Interaction of Aflatoxin B1 and M1 within Beta, Delta and Gamma Laccase Isoforms
The scores of interactions between AFs and laccase isoforms are reported in Table 3. AFM1 was
found able to interact favorably with all the laccase isoforms herein considered. AFB1 favorably
interacted instead with beta and delta, but not with gamma, as the pharmacophoric requirements were
not satisfied (see below).







The close inspection of the computed poses revealed that AFB1 adopted comparable binding
architectures within both the beta and delta laccase isoforms, wherein the methoxy moiety was
oriented toward the bottom of the binding sites. Both the interactions were mainly driven by
hydrophobic/hydrophobic interaction, in accordance with the marked hydrophobic environment of
the pockets. Indeed, a unique polar contact was found, wherein the oxygen of the methoxy group
engaged the His458 (according to the amino acids’ numeration of the beta isoform) with a hydrogen
bond (Figure 4A). AFM1 engaged the His458 with the oxygen on the difuran ring and used the
additional hydroxyl group for engaging Asp206 (according to the amino acids’ numeration of the
beta isoform), thereby embedding much more into the catalytic sites (Figure 4B) and retracing the
mode of interaction proposed for phenolic substrates [27]. In addition, the formation of the additional
hydrogen bond was responsible of the higher score recorded for AFM1 within all of the laccase
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isoforms herein considered. Conversely, AFB1 was unable to sink into the site to the extent of AFB1
since the hydroxyl-free difuran moiety did not find the energetic favors for being close to the aspartate
side chain.
Figure 4. Binding architecture of AFB1 (A) and AFM1 (B) within the beta isoform. Proteins are
represented in with cartoons and cut surfaces, and ligands and amino acids side-chains are represented
with sticks. The Cu ions are represented with spheres. Yellow dotted lines indicate H-bonds.
The incapability of AFB1 to positively interact with the gamma isoform may be explained by
the diverse capability of AFB1 and AFM1 to sink within the catalytic site, where AFM1 was found
closer to the bottom of the pocket. Indeed, the additional loop at the entrance of the binding site of the
gamma isoform redefined markedly the available space for ligands in the upper portion of the pocket
(Figure 5) and prevented the proper accommodation of AFB1.
Figure 5. Details of ligand binding site of laccase isoforms. Proteins are represented with cut surfaces
and ligands with sticks. The yellow box indicates the additional volume in the gamma isoform binding
site due to the presence of the extended loop. (A) AFB1 within the beta isoform pocket; (B) AFB1 within
the delta isoform pocket; and (C) gamma isoform pocket.
3. Discussion
The mitigation of mycotoxin content in food and feed is undoubtedly a major task for safeguarding
health and global trade. Besides the use of good agricultural practices and crop breeding, the biological
control of toxin accumulation in the final products by acting at pre- and post-harvest levels and during
food processing proved to be an effective strategy [4]. In this framework, the search for enzymes able to
convert mycotoxins into non- or low-toxic products has been the object of a growing number of studies.
The main advantage of using enzyme-based strategies is the possibility to act at the different stages of
food and feed production chains. Indeed, enzymes are currently considered as food/feed additives
or agents during the from-field-to-fork pathway, and they are aimed at reducing the carryover and
accumulation in the final products [30]. Nonetheless, while the safety and security of genetically
modified organisms for health and environment are under a heated scientific debate, the genome
engineering by introducing effective enzymes in susceptible hosts or detoxifying microorganisms can
be thought as a possible (future) strategy (e.g., ref. [31,32]).
In this scenario, novel strategies for a more effective search of mycotoxin-degrading enzymes
should be implemented. The upstream investigation via in silico approaches can be a straightforward
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choice to significantly extend the explorable space in the early stage providing reliable and informative
insights on the enzymes–substrate interaction, also in the view of the evidence-based preliminary
hierachization of candidates for the experimental trials.
As a proof of concept, in the present work, we addressed the case study of the interaction between
AFs and laccase enzymes from T. versicolor. The tertiary structures of gamma and delta isoforms,
which are not structurally resolved up to now, were obtained through the homology modeling on the
crystallographic structure of the homologous beta isoform (further details are reported in Section 5).
On the basis of the fit-for-purpose validation, the 3D receptor modeling turned out to be an effective
strategy for estimating the enzyme–substrate interaction for all of the isoforms under investigation.
Actually, the reliability of 3D models that were derived from the primary structure of proteins is
among the most relevant outcomes pinpointed herein. Indeed, the possibility to use the primary
structure for deriving reliable 3D libraries of enzymes may significantly expand the explorable space of
research beyond the enzymes that are commercially available or structurally and functionally known
so far. In this respect, the advances in structural biology and the whole-genome sequencing data are
providing a growing number of high-resolution structures to derive 3D models and a wealth of newly
identified sequences of putative proteins for an even more wide-ranging screening.
The degradation by means of laccase enzymes from T. versicolor is considered among the
most promising and cost-effective enzymatic strategies for the mitigation of AF content [14].
Typically, the development of enzyme-based strategies requires the precise understanding of the
specific enzymes–substrate activity, especially in the presence of different isoforms, in order to
isolate the most suitable for the purpose. To this end, it is mandatory to gain knowledge on the
substrate–enzyme interaction from a structural perspective, thereby understanding in-depth the
mechanism of catalysis and deciphering the reasons underlying the formation of degraded products.
Taken as a whole, this background of knowledge may reduce the extent of the try-and-error timeframe
during the optimization of degradation processes. However, the relative effectiveness of the various
laccase isoforms from T. versicolor is still unknown, as only unspecified mixtures of the various
isoforms have been assessed up to now. Furthermore, the structural organization of AFs within
the laccase binding sites has not been elucidated yet. Overall, this scenario eventually makes it
hard to refine more effective strategies based on selected enzymes. In this context, the present work
investigated the arrangement of AFB1 and AFM1 within the binding site of the beta, delta and gamma
laccase isoforms with the aim to find out some possible differences in the accommodation of AFs
in the catalytic sites. On the basis of our findings, relevant structural differences between gamma
and the other isoforms have been pointed out in terms of accessibility of the catalytic site. In fact,
AFB1 were found able to accommodate within beta and delta, but not within gamma due to the
extension of a loop lining the binding site. In particular, the re-shaping of the upper portion of the
pocket was responsible for the inappropriate accommodation of AFB1 since the hydrophobic difuran
moiety has been unfavorably arranged too close to the hydrophilic space at the bottom of the pocket.
Notably, the pathway of entrance toward the catalytic site of enzymes may strongly influence the
reaction yield and commonly concur to determine the substrate specificity [33,34]. Specifically, it has
been previously reported that mutation at the C-terminus of orthologous fungal laccases may affect the
enzyme activity influencing the accessibility to the binding sites [35,36]. Accordingly, this feature can be
accounted for gaining more specificity for the laccase enzymes from T. versicolor since the low substrate
specificity is the major drawback in the application on real food and feed matrices. Indeed, laccases can
degrade a wide spectrum of compounds, including a wealth of healthy low molecular weight food
and feed constituents (e.g., polyphenols) [37], thus possibly causing an overall pauperization of the
treated products. Therefore, the engineering of such a loop might be a straightforward strategy
to modulate the substrate specificity of laccases without significantly altering the binding site and
preserving as much as possible the catalytic environment. To this end, the gamma isoform can be
considered as the most suitable among the various isoforms holding an extended loop at the entrance of
the catalytic site, which might be accounted for mutations, while the other isoforms have a direct access.
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AFM1 was found able to positively interact within the catalytic sites of all the isoforms
herein considered. In this case, the presence of the hydroxyl group on the difuran moiety facilitated
a deeper sinking into the pocket that allowed the accommodation also within the gamma isoform.
Notably, AFM1 recorded higher scores than AFB1 within all of the catalytic sites due to the formation
of an additional hydrogen bond. The gain of enthalpy may be responsible for an increase in
substrate–enzyme affinity and, eventually, may cause a higher degrading yield. In this respect, the full
degradation of AFM1, by laccases from the edible mushroom Pleurotus pulmonarius, was reported by
Loi and coworkers [38], thus supporting the strong degradation of hydroxylated forms in accordance
with the well-known activity of laccases on poly-phenolic molecules [27].
In the framework of effectively reducing the content of toxicants, the formation of more
toxic by-products must be carefully avoided. In this respect, a decreased (geno)toxicity for AFB1
after treatment with laccases has been already reported. The modification at the level of difuran
moiety—which is responsible for the toxic action—has been proposed as the possible mechanism [15].
However, neither the exact chemistry of the degrading event nor the structure(s) of reaction product(s)
have been elucidated so far. The computed architectures of binding revealed that both AFs structures
(including the difuran moieties) were found almost entirely arranged within the proper range of
distance from the catalytic hystidine to undergo oxidation. Thus, some other parts of the AFB1
molecules might undergo modifications. Moreover, it is worth mentioning that AFM1 showed some
differences in the pattern of interaction with respect to AFB1 as the additional hydroxyl group on
the difuran moiety interacted directly with the catalytic core. Accordingly, AFM1 might undergo
the same degrading route of phenolic compounds via the electron/proton transfer mechanism [27],
which is instead less likely to occur for AFB1 due to the lack of the additional hydroxyl groups.
Therefore, differences in terms of sites, type of modification and chemical structures of products
between AFB1 and AFM1 cannot be excluded throughout and should be carefully evaluated to rule
out the formation of possible toxic byproducts.
4. Conclusions
In conclusion, the in silico simulations proved to be effective analytical tools to investigate the
enzyme–substrate interaction, correlating with the affinity of binding. Specifically, the 3D modeling
approach provided, for the first time, structural insights on the laccase–aflatoxin interaction, which may
be useful for the evidence-based hierarchization of enzymes to be used in further experimental trials.
The modeling of laccase enzyme has been shown to be reliable from previous works
(e.g., ref. [39,40]). However, the in silico screening of multiple laccase isoforms in the framework
of AF control has been never used before. In more detail, AFM1 was found to be able to arrange
positively within all the isoforms herein considered, while AFB1 was able to arrange within beta and
delta but not within gamma. Accordingly, the low degradation yield of AFB1 by laccase gamma
can be hypothesized. Furthermore, AFB1 and AFM1 showed different binding architectures in
arranging within laccase catalytic sites. Therefore, it cannot be excluded that AFB1 and AFM1 undergo
different modifications in different regions of the molecule, thus forming degraded products that are
chemically different. This might also cause the differential formation of toxic by-products. On the other
hand, the effects of the extended loop of the gamma isoform in diversifying the enzyme–substrate
recognition can be accounted for developing future strategies to modulate the substrate specificity.
Taken together, these results may provide a basic foothold for addressing future studies from a more
informed perspective.
Finally, it is worth mentioning the degradation of AFM1, which is the main mammal metabolite.
The carryover phenomenon of this metabolite in dairy products poses serious health concerns,
and, nowadays, the strategies for reducing the contamination levels in milk and derived products
primarily act on reducing the consumption of AFB1-contaminated feed by dairy animals.
However, the use of AFM1-degrading enzymes on milk might be an additional strategy to further
mitigate the contamination level of AFM1 in milk itself and dairy products.
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5. Materials and Methods
5.1. Homology Modeling and Sequence Analysis
The crystallographic structure of the enzyme beta laccase from Trametes versicolor (PDB code
1KYA [16]) was the template for the homology modeling of gamma and delta isoforms.
The Modeller software, version 9.14 (copyright © 1989–2016 Andrej Sali; maintained by Ben Webb
at the Departments of Biopharmaceutical Sciences and Pharmaceutical Chemistry, California
Institute for Quantitative Biomedical Research, Mission Bay Byers Hall, University of California
San Francisco, San Francisco, CA, USA) was used [41]. The D206A beta isoform model was
obtained by manually editing the wild type structure with the software Sybyl, version 8.1
(Certara USA, Princeton, NJ, USA). For sequence analysis, a local pairwise alignment was conducted
by using the on-line tool EMBOSS-Water Pairwise Sequence Alignment (EMBL-EBI, Wellcome Genome
Campus, Hinxton, Cambridgeshire, UK; http://www.ebi.ac.uk) and the Smith–Waterman algorithm
was chosen.
5.2. Molecular Modeling
All protein structures and ligands were processed by using the software Sybyl, version 8.1
(Certara USA, Princeton, NJ, USA). All atoms were checked for atom- and bond-type assignments.
Amino- and carboxyl-terminal groups were set as protonated and deprotonated, respectively.
Hydrogen atoms were computationally added to the protein and energy-minimized using the Powell
algorithm with a coverage gradient of ≤0.5 kcal (mol·Å)−1 and a maximum of 1500 cycles.
5.3. Pharmacophore Models
The ligand binding site was defined by using the Flapsite tool of the FLAP (Fingerprint for Ligand
And Protein) software version 2.0 (Molecular Discovery Ltd., Borehamwood, Hertfordshire, UK;
http://www.moldiscovery.com) [42], while the GRID algorithm [43,44] was used to investigate the
corresponding pharmacophoric space. The hydrophobic (DRY) probe was used to describe the
potential hydrophobic interactions, while the sp2 carbonyl oxygen (O) and the neutral flat amino (N1)
probes were used to describe the hydrogen bond acceptor and donor capacity of the target, respectively.
All images were obtained using the software PyMol version 1.7 (Schrödinger, New York, NY, USA;
http://www.pymol.org).
5.4. Docking Simulations and Re-Scoring Procedures
The coupling of GOLD (Genetic Optimization for Ligand Docking), as docking software,
and HINT [45], as rescoring function, was chosen on the basis of previous studies demonstrating the
higher reliability of HINT with respect to other scoring functions in estimating the ligand binding
free energies and evaluating the protein–ligand complex formation [19,23,46]. Software setting and
rescoring procedures reported by Ehrlich were used [47]. In more detail, HINT score provides
the evaluation of thermodynamic benefits of protein–ligand interaction, and relates with the ΔG◦
of complex formation [22,24,25]. Specifically, the empirical HINT scoring function implicitly
considers enthalpic and entropic aspects of protein–ligand interaction using experimental Log
Po/w measurements (partition coefficient for 1-octanol/water) as the basis of its force field.
Indeed, from a mechanical point of view, the forces that drive the repartition of molecules between
the two solvent phases also underline protein–ligand interaction, as well protein–protein interaction or
ligand–ligand interaction. The HINT score is the sum of the all inter-atomic contributions from binding,
thereby providing an empirical and quantitative estimate of the favors of the host–guest interaction
from an atomic point of view. Thus, the higher the score, the more favored is the arrangement of
ligands within the binding site [22,24,25,48]. The HINT equation is the following:
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where bij is the interaction score between atoms i and j, a is the hydrophobic atomic constant,
S represents the solvent accessible surface area, Tij is a logic function assuming +1 or −1 values,
depending on the nature of the interatomic interaction, and Rij and rij are functions of the distance
between atoms i and j. Further details on the basic theory of HINT can be found in ref. [49–51].
Acknowledgments: We would like to acknowledge Glen E. Kellogg and Gabriele Cruciani for the courtesy of the
HINT scoring function and the Flap software, respectively. We would like to also acknowledge Pietro Cozzini
for the kind access to all the facilities of the Molecular Modeling Laboratory (Department of Food Science,
University of Parma, Italy) and Elia Vighi for the valuable contribution with doing the analysis.
Author Contributions: L.D., G.G. and C.D. conceived and designed the experiments; L.D. performed the
experiments; L.D., C.D., M.R. and G.G. contributed equally to analyzing data; and L.D. and C.D. contributed
equally to writing the paper.
Conflicts of Interest: The authors declare no conflict of interest.
References
1. Berthiller, F.; Crews, C.; Dall’Asta, C.; Saeger, S.D.; Haesaert, G.; Karlovsky, P.; Oswald, I.P.; Seefelder, W.;
Speijers, G.; Stroka, J. Masked mycotoxins: A review. Mol. Nutr. Food Res. 2013, 57, 165–168. [CrossRef]
[PubMed]
2. Dellafiora, L.; Perotti, A.; Galaverna, G.; Buschini, A.M.; Dall’Asta, C. On the masked mycotoxin
zearalenone-14-glucoside. Does the mask truly hide? Toxicon 2016, 111, 139–142. [CrossRef] [PubMed]
3. Wu, F.; Guclu, H. Aflatoxin regulations in a network of global maize trade. PLoS ONE 2012, 7, e45151.
[CrossRef] [PubMed]
4. Jard, G.; Liboz, T.; Mathieu, F.; Guyonvarc’h, A.; Lebrihi, A. Review of mycotoxin reduction in food and feed:
From prevention in the field to detoxification by adsorption or transformation. Food Addit. Contam. Part A
Chem. Anal. Control Expo. Risk Assess. 2011, 28, 1590–1609. [CrossRef] [PubMed]
5. Karlovsky, P. Detoxification strategies for mycotoxins in plant breeding. In Masked Mycotoxins in Food:
Formation, Occurrence and Toxicological Relevance; Dall’Asta, C., Berthiller, F., Eds.; Royal Society of Chemistry:
London, UK, 2016.
6. Dellafiora, L.; Paolella, S.; Dall’Asta, C.; Dossena, A.; Cozzini, P.; Galaverna, G. Hybrid in silico/in vitro
approach for the identification of angiotensin I converting enzyme inhibitory peptides from Parma
dry-cured ham. J. Agric. Food Chem. 2015, 22, 6366–6375. [CrossRef] [PubMed]
7. Kalyanaraman, C.; Jacobson, M.P. Studying enzyme-substrate specificity in silico: A case study of the
Escherichia coli glycolysis pathway. Biochemistry 2010, 49, 4003–4005. [CrossRef] [PubMed]
8. Wu, F.; Groopman, J.D.; Pestka, J.J. Public health impacts of foodborne mycotoxins. Annu. Rev. Food Sci. Technol.
2014, 5, 351–372. [CrossRef] [PubMed]
9. European Food Safety Authority (EFSA). Opinion of the scientific panel on contaminants in the food chain
[contam] related to the potential increase of consumer health risk by a possible increase of the existing
maximum levels for aflatoxins in almonds, hazelnuts and pistachios and derived products. EFSA J. 2007, 446.
[CrossRef]
10. Raiola, A.; Tenore, G.C.; Manyes, L.; Meca, G.; Ritieni, A. Risk analysis of main mycotoxins occurring in food
for children: An overview. Food Chem. Toxicol. 2015, 84, 169–180. [CrossRef] [PubMed]
11. Prandini, A.; Tansini, G.; Sigolo, S.; Filippi, L.; Laporta, M.; Piva, G. On the occurrence of aflatoxin M1 in
milk and dairy products. Food Chem. Toxicol. 2009, 47, 984–991. [CrossRef] [PubMed]
12. Perrone, G.; Gallo, A.; Logrieco, A.F. Biodiversity of Aspergillus section Flavi in Europe in relation to the
management of aflatoxin risk. Front. Microbiol. 2014, 5, 377. [CrossRef] [PubMed]
13. Mate, D.M.; Alcalde, M. Laccase: A multi-purpose biocatalyst at the forefront of biotechnology.
Microb. Biotechnol. 2016. [CrossRef] [PubMed]
14. Scarpari, M.; Bello, C.; Pietricola, C.; Zaccaria, M.; Bertocchi, L.; Angelucci, A.; Ricciardi, M.R.; Scala, V.;
Parroni, A.; Fabbri, A.A.; et al. Aflatoxin control in maize by Trametes versicolor. Toxins (Basel) 2014, 6,
3426–3437. [CrossRef] [PubMed]
15. Zeinvand-Lorestani, H.; Sabzevari, O.; Setayesh, N.; Amini, M.; Nili-Ahmadabadi, A.; Faramarzi, M.A.
Comparative study of in vitro prooxidative properties and genotoxicity induced by aflatoxin B1 and its
laccase-mediated detoxification products. Chemosphere 2015, 135, 1–6. [CrossRef] [PubMed]
139
Toxins 2017, 9, 17
16. Bertrand, T.; Jolivalt, C.; Briozzo, P.; Caminade, E.; Joly, N.; Madzak, C.; Mouqin, C. Crystal structure of
a four-copper laccase complexed with an arylamine: Insights into substrate recognition and correlation
with kinetics. Biochemistry 2002, 41, 7325–7333. [CrossRef] [PubMed]
17. Dellafiora, L.; Mena, P.; Cozzini, P.; Brighenti, F.; Del Rio, D. Modelling the possible bioactivity of
ellagitannin-derived metabolites. In silico tools to evaluate their potential xenoestrogenic behavior. Food Funct.
2013, 4, 1442–1451. [CrossRef] [PubMed]
18. Dellafiora, L.; Mena, P.; Del Rio, D.; Cozzini, P. Modeling the effect of phase II conjugations on topoisomerase
I poisoning: Pilot study with luteolin and quercetin. J. Agric. Food Chem. 2014, 62, 5881–5886. [CrossRef]
[PubMed]
19. Dellafiora, L.; Dall’Asta, C.; Cozzini, P. Ergot alkaloids: From witchcraft till in silico analysis.
Multi-receptor analysis of ergotamine metabolites. Toxicol. Rep. 2015, 2, 535–545. [CrossRef]
20. Madzak, C.; Mimmi, M.C.; Caminade, E.; Brault, A.; Baumberger, S.; Briozzo, P.; Mougin, C.;
Jolivalt, C. Shifting the optimal pH of activity for a laccase from the fungus Trametes versicolor by
structure-based mutagenesis. Protein Eng. Des. Sel. 2006, 19, 77–84. [CrossRef] [PubMed]
21. Cozzini, P.; Dellafiora, L. In silico approach to evaluate molecular interaction between mycotoxins and the
estrogen receptors ligand binding domain: A case study on zearalenone and its metabolites. Toxicol. Lett.
2012, 214, 81–85. [CrossRef] [PubMed]
22. Cozzini, P.; Fornabaio, M.; Marabotti, A.; Abraham, D.J.; Kellogg, G.E.; Mozzarelli, A. Simple, intuitive
calculations of free energy of binding for protein-ligand complexes. 1. Models without explicit constrained water.
J. Med. Chem. 2002, 45, 2469–2483. [CrossRef] [PubMed]
23. Dellafiora, L.; Dall’Asta, C.; Cruciani, G.; Galaverna, G.; Cozzini, P. Molecular modelling approach to
evaluate poisoning of topoisomerase I by alternariol derivatives. Food Chem. 2015, 189, 93–101. [CrossRef]
[PubMed]
24. Fornabaio, M.; Cozzini, P.; Mozzarelli, A.; Abraham, D.J.; Kellogg, G.E. Simple, intuitive calculations of free
energy of binding for protein-ligand complexes. 2. Computational titration and pH effects in molecular
models of neuraminidase-inhibitor complexes. J. Med. Chem. 2003, 46, 4487–4500. [CrossRef] [PubMed]
25. Fornabaio, M.; Spirakis, F.; Mozzarelli, A.; Cozzini, P.; Abraham, D.J.; Kellogg, G.E. Simple, intuitive calculations
of free energy of binding for protein-ligand complexes. 3. The free energy contribution of structural water
molecules in HIV-1 protease complexes. J. Med. Chem. 2004, 47, 4507–4516. [CrossRef] [PubMed]
26. Christensen, N.J.; Kepp, K.P. Setting the stage for electron transfer: Molecular basis of ABTS-binding to
four laccases from Trametes versicolor at variable pH and protein oxidation state. J. Mol. Catal. B Enzym. 2014,
100, 68–77. [CrossRef]
27. Galli, C.; Madzak, C.; Vadalà, R.; Jolivalt, C.; Gentili, P. Concerted electron/proton transfer mechanism in the
oxidation of phenols by laccase. ChemBioChem 2013, 14, 2500–2505. [CrossRef] [PubMed]
28. Lee, D.; Redfern, O.; Orengo, C. Predicting protein function from sequence and structure. Nat. Rev. Mol.
Cell Biol. 2007, 8, 995–1005. [CrossRef] [PubMed]
29. Enguita, F.J.; Marçal, D.; Martins, L.O.; Grenha, R.; Henriques, A.O.; Lindley, P.F.; Carrondo, M.A.
Substrate and dioxygen binding to the endospore coat laccase from Bacillus subtilis. J. Biol. Chem. 2004, 279,
23472–23476. [CrossRef] [PubMed]
30. Hahn, I.; Thamhesl, M.; Apfelthaler, E.; Klingenbrunner, V.; Hametner, C.; Krska, R.; Schatzmayr, G.;
Moll, W.-D.; Berthiller, F.; Schwartz-Zimmermann, H.E. Characterisation and determination of metabolites
formed by microbial and enzymatic degradation of ergot alkaloids. World Mycotoxins J. 2015, 8, 393–404.
[CrossRef]
31. Igawa, T.; Takahashi-Ando, N.; Ochiai, N.; Ohsato, S.; Shimizu, T.; Kudo, T.; Yamaguchi, I.; Kimura, M.
Reduced contamination by the Fusarium mycotoxin zearalenone in maize kernels through genetic
modification with a detoxification gene. Appl. Environ. Microbiol. 2007, 73, 1622–1629. [CrossRef] [PubMed]
32. Munkvold, G.P. Cultural and genetic approaches to managing mycotoxins in maize. Annu. Rev. Phytopathol.
2003, 44, 99–116. [CrossRef] [PubMed]
33. Gerike, U.; Danson, M.J.; Hough, D.W. Cold-active citrate synthase: Mutagenesis of active-site residues.
Protein Eng. 2001, 14, 655–661. [CrossRef] [PubMed]
34. Leferink, N.G.; Antonyuk, S.V.; Houwman, J.A.; Scrutton, N.S.; Eady, R.R.; Hasnain, S.S. Impact of residues
remote from the catalytic centre on enzyme catalysis of copper nitrite reductase. Nat. Commun. 2014, 5, 4395.
[CrossRef] [PubMed]
140
Toxins 2017, 9, 17
35. Bleve, G.; Lezzi, C.; Spagnolo, S.; Tasco, G.; Tufariello, M.; Casadio, R.; Mita, G.; Rampino, P.; Grieco, F.
Role of the C-terminus of Pleurotus eryngii Ery4 laccase in determining enzyme structure, catalytic properties
and stability. Protein Eng. Des. Sel. 2013, 26, 1–13. [CrossRef] [PubMed]
36. Andberg, M.; Hakulinen, N.; Auer, S.; Saloheimo, M.; Koivula, A.; Rouvinen, J.; Kruus, K. Essential role of
the C-terminus in Melanocarpus albomyces laccase for enzyme production, catalytic properties and structure.
FEBS J. 2009, 276, 6285–6300. [CrossRef] [PubMed]
37. Reiss, R.; Ihssen, J.; Richter, M.; Eichhorn, E.; Schilling, B.; Thöny-Meyer, L. Laccase versus laccase-like
multi-copper oxidase: A comparative study of similar enzymes with diverse substrate spectra. PLoS ONE
2013, 8, e65633. [CrossRef] [PubMed]
38. Loi, M.; Fanelli, F.; Zucca, P.; Liuzzi, V.C.; Quintieri, L.; Cimmarusti, M.T.; Monaci, L.; Haidukowski, M.;
Logrieco, A.F.; Sanjust, E.; et al. Aflatoxin B1 and M1 degradation by lac2 from Pleurotus pulmonarius and
redox mediators. Toxins (Basel) 2016, 8, E245. [CrossRef] [PubMed]
39. Cambria, M.T.; Di Marino, D.; Falconi, M.; Garavaglia, S.; Cambria, A. Docking simulation and competitive
experiments validate the interaction between the 2,5-xylidine inhibitor and Rigidoporus lignosus laccase.
J. Biomol. Struct. Dyn. 2010, 27, 501–510. [CrossRef] [PubMed]
40. Suresh, P.S.; Kumar, A.; Kumar, R.; Singh, V.P. An in silico [correction of insilico] approach to bioremediation:
Laccase as a case study. J. Mol. Graph. Model. 2008, 26, 845–849. [CrossRef] [PubMed]
41. Sali, A.; Blundell, T.L. Comparative protein modelling by satisfaction of spatial restraints. J. Mol. Biol. 1993,
234, 779–815. [CrossRef] [PubMed]
42. Baroni, M.; Cruciani, G.; Sciabola, S.; Perruccio, F.; Mason, J.S. A common reference framework for
analyzing/comparing proteins and ligands. Fingerprints for ligands and proteins (FLAP): Theory and application.
J. Chem. Inf. Model. 2007, 47, 279–294. [CrossRef] [PubMed]
43. Goodford, P.J. A computational procedure for determining energetically favourable binding sites on
biologically important macromolecules. J. Med. Chem. 1985, 28, 849–857. [CrossRef] [PubMed]
44. Carosati, E.; Sciabola, S.; Cruciani, G. Hydrogen bonding interactions of covalently bonded fluorine atoms:
From crystallographic data to a new angular function in the GRID force field. J. Med. Chem. 2004, 47,
5114–5125. [CrossRef] [PubMed]
45. Kellogg, E.G.; Abraham, D.J. Hydrophobicity: Is LogPo/w more than the sum of its parts? Eur. J. Med. Chem.
2000, 37, 651–661. [CrossRef]
46. Dellafiora, L.; Galaverna, G.; Dall’Asta, C.; Cozzini, P. Hazard identification of cis/trans-zearalenone through
the looking-glass. Food Chem. Toxicol. 2015, 86, 65–71. [CrossRef] [PubMed]
47. Ehrlich, V.A.; Dellafiora, L.; Mollergues, J.; Dall’Asta, C.; Serrant, P.; Marin-Kuan, M.; Lo Piparo, E.; Schilter, B.;
Cozzini, P. Hazard assessment through hybrid in vitro/in silico approach: The case of zearalenone. ALTEX
2015, 32, 275–286. [CrossRef] [PubMed]
48. Marabotti, A.; Spyrakis, F.; Facchiano, A.; Cozzini, P.; Alberti, S.; Kellogg, G.E.; Mozzarelli, A.
Energy-based prediction of amino acid-nucleotide base recognition. J. Comput. Chem. 2008, 29, 1955–1969.
[CrossRef] [PubMed]
49. Kellogg, G.E.; Burnett, J.C.; Abraham, D.J. Very empirical treatment of solvation and entropy: A force field
derived from LogPo/w. J. Comput. Aided Mol. Des. 2001, 15, 381–393. [CrossRef] [PubMed]
50. Kellogg, G.E.; Fornabaio, M.; Spyrakis, F.; Lodola, A.; Cozzini, P.; Mozzarelli, A.; Abraham, D.J. Getting it
right: Modeling of pH, solvent and “Nearly” Everything else in virtual screening of biological targets. J. Mol.
Graph. Model. 2004, 22, 479–486. [CrossRef] [PubMed]
51. Sarkar, A.; Kellogg, G.E. Hydrophobicity-shake flasks, protein folding and drug discovery. Curr. Top. Med. Chem.
2010, 10, 67–83. [CrossRef] [PubMed]
© 2017 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access
article distributed under the terms and conditions of the Creative Commons Attribution




Novel Aflatoxin-Degrading Enzyme from
Bacillus shackletonii L7
Liang Xu 1,2,†, Mohamed Farah Eisa Ahmed 1,†, Lancine Sangare 1, Yueju Zhao 1,2,
Jonathan Nimal Selvaraj 1,‡, Fuguo Xing 1,2, Yan Wang 1,2, Hongping Yang 3 and Yang Liu 1,2,*
1 Institute of Food Science and Technology, Chinese Academy of Agricultural Sciences, 1 Nongda South Road,
Xibeiwang Town, Haidian District, Beijing 100193, China; xuliang19824@163.com (L.X.);
elfarahy89@hotmail.com (M.F.E.A.); lancin.sangar@gmail.com (L.S.); zhaoyueju@caas.cn (Y.Z.);
sjonnim@gmail.com (J.N.S.); xingfuguo@caas.cn (F.X.); awangyan@126.com (Y.W.)
2 Key Laboratory of Agro-products Processing, Ministry of Agriculture, 1 Nongda South Road,
Xibeiwang Town, Haidian District, Beijing 100193, China
3 Shenyang Institute of Engineering, No.18 Puchang Road, Shenbei New District, Shenyang 110136, China;
yanghp@sie.edu.cn
* Correspondence: liuyang01@caas.cn; Tel./Fax: +86-10-6281-5874
† These authors contributed equally to this work.
‡ Presently address: College of Life Sciences, Hubei University, Wuhan 430062, China.
Academic Editor: Ting Zhou
Received: 22 September 2016; Accepted: 11 January 2017; Published: 14 January 2017
Abstract: Food and feed contamination by aflatoxin (AF)B1 has adverse economic and health
consequences. AFB1 degradation by microorganisms or microbial enzymes provides a promising
preventive measure. To this end, the present study tested 43 bacterial isolates collected from maize,
rice, and soil samples for AFB1-reducing activity. The higher activity was detected in isolate L7,
which was identified as Bacillus shackletonii. L7 reduced AFB1, AFB2, and AFM1 levels by 92.1%,
84.1%, and 90.4%, respectively, after 72 h at 37 ◦C. The L7 culture supernatant degraded more AFB1
than viable cells and cell extracts; and the degradation activity was reduced from 77.9% to 15.3% in
the presence of proteinase K and sodium dodecyl sulphate. A thermostable enzyme purified from
the boiled supernatant was designated as Bacillus aflatoxin-degrading enzyme (BADE). An overall
9.55-fold purification of BADE with a recovery of 39.92% and an activity of 3.85 × 103 U·mg−1 was
obtained using chromatography on DEAE-Sepharose. BADE had an estimated molecular mass of
22 kDa and exhibited the highest activity at 70 ◦C and pH 8.0, which was enhanced by Cu2+ and
inhibited by Zn2+, Mn2+, Mg2+, and Li+. BADE is the major protein involved in AFB1 detoxification.
This is the first report of a BADE isolated from B. shackletonii, which has potential applications in the
detoxification of aflatoxins during food and feed processing.
Keywords: aflatoxin B1; aflatoxin-degrading enzyme; biodegradation; Bacillus shackletonii; purification
1. Introduction
Aflatoxins (AFs) are secondary metabolites produced by Aspergillus species, mainly A. flavus and
A. parasiticus [1], that are carcinogenic, teratogenic, and hepatotoxic to both humans and animals,
which has grave economic and health consequences [2–4]. AFB1, the most abundantly produced
isotype, is highly toxic [5,6]. Cytochrome P450-associated enzymes in animal liver can metabolize
AFB1 to AFM1, which is detected in the milk of dairy cows that consume AFB1-infected feeds [7,8].
Methods for decontamination and reduction of AFs in food sources have been widely investigated. AF
inactivation by physical and chemical means is not highly effective or economically feasible [6]; a promising
alternative approach is biological detoxification of AF-contaminated food and feed. AFB1 biodegradation
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by fungi and bacteria or their secondary metabolites or enzymes has been widely reported using
Nocardia corynebacterioides (formerly Lavobacterium aurantiacum) [9,10], Armillariella tabescens [11,12],
Pleurotus ostreatus [13], Bacillus licheniformis [14], Mycobacterium fluoranthenivorans [15,16],
Rhodococcus erythropolis [16–18], Stenotrophomonas maltophilia [19], Myxococcus fulvus [20], and
Bacillus subtilis ANSB060 [21]. This approach has the advantage of being highly target-specific, effective,
and environmentally safe, as the decontaminated food or feed products can be subsequently used [20].
AF-degrading enzymes have been isolated from a variety of microorganisms. Recently, an
aflatoxin oxidase from A. tabescens [12] and manganese peroxidase from the white-rot fungus
Phanerochaete sordida YK-624 [22] were shown to have AFB1-degrading ability. It was also reported that
a recombinant Trametes versicolor laccase enzyme expressed in Aspergillus niger degrades AFB1 [23].
Nine Mycobacterium smegmatis enzymes belonging to two F420H2-dependent reductase families
were found to catalyze the reduction of the α, β-unsaturated ester moiety of AFs by spontaneous
hydrolysis [24]. However, most of these enzymes are intracellular and have been isolated from fungi.
The process of crushing mycelia to recover enzymes can compromise their activity, preventing their
large-scale production. This problem can be circumvented by obtaining AF-degrading enzymes
from bacteria.
To this end, a screening method was developed in the present study to isolate AFB1-degrading
microbes from soils and contaminated kernels using coumarin medium. Several new AFB1-degrading
bacterial strains were thus identified; among them, Bacillus shackletonii strain L7 showed the strongest
activity. We evaluated the degradation efficiency of strain L7 against various AFs and purified and
characterized a thermostable enzyme named Bacillus aflatoxin-degrading enzyme (BADE) responsible
for AFB1 degradation activity. We also analyzed the genotoxicity of AFB1 degradation products treated
with proteins from strain L7.
2. Results
2.1. Screening for AFB1-Degrading Microorganisms
In total, 43 single-colony bacterial isolates were obtained from 247 samples collected from different
sources, all of which were able to reduce AFB1 to varying degrees in nutrient broth (NB) after incubation
for 72 h at 37 ◦C (Table S1). Eight of the isolates (belonging to the genera Stenotrophomonas, Pseudomonas,
Arthrobacter, Bacillus, and the family Flavobacteriaceae) showed more than 70% AFB1 degradation in the
medium, with the highest value (71.7%) observed for isolate L7.
2.2. Identification of Isolate L7
Isolate L7 was a rod-shaped Gram-positive bacterium that could grow under extreme conditions
(55 ◦C and pH 9.0). It utilized simple sugars like glucose, maltose, and sucrose as a sole carbon source,
and hydrolyzed casein but not gelatin, amylum, butyrin, or Tween 80 (Table S2). Based on a 16S rRNA
gene sequence analysis, L7 was identified as Bacillus shackletonii strain LMG 18435 (99% sequence
similarity). This is the first report of a bacterium of this genus exhibiting mycotoxin-degrading ability.
The partial 16S rRNA gene sequence of L7 was submitted to GenBank (access. no. KX364157), and the
strain was deposited at the China General Microbiological Culture Collection Center (CGMCC8868).
2.3. Degradation of AFs by Isolate L7
The degradation activity of isolate L7 towards AFB1, AFB2, AFG1, AFG2, and AFM1 was 92.1%,
84.1%, 63.6%, 76.1%, and 90.4%, respectively, when cultured in NB at 37 ◦C for 72 h (Figure 1).
The culture supernatant of isolate L7 was more effective than viable cells and cell extracts in
degrading higher concentrations of AFB1 after 72 h (77.9% vs. 28.6% and 17.2%, respectively; p < 0.05)
(Figure 2). The AFB1-degrading ability of the supernatant declined to 52.6% and 15.3% upon treatment
with proteinase K without and with sodium dodecyl sulphate (SDS), respectively (Figure 3). These
results suggest that proteins/enzymes secreted by L7 are involved in AFB1 degradation.
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Figure 1. AF degradation by isolate L7. Values represent the means of three replicates and their
standard errors.
Figure 2. AFB1 degradation by L7 culture supernatant, viable cells, and cell extracts after 72 h of
incubation. Values represent the means of three replicates and their standard errors.
Figure 3. Effect of proteinase K and SDS on AFB1 degradation by L7 culture supernatant. Values
represent means of three replicates and their standard errors.
AFB1 degradation by the culture supernatant of isolate L7 proceeded relatively rapidly and
continuously, with 40.9, 77.9, and 90.3% reduction observed in the first 12 h and after 72 h and 5 days,
respectively (Figure 4).
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Figure 4. Dynamics of AFB1 degradation by isolate L7 culture supernatant at indicated time points.
Values represent the means of three replicates and their standard errors.
2.4. Evaluation of Genotoxicity
The genotoxicity of the samples was evaluated using the SOS Chromotest, with the results
expressed as induction factor ± standard deviation (Table 1). The induction factors of degraded
samples incubated in the dark at 37 ◦C for 72 h with the culture supernatant of isolate L7 were in line
with the negative control but not the positive control. At higher concentrations (25, 50, and 100%),
the differences between the positive control and degraded samples were significant (p < 0.05). These
results indicate that AFB1 treated with the culture supernatant of isolate L7 had no genotoxicity in the
presence of the S9 crude enzyme preparation.
Table 1. Induction factors produced by samples in the SOS Chromotest.
Induction Factor ± Standard Deviation
Concentration (%) 2-Aminoanthracene a Positive Control b Degraded Sample c Negative Control d
100 3.49 ± 0.08 2.53 ± 0.06 1.06 ± 0.00 1.09 ± 0.05
50 3.02 ± 0.06 1.73 ± 0.14 1.02 ± 0.03 1.12 ± 0.10
25 2.29 ± 0.09 1.08 ± 0.06 1.00 ± 0.01 1.14 ± 0.09
12.5 1.78 ± 0.05 1.18 ± 0.09 1.02 ± 0.01 1.13 ± 0.04
6.25 1.42 ± 0.12 1.04 ± 0.05 0.96 ± 0.06 0.98 ± 0.09
3.125 1.45 ± 0.07 1.07 ± 0.08 1.07 ± 0.03 1.01 ± 0.11
a Six two-fold dilutions of 2-aminoanthracene (initial concentration = 100 μg/mL) were prepared in 10%
dimethyl sulphoxide/saline. A 10-μL volume of diluted 2-aminoanthracene was used as a positive S9 control.
b A 0.06-mL volume of AFB1 solution (50 mg/L) was added to 1.44 mL of NB to obtain a final concentration
of 2 mg/L. After incubation in the dark at 37 ◦C for 72 h, six two-fold dilutions were prepared, and a 10-μL
volume was used as a positive control. c A 0.06-mL volume of AFB1 solution (50 mg/L) was added to 1.44 mL
of culture supernatant of isolate L7 to obtain a final concentration of 2 mg/L. After incubation in the dark at
37 ◦C for 72 h (AFB1 degradation ratio = 77.9% ± 2.3%), six two-fold dilutions were prepared, and a 10-μL
volume was used as the degraded sample. d A 0.06-mL volume of methanol was added to 1.44 mL of culture
supernatant of isolate L7. After incubation in the dark at 37 ◦C for 72 h, six two-fold dilutions were prepared,
and a 10-μL volume was used as a negative control.
2.5. Preliminary Characterization of B. shackletonii BADE
The AFB1-degrading ability of the culture supernatant after incubation for 24 h increased from
47.6% to 70.1% upon concentration by 50-fold by ultrafiltration and was positively correlated with
protein concentration ( tab:toxins-09-00036-t002). When the ultrafiltered
culture supernatant was heat-treated (incubated in a boiling water bath for 10 min), there was no
decrease in degradation activity (76.7%). These results imply that heat-stable proteins or enzymes in
the L7 culture supernatant are responsible for AFB1 degradation.
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Table 2. Degradation of AFB1 by L7 culture supernatant after 24 h of incubation.
Supernatant Conditions Protein Concentration (mg/mL) Degradation (%)
Culture supernatant 0.13 ± 0.03 47.58 ± 1.09
Culture supernatant with ultrafiltration a 0.66 ± 0.04 70.12 ± 0.69
Boiled culture supernatant with ultrafiltration a 0.10 ± 0.02 76.67 ± 0.85
a The culture supernatant was concentrated by ultrafiltration with a cut-off molecular weight of 3 kDa.
2.6. BADE Purification
To isolate the BADE responsible for AFB1 degradation, L7 culture supernatant was heat-treated
(incubation in a boiling water bath for 10 min), concentrated by ultrafiltration with a cut-off
molecular weight of 3 kDa, and subjected to diethylaminoethanol (DEAE)-sepharose ion-exchange
chromatography. The maximum absorption of BADE was observed between 240 and 300 nm.
The protein concentration of each fraction was monitored at 280 nm during enzyme purification.
The separation profile of the enzyme showed one flow-through fraction (peak 1) and two eluted
protein peaks (peaks 2 and 3), and different fractions were collected and dialyzed for 24 h against
20 mmol·L−1 phosphate buffer (pH 7.4). Compared to the control (AFB1 with 20 mmol·L−1 phosphate
buffer (pH 7.4)), peak 2 (40–50 mL) was associated with the highest AFB1-degrading activity
(3.85 × 103 U·mg−1) (Figure 5), followed by peak 1 (0–20 mL) (2.63 × 103 U·mg−1), peak 2 (50–80 mL)
(2.39 × 103 U·mg−1), peak 3 (80–95 mL) (1.73 × 103 U·mg−1) and peak 3 (95–100 mL) (≈ 0.00 U·mg−1).
The specific activity after each step of purification is shown in Table 3. BADE (40–50 mL, peak 2)
was purified 9.55-fold with a 39.92% yield, and had a molecular mass of 22 kDa as determined by
SDS-polyacrylamide gel electrophoresis (PAGE) (Figure 6).































Figure 5. Ion-exchange chromatography using a DEAE-sepharose column. Red and blue lines represent
the absorption of the protein at 280 nm and conductance value, respectively. Peak 1 corresponds to the
flow-through fraction, and peaks 2 and 3 to the eluted protein.
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Culture filtrate 96.55 38.95 4.03 1.00 100.00
Peak 1 (0–20 mL) 1.35 3.55 26.30 6.53 9.10
Peak 2 (40–50 mL) 4.04 15.55 38.49 9.55 39.92
Peak 2 (50–80 mL) 6.37 15.21 23.88 5.93 39.05
Peak 3 (80–95 mL) 3.26 5.63 17.27 4.29 14.45
Peak 3 (95–100 mL) 0.20 5.5 × 10−5 0.0028 0.00069 0.00014
* One unit (U) of enzyme activity was defined as the amount of enzyme required to decrease the amount of
AFB1 by 1 ng in 72 h at 37 ◦C.
Figure 6. SDS-PAGE gels of proteins obtained during BADE purification. M, protein marker; lane 1,
crude protein in culture supernatant of isolate L7 after heat treatment for 10 min; lane 2, crude protein
in culture supernatant; lanes 3 and 4, protein in the first flow-through fraction (0–20 mL; peak 1)
obtained by ion-exchange chromatography; lanes 5 and 6, protein in the first eluted fraction (40–50 mL,
peak 2); lane 7, protein in the peak 2 fraction (50–80 mL); lane 8, protein in the second eluted fraction
(80–95 mL, peak 3); lane 9, protein in the peak 3 fraction (95–100 mL).
2.7. Effect of pH on BADE Activity
The extent of AFB1 degradation by BADE (40–50 mL, peak 2) from isolate L7 varied as a function
of pH (Figure 7). There was no significant difference in AFB1 degradation among pH 4.0, 5.0, and
7.0 without BADE, and there was little degradation. Compared to the control (AFB1 without BADE),
the degradation ratio of AFB1 in the presence of BADE increased significantly at pH 4.0 (10.40%),
pH 5.0 (14.30%), and pH 7.0 (30.73%). The degradation ratio of AFB1 without BADE was 13.52% at
pH 8.0 (shown in Figure 7), and the degradation ratio of AFB1 in the presence of BADE increased
significantly from 13.52% to 44.70% at pH 8.0. The degradation ratio of AFB1 treated with BADE
increased following the pH increase, and the degradation rate at pH 8.0 was the highest (31.18%)
among different pH values, indicating that pH 8.0 is the optimal pH for BADE activity.
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Figure 7. Effect of pH on AFB1 degradation by BADE from isolate L7. Values represent the means of
three replicates and their standard errors. Control, AFB1 without BADE; treatment, AFB1 with BADE.
2.8. Effect of Metal Ions on BADE Activity
The effect of various metal ions on BADE (40–50 mL, peak 2) activity was evaluated. There was
no significant difference in AFB1 degradation among the no-ion condition, Zn2+, Mn2+, Mg2+, Cu2+,
and Li+ in the absence of BADE, and there was little degradation. Compared to the no-ion condition in
the presence of BADE, BADE activity was inhibited by Zn2+, Mn2+, Mg2+, and Li+ (10 mmol·L−1) but
was enhanced in the presence of Cu2+ (Figure 8).
Figure 8. Effect of ions on AFB1 degradation by BADE from isolate L7. Values represent the means of
three replicates and their standard errors. Control, AFB1 without BADE; treatment, AFB1 with BADE.
2.9. Effect of Temperature on BADE Activity
The AFB1-degrading activity of BADE (40–50 mL, peak 2) from isolate L7 varied as a function
of temperature (Figure 9). There was no significant difference in AFB1 degradation among 16, 28,
37, 55, and 70 ◦C without BADE, and there was little degradation. Compared to the control (AFB1
without BADE), the degradation ratio of AFB1 in the presence of BADE increased significantly at 16 ◦C
(19.50%), 28 ◦C (24.40%), 37 ◦C (34.27%), 55 ◦C (27.01%), and 70 ◦C (47.51%). The degradation ratio of
AFB1 treated with BADE increased following the increase in temperature, and the degradation rate
at 70 ◦C was the highest (47.51%) among different temperatures, indicating that 70 ◦C is the optimal
temperature for BADE activity.
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Figure 9. Effect of temperature on AFB1 degradation by BADE from isolate L7. The mixtures were
incubated at indicated temperatures for 72 h. Values represent the means of three replicates and their
standard errors. Control, AFB1 without BADE; treatment, AFB1 with BADE.
3. Discussion
This is the first study reporting that B. shackletonii has AFB1-degrading activity. B. shackletonii
strain LMG 18435T, a strictly aerobic bacterium isolated from the eastern lava flow of northern
Candlemas Island in the South Sandwich archipelago, was reported to be capable of decomposing
large molecules into organic acids [25]. In addition, the thermophilic B. shackletonii strain K5 isolated
from a biotrickling filter of a coal-fired power plant in Guangzhou, China showed a strong capacity for
producing polyhydroxybutyrate [26].
We demonstrated that AFB1 in solution could be effectively degraded by the culture supernatant
of B. shackletonii L7. This was similar to previous findings demonstrating that extracellular extracts
from R. erythropolis liquid cultures degraded AFB1, with only 33.2% residual toxin after 72 h [17].
Incubation with 5 × 1010 resting cells/mL of Fusarium aurantiacum for 4 h completely removed AFM1
(8 μg·mL−1) [27]. Similar to R. erythropolis [17] and S. maltophilia 35-3 [19], degradation of AFB1 by
the culture supernatant produced without pre-exposure to AFB1 showed the constitutive activity of
B. shackletonii L7. The AFB1-degrading activity of the culture supernatant increased from 47.6% to
70.1% after ultrafiltration, and was decreased from 77.9% to 15.3% upon treatment with proteinase
K and SDS, similar to the trends observed for the culture supernatants of R. erythropolis, M. fulvus
ANSM068, and S. maltophilia [17,19,20]. These findings imply that the AFB1-degrading enzyme from
B. shackletonii is an extracellular enzyme, in contrast to intracellular AFB1-degrading enzymes isolated
from fungi [11,13].
The increase in AFB1 detoxification over time indicated that the AFB1-degrading enzyme from
B. shackletonii was stable at 37 ◦C for one week. Similarly, a 66.8% reduction in AFB1 was observed
over 72 h in the presence of R. erythropolis culture supernatant [28], whereas the AFB1 level was
reduced by 70%–80% within 36 h and AFB1 was completely degraded after 72 h by liquid cultures
of Mycobacterium strain FA4 [22]. AFB1 was quickly removed from liquid by binding to lactic acid
bacteria, although some of the toxin was released over a prolonged period of incubation [10,19].
Binding may not be important in AFB1 reduction, given the continuous increase in detoxification by
strain L7 over time. To further verify the role of binding (or adsorption) in the observed reduction in
aflatoxin concentration, bacterial pellets of B. shackletonii L7 cultured for 24 h were washed twice with
and resuspended in phosphate buffer (20 mM, pH 7.0). The resuspended liquid (0.026 g/mL) was
sterilized at 121 ◦C for 20 min and was used for the AFB1 degradation test, using phosphate buffer
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rather than the resuspended liquid as a control. AFB1 concentration did not decrease relative to the
control upon treatment with the resuspended liquid; the AFB1 degradation rate was 0% (data not
shown). This indicates that binding does not play a role in AFB1 reduction.
Methods for purifying enzymes from microorganisms should be selected based on the activity
and yield of the active component. In this study, crude AFB1-degrading enzymes were purified
from the B. shackletonii culture supernatant by ion-exchange chromatography on a DEAE-sepharose
column. AFB1-degrading enzymes have been purified from the fungi A. tabescens by ion-exchange
chromatography and chromatofocusing chromatography [11], and from P. ostreatus by chromatography
using DEAE-sepharose and phenyl sepharose columns [13]. In our study, BADE (40–50 mL,
peak 2) with an estimated molecular mass of 22 kDa and the highest AFB1-degrading activity
(3.85 × 103 U·mg−1) was purified 9.55-fold from B. shackletonii cultures with a 39.92% yield, implying
a low processing cost [29] which, along with the reasonably high overall yield [30], makes it suitable
for large-scale production.
B. shackletonii BADE was active at a broad range of pH values (pH 4.0–8.0) and temperatures
(16 ◦C–70 ◦C), which is advantageous for AF degradation in the digestive tracts of animals. Importantly,
there was no decrease in enzymatic activity when the culture supernatant of strain L7 was subjected to
heat treatment. This was in contrast with a previous study in which AFB1-degrading activity in the
culture supernatant of S. maltophilia 35-3 was abolished by heat treatment [19]. These results imply
that B. shackletonii BADE is heat-stable, similar to the enzyme in thermophilic B. shackletonii K5 [26].
The AFB1-degrading activity of B. shackletonii BADE was influenced by the presence of metal ions:
the activity was enhanced by Cu2+ (10 mM) and inhibited by Zn2+, Mn2+, Mg2+, and Li+ (10 mM),
in agreement with earlier reports [19,31]. We speculate that BADE is an oxidoreductase that utilizes
Cu2+ as an activator. Cu2+ may participate in redox reactions in electron transport, transferring
an oxygen atom to the AFB1 substrate; oxidized AFB1 would then be hydrolyzed into non-toxic
products [32]. In contrast, 10 mM Zn2+ inhibited AFB1 degradation by BADE, which was similar to the
one observed in F. aurantiacum [33]. Zn2+ may cause a conformational change in the enzyme that leads
to its inactivation or decreases its affinity for AFB1 [28].
We evaluated the genotoxicity of AFB1 degradation products with the SOS Chromotest.
The genotoxicity of AFB1 was significantly reduced by treatment with proteins or enzymes in
B. shackletonii L7 culture supernatant in the presence of S9. It was previously demonstrated that
treatment of AFB1 with enzymes altered the double bond of the furofuran ring, with consequent
changes in the fluorescence and mutagenicity of the molecule [23]. In this study, BADE from strain
L7 played a major role in AFB1 detoxification; we also showed that the chemical properties of AFB1
degradation products differed from those of the parent molecule, although the detailed mechanism of
AFB1 degradation by B. shackletonii BADE has yet to be described.
To date, BADE from B. shackletonii is the only AF-degrading enzyme purified from a bacterium.
Enzyme purification is the limiting factor in the industrial-scale production of AFs-degrading enzymes.
Challenges associated with obtaining BADE by B. shackletonii fermentation include contamination of
bacterial cultures and low yields. Nonetheless, our results suggest that treatment of food and feed
with recombinant B. shackletonii BADE can potentially eliminate mycotoxin contamination.
4. Conclusions
We isolated B. shackletonii strain L7, which could degrade AFB1, AFB2, and AFM1. A presumed
extracellular BADE was purified from strain L7 showed the highest activity at 70 ◦C and pH 8.0 in the
presence of 10 mmol·L−1 Cu2+, and was the main protein involved in the detoxification of AFB1. These
findings indicate that BADE from B. shackletonii L7 is a promising new agent for AF biodegradation.
The cloning and expression of the BADE-encoding gene are currently underway in our laboratory.
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5. Materials and Methods
5.1. Chemicals and Media
Standard solutions of AFB1, AFB2, AFG1, AFG2, and AFM1 were purchased from Sigma-Aldrich
(St. Louis, MO, USA). Stock solutions (500 μg/L) were prepared by diluting the standard solutions
with methanol. Coumarin medium (CM) was prepared as previously described [19]. NB was used for
bacterial culture.
5.2. Collection of Bacteria
A total of 247 samples were collected from farm soils, maize, and rice in different provinces in
China in June 2013. Bacterial strains with the ability to degrade AFB1 were isolated on CM medium [19];
selected colonies were further tested for AFB1-degrading activity.
5.3. Analysis of AFs Degradation
Isolates were cultured in NB for 12 h. For inoculation, a 12-h culture broth (1 mL) was transferred
to NB (20 mL) and cultured at 37 ◦C with agitation for 24 h in a shaking incubator. AFB1 solution
(500 μg/L; 0.1 mL) was added to 0.4 mL of microbial culture to obtain a final concentration of 100 μg/L.
The detoxification test was performed in the dark at 37 ◦C without shaking for 72 h; sterile NB
containing AFB1 at a final concentration of 100 μg/L was used as a control.
The reaction mixtures were extracted three times with chloroform according to a standard
protocol [34]. The chloroform was evaporated under nitrogen gas at 60 ◦C and dried extracts were
dissolved in 50% methanol in water (1:1, v/v), and the solution was passed through a sterile 0.22-μm
pore size filter (Merck Millipore, Darmstadt, Germany) and analyzed by high-performance liquid
chromatography using a C18 column (150 × 4.6 mm, 5 μm; Agilent Technologies, Santa Clara, CA,
USA) and methanol:water (1:1, v/v) as the mobile phase at a flow rate of 1 mL/min. AFB1 was
derived by a photochemical reactor (Waters, Milford, MA, USA) and detected with a fluorescence
detector. Excitation and detection wavelengths were set at 360 and 440 nm, respectively. Percent AFB1
degradation was calculated using the formula (1 − AFB1 peak area in treatment/AFB1 peak area in
control) × 100%. AFB2, AFG1, AFG2, and AFM1 degradations were analyzed in a similar manner.
5.4. Identification of Isolate L7
Biochemical and physiological analyses of isolate L7 were performed following standard
protocols [35]. Genomic DNA of strain L7 was extracted using the TIANamp Bacterial DNA kit
(Tiangen Biotech, Beijing, China) according to the manufacturer’s instructions. The 16S rRNA gene
was amplified using a universal primer set consisting of 27F (5′-GAGAGTTTGATCCTGGCTCAG-3′)
and 1492R (5′-TACCTTGTTACGACTT-3′) [36] and then sequenced. Similar sequences were identified
by a BLAST search of the NCBI nucleotide database [37]. Strain L7 was preserved at −80 ◦C until use.
5.5. Degradation of AFB1 by Cell-Free Supernatant, Bacterial Cells, and Intracellular Cell Extracts of Strain L7
AFB1 degradation by cell-free supernatant, bacterial cells, and intracellular cell extracts of strain
L7 was evaluated as previously described [16,19,38]. Briefly, 5 mL of fresh NB was inoculated with
strain L7 at 37 ◦C with agitation at 180 rpm for 12 h. A 1-mL volume of the culture was transferred to
100 mL of the same medium. After cultivation at 37 ◦C with shaking at 180 rpm for 72 h, cells were
harvested by centrifugation at 8000 rpm for 10 min at 4 ◦C. The culture supernatant was separated
from the cell pellet and passed through a sterile 0.22-μm pore size filter and used for analysis of AFB1
degradation, as described above. NB was used rather than the supernatant as a control.
Bacterial cell pellets were washed twice with phosphate buffer (50 mM, pH 7.0) and resuspended
in the same buffer. AFB1 degradation was evaluated as described above. Phosphate buffer was used
rather than the bacterial cell suspensions as a control.
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Cell pellets resuspended in phosphate buffer (50 mM, pH 7.0; 3 mL of buffer per gram of cell
mass) were lysed on ice using an ultrasonic cell disintegrator (Ningbo Xinzhi Instruments, Ningbo,
China). Cell lysates were centrifuged at 12,000× g for 10 min at 4 ◦C, and passed through a sterile
0.22-μm pore size filter. The AFB1 degradation test was performed as described above. Phosphate
buffer was used rather than intracellular cell extracts as a control.
5.6. Effects of Incubation Period, Proteinase K + SDS, and Heat Treatment on AF Degradation by Strain L7
Culture Supernatant
The culture supernatant of strain L7 was prepared as described above. A 0.1-mL volume of
AFB1 solution (500 μg/L) was combined with 0.4 mL of culture supernatant in a 10-mL tube, and the
mixture was incubated in the dark at 37 ◦C without shaking. For incubation time studies, degradation
was measured at 1, 6, 12, 24, 48, 72, 96, 120, and 168 h. The effect of heat treatment was assessed
by immersing the culture supernatant in a boiling water bath for 10 min. The effect of proteinase
K treatment with and without SDS was evaluated as previously described [19]. To determine the
correlation between AFB1 degradation and protein concentration, an Amicon Ultra-15 centrifugal filter
unit (Merck Millipore, Tullagreen, Iealand) with a cut-off molecular weight of 3 kDa was used for
ultrafiltration of the culture supernatant to obtain different protein concentrations. NB alone processed
in a similar manner and treated with AFB1 served as a control.
5.7. Genotoxicity Assay
The genotoxicity of AFB1 degradation products was evaluated using SOS Chromotest Basic S9
Activation Enzymes v.64 (Environmental Bio-detection Products, Mississauga, ON, Canada) according
to the manufacturer’s instructions. Cell viability was monitored according to alkaline phosphatase
activity at 420 nm using a microplate reader [39,40]. Sample concentrations are expressed as the
percentage of sample volume in each well of a 96-well microtiter plate. AFB1 solution combined with
NB was used as a positive control, AFB1 solution combined with culture supernatant of isolate L7 was
used as a degraded sample, and methanol added to the culture supernatant of isolate L7 served as a
negative control. After incubation in the dark at 37 ◦C for 72 h (at which point the AFB1 degradation
ratio was 77.9% ± 2.3%), 10 μL of the diluted solution was dispensed into the appropriate wells,
and a range of sample concentrations (100, 50, 25, 12.5, 6.25, and 3.125%) was tested using dimethyl
sulphoxide as a diluent and reagent blank and 2-aminoanthracene serving as a positive control for S9.
5.8. Preparation of BADE
Large-scale B. shackletonii cultures were prepared in a 1-L working volume of NB (pH 7.4). A 10-mL
volume of fresh NB was inoculated with strain L7 at 37 ◦C, with agitation at 180 rpm for 12 h; 10 mL of
the culture was then transferred to 1 L of the same medium. After cultivation at 37 ◦C with shaking at
180 rpm for 72 h, cells were harvested by centrifugation at 8000 rpm for 10 min at 4 ◦C. The culture
supernatant was separated from the cell pellet and passed through a sterile 0.22-μm pore size filter.
The supernatant of the 1-L culture was heated for 10 min and then subjected to ultrafiltration with a
cut-off molecular weight of 3 kDa at 5000× g for 20 min in a refrigerated centrifuge to obtain a final
volume of 20 mL, yielding a sample that was concentrated 50-fold. The concentrated sample was
dialyzed against 20 mmol·L−1 Tris-HCl buffer (pH 8.5) for 24 h at 4 ◦C.
5.9. Purification of B. shackletonii BADE
The dialyzed concentrated sample was subjected to ion-exchange chromatography on a
DEAE-sepharose column (1.6 × 20 cm; GE Healthcare, Little Chalfont, UK). Proteins were packed
in the column pre-equilibrated with 20 mmol·L−1 Tris-HCl buffer (pH 8.5) and were eluted with an
increasing linear gradient (0%–100%) of 1 mol·L−1 NaCl with 20 mmol·L−1 Tris-HCl buffer (pH 8.5)
at a flow rate of 2 mL·min−1 until no protein was detected. The flow-through and eluted enzyme
fractions were collected and dialyzed for 24 h against 20 mmol·L−1 phosphate buffer (pH 7.4). Each
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fraction was concentrated by ultrafiltration with a cut-off molecular weight of 3 kDa; the final volumes
of each fraction were 20 mL for Peak 1 (0–20 mL), 10 mL for Peak 2 (40–50 mL), 30 mL for Peak 2
(50–80 mL), 15 mL for Peak 3 (80–95 mL), and 5 mL for Peak 3 (95–100 mL). Protein concentration was
determined by the Bradford method using Coomassie Brilliant Blue, and AFB1-degrading activity was
evaluated as described above. After each fraction was incubated with AFB1 for 72 h, residual AFB1
was detected by high-performance liquid chromatography. To assess the degradation of AFB1 with the
proteins in different peaks, AFB1 with 20 mmol·L−1 phosphate buffer (pH 7.4) was used as a control.
One unit (U) of enzyme activity was defined as the amount of enzyme required to decrease the amount
of AFB1 by 1 ng in 72h at 37 ◦C. This purification step yielded the active fraction, which was tested for
AFB1-degrading activity. The molecular mass of the active fraction was verified by SDS-PAGE.
5.10. Determination of Molecular Mass
The molecular mass of the purified BADE from B. shackletonii L7 was determined by SDS-PAGE
based on the method of Laemmli [41] on a 12% polyacrylamide gel with molecular weight markers
(Thermo Fisher Scientific, Waltham, MA, USA). Protein bands were stained using the MS-Compatible
Silver Stain kit (Tiandz, Beijing, China) according to the manufacturer’s protocol.
5.11. Characterization of BADE
5.11.1. Determination of Optimum pH and Temperature for Enzymatic Activity
To determine the effects of pH on BADE activity, the initial pH value was adjusted to 4.0 and 5.0
with 0.1 mol·L−1 citrate phosphate, and to 7.0 and 8.0 with 0.1 mol·L−1 sodium phosphate. The effect
of temperature on BADE activity was determined at 16, 28, 37, 55, and 70 ◦C in 0.1 mol·L−1 sodium
phosphate buffer (pH 7.0). A 0.1-mL volume of AFB1 solution (500 μg/L) was added to 0.4 mL of
BADE solutions with different pH and at different temperatures, with a solution at pH 7.0 and 37 ◦C
used as a control along with solutions without BADE under the same conditions. The assays were
performed in the dark at 37 ◦C without shaking for 72 h.
5.11.2. Effect of Metal Ions on Enzyme Activity
To determine the effect of different metal ions on BADE activity, Zn2+ (ZnSO4), Mn2+ (MnCl2),
Mg2+ (MgCl2), Cu2+ (CuSO4), and Li+ (LiCl) solutions at a final ion concentration of 10 mmol·L−1
were added to 0.1 mL of AFB1 (500 μg/L) combined with 0.4 mL of BADE solution (pH 7.0). BADE
solution without any metal ions (no ion) was also used as a treatment. To assess the degradation of
AFB1 in the presence of metal ions, solutions without BADE under the same conditions were used as
controls. The assay was performed in the dark at 37 ◦C without shaking for 72 h.
5.12. Statistical Analysis
Differences between groups were evaluated by analysis of variance with the general linear model
procedure in a completely randomized single-factor design using SAS software (SAS Institute, Cary,
NC, USA). F tests were performed at the 0.05 level of probability. When a significant F value was
detected, significant differences among the means were assessed with Duncan’s multiple range test.
Supplementary Materials: Supplementary materials can be accessed at: www.mdpi.com/2072-6651/9/1/36/
s1, Table S1: AFB1 degradation by individual microbial isolates selected using coumarin medium, Table S2:
Characteristics of strain L7.
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Abstract: Aflatoxins are a group of secondary metabolites produced by members of Aspergillus Section
Flavi that are dangerous to humans and animals. Nuts can be potentially contaminated with aflatoxins,
often over the legal threshold. Food processes, including roasting, may have different effects on
mycotoxins, and high temperatures have proven to be very effective in the reduction of mycotoxins.
In this work, two different roasting methods—traditional static hot air roasting and infra-red rays
roasting—were applied and compared for the detoxification of hazelnuts from Italy and Turkey.
At the temperature of 140 ◦C for 40 min of exposure, detoxification was effective for both roasting
techniques. Residual aflatoxins after infra-red rays treatments were lower compared to static hot air
roasting. On Italian hazelnuts, residual aflatoxins were lower than 5%, while for Turkish hazelnuts
they were lower than 15% after 40 min of exposure to an infra-red rays roaster. After roasting,
the perisperm was detached from the nuts and analyzed for aflatoxin contents. Residual aflatoxins in
the perisperm ranged from 80% up to 100%. After roasting, the lipid profile and the nutritional quality
of hazelnuts were not affected. Fatty acid methyl esters analyses showed a similar composition for
Italian and Turkish hazelnuts.
Keywords: aflatoxins; Aspergillus flavus; Corylus avellana; fatty acids; thermal treatment
1. Introduction
Aflatoxins (AFs) are a group of secondary metabolites produced by members of Aspergillus Section
Flavi—mainly A. flavus and A. parasiticus [1]—on a variety of food products, such as nuts, grains,
and spices [2]. Since 1960, more than 20 aflatoxins have been identified; only four of them—aflatoxin B1
(AFB1), aflatoxin B2 (AFB2), aflatoxin G1 (AFG1), aflatoxin G2 (AFG2)—occur naturally [3,4]. AFs are
a group of difuranocoumarin derivatives named based on their fluorescence under UV-light. AFB1
and AFB2 have a blue fluorescence due to the difuro-coumaro-cyclopentenone structure, while a
six-member lactone ring replacing the cyclopentenone is responsible for the yellow-green fluorescence
of AFG1 and AFG2 [5]. AFB1 and AFG1 have also an olefinic double bond at the C8-C9 position,
whereas AFB2 and AFG2 lack this bond. AFs are toxic, mutagenic, teratogenic, carcinogenic compounds
implicated in human hepatic and extrahepatic carcinogenesis [6]. AFB1 is the most widespread among
AFs, and has the most potent carcinogenic effect. In fact, AFB1 is the only one classified by International
Agency of Research on Cancer (IARC) as a Group 1 carcinogen [7].
Toxicological and epidemiological data, together with occurrence and distribution data, were used
to fix limits for food consumption contaminated with mycotoxins. In Europe, thresholds for AFB1 and
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total AFs in hazelnuts for direct human consumption and for use as ingredient in foodstuffs are 5 and
10 μg/kg, specified by the Commission Regulation (EU) No 165/2010, based on scientific opinion of
authoritative bodies, such as JECFA (Joint FAO/WHO Expert Committee on Food Additives), WHO
(World Health Organization), FAO (Food and Agriculture Organization of the United Nations), EFSA
(European Food Safety Authority). Moreover, the Codex Alimentarius Commission has specified
15 μg/kg as limit for peanuts, almonds, shelled Brazil nuts, hazelnuts, and pistachios [8].
Nuts and dried fruits are known to be possibly contaminated with mycotoxins. Different studies
on pistachios, almonds, groundnuts, peanuts, chestnuts, and hazelnuts have demonstrated that
contamination with aflatoxins often exceeds the legal threshold in commercial samples [9–11].
Prevention of mycotoxin contamination in the field is the best way to reduce mycotoxins in
food and feed, while decontamination is difficult and frequently lowers the quality or quantity of the
commercial product. Chemical, physical, and biological approaches for the detoxification of aflatoxins
have been reported in previous studies on nuts, and include strategies such as ozone, plasma, UV or
gamma irradiation, thermal treatments, or microorganisms [12–15]. However, most of the current
methods are not practical, due to time consumption, nutrition losses, or low detoxification efficiency.
Many nuts are predominantly consumed roasted. Thermal treatments such as roasting lead to
chemical changes in carbohydrates, proteins, and fats. The flavor, color, texture, and appearance of
hazelnuts are significantly enhanced by roasting, and this process is also used to remove the pellicle
of kernels, to inactivate enzymes that cause nutrient loss, and to destroy microorganisms, toxins or
allergens [16].
Turkey is the main hazelnut producing country in the world, with 660,000 tons in 2012 [17].
The main cultivar produced in Turkey is “Tombul”, which occupies 29.8% of all production areas,
followed by the cultivars “Çakildak” (15.2%), “Mincane” (14.1%), “İncekara” (12.4%), “Palaz” (11.9%),
“Foşa” (7.0%), and “Kalinkara” (2.7%). Italy is the second world hazelnut producer, with about
85,000 tons in 2012 [17], and “Tonda Gentile Trilobata” is the main cultivar in Piedmont, Northern
Italy (15,000 tons in 2014). Hazelnuts provide an excellent source of energy due to their high oil
content of about 60% and several bioactive nutrients. Hazelnut oil has been reported to be the richest
source of vitamin E and fatty acids, in particular oleic acid [18]. Among the fatty acids of hazelnut
oil, palmitic acid (2.96%–7.40%) is the main saturated fatty acid (SFA). The highest percentage of fatty
acids are instead covered by monounsaturated fatty acid (MUFA) as oleic acid (73.1%–90.7%) and
polyunsaturated fatty acid (PUFA) as linoleic acid (4.4%–16%), which confer heart and blood beneficial
attributes to the hazelnut oil [14]. Moreover, MUFA and PUFA—and particularly linoleic acid—play
an important role not only in terms of health, but also in stability, because their oxidation may cause
flavor degradation and rancidity. [19]. Fatty acid composition is closely correlated with the stability
and degradation kinetics of hazelnuts. In particular, linoleic acid plays the most important role in the
stability, and its oxidation may cause flavor degradation and rancidity.
By considering the possibility of aflatoxin contamination on hazelnuts that is often over the
legal threshold and the effect of high temperature on mycotoxin reduction, in this work two different
roasting methods—traditional static hot air roasting and infrared rays roasting—were compared in the
detoxification of hazelnuts from aflatoxins, and their effect on hazelnut quality.
2. Results and Discussion
2.1. Static Hot Air Treatments
Data of the first trial on hazelnuts roasted with a static hot air roaster are shown in Table 1 for
two temperatures (120 ◦C and 170 ◦C) at two exposure times (20 and 40 min). Residual aflatoxins
after roasting showed a different trend for Italian and Turkish hazelnuts; a decrease was observed at
the same temperature with increasing exposure time only for Turkish hazelnuts. With the increase of
temperature, differences in reduction were registered, either considering the geographical origin of
the hazelnuts or the mycotoxin. In general, the residue was lower in AFB1 and AFG1 than AFB2 and
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AFG2. The influence of temperature was different in both types of hazelnuts used. Turkish hazelnuts
showed a decrease in AFs concentration with increasing temperatures and the same exposure time.
On the contrary, in Tonga Gentile Trilobata (TGT) hazelnuts, a decrease in the residual concentration
was not observed. The decomposition temperature of aflatoxins ranges from 237 ◦C to 306 ◦C [20];
in particular, AFB1 is stable to dry heating at temperature below its thermal decomposition temperature
(267 ◦C), so the temperatures used during the experiments were below this threshold. Normal home
cooking conditions failed to totally destroy AFB1 and AFG1, and temperatures of approximately
150 ◦C were necessary to obtain a partial degradation of AFs [21]. In a study on pistachio nuts [22],
the reduction of AFs ranged from 17% to 63% and was time and temperature dependent. In coffee beans,
a reduction of about 42%–56%—depending on temperature and type of roasting—was achieved [23].
Other parameters seem to influence the rate of AFs destruction: higher moisture content increased
AFB1 destruction on rice. The presence of water could help the lactone ring opening of AFB1 with
the formation of a carboxylic group. On both hazelnut types, fatty acid methyl esters (FAMEs) were
analyzed (Supplementary Tables S1 and S2), showing that the nutritional composition was not affected
at all tested temperatures and exposure times.
Table 1. Residual (%) aflatoxin B1 (AFB1), aflatoxin B2 (AFB2), aflatoxin G1 (AFG1), and aflatoxin G2
(AFG2) after treatment with static hot air in the first set of experiments.
Hazelnut T (◦C) t (min) AFB1 AFB2 AFG1 AFG2
Italian
120 20
17.5 ± 4.3 17.5 ± 3.8 5.62 ± 2.9 9.46 ± 3.8
Turkish 47.2 ± 2.4 81.7 ± 5.1 77.8 ± 10 69.9 ± 6.0
Italian
120 40
11.7 ± 1.4 13.9 ± 2.5 17.8 ± 5.4 22.5 ± 6.0
Turkish 12.9 ± 8.0 53.1 ± 4.9 12.0 ± 5.2 13.9 ± 5.5
Italian
170 20
38.7 ± 7.7 62.9 ± 5.8 24.7 ± 5.4 68.9 ± 14
Turkish 7.39 ± 1.8 42.3 ± 8.4 10.4 ± 1.9 13.6 ± 5.3
Italian
170 40
17.9 ± 7.3 43.6 ± 10 8.21 ± 1.1 34.5 ± 8.3
Turkish 4.09 ± 4.2 31.3 ± 6.6 6.04 ± 8.5 5.97 ± 8.4
Mean of three replicates ± standard deviation.
2.2. Comparison of Static Hot Air and Infrared Rays Roasting
In a second experimental set, a new roasting technology—infrared rays roasting—was compared
to static hot air roasting. An intermediate temperature (140 ◦C) and two exposure times (20 min and
40 min) were used for both methods.
FAMEs analysis showed a similar composition for both Italian (Table 2) and Turkish (Table 3)
hazelnuts, and a total of fourteen fatty acids (FAs) were identified. The main FAs were oleic acid,
linoleic acid, palmitic acid, and stearic acid. Monounsaturated fatty acids were always higher
than polyunsaturated fatty acids and saturated fatty acids. FAs distribution was preserved after
all treatments for both types of hazelnuts, both after static hot air and infrared rays treatment.
FAs composition is important for nutritional quality and health benefits offered by MUFAs and
PUFAs, flavor, kernel texture, and quality [18]. Some minor changes occurred in the FAs profile after
both types of roasting. In particular, the content of SFAs remained low, and the content of UFAs that
promote health benefits was always high.
The oleic to linoleic acid (O/L) ratio was considered an important criterion to evaluate the kernel
quality, and a greater value indicates better oxidative stability [24]. In TGT hazelnuts, the O/L ratio
was reduced after all treatments, but the ratio was higher after infrared rays than after static hot air.
The degree of unsaturation expressed as iodine value (IV) was higher after static hot air treatments at
both exposure times (88.43 and 88.99 instead of 88.34 of raw hazelnuts). After infrared rays treatments
at 140 ◦C for 20 min, a slight IV reduction occurred (87.97 instead of 88.34 of raw hazelnuts).
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Table 2. Fatty acid composition (%), of Tonga Gentile Trilobata (TGT) hazelnuts raw and roasted with







Static Hot Air Treatment
Myristic (C14:0) 0.02 ± 0.00 0.02 ± 0.00 0.02 ± 0.00 ns
Palmitic (C16:0) 5.79 ± 0.00 b 5.92 ± 0.01 a 5.74 ± 0.01 a ***
Palmitoleic (C16:1) 0.24 ± 0.00 b 0.24 ± 0.00 c 0.24 ± 0.00 a ***
Margaric (C17:0) 0.04 ± 0.00 0.04 ± 0.00 0.04 ± 0.00 ns
Heptadecenoic (C17:1) 0.07 ± 0.00 a 0.07 ± 0.00 b 0.07 ± 0.00 b ***
Stearic (C18:0) 2.32 ± 0.00 c 2.36 ± 0.00 a 2.27 ± 0.00 b ***
Elaidic (C18:1 ω9t) 0.02 ± 0.00 0.02 ± 0.00 0.02 ± 0.00 ns
Oleic (C18:1 ω9c) 84.86 ± 0.00 c 84.44 ± 0.02 b 84.35 ± 0.03 a ***
Linoleic (C18:2 ω6c) 6.27 ± 0.00 a 6.53 ± 0.01 b 6.88 ± 0.02 c ***
Arachidic (C20:0) 0.11 ± 0.00 0.11 ± 0.00 0.11 ± 0.00 ns
Eicosenoic (C20:1) 0.12 ± 0.00 a 0.12 ± 0.00 b 0.12 ± 0.00 c ***
α-Linolenic (C18:3 ω3) 0.08 ± 0.00 b 0.08 ± 0.00 a 0.08 ± 0.00 a *
Docosanoic (C22:0) 0.02 ± 0.00 ab 0.02 ± 0.00 b 0.02 ± 0.00 a *
Arachidonic (C20:4 ω6) 0.03 ± 0.00 a 0.03 ± 0.00 a 0.03 ± 0.00 b *
∑ SFA 8.31 ± 0.00 c 8.48 ± 0.01 a 8.20 ± 0.01 b ***
∑ MUFA 85.31 ± 0.00 c 84.89 ± 0.02 b 84.80 ± 0.03 a ***
∑ PUFA 6.38 ± 0.00 a 6.64 ± 0.01 b 6.99 ± 0.02 c ***
UFA/SFA 11.03 ± 0.00 a 10.80 ± 0.01 c 11.19 ± 0.02 b ***
Oleic/Linoleic (O/L) 13.54 ± 0.01 c 12.93 ± 0.02 b 12.26 ± 0.03 a ***
Iodine value (IV) 88.34 ± 0.00 a 88.43 ± 0.01 b 88.99 ± 0.01 c ***
Infrared Rays Treatment
Myristic (C14:0) 0.02 ± 0.00 0.02 ± 0.00 0.02 ± 0.00 ns
Palmitic (C16:0) 5.79 ± 0.00 b 6.16 ± 0.02 b 5.94 ± 0.01 a *
Palmitoleic (C16:1) 0.24 ± 0.00 b 0.27 ± 0.00 a 0.25 ± 0.00 b ***
Margaric (C17:0) 0.04 ± 0.00 0.04 ± 0.00 0.04 ± 0.00 ns
Heptadecenoic (C17:1) 0.07 ± 0.00 0.07 ± 0.00 0.07 ± 0.00 ns
Stearic (C18:0) 2.32 ± 0.00 b 2.44 ± 0.00 a 2.34 ± 0.00 b *
Elaidic (C18:1 ω9t) 0.02 ± 0.00 0.02 ± 0.00 0.02 ± 0.00 ns
Oleic (C18:1 ω9c) 84.86 ± 0.00 a 84.28 ± 0.03 b 84.44 ± 0.02 a ***
Linoleic (C18:2 ω6c) 6.27 ± 0.00 b 6.32 ± 0.01 a 6.50 ± 0.01 b ***
Arachidic (C20:0) 0.11 ± 0.00 0.12 ± 0.00 0.12 ± 0.00 ns
Eicosenoic (C20:1) 0.12 ± 0.00 0.12 ± 0.00 0.12 ± 0.00 ns
α-Linolenic (C18:3 ω3) 0.08 ± 0.00 b 0.08 ± 0.00 a 0.08 ± 0.00 b ***
Docosanoic (C22:0) 0.02 ± 0.00 0.02 ± 0.00 0.02 ± 0.00 ns
Arachidonic (C20:4 ω6) 0.03 ± 0.00 b 0.03 ± 0.00 a 0.03 ± 0.00 b ***
∑ SFA 8.31 ± 0.00 b 8.81 ± 0.02 a 8.48 ± 0.01 b *
∑ MUFA 85.31 ± 0.00 a 84.76 ± 0.03 b 84.91 ± 0.01 a ***
∑ PUFA 6.38 ± 0.00 b 6.44 ± 0.01 a 6.62 ± 0.01 b ***
UFA/SFA 11.03 ± 0.00 a 10.36 ± 0.02 b 10.80 ± 0.01 a *
Oleic/Linoleic (O/L) 13.54 ± 0.01 a 13.34 ± 0.03 b 12.99 ± 0.02 a ***
Iodine value (IV) 88.34 ± 0.00 87.97 ± 0.00 a 88.40 ± 0.00 b *
Values are expressed as mean ± standard deviation (n = 3). Means followed by different letters were significantly
different at p < 0.05. Where letters in columns were not reported, no statistical differences were observed.
Significance: * p < 0.05; *** p < 0.001; ns = not significant. SFA: saturated fatty acid; MUFA: monounsaturated fatty
acid; PUFA: polyunsaturated fatty acid.
Turkish hazelnuts (Table 3) showed a similar behavior. The O/L ratio was reduced after all
treatments. At 140 ◦C for 20 min, the O/L ratio was higher after infrared rays than after static hot air
(13.34 instead of 12.93). At 140 ◦C for 40 min, IV was high after static hot air and lower after infrared
rays (88.87 and 87.91, respectively, instead of 88.83 of raw hazelnuts).
These results are in agreement with Amaral et al. [25] and Belviso et al. [26], confirming that the
lower roasting temperature did not strongly affect the lipid profile and thus the nutritional quality
of hazelnuts.
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Static Hot Air Treatment
Myristic (C14:0) 0.03 ± 0.00 b 0.03 ± 0.00 a 0.03 ± 0.00 b ***
Palmitic (C16:0) 5.57 ± 0.00 a 5.58 ± 0.00 a 5.76 ± 0.01 b ***
Palmitoleic (C16:1) 0.17 ± 0.00 a 0.17 ± 0.00 b 0.18 ± 0.00 c ***
Margaric (C17:0) 0.04 ± 0.00 a 0.04 ± 0.00 a 0.04 ± 0.00 b ***
Heptadecenoic (C17:1) 0.07 ± 0.00 a 0.07 ± 0.00 b 0.07 ± 0.00 a ***
Stearic (C18:0) 2.21 ± 0.00 c 2.04 ± 0.00 a 2.17 ± 0.00 b ***
Elaidic (C18:1 ω9t) 0.02 ± 0.00 0.02 ± 0.00 0.02 ± 0.00 ns
Oleic (C18:1 ω9c) 84.87 ± 0.01 b 85.44 ± 0.01 c 84.55 ± 0.01 a ***
Linoleic (C18:2 ω6c) 6.64 ± 0.01 b 6.25 ± 0.00 a 6.81 ± 0.01 c ***
Arachidic (C20:0) 0.12 ± 0.00 b 0.11 ± 0.00 a 0.12 ± 0.00 b ***
Eicosenoic (C20:1) 0.15 ± 0.01 0.14 ± 0.00 0.13 ± 0.00 ns
α-Linolenic (C18:3 ω3) 0.06 ± 0.00 a 0.06 ± 0.00 b 0.07 ± 0.00 c ***
Docosanoic (C22:0) 0.02 ± 0.00 0.02 ± 0.00 0.02 ± 0.00 ns
Arachidonic (C20:4 ω6) 0.03 ± 0.00 0.03 ± 0.00 0.03 ± 0.00 ns
∑ SFA 8.00 ± 0.00 b 7.83 ± 0.01 a 8.15 ± 0.00 c ***
∑ MUFA 85.28 ± 0.01 b 85.83 ± 0.01 c 84.95 ± 0.01 a ***
∑ PUFA 6.73 ± 0.01 b 6.34 ± 0.00 a 6.91 ± 0.01 c ***
UFA/SFA 11.51 ± 0.00 b 11.78 ± 0.01 c 11.27 ± 0.00 a ***
Oleic/Linoleic (O/L) 12.78 ± 0.02 b 13.68 ± 0.01 c 12.42 ± 0.01 a ***
Iodine value (IV) 88.83 ± 0.03 a 88.64 ± 0.00 c 88.87 ± 0.00 b ***
Infrared Rays Treatment
Myristic (C14:0) 0.03 ± 0.00 b 0.03 ± 0.00 a 0.03 ± 0.00 b ***
Palmitic (C16:0) 5.57 ± 0.00 c 5.63 ± 0.01 b 5.36 ± 0.04 a ***
Palmitoleic (C16:1) 0.17 ± 0.00 b 0.17 ± 0.00 b 0.16 ± 0.00 a ***
Margaric (C17:0) 0.04 ± 0.00 b 0.04 ± 0.00 a 0.04 ± 0.00 a ***
Heptadecenoic (C17:1) 0.07 ± 0.00 a 0.07 ± 0.00 b 0.07 ± 0.00 a **
Stearic (C18:0) 2.21 ± 0.00 c 2.08 ± 0.00 a 2.19 ± 0.02 b ***
Elaidic (C18:1 ω9t) 0.02 ± 0.00 a 0.02 ± 0.00 ab 0.03 ± 0.00 b **
Oleic (C18:1 ω9c) 84.87 ± 0.01 85.08 ± 0.02 84.96 ± 0.58 ns
Linoleic (C18:2 ω6c) 6.64 ± 0.01 b 6.52 ± 0.00 c 6.10 ± 0.04 a ***
Arachidic (C20:0) 0.12 ± 0.00 b 0.11 ± 0.00 a 0.12 ± 0.00 c ***
Eicosenoic (C20:1) 0.15 ± 0.01 0.14 ± 0.00 0.14 ± 0.00 ns
α-Linolenic (C18:3 ω3) 0.06 ± 0.00 a 0.06 ± 0.00 c 0.06 ± 0.00 b ***
Docosanoic (C22:0) 0.02 ± 0.00 b 0.02 ± 0.00 a 0.02 ± 0.00 b ***
Arachidonic (C20:4 ω6) 0.03 ± 0.00 0.03 ± 0.00 0.03 ± 0.00 ns
∑ SFA 8.00 ± 0.00 b 7.90 ± 0.01 a 7.76 ± 0.06 a ***
∑ MUFA 85.28 ± 0.01 85.48 ± 0.02 85.35 ± 0.59 ns
∑ PUFA 6.73 ± 0.01 b 6.61 ± 0.00 c 6.19 ± 0.05 a ***
UFA/SFA 11.51 ± 0.00 a 11.65 ± 0.02 b 11.79 ± 0.01 a ***
Oleic/Linoleic (O/L) 12.78 ± 0.02 b 13.05 ± 0.01 a 13.92 ± 0.01 c ***
Iodine value (IV) 88.83 ± 0.03 b 88.81 ± 0.01 c 87.91 ± 0.61 a ***
Values are expressed as mean ± standard deviation (n = 3). Means followed by different letters were significantly
different at p < 0.05. Where letters in columns were not reported, no statistical differences were observed.
Significance: ** p < 0.01; *** p < 0.001; ns = not significant.
During hot air roasting, the moisture was initially removed from the surface, inducing a water
diffusion from the interior to the dried surface. Hot air roasting is a convective heat transfer process,
and the temperature rises as a function of heat transfer. As the nut temperature approaches 120 ◦C,
the rate of temperature increase slows and the moisture evaporation accelerates [27]. In the present
study, static hot air treatment generally induced a higher detoxification with increasing exposure time.
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In particular, for Turkish hazelnuts, a higher decontamination of AFB1 and AFG1 was registered after
40 min of treatment (Figure 1). Italian hazelnuts showed a higher concentration range, but AFB1 was
always more decontaminated than the other AFs.
Figure 1. Residual AFB1, AFB2, AFG1, and AFG2 after treatments with static hot air roaster compared
with infrared rays roaster. Different colors represent different treatments: green, 140 ◦C for 20 min; blue,
140 ◦C for 40 min. The treatments were performed on (A) Italian TGT hazelnuts roasted with static hot
air roaster; (B) Turkish hazelnuts roasted with static hot air roaster; (C) Italian TGT hazelnuts roasted
with infrared rays roaster; (D) Turkish hazelnuts roasted with infrared rays roaster. Boxes represent
the interquartile range (IQR) between the first and third quartiles, and the line inside represents the
median (second quartile). Whiskers denote the lowest and the highest values within 1.56 IQR from the
first and third quartiles, respectively. Circles represent outliers beyond the whiskers.
With infrared rays, heat is transferred by radiation, and the wavelength determines the temperature.
During this type of heating, surface irregularities have a small effect on heating transfer [28].
After infrared rays treatments, residual aflatoxins were lower than 5% and 15%, respectively, on
Italian and Turkish hazelnuts. Turkish hazelnuts showed a high decontamination of AFG1 for both
exposure times and roasting methods, with the lowest value at 40 min treatment. For both methods, a
higher reduction of AFB1 and AFG1 compared to AFB2 and AFG2 was confirmed. Infrared rays roasting
showed better AFs reduction compared to static hot air roasting, due to higher heat transfer efficiency.
2.3. Analysis of Perisperm
A third set of experiments was realized to understand if the AFs were removed with the perisperm
or if they were degraded after exposure to high temperature (Figure 2). The two roasting methods
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were used only on Italian hazelnuts, and two temperatures (120 ◦C and 140 ◦C) were used for 20 and
40 min. After treatments, perisperm was detached from hazelnut and collected separately.
Figure 2. Residual AFB1, AFB2, AFG1, and AFG2 on hazelnuts (green) and perisperm (blue). (A) 120 ◦C
for 20 min with static hot air roaster; (B) 120 ◦C for 40 min with static hot air roaster; (C) 140 ◦C for
20 min with infrared rays roaster; (D) 140 ◦C for 40 min with infrared rays roaster. All treatments were
applied on TGT hazelnuts. Boxes and whiskers meaning is described in Figure 1.
Infrared rays roasting confirmed a lower level for the four AFs (<10%) similar at 20 and 40 min of
exposure. Static hot air treatment also showed a similar trend at both exposure times, but the final
residue was higher. The perisperm analysis revealed a high concentration of aflatoxins: 72%–126% for
the static hot air method, and 73%–114% for infrared rays roasting.
3. Conclusions
Both treatments were useful for the detoxification of AFs in hazelnuts without affecting the
nutritional properties. After roasting, minor changes occurred in FAs, but the FAs profile was
preserved, and unsaturated fatty acids were maintained at high levels. Hot static air roasting induced
a detoxification in both types of hazelnuts, with some differences due to the temperature. AFB1 and
AFG1 were always lower than AFB2 and AFG2 after roasting. When both heating methods were tested
under the same conditions, infrared rays roasting induced a higher decontamination. Both thermic
treatments were unable to degrade AFs which were accumulated in the perisperm. In conclusion,
infrared rays roasting could be considered a promising method for aflatoxin detoxification during
hazelnut processing.
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4. Materials and Methods
4.1. Chemicals
LC-MS grade methanol, acetonitrile, and acetic acid used as mobile phases and as extraction
solvents were purchased from Sigma-Aldrich (St. Louis, MO, USA). NaCl, KCl, Na2HPO4, and
KH2PO4 used to prepare phosphate-buffered saline (PBS) solution were purchased from Merck
(Darmstadt, Germany) and dissolved in ultrapure water (Maina, Turin, Italy). Pure standards of AFB1
(purity ≥ 98%), AFB2 (purity ≥ 98%), AFG1 (purity ≥ 98%), and AFG2 (purity ≥ 98%) were purchased
from Sigma-Aldrich. AflaClean select immunoaffinity columns (IAC) were obtained from LCTech
(Dorfen, Germany). A working solution of AFs at the concentration of 1 mg/mL was prepared in
methanol and diluted in order to contaminate hazelnuts and to prepare calibration curves.
4.2. Samples and Contamination Procedure
Hazelnuts used in this work came from Italy and Turkey. The Italian cultivar, “Tonga Gentile
Trilobata” (TGT) was harvested in Cortemilia, northern Italy, and provided by La Gentile s.r.l. Turkish
hazelnuts were a blend of three major cultivars—“Tombul”, “Palaz”, and “Kalinkara”—from the Ordu
region, northern Turkey. All the hazelnuts used were free from aflatoxins. All samples were divided
in two parts—one for detoxification experiments and the other for quality analyses; all the hazelnuts
were stored in plastic bags, in the dark, at low relative humidity and a temperature of 4 ◦C before
the experiments.
Dehulled raw hazelnuts were artificially contaminated by spraying at the final concentration
of 100 ng/g for each of the four aflatoxins in the first set of experiments. In the second set of experiments,
the nuts were contaminated with 8 ng/g of AFB1 and 2 ng/g of the other three AFs (14 ng/g for
total aflatoxins).
4.3. Roasters and Other Equipment
Hazelnuts were roasted at the Brovind–GBV s.r.l. company (Cortemilia, CN, Italy) using different
equipment. Known quantities of contaminated hazelnuts were roasted in two ovens at specific
temperatures and for selected times.
Hot air static roaster model SD-80. The SD-80 static hot air roaster is a laboratory batch roaster,
which does not include product mixing and stirring, and hazelnuts are placed on a perforated
grill. Roasting is performed by forced circulation of air heated through electric resistance. Working
parameters are set up from the master control panel.
Infrared rays roaster model RI/800. The RI/800 roasting oven is a discontinuous laboratory
batch machine equipped with an infrared rays heating system. Through a conical hopper, the raw
material is introduced into the roasting chamber. Hazelnuts are heated through a battery of IR lamps,
and gentle stirring and mixing is supplied by a vibrating tray, which guarantees the homogeneity
of the process. After roasting, the product is expelled through a gate into the cooling unit. Working
parameters (temperature, time, and vibration) are set from the master control panel.
Cooler/peeler model PR/1. The PR/1 cooler/peeler is made of a circular tank. Hazelnuts are
gently stirred by mixing blades, which guarantee a uniform cooling, and nuts are peeled by friction.
Cooling is guaranteed by an aspirating collector and an electro-fan with flux regulator.
Pellicle extractor model CSACK/1. The CSACK/1 pellicle aspirator is used to extract powders
and fragments of perisperm with a centrifugal electro-fan and store them in a bag.
4.4. Treatments
In accordance with the commercial hazelnut treatments, in the first experimental set, two temperatures
were chosen for the experiments with the static hot air roaster (120 ◦C and 170 ◦C), and two exposure
times (20 and 40 min) were applied for each temperature.
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In the second experimental set, a new roasting technology—infrared rays roasting—was compared
to static hot air roasting. One temperature (140 ◦C) and two exposure times (20 min and 40 min) were
used for both methods. First and second experiments were performed on Italian and Turkish hazelnuts.
A third trial was developed with both roasting methods only on Italian hazelnuts, at the same
temperatures (120 ◦C and 140 ◦C) and exposure times (20 and 40 min) already tested. After treatments,
the hazelnut perisperm was collected separately for the analysis of aflatoxin contents.
4.5. Fatty Acid Composition
Fatty acid methyl esters (FAMEs) were determined by gas chromatography according to the
method described by Ficarra et al. [29] with slight modification.
Briefly, 50 mg of oil was mixed thoroughly with 1 mL of hexane and 300 μL of 2 M KOH in methanol
(w/v) in a dark tube. The extract was then transferred into a dark glass vial and immediately analyzed
by GC. Profiling of the FAMEs was determined using a GC-2010 Shimadzu gas chromatograph
(Shimadzu, Kyoto, Japan) equipped with a flame ionization detector, split-splitless injector, an AOC-20i
autosampler, and a SP-2560 capillary column (100 m × 0.25 mm id × 0.20 μm, Supelco, Milan, Italy).
The following temperature program was used: the initial oven temperature was 165 ◦C, increasing to
200 ◦C at 3 ◦C/min, and then the temperature was held at 200 ◦C for 45 min. The injector temperature
and the detector were 250 ◦C. Each fatty acid methyl ester was identified and quantified by comparing
retention times with Supelco 37 components FAME mix 10 mg/mL. The fatty acid concentration
was expressed in relative percentage of each fatty acid, calculated by internal normalization of the
chromatographic peak areas. The obtained fatty acid composition was used to calculate the sum of the
saturated (∑ SFA), monounsaturated (∑ MUFA), and polyunsaturated (∑ PUFA) fatty acids, as well as
the ratio (∑ MUFA + ∑ PUFA)/(∑ SFA). Moreover, to evaluate the oxidative stability, the ratio of oleic
to linoleic (O/L) and the iodine value (IV) were determined. The IV was determined according to the
percentages of fatty acids using the following formula: (palmitoleic acid × 1.901) + (oleic acid × 0.899)
+ (linoleic acid × 1.814) + (linolenic acid × 2.737). Significant differences (p < 0.05) among the means
were determined using a one-way analysis of variance (ANOVA) with Duncan’s test at a fixed level of
a = 0.05. All calculations were performed with the STATISTICA software for Windows (Release 7.0;
StatSoft Inc., Tulsa, OK, USA).
4.6. Extraction, Clean-Up, and LC-MS/MS Conditions
The AFs were extracted and analyzed using the validated method described by Prelle et al. [30].
The analyses were performed on twenty-five grams of ground hazelnuts. For perisperm analysis, 2 g
hazelnut skins, obtained after roasting, were extracted for 2 h on a shaker at 165 rpm with 10 mL of
mixture solution (methanol:water; 80:20). Samples were centrifuged at 4000 rpm and subsequently
filtered by using a Whatman CA 0.45 μm syringe filter (Maldstone, UK). Filtrate was diluted 1:4 in
phosphate buffer solution (PBS) for clean-up using IAC. All samples were analyzed in triplicate.
Analyses were performed using a Varian Model 212-LC micro pumps (Palo Alto, CA, USA)
with a Varian autosampler Model 410 Prostar coupled with a Varian 310-MS triple quadrupole mass
spectrometer with an electrospray ion source operating in positive ionization mode. Chromatographic
separation was performed with a Zorbax Eclipse Plus C18 (100 mm × 4.6 mm, 3.8 μm particle size,
Agilent, Santa Clara, CA, USA) column using H2O and CH3OH as eluents, both acidified with 0.1%
CH3COOH at the flow rate of 0.2 mL/min. Monitoring reaction mode (MRM) transitions used for
quantification were: 313 > 285 (CE 14 V) for AFB1, 315 > 287 (CE 18 V) for AFB2, 329 > 243 (CE 18 V)
for AFG1, 331 > 245 (CE 24 V) for AFG2. AFs quantification was performed using external calibration
based on serial dilution of a multi-analyte stock solution.
Supplementary Materials: The following are available online at www.mdpi.com/2072-6651/9/2/72/s1, Table S1:
Fatty acid distribution (%) of TGT hazelnuts before and after treatment with static hot air at two temperatures
(120 ◦C and 170 ◦C) at the two different exposure times (20 and 40 min), Table S2: Fatty acid distribution (%) of
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Turkish hazelnuts before and after treatment with static hot air at two temperatures (120 ◦C and 170 ◦C) at the
two different exposure times (20 and 40 min).
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24. Vujević, P.; Petrović, M.; Vahčić, N.; Milinović, B.; Čmelik, Z. Lipids and minerals of the most represented
hazelnut varieties cultivated in Croatia. Ital. J. Food Sci. 2014, 26, 25–29.
25. Amaral, J.S.; Casal, S.; Seabra, R.M.; Oliveira, B.P.P. Effects of roasting on hazelnut lipids. J. Agric. Food Chem.
2006, 54, 1315–1321. [CrossRef] [PubMed]
26. Belviso, S.; Dal Bello, B.; Giacosa, S.; Bertolino, M.; Ghirardello, D.; Giordano, M.; Rolle, L.; Gerbi, V.; Zeppa, G.
Chemical, mechanical and sensory monitoring of hot air- and infraredroasted hazelnuts (Corylus avellana L.)
during nine months of storage. Food Chem. 2017, 217, 398–408. [CrossRef] [PubMed]
27. Ciarmiello, L.F.; Piccirillo, P.; Gerardi, C.; Piro, F.; De Luca, A.; D’Imperio, F.; Rosito, V.; Poltronieri, P.;
Santino, A. Microwave irradiation for dry-roasting of hazelnuts and evaluation of microwave treatment on
hazelnuts peeling and fatty acid oxidation. J. Food Res. 2013, 2, 22–35. [CrossRef]
28. Rastogi, N.K. Recent trends and developments in infrared heating in food processing. Crit. Rev. Food
Sci. Nutr. 2012, 52, 737–760. [CrossRef] [PubMed]
29. Ficarra, A.; Lo Fiego, D.P.; Minelli, G.; Antonelli, A. Ultra fast analysis of subcutaneous pork fat. Food Chem.
2010, 121, 809–814. [CrossRef]
30. Prelle, A.; Spadaro, D.; Garibaldi, A.; Gullino, M.L. Aflatoxin monitoring in Italian hazelnut products by
LC-MS. Food Addit. Contam. Part B 2012, 5, 279–285. [CrossRef] [PubMed]
© 2017 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access
article distributed under the terms and conditions of the Creative Commons Attribution




Plasma-Based Degradation of Mycotoxins Produced
by Fusarium, Aspergillus and Alternaria Species
Lars ten Bosch 1,*, Katharina Pfohl 2,*, Georg Avramidis 1,*, Stephan Wieneke 1,
Wolfgang Viöl 1,3 and Petr Karlovsky 2
1 University of Applied Sciences and Arts, Faculty N, Von-Ossietzky-Strasse 99/100, 37085 Göttingen,
Germany; stephan.wieneke@hawk-hhg.de (S.W.); wolfgang.vioel@hawk-hhg.de (W.V.)
2 Molecular Phytopathology and Mycotoxin Research, Georg-August-University Göttingen,
Grisebachstrasse 6, 37077 Göttingen, Germany; pkarlov@gwdg.de
3 Fraunhofer IST Application Centre, Von-Ossietzky-Strasse 100, 37085 Göttingen, Germany
* Correspondence: lars.bosch@hawk-hhg.de (L.t.B.); kpfohl@gwdg.de (K.P.);
georg.avramidis@hawk-hhg.de (G.A.); Tel.: +49-551-3705-361 (L.t.B.); +49-551-39-13230 (K.P.);
+49-551-3705-293 (G.A.)
Academic Editor: Ting Zhou
Received: 13 January 2017; Accepted: 7 March 2017; Published: 10 March 2017
Abstract: The efficacy of cold atmospheric pressure plasma (CAPP) with ambient air as working gas
for the degradation of selected mycotoxins was studied. Deoxynivalenol, zearalenone, enniatins,
fumonisin B1, and T2 toxin produced by Fusarium spp., sterigmatocystin produced by Aspergillus spp.
and AAL toxin produced by Alternaria alternata were used. The kinetics of the decay of mycotoxins
exposed to plasma discharge was monitored. All pure mycotoxins exposed to CAPP were degraded
almost completely within 60 s. Degradation rates varied with mycotoxin structure: fumonisin B1
and structurally related AAL toxin were degraded most rapidly while sterigmatocystin exhibited
the highest resistance to degradation. As compared to pure compounds, the degradation rates
of mycotoxins embedded in extracts of fungal cultures on rice were reduced to a varying extent.
Our results show that CAPP efficiently degrades pure mycotoxins, the degradation rates vary with
mycotoxin structure, and the presence of matrix slows down yet does not prevent the degradation.
CAPP appears promising for the decontamination of food commodities with mycotoxins confined to
or enriched on surfaces such as cereal grains.
Keywords: DBD; atmospheric pressure; low temperature plasma; mycotoxins; degradation
1. Introduction
Phytopathogenic fungi infect crops in the field (pre-harvest spoilage) while spoilage fungi
colonize harvested commodities during storage (post-harvest spoilage). Besides the reduction of
yield and quality, infection with fungal pathogens often leads to contamination with mycotoxins [1,2].
These toxic fungal metabolites have the potential to harm the health of consumers and livestock.
Reduction of mycotoxin content in food and feedstuff is therefore an important goal of food and feed
safety improvement.
Prevention of fungal contamination is the primary means of agricultural and food industry when
it comes to compliance with maximum limits for mycotoxin content. In current production systems,
however, even the best agricultural and manufacturing practices cannot fully prevent mycotoxin
contamination. Degradation of toxic metabolites may be used to decontaminate food and feed products.
Since most mycotoxins exhibit a high chemical stability, development of decontamination methods
compatible with food quality standards is a challenging task. Over the last decades chemical, biological
and physical strategies for the degradation of mycotoxins and the effect of food processing technologies
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on mycotoxin content were investigated extensively [3–5]. Among physical treatments mainly heating,
irradiation and washing were studied. Mineral and organic mycotoxin binders are established since
decades in animal production. More recently chemical and biological decontamination methods
were studied. Among chemical methods, successful application of acids, bases, oxidizing agents,
chlorinating agents, formaldehyde and ammoniation was described, especially for the decontamination
of aflatoxin- and ochratoxin A-contaminated feeds. Although biological and enzymatic strategies have
been developed since 1960’s [4] physical techniques still offer the most efficient removal of mycotoxins
from food and feed [5].
Technical plasma is a novel physical method with a great potential as a post-harvest treatment
method for mycotoxin mitigation. Plasma has been successfully used for sterilization and in plasma
medicine [6–11]. Recent application of cold atmospheric pressure plasma (CAPP) in breaking seed
dormancy and destruction of plant pathogens showed that the technology is suitable for sensitive
biological materials [12–15]. Plasma of different types were used in studies of the inhibition of
mycotoxin production and mycotoxin degradation. Ouf et al. [16] demonstrated inhibition of the
synthesis of fumonisin B2 and ochratoxin A by A. niger after treatment with an atmospheric pressure
argon plasma jet. Park et al. [17] successfully degraded aflatoxin B1 (AFB1), deoxynivalenol (DON)
and nivalenol (NIV) within 5 s using a microwave-induced argon jet at atmospheric pressure.
Physical and chemical treatment of plant products bear a risk of reducing nutritional value and
negatively affecting the palatability and sensory quality of the product. Long treatment duration,
required by some methods for satisfactory decontamination of large quantities of goods, may increase
the risk of these side effects. The effect of physical and chemical decontamination on nutritional value
and quality of food commodities has rarely been systematically investigated. Because the energy of
free electrons and excited ions and molecular species in CAPP exceeds the dissociation energy of a C-C
bond, organic molecules in the discharge are subjected to unspecific degradation. This feature of CAPP
was used to degrade chemically stable pollutants in gaseous phase (e.g., [18]). Low penetration depth
of CAPP protects nutrients in bulk material from degradation, limiting degradation to a thin surface
layer [19]. Kříž et al. [20,21] showed that the content of proteins and fibers as well as residual dry matter,
nitrogen-free extract, fat and ash in intact barley grains were not significantly affected by treatment
with CAPP while the content of selected mycotoxins was reduced by 20%–70%. We hypothesize that
the confinement of mycotoxin contamination to the surface of grains accounted for the selectivity of
the degradation in this study.
In the presented study, a dielectric barrier discharge (DBD) operated with ambient air at
atmospheric pressure was utilized for the degradation of mycotoxins. Preliminary experiments
using a similar setup and comparable dissipated discharge power applied on pea seeds (Pisum sativum)
revealed no decline of seed germination rate, thus indicating negligible thermal effect due to plasma
treatment [22]. The aim of this work was to test the effectiveness of cold atmospheric pressure air
plasma based on a dielectric barrier discharge for the degradation of selected mycotoxins important in
food and feed safety.
2. Results
2.1. Treatment of Cover Glasses
Mycotoxin solutions were applied on untreated and 5 s pre-treated cover glasses in order to find
out whether the activated surface of plasma-pretreated cover glasses (Section 4.3) might chemically
affect mycotoxins. Mycotoxin content was determined as described in Section 4.4. As shown in
Figure 1, pre-treatment of cover glasses with air plasma did not significantly affect mycotoxins on
glass surface.
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Figure 1. Effect of cover glass pretreatment on mycotoxins. Round cover-glasses were pre-treated with
air-plasma for 5 s or not treated (controls). The further sample preparation was executed as described
in Section 4.3. Significance of differences between treatments and control was tested by t-test at p = 0.05
with correction for multiple testing, according to Bonferroni. No significant difference was found.
2.2. Treatment of Pure Mycotoxins and Fungal Extracts
AAL toxin, FB1, DON, ZEN, EnnA, EnnB, T2-toxin and ST as pure compounds covering the
surface of cover glasses were subjected to air-plasma for 5 s, 10 s, 20 s, 30 s, and 60 s. HPLC-MS/MS
analysis of residues on the glass surface revealed that the plasma treatment led to time-dependent
degradation of all mycotoxins (Figure 2a,b). Searching for degradation products by HPLC-MS in a
full-scan mode failed to detect any distinct MS signal.
The degradation kinetics seemingly followed an exponential decay. Since distinct differences
among the toxins were apparent in their degradation rates, the measured data sets were fitted by an
exponential function (Figure 2a,b).
C(t) = y0 + C0·e−t/τ (1)
C(t) is the concentration at time t, C0 is the initial concentration, y0 represents the threshold and τ
represents the half-life. Half-life values calculated for all toxins by fitting Equation (1) to the data sets
(Figure 2) are shown in Table 1.
Table 1. Half-life at ≈4 W/cm2, molecular mass and chemical formula of the mycotoxins.
Mycotoxin Half-Life τ [s] Molecular Mass [Da]
Sterigmatocystin 5.0 ± 0.4 324.3
Enniatin A 4.5 ± 0.5 681.9
Zearalenone 4.2 ± 0.5 318.4
Deoxynivalenol 4.0 ± 0.7 296.3
T2-toxin 3.6 ± 0.1 466.5
Enniatin B 3.1 ± 0.2 639.8
AAL-toxin 1.9 ± 0.4 521.6
Fumonisin B1 1.9 ± 0.3 721.8
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(b)
Figure 2. (a). Time-dependent decay of four pure mycotoxins exposed to air plasma (N = 5). (A)
AAl-Toxin TA, (B) Enniatin A, (C) T2-toxin, (D) Deoxynivalenol; (b). Time-dependent decay of four
pure mycotoxins exposed to air plasma (N = 5). (E) Fumonisin B1, (F) Enniatin B, (G) Zearalenone,
(H) Sterigmatocystin.
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Four mycotoxins (FB1, EnnB, ST and ZEN) were selected to investigate the effect of matrix
on mycotoxin degradation by plasma. Extracts of rice cultures of fungal strains producing these
mycotoxins (Fusarium verticillioides, Fusarium avenaceum, Aspergillus nidulans and Fusarium graminearum),
containing approx. 100 μg/mL of each toxin, were exposed to air plasma under the same conditions as
pure compounds. The degradation rates were reduced as compared to pure compounds for all four
mycotoxins (Figure 3). Particularly strong reduction of degradation rates was observed for FB1 and
EnnB; nearly half of these toxins remained intact at the end of the treatment. Moreover, the course of
the degradation of FB1 and EnnB was linear, contrasting to exponential decay of pure compounds.
Degradation rates of ZEN and ST were reduced to a lesser extent and the progress of degradation of
these toxins in matrix followed exponential decay similarly as the degradation of pure compounds
(Figure 3).
Figure 3. Time-dependent decay of mycotoxins embedded in rice extract (green line) exposed to air
plasma (N = 5). (A) Fumonisin B1; (B) Enniatin B; (C) Zearalenone; (D) Sterigmatocystin. The red
dotted line displays the decay slopes of the respective pure mycotoxin standards as shown in Figure 2b.
3. Discussion
All investigated mycotoxins, when present as pure compounds, showed a distinct decay within
a few seconds of plasma treatment duration and were reduced by approx. 2 log-ranges within
30 s as shown in Figure 2a,b. It is assumed that the energy dissipated in the discharge gap
induces a combination of different degrading mechanisms acting on the toxins such as chemical
reactions with reactive species generated in the plasma volume such as O, O3, OH, and NOx [23,24]
and/or decomposition after collision with electrons and ions [25,26] leading to cleavage of molecular
bonds. Further reactions with plasma species can result in fragmentation and generation of volatile
compounds. Decomposition of organic compounds into volatile products such as CO, CO2, and H2O
during exposition of various polymer materials to oxygen-containing plasmas is a known phenomenon
that was reported by several authors (e.g., [27–29]).
No stable residues of toxin degradation could be detected with HPLC-MS. Rapid degradation
of toxin fragments into volatile products can be expected in analogy with the results of the study of
Doraj and Kushner [27] in which degradation of polypropylene was elucidated. We assume that
mycotoxin fragments were rapidly converted into volatile compounds which were immediately
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removed by the gas stream in the discharge gap. Therefore, future work will be dedicated to mass
spectrometric investigation of the plasma effluent.
Our results (Figure 2a,b) are in accordance with the degradation of aflatoxin B1, DON, and
nivalenol by Park et al. [17] who used a microwave argon plasma jet as well as by Ouf et al. [16] who
demonstrated the reduction of fumonisin B2 and ochratoxin A by an atmospheric pressure argon
kHz-operated jet. It should be kept in mind that sample temperature measured after the treatment
by different approaches differed significantly: 35 ◦C were estimated after 9 min of treatment by
Ouf et al. [16] and 105 ◦C after 5 s of treatment by Park et al. [17,30]. Elevated temperatures may cause
thermal degradation. Since gas temperature and substrate temperature in this study did not exceed
60 ◦C, no thermal degradation of mycotoxin is expected.
Decay curves of individual toxins showed distinctly different degradation kinetics (Figure 2a,b).
These differences were quantified by exponential fitting (Table 1). FB1 and AAL-toxin were degraded
at the highest rate (τ = 1.9 ± 0.3) and ST at the lowest rate (τ = 5.0 ± 0.4).
The decay rates did not correlate with molecular mass. For example, EnnA with a molecular
mass of 681.9 Da showed a similar decay rate as ST with a mass of 324.3 Da. The degradation rate
might however be affected by the chemical structure. FB1 and structurally related AAL-toxin with
long aliphatic chains were degraded rapidly, while ST with a compact structure of condensed aromatic
rings had the highest half life. Most other mycotoxins with intermediate decay rates possessed mixed
structures of condensed rings and aliphatic chains.
A relationship between the degradation rate of chemical compounds and their molecular structure
was described by Gröning et al. [31] investigating plasma-based decay of polymers. These researchers
suggested a buffering effect of aromatic structures on the degradation by low-pressure air-plasma.
Klarhöfer et al. [32] reported higher resistance of lignin (which contains aromatic structures) exposed
to an air DBD compared to cellulose and ascribed this observations to a similar mechanism. Aromatic
structures occurring in mycotoxins might therefore slow down plasma-induced degradation. Future
investigations will focus on degradation pathways, especially considering wide-spread toxins lacking
aromatic rings. It is desirable to verify the postulated structural effects on degradation and identify
reactive species in the plasma accountable for the degradation. Degradation of chemical constituents
of solid materials by cold plasma is confined to thin surface layers [19]. Mycotoxins produced by
Fusarium species in small-grain cereals are often enriched in the outer layers of grains [33,34]; this
circumstance may facilitate selective degradation of mycotoxins in grains by cold plasma with a small
loss of nutrients.
Mycotoxins imbedded in extracts of fungal cultures were degraded with lower rates than pure
compounds. Presumably, components of the extracts scavenged reactive molecular species in the
plasma, shielding mycotoxins from degradation. Activated components of the extracts are expected to
rapidly react with other compounds including mycotoxins. Because the presence of matrix significantly
reduced the degradation rates of mycotoxins, secondary chemical reactions apparently did not
compensate for the loss of reactive molecular species by scavenging. We hypothesize that the effect of
matrix on the degradation of other mycotoxins by plasma will be similar. In spite of the protective
effects of culture extracts, significant decay of mycotoxins in culture matrix occurred, suggesting that
plasma-based methods are promising for mycotoxin degradation in thin surface layers even in the
presence of complex matrices.
4. Experimental Setup and Materials
4.1. Mycotoxin Standards
Pure mycotoxin standards of AAL toxin (TA1 + TA2), enniatin A (Enn A), enniatin B (Enn B),
fumonisin B1 (FB1), sterigmatocystin (ST), deoxynivalenol, T2-toxin and zearalenone (ZEN) were
purchased from Sigma Aldrich (Munich, Germany). Stock solutions were prepared in LC-MS grade
methanol (Th. Geyer GmbH, Renningen, Germany).
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4.2. Fungal Strains, Rice Cultures and Mycotoxin-Containing Fungal Extracts
Fusarium verticillioides VP2 [35] was kindly provided by Francesca Cardinale (University of Turin,
Turin, Italy). F. avenaceum DSM 21724 was purchased from Deutsche Sammlung von Mikroorganismen
und Zellkulturen (DSMZ, Braunschweig, Germany). F. graminearum IFA 66 was kindly provided by
Marc Lemmens (Institute of Biotechnology in Plant Production, Tulln, Austria) via Thomas Miedaner
(University of Hohenheim, Stuttgart, Germany). F. graminearum Fg71 was kindly provided by Thomas
Miedaner. Aspergillus nidulans RDIT2.3 was kindly provided by Marko Rohlfs (University of Göttingen,
Goettingen, Germany).
Fungal spores of Fusarium strains were produced according to Bai [36] with modification
(Becker et al. [37]). The spores were suspended in sterile tap water and stored at −60 ◦C. Rice cultures
were prepared as described (Nutz et al. [38]). All mycotoxins except fumonisins were extracted from
5 g rice cultures with 40 mL acetonitrile overnight with shaking, while fumonisins were extracted
with methanol. An aliquot of 1 mL was dried, redissolved in 1 mL of methanol/water (1:1) and the
concentration of mycotoxins was determined by HPLC-MS (see below). Remaining supernatants were
dried in vacuum and the residues were dissolved and adjusted to a concentration of 100 μg/mL of
ST (A. nidulans RDIT2.3), FB1 (Fusarium verticillioides VP2), Enn B (F. avenaceum DSM 21724) and ZEN
(F. graminearum Fg71 and IFA 66).
4.3. Sample Preparation
Round cover-glasses (thickness 100 μm, diameter 16 mm) were placed onto microscopy slides
and pre-treated with air-plasma for 5 s to facilitate an even spread of the toxin solution on the surface
by increased surface tension (see e.g., Gerhard et al. [39]). Subsequently, 1.5 μL mycotoxin solution
(100 μg/mL in methanol) were centrally applied onto the cover glass; the solution spread over the entire
glass area spontaneously. After solvent evaporation at room temperature, the specimen underwent a
plasma treatment at constant input power and varying treatment durations (0 s, 5 s, 10 s, 20 s, 30 s and
60 s). Then, the cover glasses were immersed in 0.5 mL methanol for at least 24 h to dissolve residual
mycotoxins for analysis. 5 replicates per mycotoxin and treatment were used.
4.4. Mycotoxin Analyses
High performance liquid chromatography was performed as described (Ratzinger et al. [40])
using C18 column (Kinetex, 50.0 mm × 2.1 mm, particle size 2.6 μm; Phenomenex, Aschaffenburg,
Germany); for the quantification of enniatins, 10 μM sodium acetate were added to the mobile phase.
The analytes were ionized by electrospray and analyzed either by tandem mass spectrometry for
quantification of mycotoxins or in a full scan mode while searching for degradation products using an
ion trap detector 500 MS (Varian, Darmstadt, Germany). For the identification of mycotoxins retention
time, m/z of molecular ions and fragmentation spectra were used. DON and ZEN were detected in
a negative mode while all other mycotoxins were analyzed in positive ionization mode. The m/z
values for molecular ions and mass transitions used were 522 > 328 for AAL-toxin, 722 > 686 for FB1,
662 > 549 for Enn B, 704 for Enn A, 325 > 310 for ST, 489 > 387 for T2-toxin, 355 > 295 for DON and
317 > 175 and 317 > 273 for ZEN. Quantification was carried out based on a linear calibration curve
constructed with pure external standards. The estimated limits of quantification were 3 ng/mL for
FB1, 5 ng/mL for Enn A/B, ST, AAL-toxin and T2-toxin, 10 ng/mL for DON 1 ng/mL and for ZEN.
For all mycotoxins analyzed in positive ionization mode full-scan search for degradation products was
carried out as described by Ratzinger et al. [40] followed by pairwise comparison of signal intensities
after peak alignment and normalization [41].
4.5. Plasma Device
For plasma treatment, samples were positioned on a glass-insulated (float glass; thickness 4 mm)
ground electrode (aluminum) so that the discharge gap between the samples and the upper electrode
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was 2 mm (Figure 4a). The upper electrode (145 × 85 × 28 mm, filling: bronze powder, dielectric:
Al2O3, thickness of dielectric 3 mm) was connected to an alternating high-voltage (≈19 kV peak) pulse
generator producing bipolar high-voltage pulses of a duration of approximately 1.9 μs and a repetition
frequency of 17 kHz.
Figure 4. Principle of the electrode configuration (a) and scheme of experimental setup (b).
Figure 4b depicts the plasma-setup and Table 2 the operational parameters. The upper high
voltage electrode is attached to a cross-table and can be moved along 3 axes. One transition over the
sample surface results in 5 s of plasma exposition at the chosen movement speed. The treatment of
the samples was carried out by several consecutive sample transits by the upper electrode. During
treatment compressed air flow was applied in order to cool the system and to homogenize the discharge.
The gas temperature, estimation via optical emission spectroscopy (high resolution spectra applying
an Echelle spectrograph, see e.g., [42,43]), and substrate temperatures, estimation via thermographic
analysis (Fluke TiS Thermal Imager, Fluke Corporation, Everett, WA, USA), did not exceed 330 K or
60 ◦C after 60 s of treatment.
Table 2. Input parameters for experimental setup.
Input Parameter Value
power density ≈4 W/cm2
discharge gap 2 mm
air flow 130 sl/min
appl. voltage ≈38 kV (p-p)
waveform pulsed sine
gas temperature Trot ≈ 330 K
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4.6. Measurement of Injected Power
The total energy converted in the gas discharge is an important parameter to characterize dielectric
barrier discharges and was determined following the established cyclogram/Lissajous method [44].
The voltage/charge Lissajous figure (Q-U-plot) of the transferred charge and the applied voltage was
used to calculate the energy dissipated into the system. The electrical parameters were measured using
a high voltage probe (3 pF, 100 MΩ, Tektronix P6015A, Tektronix Inc., Beaverton, OR, USA) and a
parallel circuit consisting of a capacitor (200 nF) and a resistor (1 kΩ). This parallel circuit was used
for the charge measurement using a Yokokawa DL1740EL Dual 500 MHz oscilloscope (Yokogawa
Electric Corp., Musashino, Tokyo, Japan) for digitalization. The voltage applied to the upper electrode
was measured directly, whereas the transferred charge was determined by the measurement of the
voltage drop on the capacitance (2 × WIMA FKP1, 100 nF). The calculated power injected to the system
was approx. 500 W for all sample treatments. Considering the electrode geometry, a power density
of ≈4/cm2 was calculated as depicted in Table 2.
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Abstract: Aflatoxins, a group of extremely hazardous compounds because of their genotoxicity
and carcinogenicity to human and animals, are commonly found in many tropical and subtropical
regions. Ultraviolet (UV) irradiation is proven to be an effective method to reduce or detoxify
aflatoxins. However, the degradation products of aflatoxins under UV irradiation and their
safety or toxicity have not been clear in practical production such as edible oil industry. In this
study, the degradation products of aflatoxin B1 (AFB1) in peanut oil were analyzed by Ultra
Performance Liquid Chromatograph-Thermo Quadrupole Exactive Focus mass spectrometry/mass
spectrometry (UPLC-TQEF-MS/MS). The high-resolution mass spectra reflected that two main
products were formed after the modification of a double bond in the terminal furan ring and the
fracture of the lactone ring, while the small molecules especially nitrogen-containing compound
may have participated in the photochemical reaction. According to the above results, the possible
photodegradation pathway of AFB1 in peanut oil is proposed. Moreover, the human embryo
hepatocytes viability assay indicated that the cell toxicity of degradation products after UV irradiation
was much lower than that of AFB1, which could be attributed to the breakage of toxicological sites.
These findings can provide new information for metabolic pathways and the hazard assessment of
AFB1 using UV detoxification.
Keywords: aflatoxin B1; photodegradation product; TQEF-MS/MS; cell viability; furan rings
1. Introduction
Aflatoxins are the secondary metabolites of Aspergillus flavus and Aspergillus parasiticus, which
are found worldwide in air and soil to infest living and dead plants [1,2]. Aflatoxin B1 (AFB1) is the
most potent mycotoxin associated with hepatocellular carcinoma, immune-dysfunction, and protein
deficiency syndromes, which is classified as a Group I carcinogen by the International Agency for
Research in Cancer [3]. It is well known that the double bond in the terminal furan ring was a key active
site for its toxic and carcinogenic activities. A chemical molecular structure diagram of AFB1 is shown
in Figure 1. Aflatoxins frequently occur in tropical and subtropical regions, and many agricultural
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commodities and main crops, such as peanut and corn, are susceptible to such contamination in the
period of growth and storage. While the contaminated peanuts or corns are used as raw material
without appropriate processing measures in the food industry, they will become a serious threat or
hazard to human health. The most rational strategy to avoiding hazards associated with aflatoxins is
the prevention of aflatoxin contamination by the toxigenic fungi. However, it is difficult to prevent or
control the contamination of peanuts by the toxigenic fungi due to that the hazard of fungi is naturally
occurring and is not always possible under certain agronomic storage practices [4].
Figure 1. Chemical molecular structure of aflatoxin B1 (AFB1).
Many kinds of chemical, physical, and biological approaches for the detoxification of aflatoxins
have been reported in previous studies [5–8]. Chemical detoxification is an effective measure using
strong alkalis or oxidants such as ammoniation, ozone to break the structure of aflatoxins. However,
the quality and nutritional compositions in food may be affected by strong alkalis or oxidants during
these chemical measures. Alberts et al. reported that a remarkable reduction in AFB1 was observed
after 2 h in the presence of R. erythropolis extracellular extractions, and only 33.2% residue AFB1
was detected after 72 h by degrading enzymes from extracellular extractions [7]. The biological
methods showed the high efficiency and selectivity, but these methods may be difficult to reutilize
on a large scale. Ultraviolet (UV) irradiation as a non-thermal technology is widely applied in the
food industry for disinfection, which is also considered to be practical and cost-effective method to
reduce aflatoxins for its photosensitive properties [8]. As an effective physical method, many studies
have been done to investigate the efficiency of UV irradiation, the degradation product of aflatoxins,
the safety of degradation products and quality of foods after being irradiated [9–14]. It was found
that aflatoxins could be efficiently degraded by UV irradiation, and the degradation efficiency varied
with the differences of irradiation conditions [9,10]. For the studies in photodegradation products of
aflatoxins, ultra-performance liquid chromatography-quadrupole time-of-flight mass spectrometry
(UPLC-Q-TOF MS) was used to identify the photodegradation products. Different degradation
products were identified on the basis of low mass error and high matching property in aqueous or
acetonitrile solution, and the different AFB1 degradation pathways were proposed [12,14]. Moreover,
in other study, it was found that three products of AFB1 formed using UV irradiation for 120 min in the
presence of methylene blue [15]. These conclusions indicated that depending upon reaction conditions
such as medium or solvent, the degradation products of AFB1 was different under UV irradiation.
In addition, most studies were carried out on the Ames test and cytotoxicity of HepG2 cells of
AFB1 products after irradiation [10,13,16,17]. The toxicities of the photodegradation products of AFB1
in water and peanut oil on HepG2 cells were investigated, and it was found that the cytotoxicity of
products of AFB1 in water decreased 40%, while that of products of AFB1 in peanut oil reduced about
100% [13]. Moreover, similar results were obtained after being irradiated of AFB1 in peanut oil using
a photodegradation reactor in a previous study [16]. This might be because toxicological sites were
destroyed by UV irradiation.
From the above studies, it can be determined that the studies on degradation products of AFB1
are mostly in acetonitrile or aqueous media, and the pathway of AFB1 in different solutions are
entirely different. However, the identification of degradation products and their toxicity have been
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poorly investigated in practical production. For instance, the product of AFB1 in peanut oil under UV
irradiation has not yet been reported, which may be due to the complicated compositions in peanut oil.
Therefore, the aim of this article is to examine the products of AFB1 in peanut oil under UV irradiation
and the safety or toxicity of degradation products after UV irradiation, and to provide clues to the
study of the degradation mechanism of AFB1 in peanut oil and the assessment of safety issues of
the UV method applied in aflatoxins detoxification. In this study, the photodegradation efficiency of
AFB1 in peanut oil were investigated; after optimizing the extract conditions, the photodegradation
products were analyzed by Thermo Quadrupole Exactive Focus spectrometry-mass spectrometry/mass
spectrometry (TQEF-MS/MS). On the basis of low mass error and high matching property from data
of MS/MS, the feasible pathway of AFB1 in peanut oil was deduced. Moreover, the in vitro toxicity of
AFB1 and its degradation products towards human embryo hepatocytes (L-02 cell) were investigated.
2. Results and Discussions
2.1. Effect of the AFB1 Initial Concentration on Degradation Performance in Peanut Oil
The effect of the AFB1 initial concentration on degradation performance in peanut oil was
investigated in this study. The result from Figure 2 confirmed that the AFB1 can be degraded under
365 nm UV irradiation, and there were no obvious changes found in the blank experiment without
UV irradiation. The initial concentrations of AFB1 were 48, 68, 88, 108, and 128 ppb, and it could be
seen that the initial concentration of 128 ppb showed only a slightly improved degradation efficiency
compared with the others before 20 min, and the value of Ct/C0 then remained around 4% after 20 min.
It was revealed that the effect of the initial concentration of AFB1 in our selected range on degradation
activity was unremarkable, which is in agreement with the result of the previous report [12]. Moreover,
after 30 min of irradiation, it was found that there was only about 4% AFB1 residual in each sample.
As we know, many countries have regulated the limitation standard of aflatoxins to protect consumers’
health and prevent food safety issues. The Food and Drug Administration (FDA), the World Health
Organization (WHO), and the Codex Alimentarius Commission (CAC) have regulated a maximum
contamination level for total content of aflatoxin B1, B2, G1, and G2 (15 μg/kg) in food. Moreover,
according to national standard (GB 2461-2011) in China, the limitation standard of AFB1 in peanut oil
is 20 μg/kg (ppb). It can be concluded that the contents of AFB1 in peanut oil with different initial
concentrations after 30 min UV treatment in this study are within an acceptable range according
to the above limitation standards. However, the European Commission has regulated a maximum
contamination level for AFB1 (2 μg/kg) and total aflatoxin (4 μg/kg) in argo-products according to (EU)
No 165/2010, 2010. For this strict restriction in EU, the optimization of the conditions of UV irradiation
treatment, such as enhancing the intensity of UV within a defined and accepted range [12,14], may be
an effective strategy to reduce and control the content of AFB1 below the limitation standard of EU.
Figure 2. The effect of the AFB1 initial concentration on degradation performance in peanut oil under
UV irradiation from 0 min to 30 min.
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2.2. Identification of Photodegradation Products of AFB1 in Peanut Oil
It is well known that the degradation products of AFB1 under UV irradiation in various media
are different. Three products, C17H14O7, C16H14O6, and C16H12O7, were formed in aqueous medium
and identified by UPLC-Q-TOF-MS [12], while C17H15O6, C16H13O5, and C14H11O6 were obtained in
acetonitrile medium by the same identification method [14]. Moreover, in other previous articles, it was
reported that the photodegradation products in peanut oil extracted by acetonitrile cannot be detected
in UV-treated extracts [9]. In our study, the extraction solvent type and volume were optimized.
Various organic reagents were used to extract the photodegradation products of AFB1, and it was
found that the products extracted by methyl alcohol-water (10:90) solution could be detected. To study
the photodegradation products of AFB1 and identify their structures, the samples ((a) the sample
containing AFB1 without UV irradiation; (b) the sample without AFB1 after UV irradiation; and (c)
the sample containing AFB1 after UV irradiation) were analyzed by UPLC-QEF-MS/MS. It can be
observed distinctly from Figure 3 that AFB1 was degraded within 30 min, leading to the formation of
the two new compounds denoted ‘P1’ and ‘P2’, which were not detected in the blank experiment a and
b. Moreover, these two compounds were considered as the irradiated products of AFB1 in peanut oil.
P1, P2, and AFB1 had a retention time of 8.42, 11.34, and 15.68 min, respectively, showing an order of
polar character P1 > P2 > AFB1.
Figure 3. The UPLC chromatogram of peanut oil samples before and after irradiation. ((a) the sample
containing AFB1 without UV irradiation, (b) the sample without AFB1 after UV irradiation, and (c) the
sample containing AFB1 after UV irradiation).
In a separate QEF MS mode, the ions of P1, P2, and AFB1 were used as precursor compounds, and
the ion-filtering function of the quadrupole permitted only ions of m/z = 340, 227, and 313 to pass to the
collision cell, where 35 eV was applied for 340, 227, and 313. Compared with the standard substance of
AFB1, m/z = 313 was in agreement with the molecular mass of the parent compound (AFB1). In order to
present the structure of these two products, P1 and P2, the MS-MS spectra of degradation products m/z
= 340 and m/z = 227 were also recorded. The secondary mass spectrum and fragmentation information
of these two precursor compounds were derived, and they are shown in Figure 4. The structural
formulas of these photodegradation products were demonstrated on account of the molecular formula
calculated from accurate mass analysis. The MS-MS fragmentation formation was supplied by the
QEF mode, and illuminated by the tool mass fragment incorporated in the Mass Frontier 7.0 software
to verify how much the results matched the corresponding fragment information (Table 1 contains
detailed calculation data). From Table 1, it can be seen that the experimental mass of these fragments
matched the theoretical mass of these fragments. Moreover, a maximum mass error of 10 ppm for
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the range of masses was discussed in this study. It can be seen clearly that the mass errors of these
fragments of photodegradation products were all below 7 ppm, which indicated at least 93% confidence
in the accuracy of the suggested results. From Figure 4a,b, it can be easily found that m/z = 340 and
m/z = 227 have many of the same fragmentations such as m/z = 209, m/z = 114, m/z = 96, m/z = 79,
etc. Moreover, through accurate calculation and careful molecular model derivation, we finally arrived
at the conclusion that the fragmentation of m/z = 227 may be the metabolite of m/z = 340 under UV
irradiation. More important than the above results, and to confirm the relationship between these two
products, the time development of the formation of photodegradation products of AFB1 in peanut oil
was also investigated in our study. From Figure 5, it can be seen that P1 and P2 were detected during
the procedure of UV irradiation, and the content of AFB1 in peanut oil decreased gradually with time.
Moreover, by comparing the ratio of the intensities of two photodegradation products at different time
under UV irradiation, it was found that the response and intensity of P1 weakened from 10 min to
30 min, while that of P2 increased over time. This result may be due to the fact that some of the P1
translated to P2 during the UV irradiation in peanut oil. These results provided important information
for the photodegradation pathway of AFB1 in peanut oil.
(a)
(b)
Figure 4. The QEF MS/MS spectra and proposed fragmentation of two degradation products under
UV irradiation. Proposed fragmentations are shown on the right side of spectra. (a) m/z = 340;
(b) m/z = 227.
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Table 1. QEF-MS/MS accurate mass, mass error, and formula of photodegradation product fragments.
Theoretical Mass Experimental Mass Fragment Formula Mass Error (ppm)
79.05478 79.05429 C6H7 −6.19823
79.05478 79.05428 C6H7 −6.32473
96.08132 96.08075 C6H10N −5.93247
114.09189 114.09132 C6H12NO −4.99597
114.09189 114.09133 C6H12NO −4.90832
209.16539 209.16478 C12H21N2O −2.91635
209.16539 209.16507 C12H21N2O −1.52989
227.17595 227.17520 C12H23N2O2 −3.30141
227.17595 227.17525 C12H23N2O2 −3.08131
340.26002 340.25909 C18H34N3O3 −2.73320
Figure 5. Time development of the formation of photodegradation products of AFB1 in peanut oil.
2.3. Proposed Pathway of AFB1 under UV Irradiation in Peanut Oil
From the above results and discussion, the possible photodegradation pathway of AFB1 in peanut
oil was proposed, which was based on the identified chemical structure of the photodegradation
products and shown in Figure 6. Because there are kinds of compounds such as proteins, amino
acids, polyphenols, and other small molecule compounds in peanut oil [18,19], the photodegradation
pathways of AFB1 in peanut oil might be complicated and accompanied by some complex chemical
reactions. As shown in Figure 6, it can be deduced that AFB1 might lose the C=O of the lactone ring
and become to C16H14O4 firstly, because the lactone ring was the active site of AFB1 [20]. Then, the
additional reaction and substitution reaction of small molecules such as R-NH2 and -NH2, which may
due to the fact that the concomitant cracking reactions of the nitrogen-containing compound in the
peanut oil under UV irradiation occurred on the unsatisfied chemical double bond on the furan ring
and the right side five-membered ring of C16H14O4, while the OH groups had been replaced by NH2.
Moreover, the H addition reaction definitely occurred on C=O [21]. After these complex reactions,
the structure of C19H33N3O4 was formed. Thus, the P1 (C18H33N3O3) may be the metabolites of
C19H33N3O4 after dropping the methoxy group (OCH3) under UV irradiation. Finally, as a result of
the cracking of the five-membered ring in the middle of the compound of P1, the compound of P2
(C12H22N2O2, molecular weight: 226) formed. Although the proposed photodegradation pathway of
AFB1 in peanut oil was on the base of photochemical principles and identified structural formulas, the
detailed and comprehensive degradation pathway need to be proved further in a future study.
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Figure 6. Possible photodegradation pathway of AFB1 in peanut oil under 365 nm UV irradiation in
this study.
2.4. Cell Viability Assay of AFB1 and Its Photodegradation Products
In order to investigate the toxicity and hazard of photodegradation of AFB1 after UV irradiation,
the viabilities of human embryo hepatocytes (L-02 liver cells) were assessed using the MTT assay
and the CCK-8 assay. As shown in Figure 7a, it can be seen that the consequences of the MTT and
CCK-8 assays were similar, and the viability of L-02 liver cells decreased in a linear relation with
increasing concentrations of AFB1 from 48 to 128 ppb after incubation for 24 h. The cell viability treated
by the concentration of AFB1 at 128 ppb decreased more significantly than that of other samples.
Compared with a blank control trial, the cell viability of L-02 liver cells was reduced by about 40% after
incubation at a concentration of 128 ppb. However, the loss of cell viability of irradiated samples at the
same concentration was significantly decreased compared with that of samples without irradiation
treatment, which indicated that the toxicity of the degradation products of AFB1 in peanut oil lowered
after UV irradiation. Moreover, it can be seen from Figure 7b that the mortality rates of L-02 liver cells
was time-dependent in the presence of AFB1 while the mortality rates of L-02 liver cells had no obvious
changes with time in the presence of the photodegradation products of AFB1, and the mortality rate of
L-02 liver cells in the presence of AFB1 was up to 70% for 48 h. This investigation further confirmed
that the cytotoxicity of AFB1 was significantly reduced after UV irradiation, which may be due to the
changes in the molecular structure of AFB1. In this present study, the MS/MS date expounded that P1
(C18H33N3O3) and P2 (C12H22N2O2) were formed after the removal of the double bond in the terminal
furan ring and the modification or splitting decomposition of the lactone ring, which may be the main
reason for the decrease in toxicity after UV irradiation. Moreover, it is well known that the structure of
AFB1 contained a lactone ring and a furan moiety, and the double bond in the terminal furan ring was
the key active site for its toxic and carcinogenic activities [22–24]. This viewpoint is also confirmed
by a previous study that the toxicity of radiolytic products was significantly reduced compared with
that of AFB1 because of the addition reaction that occurred on the double bond in the terminal furan
ring [25]. Lee et al. found that the lactone ring played a significant role in the fluorescence of AFB1,
and the AFB1 without the lactone ring became non-florescent with a subsequent decline in toxicity [26].
Therefore, it could be deduced that, due to the reaction on the double bond of the terminal furan ring
and the lactone ring for AFB1 in this study, the toxicity of the two degradation products decreased
after UV irradiation treatment compared with that of AFB1.
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(a) (b)
Figure 7. Cell viability assay of AFB1 and its photodegradation products. (a) The effect of different
concentrations of AFB1 and the same initial concentrations of its photodegradation products in peanut
oil on L-02 liver cells viability evaluated by the MTT and CCK-8 assay. (b) L-02 liver cells viability
exposed to 128 ppb AFB1 and the same concentration photodegradation products for 0, 24, and 48 h
evaluated by the CCK-8 assay.
3. Conclusions
To our knowledge, this is the first report to demonstrate the proposed degradation products
and pathway of AFB1 in peanuts oil under UV irradiation. The products of AFB1 in peanut
oil under UV irradiation were extracted by methyl alcohol and deionized water and analyzed
by UPLC-TQEF-MS/MS. It was found that two photodegradation products (P1:C18H33N3O3 and
P2:C12H22N2O2) were formed. Moreover, reactions of photodegradation mainly occurred on the
terminal furan ring and the lactone ring, which were the primary toxicological sites of AFB1.
After the resolution of accurate mass spectra and a comparison of UPLC spectra at different times
during irradiation, the metabolic pathways of AFB1 in peanut oil were proposed. In addition, the
toxicity assessment of degradation products through a human embryo hepatocytes viability assay
revealed that the toxicity of degradation products decreased significantly compared with that of
AFB1, which reaffirmed that the reactions occurred on the primary toxicological sites of AFB1 under
irradiation. The present findings could provide a new idea and means for future studies on metabolic
pathways and toxicity assessments of hazardous substances in foodstuffs.
4. Materials and Methods
4.1. Materials and Synthesis
AFB1 (2, 3, 6α, 9α-tetrahydro-4-methoxycyclopenta [c] furo [2, 3:45] furo [2, 3-h] chromene-1,
11-dione; purity >98%) was obtained from Sigma (Sigma-Aldrich, St. Louis, MO, USA). Methyl alcohol,
dimethyl sulfoxide (DMSO), and other reagents are analytical reagents and purchased from Sinopharm
(Sinopharm Chemical Reagent Co., Ltd., Shanghai, China) Peanut oil was purchased from Wal-Mart
supermarket in Wuhan, China.
For high-performance liquid chromatography (HPLC) and TQEF-MS/MS analysis, chromatographic
grade acetonitrile and methyl alcohol were purchased from Sigma (St. Louis, MO, USA). The deionized
water was obtained from a Milli-Q SP Reagent Water system (Millipore, Bedford, MA, USA).
For cytotoxicity tests, human embryo hepatocytes (L-02 cells) were purchased from Procell (Procell
Co. Ltd., Wuhan, China). Culture medium RPMI-1640 and fetal calf serum were purchased from
HyClone ((GE-Healthcare, Logan, UT, USA). The 0.05% trypsin solution was from Thermo Fisher
(Thermo Fisher Scientific, Waltham, MA, USA).
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4.2. Photodegradation Treatment
For UV degradation experiments, 20 g of peanut oil with different initial concentrations of
48 ppb, 68 ppb, 88 ppb, 108 ppb, and 128 ppb AFB1 were put in glass petri dishes and irradiated
under a 100 W ultraviolet lamp (λ = 365 nm, 55–60 mw/cm2, Changzhou YuYu Electro-Optical
Device Co., Ltd., Changzhou, China). The photoreaction was performed in a close reaction box in a
temperature-controlled room, and temperature was kept at 26 ◦C. The distance between the UV lamp
and the peanut oil was 40 cm. At certain selected time intervals, irradiated samples were collected
and analyzed via HPLC (Agilent 1100, Agilent Technologies, Santa Clara, CA, USA). Each test was
repeated five times.
4.2.1. Extraction and Instrumental Analysis for AFB1 in Peanut Oil
A total of 2.5 g of peanut oil was weighed after UV treatment in a 50 mL centrifuge tube,
and 7.5 mL of acetonitrile was then added. The mixture was shaken for 5 min with a platform shaker
at room temperature and extracted by sonicator (Nanjing Jiancheng Bioengineering Institute, Nanjing,
China) for 10 min. Then, the mixture was centrifuged at 7000 rpm for 15 min, and the precipitate was
discarded. A 1.5 mL supernatant with 4 mL of deionized water was collected in a clean test tube. Then,
the above mixture was filtered through a 0.22 μm organic ultra-filter membrane (Agilent Technologies,
Santa Clara, CA, USA). The filtrate was passed through immunoaffinity columns and washed with
1 mL of methyl alcohol into a glass tube.
HPLC-FLD analysis was performed on an Agilent 1100 system equipped with a fluorescence
detector, an auto-injector, and a quaternary solvent-delivery system. The chromatographic column
was a 150 mm × 4.6 mm Agilent C18 column (Agilent Technologies, Santa Clara, CA, USA) with
a 5 μm particle size. The injection volume was 10 μL. The mobile phases were methyl alcohol (A) and
aqueous solution (B) in a 45:55 (VA/VB) solution with a flow rate of 0.7 mL·min−1. The detection of
the excitation and emission wavelengths were at 360 nm and 440 nm, respectively
4.2.2. Test Compounds of Photodegradation Products
The mixtures of photodegradation products in peanut oil was extracted by a methyl alcohol-water
solution with a volume ratio of 10:90, and then passed through a 0.22 μm organic ultrafilter membrane
(Agilent Technologies, Santa Clara, CA, USA) into a glass tube.
The samples were analyzed and recorded by Ultra Performance Liquid Chromatograph-Thermo
Quadrupole Exactive Focus mass spectrometry/mass spectrometry (UPLC-TQEF-MS/MS, Thermo
Fisher Scientific, Waltham, MA, USA). UPLC was performed on a Thermo system with a quaternary
solvent-delivery system and an autosampler. The injection volume was 10 μL. The chromatographic
column was presented on a 100 mm × 2.1 mm Thermo C18 column (Thermo Fisher Scientific, Waltham,
MA, USA) with a particle size of 5 μm. The mobile phase was a gradient prepared from acetonitrile
(A) and a 0.2% formic acid aqueous solution (B). The elution began with 5% A for 0.1 min, and the
proportion of A was increased linearly to 100% at 36 min, and then brought back to 5% A at 40 min
and kept for 5 min for a total of 45 min. The flow rate of the mobile phase was kept at 200 μL·min−1.
Mass spectrometry was performed on a Thermo Quadrupole Exactive Focus (QEF) system
(Thermo Fisher Scientific, Waltham, MA, USA). The products were analyzed under positive-ion (PI)
mode. The optimized conditions were Sheath gas 35 L·min−1, Aux gas (Ar) 5 L·min−1, and capillary
potentials at 3000 kV. The QEF instrument was operated in full scan mode, and data were collected
between m/z = 50 and 500, with a scan accumulation time of 0.2 s. The MS/MS experiments were
performed using a collision energy of 35 eV, which was optimized for each product.
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4.3. Cell Viability Assay
4.3.1. Cell Culture
L-02 liver cells were serially cultivated in the RPMI-1640 complete medium (15% v/v fetal calf
serum, 100 U/mL penicillin, 100 U/mL streptomycin) at 37 ◦C, with 4% CO2 in air until an 80% degree
of fusion was reached, and then incubated with DMSO, in which the final concentration of DMSO was
less than 0.1%.
4.3.2. Cell Viability Assay
A total of 1 × 103 cells were seeded in a 96-well plate, allowing the attachment of cells to the
substrate for 6–8 h, and the cells were then divided into different groups (six wells per group). For the
sample of photodegradation products, the methyl alcohol-water solution with a volume ratio of 10:90
was used to extract the products of AFB1 in peanut oil after UV irradiation, and the products were
then evaporated under a stream of nitrogen and then collected in DMSO for cell viability assay. Cells
were exposed to different concentrations of AFB1, photodegradation products of AFB1 and DMSO
were used as a control, and cultivation continued for 24 h and 48 h. Cell viability was determined
with a MTT assay and a CCK-8 assay. In brief, for the MTT method, 20 μL of 5 mg·mL−1 MTT in PBS
buffer solution was added to each well, and the plate was incubated at 37 ◦C for 4 h. After incubation,
the medium was then discarded, and the formed crystals were dissolved in 150 μL of DMSO. The
absorbance of each well was then measured at 490 nm using a microplate reader (SpectraMax M2e,
Molecular Devices, Sunnyvale, CA, USA), and the percentage viability was calculated. Moreover, for
the CCK-8 assay, 10 μL of the CCK-8 solution was added to each well, and the plate was incubated
at 37 ◦C for 4 h. After incubation, the absorbance of each well was measured at 450 nm using a
microplate reader (SpectraMax M2e, Molecular Devices, Sunnyvale, CA, USA), and the percentage
viability was calculated.
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Abstract: Mycotoxins are secondary metabolites produced by several filamentous fungi, which
frequently contaminate our food, and can result in human diseases affecting vital systems such as
the nervous and immune systems. They can also trigger various forms of cancer. Intensive food
production is contributing to incorrect handling, transport and storage of the food, resulting in
increased levels of mycotoxin contamination. Mycotoxins are structurally very diverse molecules
necessitating versatile food decontamination approaches, which are grouped into physical, chemical
and biological techniques. In this review, a new and promising approach involving the use of cold
atmospheric pressure plasma is considered, which may overcome multiple weaknesses associated
with the classical methods. In addition to its mycotoxin destruction efficiency, cold atmospheric
pressure plasma is cost effective, ecologically neutral and has a negligible effect on the quality of food
products following treatment in comparison to classical methods.
Keywords: cold atmospheric pressure plasma technology; mycotoxins; physical decontamination;
chemical decontamination; biological decontamination
1. Introduction
Many species of filamentous fungi have the ability to produce toxic secondary metabolites known
as mycotoxins. The term mycotoxin is used only for toxic substances produced by fungi related to
food products and animal feed; it does not include toxins produced by mushrooms [1]. Today, about
400 structurally different mycotoxins have been discovered and divided into the following main
groups: (i) aflatoxins produced by Aspergillus species and ochratoxins produced by both Aspergillus
and Penicillium species; (ii) trichothecenes, zearalenone and fumonisins produced by Fusarium species;
and (iii) ergot alkaloids, produced by Claviceps species, and others [2]. Generally, mycotoxins represent
a significant threat to human health as they can be carcinogenic, neurotoxic and toxic to the endocrine
or immune system [3]. They can appear in the food chain due to infected crops, which are either
consumed directly by humans or used as livestock feed, appearing in meat, milk or eggs. Beside this,
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they can contaminate food such as cereals, fruits, nuts, spices and other by-products as seen from
Table 1 [4].
Table 1. Overview of the main characteristics of the most important mycotoxins.
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Today, the trend of mycotoxins food contamination is increasing to alarming values with 25%
of cereals worldwide already unsuitable for consumption [5]. Undesirable fungal growth and
mycotoxin production is usually a result of incorrect agricultural and harvesting practices as well
as the low effectiveness of prevention methods [3]. To reduce the potential danger to human
health, many countries worldwide adopted strict legislation to control the mycotoxin presence
in food and feed. In European Union, the presence of mycotoxins in food and feed is regulated
by Regulation (EC) No 1881/2006, Directive 2002/32/EC, Recommendations 2006/576/EC and
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2013/165/EU, and their amendments [6–9]. On top of this, recent studies have revealed a correlation
between the increased presence of mycotoxins and global climate change [10]. Parameters including
elevated temperatures, moisture levels and plant stress-related response stimulate fungal growth and,
consequently, production of mycotoxins [10–13]. Furthermore, climate change plays a significant role
in the global economy, where food is transported over long distances from producer to consumer, and
may be subject to different local climates, transport and prolonged storage times. All these factors may
contribute to increased food contamination [14].
Looking forward, it is expected that by the year 2050 the human population will exceed
9.2 billion. This will place an additional and unprecedented burden on the global food supply chain.
The combination of modified climatic conditions and a tendency for consumers to eat healthier and
fresher foods makes it imperative that new, sustainable and more effective approaches in agriculture,
processing, transportation, and storage methods are developed. New mycotoxin-decontamination
technologies will play a role in all stages of the supply chain. Beside this, the novel methods will have
to preserve the quality of food products, be environmentally benign and economically suitable [14].
Considering the above-mentioned requirements, cold plasma technology represents a promising
non-thermal mycotoxin-decontamination approach. Plasma is generally known as the fourth state
of matter; a plasma state is reached by increasing the energy level of a substance from a solid state
through the liquid and gaseous states of matter, ending in an ionized state of gas, which has unique
physical and chemical properties (Figure 1) [15]. In electrically created plasmas, energy is delivered
in the form of an electric field from an electrical power source; seed electrons produced by UV or
background radiation are accelerated by the applied electric field leading to the excitation, dissociation
or ionization of the background gas. Ionization, caused by the collision of an energetic electron with
a neutral atom or molecule, results in the production of further electrons which are also accelerated in
electric field. These free and energetic electrons subsequently collide with other surrounding molecules
and atoms present in the gas, resulting in an avalanche process. Through the simultaneous generation
and interaction among electrons, neutrals, metastables and ions, a vast number of reactions occur,
yielding a wide variety of reactive chemical species [16,17]. In complex gas mixtures, such as humid
air, a large number of reactive chemical species are created which take part in many hundreds of
reactions [18]. In addition, molecules or atoms in an exited state can emit photons with wavelengths in
the UVC, UVB and UVA range [19].
Figure 1. The generation of plasma: by adding energy to material, gas of electrons and ions is eventually
produced. This fourth state of matter is referred to as “plasma”.
Plasma can be produced under low pressure or even atmospheric pressure conditions. Typically,
low-pressure plasma systems require a discharge generator, a gas source and an expensive vacuum
system, consisting of pumps and vacuum chamber. Such systems are widely used for applications
in material processing. Nevertheless, they are not suitable for materials sensitive to low-pressure
conditions including biological material [17]. The use of atmospheric pressure plasma avoids the
disadvantages of vacuum systems and enables the treatment of biological materials. Common examples
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of atmospheric pressure plasma systems include arc, corona and dielectric barrier discharges [20].
The most perspective discharges for the treatment of biological materials are those that are in thermal
non-equilibrium, having a gas temperature that is close to room temperature, and are typically
referred to as cold plasmas. Recent developments in cold atmospheric pressure plasma (CAP) sources
and the ability to tailor discharges to produce highly reactive species in high concentrations, but
at temperatures close to room temperature, have paved the way for a wide number of biological
applications. Such CAPs are also suitable for use in electronics, surface modifications in polymer
and textile industry, synthesis of nanoparticles and degradation of pollutants [21]. The new findings
and developments in plasma science through the last decade reveal the great potential of CAP as
an innovative technology in the field of biology, moving from the treatment of inanimate materials
to living or cellular objects. Such applications include CAP treatments in medicine as well as in
agriculture and the food industry. In the area of plasma medicine, research is mostly focused towards
CAP use for skin treatment and wound healing, cancer cell and tumour treatment, dental implant
sterilization, bone growth and many others [22].
CAP technology is, on the other hand, a newcomer to the field of agriculture and food industry.
The main advantage of the CAP treatment of food products refers to its high chemical reactivity, achieved
through the reactive species generated, and consequently its ability to deactivate harmful agents such
as pathogenic bacteria and toxic pollutants in short processing times and at low temperatures with
almost negligible impact on the treated food products. The technology can be applied to different
types of food products in both solid and liquid form. In addition, the low energy consumption of such
discharges and price-value inputs contribute to CAP being considered as an economically acceptable
method [16,21,23,24]. Considering this, CAP technology also has a high potential as a decontamination
tool for both mycotoxin-producing fungi and the mycotoxins that they produce. Different set-ups in
both low and atmospheric pressure conditions have been used on mycotoxins such as aflatoxin B1,
deoxynivalenol and nivalenol (AFB1, DON, and NIV, respectively) resulting in high decontamination
rates in only a matter of seconds [25–27]. Treatments of the mycotoxin-producing fungi, e.g., one of
the main mycotoxin producers Aspergillus spp. and Penicillium spp., with plasma, demonstrated very
promising results as well. Plasma was able to stop or significantly reduce the further growth of fungi on
different contaminated food products including corn, bean, cereals, fruits, nuts and many others [28–33].
Perhaps even more importantly, plasma treatments did not significantly influence the organoleptic
characteristics of the treated foods or their nutritional properties [27,33–35]. Despite promising results,
the use of CAP in the field of mycotoxin decontamination needs further exploration to uncover the
CAP-related decontamination chemical processes and to develop optimised plasma systems suitable
to meet the requirements of food processing and safety.
The aim of this contribution is to critically review plasma technology as a new food processing
approach in the field of mycotoxin decontamination. The main advantages of this method over the
classical mycotoxin-decontamination methods are considered and compared.
2. The Background of CAP Decontamination in Agriculture and Food Industry
A key benefit of the use of CAP technology in the field of agriculture and food is its high
decontamination efficiency, which can be achieved in short treatment times and in non-thermal
conditions. Its applicability has been widely demonstrated by successful decontamination of
food with bacterial pathogens (Escherichia coli, Salmonella typhimurium, Staphylococcus aureus,
Listeria monocytogenes, etc.) and harmful compounds (phenolic compounds, pesticides, azo dyes,
etc.) [21,35–43]. The mechanisms of CAP decontamination are attributed primarily to the highly
reactive oxygen and nitrogen species (ROS and RNS) created within the plasma as well as UV radiation,
which induce highly oxidizing effects [22,24,44–46].
The prevalent primary species in an air plasma include radicals such as OH•, H•, O•, and NO.
These radicals can react with each other, and with the ambient/background gas (air), vapour or even
liquids, where they create oxygen- and nitrogen-based secondary species such as H2O2, NOx, O3,
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NO2−, NO3−, peroxynitrite, etc. These plasma species can be divided into short- and long-lived
species depending on their lifetime [18]. Long-lived species can also exist after the plasma source is
removed or turned off resulting in post-discharge reactions, which is named the plasma afterglow [44].
The importance of these species can be observed after primary interaction such as in the case of living
cells, where these species first react with the cell plasma membrane, and later can enter the cell and
cause damage to intercellular elements, such as organelles and biomolecules such as DNA, RNA
and proteins. Similarly, when toxic compounds are exposed to the ROS and RNS produced in the
plasma, they are decomposed directly or indirectly through secondary chemical processes with the
transformation of toxic substances into less toxic reaction products (Figure 2) [47].
Figure 2. (a) Scheme of an air surface dielectric barrier (SDB) CAP set up; and (b) photo showing the
CAP SDB system used in the presented experiments.
Among all plasma species, many studies have highlighted the key role played by atomic Oxygen
(O), hydroxyl radical (OH•), ozone (O3), hydrogen peroxide (H2O2) and peroxynitrite in CAP-related
decontamination effects, since they all possess a very high oxidative potential. In biological systems
such as bacterial and fungal cells, the short-lived O and OH• first react with cell walls and membranes
and with all the compounds composing these two structures (lipids, proteins and polysaccharides).
The lipids are the most sensitive to oxidation. The mechanism of OH• reaction with lipids refers to its
H-abstraction from the unsaturated carbon bonds of the fatty acids, ending in lipid peroxidation [44].
O3 is also a powerful oxidant; ozonation alone represents one of the most potent sanitizing and
detoxifying approaches in the food industry and mycotoxin decontamination. O3 has high reactivity,
penetrability, and spontaneous decomposition into non-toxic oxygen without forming harmful oxygen
species. Compared to OH•, O3 induced reaction kinetics are slower [48]. In addition, the antimicrobial
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activity of H2O2 is well explored. Generally, cytotoxicity caused by H2O2 begins with penetration into
cells and then transformation to OH• through Fenton’s reaction causing intercellular damage [49].
Peroxynitrite has recently been the object of many studies as it has been found to play an important role
in oxidative stress and various diseases (neurodegenerative diseases, AIDS, arteriosclerosis, etc.) [50].
It oxidizes biomolecules directly or through H+- or CO2-catalysed homolysis. As for direct reactivity,
it has affinity on key parts in proteins such as thiols, iron/sulphur centres, and zinc fingers. The lifetime
of peroxynitrite is relatively short, nonetheless, it can still cross membranes and reach deep within the
cell, which allows it to interact with most of the important biomolecules [51,52]. Regarding the CAP
decontamination of toxic compounds, OH• as one of the strongest oxidative species initiates the toxic
molecule oxidation, resulting in its degradation. However, other slower reaction pathways such as
those caused by O3 and H2O2 are shunted or even bypassed [43].
Plasma species production strongly depends on the CAP system design and its mode of operation.
When building a plasma system for food processing, there is a wide range of operating or so-called
discharge parameters to choose from, including different gasses (air, O2, N2, He, Ar, etc.) and gas
flows, discharge types, discharge volumes, electrode setups, etc. The discharge can be generated
using high-voltage electrical power sources or intense laser light [46]. In general, these systems can
be divided into three groups defined by the position of the treated food product with respect to the
point of plasma generation: at some significant distance from the generation point, relatively close
to generation point or within the plasma discharge itself. With a change in position of the sample
with respect to the plasma, the nature and flux of chemical species varies significantly and result in
different surface effects [53]. The first category refers to remote treatment with CAP where the sample
is physically separated from the plasma generation point. In this scenario, the plasma generated
species are usually transported to the sample by diffusion or by an induced flow. By the time plasma
species reach the targeted surface, they are mostly composed of longer-lived plasma species, with
a negligible concentration of highly reactive species (Figure 3a) [54]. The second category of system
enables a semi-direct treatment with CAP. Then the target is exposed to higher concentrations of
short-lived and highly reactive chemical species due to the relatively short distance between plasma
generation point and substrate. In this scenario, the flux of UV photons reaching the targeted surface
is also relatively high (Figure 3b) [55]. The last category is known as a direct contact system where
the sample is placed between the electrodes of the plasma generation system and is consequently
bombarded by large fluxes of reactive species and UV light (Figure 3c) [56,57]. While direct treatment
should offer the highest possible degradation and decontamination efficacy, its implementation is
problematic. The sample forms part of the electrical circuit and its presence can disrupt the discharge
leading to the formation of hot spots that can damage the product.
Figure 3. Schematic overview of common CAP systems considered for use in the food industry:
(a) remote treatment where the sample is physically separated from the plasma generation point
(b) semi-direct exposure, where the sample is placed close to the plasma generating electrodes; and
(c) direct-exposure, where the sample is positioned between the plasma generating electrodes.
A wide range of design elements and discharge parameters enable a high degree of flexibility
when designing CAP systems for food processing purposes no matter the type, size, and shape
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of the treated food products [58]. In terms of mycotoxin removal, plasma technology has mostly
been used for the treatment of seeds, cereals, crops and fresh products [30,34,58,59]. For example,
the use of an atmospheric pressure fluidized bed plasma system with air and nitrogen as a feed gas,
which was used for the inactivation of A. flavus and A. parasiticus contaminated maize resulting in
a 5.48 log reduction [28]. Furthermore, the production of fumonisin B2 and ochratoxin A (FB2 and OTA,
respectively) was inhibited after the exposure of A. niger on date palm fruits to an argon CAP source.
Oxygen CAP was applied for the treatment of C. cladosporioides and P. citrinum on the surface of dried
filefish fillets reducing the fungi by more than 90% [33]. Moreover, argon and oxygen CAP proved to be
efficient against A. brasiliensis contaminating pistachios [60]. Siciliano et al. performed CAP treatment
with different mixtures of oxygen and nitrogen for decontamination of AFB1 from dehulled hazelnuts
succeeding 70% decontamination rate [27]. One of the most interesting CAP applications is also the
in-package treatment of food. In this scenario, strawberries were treated with CAP generated between
the electrode gap and inside a sealed package. The background microflora containing fungal species
was reduced by 2 log reduction which could significantly prolong the food product expiry date [35].
3. The Comparison of “Classic” Approaches and CAP Technology in the Field of
Mycotoxin Decontamination
Actions for preventing the fungal and mycotoxin contamination of feedstuff are performed at
critical points before the expected fungal infestation. This may occur at the pre-harvest stage, during
the harvest-time or at the post-harvest handling and storage stages [61]. The most effective approach is
primary prevention, which should be carried out before the fungal invasion and mycotoxin production
occurs. Current approaches include the use of fungicides to inhibit fungal growth, an appropriate
scheduling of harvesting, and maintaining the optimum storage conditions after harvest [62,63].
Unfortunately, such techniques are not entirely effective and the efficiency of fungicides varies
for different fungal species [64]. For this reason, several recent approaches have focused on the
development of fungi-resistant plants [65]. The various physical, chemical and biological methods for
the reduction of mycotoxin contamination currently in use or under active investigation for food and
feed products are reviewed below, and compared with CAP technology (Figure 4) [61].
Figure 4. Overview of the currently available mycotoxin prevention and decontamination measures
taken before and after fungal and mycotoxin contamination of food.
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Methods for the physical decontamination of contaminated food are typically divided into
traditional measures and novel non-thermal methods. The first group refers to methods that include
sorting, washing, dehulling, density segregation, grain milling and thermal treatment. The principle
of their decontamination is mostly based on the removal of the contaminated food parts and
consequently the mycotoxins [66]. On the contrary, thermal treatment causes thermal degradation
of mycotoxins [67–69]. Most of the traditional methods can reach satisfying decontamination rates
for different types of toxins [2,70]. However, the processing time is usually very long, requiring high
energy input, and is therefore very expensive. In addition, heat treatment can significantly affect the
quality of the treated food products [61]. For these reasons, the food industry is looking to further
develop new non-thermal approaches such as UV- and gamma-irradiation, pulsed-light treatment as
well as CAP technology. Non-thermal methods typically affect the chemical structure of the mycotoxins
leading to their degradation. Their decontamination efficiency depends on the presence of water in
the treated food products, the extent of mycotoxin contamination, and the intensity of exposure [66].
For gamma irradiation technology, it has been reported that the decontamination of various mycotoxins
was significantly more successful when they were present in solution, reaching up to 90% removal
rate. The dosages of gamma irradiation used were from 1 to 20 kGy. Degradation in this case was
probably a result of the formation of free radicals which were produced by the radiolysis of water.
On the contrary, gamma irradiation decontamination of the mycotoxin-contaminated solids and dry
food products in conditions with low moisture values was notably less effective [71]. High doses of
gamma irradiation could, however, negatively affect the quality of food products such as grains and
seeds, reducing their germination ability for example [72]. UV light irradiation also demonstrated high
efficiency in mycotoxin decontamination. Treatments using a wavelength of 365 nm were capable of
reducing the content of aflatoxins (AFs) from various types of nuts by more than 90% [73]. The 365 nm
light irradiation was capable of removing the AFB1 in peanut oil almost completely. Moreover,
toxicity tests employing human embryo hepatocytes showed a significant reduction of toxicity of
the degradation products [74]. When an AFB1 aqueous solution underwent the UV light irradiation
treatment, three major degradation products were observed (Table 2). It was indicated that the UV
light irradiation probably interacted with most of the active sites on AFB1, i.e., C8-C9 and O1-C14
bonds. These two bonds have been recognized as being responsible for the AFB1 toxicity and were
transformed to more stable saturated bonds [75]. Interestingly, the structure of AFB1 degradation
products depended significantly on the media. Different degradation products were identified when
the treatment was performed in acetonitrile or in peanut oil solution (Table 2) [74,76]. UV light
irradiation was also used for patulin (PAT)-contaminated apple juice. Performed at 222 nm, a 90%
reduction of mycotoxin content was achieved. However, such treatments lowered the concentration
of some other photosensitive substances in the juice, including healthy ascorbic acid [77]. Similar to
UV light irradiation, Moreau et al. studied mycotoxin, OTA, ZEN, DON or AFB1, decontamination
with pulsed light. The light flashes used were 300 μs in duration with a broad spectrum of light
ranging from 180 to 1100 nm and a light flux 1 J/cm2. The analysis demonstrated that eight light
flashes almost completely removed mycotoxins from the solution. Remaining toxicity was assessed
on nematode Caenhorhabditis elegans. Degradation products of DON and ZEN were evaluated as not
toxic. The mutagenic activity based on an Ames test showed that AFB1 degradation products were not
mutagenic [78]. In a recent study, a pulsed light system of 0.52 J/cm2/pulse and 360 μs long flashes,
with wavelengths ranging from 100 to 1100 nm were used to decontaminate AFB1 and aflatoxin B2
(AFB2) on different rice products. Decontamination efficiency higher than 90% was achieved for AFB1
after 15 s of treatment in the case of rice bran [79].
An alternate detoxification strategy employs chemical agents, which are able to detoxify
mycotoxins when added to a contaminated feedstuff. The effect is achieved by many synthetic
and naturally occurring compounds including various organic acids, ammonium hydroxide, calcium
hydroxide mono-methylamine, hydrochloric acid, hydrogen peroxide, bisulphite, chlorinating agents,
formaldehyde, ammonia, clove oil and many more [63]. Ammoniation is conventionally used for AFs
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decontamination of feed such as cottonseed and peanut meal. The effectiveness of detoxification with
ammonia increases with the quantity of ammonia used, the time of treatment, the temperature and
pressure level [80]. Many types of ammoniation are available, with the two most commonly used
being high-pressure/high-temperature treatment and atmospheric pressure/moderate temperature
treatment. Both methods are able to reduce mycotoxin content up to 90%. For example, the degradation
of AFB1 by ammoniation is accomplished by hydrolysis of the lactone ring, which is followed by
decarboxylation to AFD1 and subsequent loss of cyclopentane ring (Table 2) [81–83]. Ozonation is
a rather new way of mycotoxin decontamination in food processing [48]. When AF-contaminated corn
flour was exposed to 75 mg/L of ozone for 60 min, the content of AFB1, aflatoxin G1 (AFG1) and AFB2
decreased from 53.60, 12.08 and 2.42 μg/kg to 11.38, 3.37 and 0.71 μg/kg, respectively [84]. In another
study, 89.4% decomposition of AFB1 was achieved after AFB1-contaminated peanuts exposure to
ozone of 50 mg/L at a flow rate of 5 L/min for 60 min. Following this results, the two most probable
AFB1-degradation pathways were proposed. In the first, the ozone initially reacts with a C8-C9
double bond of the furan ring in AFB1 in electrophilic reaction based on Criegee mechanism, whereas
the second degradation pathway starts with oxidation of the AFB1 benzene methoxy group. Both
reaction pathways lead to five final degradation products (Table 2). Generally, the toxicity of most
degradation products is reduced under the assumption that a C8-C9 double bond represents one of the
sites responsible for toxicity of AFB1 [85]. Wang et al. used ozone to achieve a reduction in toxicity of
DON contaminating wheat grains. After 60 min of 100 mg/L ozone treatment, the concentration of
DON decreased from 3.89 mg/kg to 0.83 mg/kg, which is under the generally recognized maximum
mycotoxin limit in feed [86]. Another method of chemical mycotoxin decontamination is the use of
feed additives. These inorganic and organic mycotoxin binders are added to a feedstock when there
is an indication of mycotoxin contamination. Typical additives include clays as natural mycotoxin
adsorbents made of silicates or aluminosilicates. The level of adsorption of mycotoxins depends on
the size and the charge of the mycotoxin with regard to the specific structure of the clay used [61].
The majority of clays are able to bind AFs, but not ZEN, fumonisins and trichothecenes, when added
at a concentration of 10 g/kg [87,88]. On the other hand, bentonite was able to adsorb T-2 toxin,
but to achieve high binding efficiency much more than 10 g of adsorbent per kg had to be used [89].
Inconveniently, clays are also able to adsorb the micronutrients from feed and disturb the bioavailability
of minerals and trace elements. Furthermore, the contamination of clays with dioxins is possible [90].
As the inorganic adsorbents proved to be inefficient removers of the majority of mycotoxins, natural
eco-friendly organic binders have been introduced instead, including oath fibres and cell extracts
of lactic acid bacteria and Saccharomyces cerevisiae [91,92]. The decontamination of food by chemical
means may be inexpensive and can achieve good decontamination results; however, most of these
methods can present a risk for the environment as well as for human health. A further disadvantage is
the long treatment time, which is not good for preservation of high quality foods.
The final category of mycotoxin decontamination measures includes biological methods.
These procedures are based on the ability of microorganisms such as bacteria, yeast, moulds, actinomycetes
and algae to remove or degrade mycotoxins in food and feed products. A clear advantage of
biological decontamination approaches is that no chemicals are involved. The methods are based on
biological transformation, enzymatic degradation, or modification of mycotoxins to less toxic substances.
Mycotoxins can be thus acetylated, glucosylated, cleaved at their rings, hydrolysed, deaminated or
decarboxylated [93]. Microorganisms capable of mycotoxin detoxification include species such as
Bacillus spp., Brevibacterium spp., Pseudomonas spp., Rhodococcus erythropolis, Aspergillus spp., Rhizopus spp.
and Trichosporon mycotoxinivorans. They can efficiently detoxify a wide range of mycotoxins including
AFB1, AFG1, OTA, ZEN, PAT and DON [94–103]. In addition to reducing bioavailability of mycotoxins,
some microorganisms, e.g., probiotic bacteria, are frequently added to feed as an additive with positive
effect on the gut flora. The effectiveness of such microorganisms to act anti-mycotoxically largely
depends on their ability to remain stable in the gastrointestinal tract. The main representatives of this
group of bacteria are lactic acid bacteria [104]. Generally, biological approaches are not expensive
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and their environmental impact is low. Nevertheless, mycotoxin decontamination processes using
microorganisms can be quite time-consuming [93].
In comparison with the methods described previously, CAP mycotoxin decontamination of
food overcomes many of the disadvantages and obstacles of physical, chemical and microbial
decontamination procedures. As depicted in Table 3, most of the CAP systems used for decontamination
of food are environmentally benign, require a low energy input and are economically favourable.
Beside this, plasma approaches have proven to have a negligible effect on the quality of many types
of treated food. These advantages are based on the reactivity of the plasma species which enable
the high decontamination efficiency in a very short time compared to alternative decontamination
methods [46,53,105]. To demonstrate the efficiency of the plasma approach, a microwave-induced
atmospheric pressure plasma system was used with argon as a carrier gas to treat three different
mycotoxins, AFB1, DON, and NIV dried on glass coverslips. The treatment resulted in the complete
decontamination of all three mycotoxins after only 5 s of plasma exposure. Plasma treatment completely
eliminated their cytotoxicity as tested on mouse macrophage RAW264.7 cells in vitro [25]. Furthermore,
low-temperature radiofrequency plasma was used to degrade AFB1. After 10 min of treatment, 88.3%
AFB1 was degraded. Analysis of the degradation products indicated that the toxicity should be reduced
based on the structure-activity criteria; the degradation pathways indicated the formation of five
different decay products (Table 2), where plasma induced the loss of the double bond in the terminal
furan ring (C8-C9) [26]. AFs were exposed to a dielectric barrier discharge (DBD) plasma system,
resulting in the complete destruction of mycotoxins when they were treated alone. Using the same
plasma system, a 70% decontamination level was achieved for the treatment of AFB1 contaminated
dehulled hazelnuts [27]. To demonstrate the effectiveness of CAP, our recent experiments consider the
use of an air surface barrier discharge (SBD) plasma treatment compared with UV light irradiation or
thermal treatment in regards to AFB1-destruction efficiency. Standard solution of AFB1 was prepared
in the mixture of acetonitrile and deionized water (2:1). One hundred microlitres of AFB1 standard
solution was applied on the glass coverslips and dried for 5 min. Such wet samples were then exposed
to CAP, UVC light, or thermal treatment. CAP set-up was similar to the one reported by Ni et al. [40]
and was operated at three different discharge powers (Pd): low (10 W), medium (15 W) and high
(20 W). Low Pd operated plasma mostly contained ROS whereas RNS were the prevalent species at
high Pd conditions. Plasma was observed to achieve more than 80% destruction level after just 15 s
of treatment of AFB1 applied on, regardless of the Pd used. In contrast, no significant transformation
of AFB1 was observed under thermal or UV light treatments, even at the longest exposure times
(Figure 5). The ability of plasma to rapidly affect the AFB1 molecular structure was confirmed by
UV-Vis spectrometry. As evident from Figure 6, both major peaks in the UV-Vis spectra of AFB1
significantly changed after 8 min of exposure of AFB1 to plasma, independently of the Pd. On the
other hand, the AFB1 UV-Vis spectra remained almost the same following the UV or thermal treatment
for the same time period. UV light irradiation treatment is usually efficient in degrading only the
mycotoxin molecules, in particular AFs, which are known for their photosensitivity [74–76]. Beside
this, UV irradiation represents one of the most commonly used decontamination approaches in food
processing [106]. Comparing to CAP, to achieve adequate results, this method requires much longer
exposure times (more than 10 min compared to some seconds in the case of CAP). Here, it is worth
mentioning that UV requires higher power inputs which further impacts the decontamination efficiency.
In addition to the mentioned drawbacks, it has been reported that UV irradiation could even increase
the mutagenicity of AFs [107]. The characteristics of mycotoxin plasma treatment can be compared to
some extent with ozone treatment, since one of the prevalent plasma-produced long-lived molecular
species is ozone [108]. As many other reactive species beside ozone are produced in the plasma,
synergistic effects can occur, resulting in the mycotoxin decontamination of food requiring significantly
less exposure times than ozone alone [48,84,85]. Despite numerous advantages, CAP technology also
has some limitations. One of the major problems is an inability to precisely control the gas phase
chemistry when using ambient air, given that it varies with conditions in the surrounding atmosphere
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(for example increases in humidity). Since CAP contains ROS, it is not suitable for the treatment of
high-fat food products. Furthermore, when carried out using very high voltages, additional safety
measures are required as well as systems for the destruction and exhaust of potentially harmful
long-lived species such as O3 and NO2 [46].










































Thermal treatment 85–100% (FBs, ZEN, AFs) Corn Long High Significant [70,109,110]
Gamma irradiation 90% (mixture) Grains, seeds Short Low Significant [71]
UV light irradiation 90% (AFB1, PAT)
Peanut oil; apple
juice; Short Low Negligible [74,77]
Pulsed light
technology 90% (AFB1) Rice products Short Low Negligible [79]
Ammoniation 90–100% (AFB1) Rice Long High Significant [83]
Ozonation 80% (AFs) Corn flour,peanuts Long Low Negligible [84,85]
Bacillus spp. 92.5% (OTA) / Long Low Negligible-significant [111]
Rhodococcus
erythropolis 90% (AFB1) / Long Low Negligible [98]
Aspergillus spp. 100% (ZEN) / Long Low Negligible-significant [99]
Trichosporon
mycotoxinivorans 100% (OTA) Animal Feed Long Low Negligible [103]
Lactic acid bacteria 80–100% (FBs) / Long Low Negligible [112]
CAP technology 100% (AFs, DON, NIV) Seeds, crops,cereals Short Low Negligible [25,27]
Figure 5. Comparison of decontamination efficiency (%) of aflatoxin B1 (AFB1) between cold atmospheric
pressure plasma (CAP) and conventional decontamination approaches, UV light irradiation and thermal
treatment; and air surface barrier discharge (SBD) plasma operated with three different discharge
powers (Pd; low Pd, 10 W; med Pd, 15 W; and high Pd, 20 W). Ambient gas was used as a feed gas.
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Figure 6. The comparison of aflatoxin B1 (AFB1) UV-Vis spectra after 8 min of exposure to heat treatment,
UV irradiation and air surface barrier discharge (SBD) plasma operated with three different discharge
powers (Pd; low Pd, 10 W; med Pd, 15 W; and high Pd, 20 W). Ambient gas was used as a feed gas.
4. Conclusions
Mycotoxin contaminated food represents a significant and increasing threat to human health
and an enormous burden for the global economy. Decontamination methods to tackle this problem
are based on physical, chemical and biological principles. In spite of constant improvements, these
methods can still suffer from a lack of mycotoxin removal efficiency, they can be environmentally
harmful and economically unfavourable. With no doubt, the food industry continuously strives for
more effective mycotoxin decontamination approaches.
One of the most promising new procedures to deactivate mycotoxins on food is CAP technology.
On the laboratory level, it has been convincingly demonstrated that CAP efficiently kills fungi on the
surface of food and destroys the mycotoxins that these organisms secrete. In favour over many of
the traditional food decontamination methods, plasma-based decontamination methods are generally
lower-cost and ecologically benign. Most importantly, plasma-based mycotoxin decontamination of
food has been demonstrated significantly more efficient in both the mycotoxin degradation level and
speed of decontamination in comparison to conventional decontamination methods, as presented for
the case of one of the most toxic mycotoxins, AFB1.
Before industrialization of CAP technology can be realised, the molecular mechanisms and
kinetics of plasma-based mycotoxin decontamination should be better characterized in order to
become standardized. For this reason, additional experimental work is needed to:
- Draw firm correlations between different plasma operating parameters and the specific reactive
chemical species formed.
- Draw correlations between the composition of the plasma and the structure of the mycotoxin
degradation products. As toxicities of the mycotoxin degradation products can be experimentally
determined, in this way, the mycotoxin decontamination efficiency would be defined as well.
- Examine the effects of different plasma treatments on the quality of food products, for example
on their nutritional value and organoleptic qualities.
- Design plasma-forming systems for efficient mycotoxin decontamination of various types and
sizes of food products.
- Test if hybrid plasma-conventional systems for mycotoxin decontamination of food products can
be even more effective.
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Abstract: Different in vitro and in silico approaches from our research group have demonstrated that
neutral electrolyzed water (NEW) can be used to detoxify aflatoxins. The objective of this investigation
was to evaluate the ability of NEW to detoxify B-aflatoxins (AFB1 and AFB2) in contaminated maize
and to confirm detoxification in an in vivo experimental model. Batches of aflatoxin-contaminated
maize were detoxified with NEW and mixed in commercial feed. A total of 240 6-day-old female
large white Nicholas-700 turkey poults were randomly divided into four treatments of six replicates
each (10 turkeys per replicate), which were fed ad libitum for two weeks with the following dietary
treatments: (1) control feed containing aflatoxin-free maize (CONTROL); (2) feed containing the
aflatoxin-contaminated maize (AF); (3) feed containing the aflatoxin-contaminated maize detoxified
with NEW (AF + NEW); and (4) control feed containing aflatoxin-free maize treated with NEW (NEW).
Compared to the control groups, turkey poults of the AF group significantly reduced body weight
gain and increased feed conversion ratio and mortality rate; whereas turkey poults of the AF + NEW
group did not present significant differences on productive parameters. In addition, alterations
in serum biochemical constituents, enzyme activities, relative organ weight, gross morphological
changes and histopathological studies were significantly mitigated by the aflatoxin-detoxification
procedure. From these results, it is concluded that the treatment of aflatoxin-contaminated maize with
NEW provided reasonable protection against the effects caused by aflatoxins in young turkey poults.
Keywords: maize; aflatoxins; neutral electrolyzed water; detoxification; turkey
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1. Introduction
Among the many types of microorganisms that cause food-borne disease outbreaks, toxigenic
fungi and their products (mycotoxins) threaten the health and economy of the poultry industry by
contaminating feed materials [1–4]. Mycotoxins are widespread food and feed compounds capable
of causing innumerable damaging effects to humans and animals; these contaminants are a chemical
assemblage of fungal-originated toxins that may be found naturally in grains and cereal products.
Aflatoxins are a special group of mycotoxins compelling investigation due to their toxic, mutagenic,
teratogenic and carcinogenic potential. Some species of fungi of the Aspergillus genus, for instance
Aspergillus flavus and Aspergillus parasiticus, produce aflatoxins. These are secondary metabolites easily
found in fungal-contaminated peanuts, maize, pistachios and rice, among others, and include four
major structures: AFB1, AFB2, AFG1, and AFG2 [5–8].
Aflatoxins have been reported to cause severe economic losses in the poultry industry due to
their various health effects. Specific responses of aflatoxicosis include reduced growth performance,
increased relative pancreas weight, decreased relative liver weight, immunosuppression, hemorrhage,
alteration in digestion absorption, nutrient metabolism, serum enzyme activities, biochemical and
hematological values and possibly death [9,10]. Specifically, turkeys fed with aflatoxins rapidly
incorporate the metabolite in the small intestine, thus mainly damaging the liver. Reduction of
protein production, increase in hepatic enzyme activity and coagulopathies indicate fat degeneration
and proliferation of biliary ducts [11]. Turkey poults generally exhibit aflatoxicosis as erratic walk,
inappetence, reduced activity, anemia, and even death. Therefore, in the poultry industry, production
parameters such as body weight gain, feed consumption and mortality rate may be affected by aflatoxin
poisoning [12].
Developing strategies to detoxify mycotoxin contamination is crucial for the food and animal feed
industries. The best option to prevent mycotoxicosis is to avoid the use of contaminated materials,
followed by fungi disinfection [13,14], and finally inactivation of the mycotoxin. A diversified portfolio
of strategies to detoxify food and feed has been proposed to reduce the adverse effects of aflatoxin
contamination, including physical selection of the contaminated commodity, thermal inactivation,
irradiation and supplementation with nano-clay adsorbent, biological degradation by microbial
fermentation, and chemical treatment with acids, bases, organic solvents, and gases [1,15]. Many
control methods are impractical because they also alter the quality of the food and feed materials;
moreover, some of them are expensive and environmental unfriendly. Hence, research into safe and
effective alternatives of decontamination has gained much attention recently.
Electrolyzed oxidizing water (EOW) has notable biocidal activity mainly due to three
physicochemical properties: pH, oxidation-reduction potential (ORP) and available chlorine
concentration (ACC). EOW is produced by electrolysis of pure water added with sodium chloride in an
electrolysis apparatus. Water molecules and chloride ions are transformed into chlorine oxidants such
as hypochlorous acid (HOCl), hypochlorite ions (ClO−) and chlorine (Cl2) [16]. During the electrolysis,
neutral electrolyzed water (NEW) is generated and it is stable in terms of loss of chlorine oxidants
and ORP. Since NEW is non-toxic, non-corrosive and safe due to its physicochemical properties and a
reverting capacity to ordinary water when diluted with tap water [17], NEW could be used for the
application of safer, healthier and more acceptable methods for aflatoxin detoxification. Mounting
evidence suggests that EOW has strong antifungal activity [18,19] and it is also effective in detoxifying
AFB1 in peanuts and maize [20,21]; however, there are some challenges faced in the development of
this technology, such as the quick loss of activity in the presence of organic matter. Nevertheless, the
application of NEW to detoxify aflatoxin-contaminated maize and the confirmation of the detoxification
process in an in vivo experimental model have not yet been reported. Consequently, the purpose of
this study was to evaluate the ability of NEW to detoxify B-aflatoxins in contaminated maize and
confirm detoxification in turkey poults.
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2. Results and Discussion
2.1. Physicochemical Properties of NEW
Regarding the main physicochemical properties of NEW, after electrolysis and up to the end of
the experiment, the pH value (pH 7.03 ± 0.02), ORP (862 ± 3.9 mV) and ACC (54 ± 1 mg/L) were
completely stable. It has been established that the most important factor in AFB1 transformation is
the high level of ACC, which is totally dependent on the electrolysis conditions. Taking into account
that NEW contains primarily hypochlorous acid and the hypochlorite ions [16], their concentrations
were also determined spectrophotometrically. Ultraviolet spectrum demonstrated two absorption
peaks, one at 237 nm and one at 293 nm (Figure 1). Thus, using Lambert-Beer’s law equation, NEW
contained 43.01 ± 1.7 mg/L and 10.87 ± 0.71 mg/L of HOCl and OCl−, respectively. The Ultra High
Range Chlorine photometer uses the N,N-diethyl-p-phenylenediamine ferrous ethylenediammonium
sulfate (DPD-FEAS) method, which is a titrimetric procedure for determining free available chlorine;
however, care should be taken with this procedure as it cannot differentiate between the HOCl and
OCl− concentrations. Consequently, ultraviolet determination could be considered as a practical,
inexpensive and environmentally friendly technique for chlorine measurement that allows separate
determinations of the two free chlorine species in NEW without the use of chemicals [22].














Figure 1. Ultraviolet absorption spectrum of neutral electrolyzed water (NEW) at 25 ◦C.
2.2. Aflatoxin Analyses and NEW Detoxifying Capacity
The aflatoxin analyses indicated that artificially contaminated feed contained 430 ± 17 ng/g.
The Ultra Performance Liquid Chromatography (UPLC) chromatogram confirmed that the toxins were
only AFB2 and AFB1. The retention time (Rt) values for these toxins were 1.60 and 2.00 min, respectively.
AFB1 was the most abundant toxin, making up 77% (≈331 ng/g) of the total aflatoxin content (Figure 2).
In this research, the presence of AFB2 in the contaminated feed was considered insignificant, since
this molecule is approximately 200-fold less toxic than AFB1 [23]. Moreover, no T-2/HT-2 toxins or
fumonisins (B1, B2 and B3) were detected in the ration. After treatment with NEW, the aflatoxin content
in the detoxified ration did not significantly decrease (determined with both methods via fluorescence
detection); in consequence, the aflatoxin fluorescence strength of NEW-detoxified feed was almost
similar to the aflatoxin-contaminated feed samples, since it has been reported that this particular
detoxification procedure does not reduce the aflatoxin content, measured as loss of fluorescence [20].
Recently, our research group demonstrated that –Cl and –OH groups of the HOCl were added to the
C8 and C9 atoms in the terminal furan ring of the AFB1 molecule to yield 8-chloro-9-hydroxy-aflatoxin
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B1. Data of the compound indicate an important reduction in the cytotoxic and genotoxic potential,
as demonstrated by using different in vitro and in silico assays [20,24]. The most important factor in
AFB1 detoxification is the high concentration of HOCl [24]; in this study, NEW contained 43.01 mg/L;
however, the post-reaction concentration was <1 mg/L. This reduction represents about 98% decrease
in HOCl concentration. In addition, the pH and ORP values were also significantly reduced, reaching
values of 5.99 and 232 mV, respectively.















Figure 2. Representative Ultra Performance Liquid Chromatography (UPLC) profile of the
aflatoxin-contaminated turkey feed. The retention time values for AFB2 and AFB1 were 1.60 and
2.00 min, respectively.
2.3. Poult Performance
The effects of providing the aflatoxin-contaminated and NEW-detoxified feed on poult
performance and mortality rate are summarized in Table 1. At the end of week 1 (13 days-old),
there were no statistical differences in body weight gain among the four treatments. However, by
the end of week 2 (20 days-old), body weight gain was significantly reduced in poults of the AF
group when compared to the CONTROL and NEW groups, respectively. The poults receiving the
aflatoxin-contaminated diet had a 33.6% reduction in body weight gain as compared to the controls.
This notable decrement in body weight gain caused by the aflatoxins was significantly ameliorated
by the detoxification procedure of the aflatoxins with NEW. Moreover, cumulative data (6 to 20 days)
showed that poults of the AF group had −24% deviation in body weight gain in comparison with
the CONTROL and NEW groups, respectively. However, a moderate deviation in body weight gain
(−11%) was observed in poults of the AF + NEW group, which means that NEW treatment offers a
reasonable protection against the harmful effects in body weight gain caused by the aflatoxins. It is
also important to mention that performance was not affected by treatment with NEW alone.
It is well known that growth performance of turkey poults can be modified significantly by
the presence of aflatoxins in the diet in a dose-dependent manner [4]. McKenzie et al. [2] reported
23% reduction in body weight gain in turkey poults receiving approximately 560 ng/g AFB1 in
the diet by the end of week 3. Rauber et al. [4] showed growth rate depressions of 16% and 39% in
initial-phase turkey poults fed a diet containing 500 ng/g and 1000 ng/g total aflatoxins (AFB1 = 75.2%,
AFB2 = 1.4%, AFG1 = 22.6%, AFG2 = 0.8%), respectively. The current study demonstrated that a dose
of 331 ng/g of AFB1 in the diet significantly reduced the body weight gain in turkey poults from 6
to 20 days of age. This finding is in close agreement with the results found by Hamilton et al. [25] and
Giambrone et al. [26], who reported that 250 ng/g and 400 ng/g are the minimum contents of AFB1
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that can significantly affect body weight gain in turkey poults. On the other hand, feed conversion
ratio (g feed:g body weight gain) was only affected in poults of the AF group, presenting values up
to 2.841 (Table 1). Lala et al. [1] reported a feed conversion rate of 2.930 in starter turkeys fed a diet
containing 110 ng/g AFB1, which is consistent with our findings. In this investigation, the observed
mortality during the 2-week period was as follows: 13 poults in the AF group (22%), 2 poults in
the group AF + NEW (3%) and 0 mortality in the CONTROL and NEW groups, respectively. It is
important to mention that mortality in the AF group occurred within the first days of the second
week of the trial and that the second poult in the AF + NEW group died from chronic staphylococcal
peritonitis. The high mortality rate registered in poults of the AF group could be attributed to the
formation of the intermediate product 2,3-dihydro-AFB1 in the liver, resulting in the rapid onset
of necrosis, breakdown of the immune system and eventually death [3]. Rauber et al. [4] reported
mortality rates of 18.7% and 37.5% in turkey poults receiving 200 ng/g or 1000 ng/g total aflatoxins.
Data shown by these researchers are consistent with our results. Aflatoxin sensibility varies among
species, with turkeys being the most sensitive due to a combination of efficient activation and deficient
detoxification of this mycotoxin in the liver, the primary target organ [27]. Turkeys that consume
aflatoxins in their diet generally develop inappetence, reduced activity, unsteady gait, recumbence
and ultimately death [28]. During the experiment, turkey poults of the AF group showed these
markedly clinical signs of aflatoxicosis plus poor fathering, apathy and convulsive crises, signs that
were completely alleviated by the detoxification treatment with the use of NEW.
Table 1. Effects of aflatoxin-contaminated and NEW-detoxified feed on body weight gain, feed
conversion ratio and mortality rate in turkey poults.
Treatment
Body Weight Gain (g) Deviation from
CONTROL (%)
FCR
(g Feed: g Gain)
MR (%)
6 to 13 days old 13 to 20 days old 6 to 20 days old
CONTROL 51.3 ± 4.2 a 131.9 ± 4.5 a 183.2 0 2.021 a 0
AF 52.2 ± 1.9 a 87.6 ± 5.8 b 139.8 −24 2.841 b 22
AF + NEW 50.5 ± 3.3 a 111.8 ± 7.5 a 162.3 −11 2.184 a 3
NEW 52.2 ± 3.0 a 131.8 ± 11.9 a 184.0 0 2.149 a 0
Mean of six replicates of ten poults each per treatment (minus mortality) ± standard error. a,b Means, within the
same column, not sharing a common superscript differ significantly (Dunnett test p < 0.05). FCR = feed conversion
ratio, MR = mortality rate.
2.4. Biochemical Constituents
Table 2 shows the summarized serum biochemical results. In general, aflatoxins caused a
significant decrease in the total protein and albumin concentrations; reductions of 35% and 38% in these
parameters were observed in poults of the AF group in comparison to the CONTROL group. McKenzie
et al. [2] reported decrements of 59% and 53% in the serum concentrations of total protein and albumin
in turkey poults fed a diet containing 560 ng/g AFB1 during a 3-week period. Quist et al. [12] reported
reductions of 19% and 27% in the total protein and albumin concentrations in 4-month old wild
turkey poults fed a diet containing 400 ng/g total aflatoxins during 14 days. It has been reported that
biochemical changes in the nitrogenous compounds in poults are maximal during the first three weeks
after aflatoxin exposure, with hypoalbuminemia and the resultant hypoproteinemia being the most
sensitive indicators of aflatoxin intoxication [29]. These effects are compatible with the compromised
hepatic function seen in turkey poults of the AF group. Furthermore, an increment of 49% in the
creatinine concentration was recorded in poults of the same experimental group (Table 2). Mathuria
and Verma [30] reported a dose-dependent increase in creatinine concentration in young inbred Swiss
strain male albino mice administered with aflatoxins for a 45-day period. Authors reported that low
doses of aflatoxins (750 μg/kg body weight) caused a 60% increment in the creatinine concentration as
compared to the vehicle control. The heightened appearance of creatinine in the serum of poults in
the AF group indicates the increased transformation of phosphocreatinine to creatinine in the muscle,
which might be due to a lesser utilization of phosphocreatinine during muscular contraction. Since the
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kidney rapidly excretes creatinine, the significant increase in creatinine concentration in the serum
could be due to increased release from muscles and/or decreased excretion from the kidney, suggesting
that aflatoxins cause adverse changes in both skeletal muscle and kidney at very early stages [30].
Furthermore, there were no significant differences in total bilirubin and uric acid concentrations among
all four treatments (Table 2). In general, it can be concluded that the detoxification procedure with
the use of NEW ameliorates aflatoxin-induced effects in the serum parameters as compared to the
aflatoxin alone treated group.
Table 2. Effects of aflatoxin-contaminated and NEW-detoxified feed on some biochemical constituents
in turkey poults at the end of the trial.
Treatment
Total Protein Albumin Total Bilirubin Creatinine Uric Acid
(g/dL) (mg/dL)
CONTROL 2.42 ± 0.64 a 0.69 ± 0.16 a 0.28 ± 0.32 a 0.35 ± 0.04 a 6.98 ± 1.88 a
AF 1.57 ± 0.07 b 0.43 ± 0.02 b 0.22 ± 0.15 a 0.52 ± 0.10 b 4.09 ± 0.92 a
AF + NEW 1.97 ± 0.33 a 0.61 ± 0.23 a 0.25 ± 0.04 a 0.35 ± 0.12 a 4.24 ± 0.17 a
NEW 2.38 ± 0.51 a 0.79 ± 0.09 a 0.25 ± 0.19 a 0.39 ± 0.08 a 6.26 ± 1.70 a
Mean of six replicates of three poults each per treatment (n = 18) ± standard error. a,b Means, within the same
column, not sharing a common superscript differ significantly (Dunnett test p < 0.05).
2.5. Serum Enzyme Activities
Conspicuous symptoms of aflatoxin toxicity were detected in poults of the AF group by the
serum aspartate aminotransferase (AST) activity level, which increased by 1.34-fold in comparison
to the CONTROL group (Table 3). On the other hand, there were no significant differences in
alanine aminotransferase (ALT), gamma glutamiltranspeptidase (GGT) and alkaline phosphathase
(AP) activities among all four treatments, which is in close agreement with data reported by Rauber
et al. [4] in turkey poults fed seven different doses of aflatoxins in their diet. It is well known that
AST is present in the cytosol, and whenever liver hepatocytes are damaged, the enzyme is released
into the blood stream; consequently, a significant increase in its activity indicates damage. The results
obtained in the present study showed a significant increase in the AST activity in poults of the AF
group; similar results have been reported by different researchers [2,12,31]. However, this effect was
completely mitigated by the treatment of the aflatoxin molecules with NEW.
Table 3. Effects of aflatoxin-contaminated and NEW-detoxified feed on serum enzyme activities in
turkey poults at the end of the trial.
Treatment
AST ALT GGT AP
(IU/L)
CONTROL 478.00 ± 8.49 a 49.55 ± 3.66 a 7.60 ± 0.75 a 2360.91 ± 26.35 a
AF 644.32 ± 5.60 b 54.82 ± 9.83 a 7.60 ± 0.61 a 2136.66 ± 59.52 a
AF + NEW 369.01 ± 2.50 a 67.32 ± 5.55 a 6.66 ± 0.78 a 2189.73 ± 33.80 a
NEW 536.44 ± 7.05 a 50.60 ± 7.17 a 9.67 ± 0.42 a 2481.40 ± 85.24 a
Mean of six replicates of three poults each per treatment (n = 18) ± standard error. a,b Means, within the same column,
not sharing a common superscript differ significantly (Dunnett test p < 0.05). AST = aspartate aminotransferase,
ALT = alanine aminotransferase, GGT = gamma glutamiltranspeptidase, AP = alkaline phosphathase.
2.6. Relative Organ Weight
As shown in Table 4, no significant differences were noted among all treatments in the relative
spleen and bursa of Fabricius relative weights. However, when compared to the CONTROL group,
the relative weight of the liver decreased significantly (20%), whereas the relative weight of the kidney
increased (37%), in poults of the AF group. The reduced relative liver weight and the increments
in the relative kidney weight in poults of the AF group are consistent with previous studies [2,4,12].
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In general, the aflatoxin detoxification procedure with the use of NEW protected the poults from
significant relative organ weight changes.
Table 4. Effects of aflatoxin-contaminated and NEW-detoxified feed on relative organ weight in turkey
poults at the end of the trial.
Treatment Liver Kidney Spleen Bursa of Fabricius
CONTROL 3.18 ± 0.27 a 1.02 ± 0.12 a 0.09 ± 0.01 a 0.18 ± 0.03 a
AF 2.55 ± 0.10 b 1.40 ± 0.07 b 0.08 ± 0.01 a 0.14 ± 0.02 a
AF + NEW 2.91 ± 0.08 a 1.07 ± 0.04 a 0.08 ± 0.01 a 0.14 ± 0.02 a
NEW 3.16 ± 0.04 a 0.97 ± 0.05 a 0.08 ± 0.01 a 0.14 ± 0.01 a
Mean of six replicates of three poults each per treatment (n = 18) ± standard error. a,b Means, within the same
column, not sharing a common superscript differ significantly (Dunnett test p < 0.05).
2.7. Gross Morphological Changes and Histopathological Studies
No gross morphological alterations were observed in the liver, kidney, spleen or bursa of Fabricius
of the poults in the CONTROL, AF + NEW and NEW groups throughout the course of the experiment.
However, livers of the AF group were pale, friable and appeared smaller in size compared to those of
the CONTROL group. These lesions were also accompanied by hemorrhagic streaks and accentuated
lobular patterns. On the other hand, the AF group kidneys showed no gross lesions but were swollen
and had light colored areas on the surface. Furthermore, histological studies provided additional
evidence of the beneficial effect of NEW treatment on suppressing the toxicity induced by the aflatoxins.
In general, aflatoxin exposure caused extensive liver damage in all poults of the AF group; lesions
observed were composed of variable areas of hepatic degeneration, massive bile duct epithelial
necrosis as well as severe hyperplasia of the epithelium and bile duct proliferation (Figure 3, profile b).
In contrast, only a minimal degree of bile duct epithelial necrosis and minimal bile duct proliferation
was seen in the livers of AF + NEW group (Figure 3, profile c). Histopathological examination of
the bursa of Fabricius indicated lymphoid depletion, abundant apoptotic figures in the germinal
centers and hyperplasia of the epithelium—all of them in severe grade—in poults of the AF group
(Figure 4, profile b). On the contrary, only a minimal degree of lymphoid depletion and hyperplasia
of the epithelium was seen in the bursa of Fabricius of poults of the AF + NEW group (Figure 4,
profile c). Lesions on the spleen were more discrete; the changes seen in poults of the AF and
AF + NEW groups, but not seen in the CONTROL and NEW groups, were severe and minimal
lymphoid depletion, respectively (Figure 5, profiles b,c). Finally, no significant pathological changes
on the kidney were found in poults of the four experimental groups (not shown). It has been reported
that the principal target organ for aflatoxicosis is the liver; consequently, all microscopic lesions caused
by the aflatoxins agree with our previous studies [32]. On the contrary, the severity of lesions in the
liver was significantly reduced in the AF + NEW treatment group, suggesting that the detoxification
procedure with the use of NEW is effective in reducing the toxicity of aflatoxins in the liver of turkey
poults. Aflatoxins are also potent immunosuppressive agents causing immunosuppression through
impairment of humoral and cellular immune responses [26]; thus, resistance to infectious diseases is
generally dependent on antibody production which is dependent in turn on the bursa of Fabricius.
In this research, aflatoxins caused severe depletion of lymphoid cells in the bursa of Fabricius and
spleen, indicating that lymphoid organs are very sensitive to aflatoxins. However, similar but less
severe changes in the bursa of Fabricius and spleen were seen in turkey poults of the AF + NEW group
when compared with the AF group. These findings provide further evidence of the effectiveness of the
detoxification treatment in reduction of aflatoxin toxicity.
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(a) (b)
(c) (d)
Figure 3. Comparative histological changes in the liver (20×, H & E stain). The normal histological
structure is similar in the CONTROL (profile a) and NEW (profile d) groups. Massive bile duct epithelial
necrosis as well as severe hyperplasia of the epithelium and bile duct proliferation is observed in the
AF group (profile b), in contrast with a minimal degree of bile duct epithelial necrosis and minimal bile
duct proliferation seen in the AF + NEW group (profile c).
(a) (b)
(c) (d)
Figure 4. Comparative histological changes in the bursa of Fabricius (20×, H & E stain). The normal
structure is similar in the CONTROL (profile a) and NEW (profile d) groups. Severe lymphoid depletion
and hyperplasia of the epithelium is clear in the AF group (profile b), in comparison with minimal
degree of lymphoid depletion and hyperplasia of the epithelium in the AF + NEW group (profile c).
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(a) (b)
(c) (d)
Figure 5. Comparative histological changes in the spleen (20×, H & E stain). The normal histological
structure in the CONTROL (profile a) is similar to that of group NEW (profile d). Severe and minimal
lymphoid depletion was observed in the AF and AF + NEW groups (profiles b,c), respectively.
To the best of our knowledge, the present study is the first one to demonstrate that treatment
of aflatoxin-contaminated maize with NEW significantly diminishes AFB1-toxicity in young turkey
poults. This effect can be related to the reaction of hypochlorous acid with the double bond in the
terminal furan ring of the AFB1 molecule to yield 8-chloro-9-hydroxy-aflatoxin B1. Nevertheless,
further studies on the complete growing cycle of other animal species need to be conducted. Finally, to
accurately determine the risk of using chlorine compounds in the animal feed industry, the available
chlorine concentration used and the reactivities of the chlorine species with feed components such as
carbohydrates, lipids, and proteins should be extensively evaluated.
3. Materials and Methods
3.1. Safety Precautions
Procedures used for handling and decontaminating aflatoxin-contaminated materials were
adopted from recommendations published by the International Agency for Research on Cancer [33].
3.2. Animal Ethics
This study was conducted according to the Internal Committee for Care and Use of Experimental
Animals (CICUAE), approved by the National Autonomous University of Mexico. Ethical approval
code: CICUAE-29102009. Date of approval: 29 October 2009. Project identification code: C16_02. Date
of approval: 8 April 2016. Ethics committee: Internal Committee for Care and Use of Experimental
Animals (CICUAE, from its abbreviation in Spanish).
3.3. Chemicals and Reagents
B-aflatoxins, tween-80, sodium chloride, formaldehyde, xylenes and hematoxylin-eosin staining
solution were purchased from Sigma-Aldrich Co. (St. Louis, MO, USA). Acetonitrile (HPLC grade),
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ethanol, methanol, and methanol (HPLC grade) were obtained from J.T Baker, Mallinckrodt Baker
(Ecatepec, Mexico). Paraffin for tissue embedding was procured from Leica Biosystems Richmond Inc.
(Richmond, IL, USA). Malt extract-sodium chloride-agar (MSA) medium was obtained from DIBICO
SA de CV (Mexico, DF, Mexico). Saline solution was purchased from Becton Dickinson Co. (Mexico,
DF, Mexico). All other chemicals used were analytical reagent grade.
3.4. Preparation of Neutral Electrolyzed Water (NEW)
NEW was electrochemically generated using two patented generators from Esteripharma SA
de CV (Atlacomulco, Mexico). This method of NEW production has been previously described
in detail by Jardon-Xicotencatl et al. [20]. NEW was used immediately after elaboration. Three
physicochemical properties were verified: the pH and ORP values were measured with a combination
pH/ORP/temperature meter PC-45 (Conductronic, Mexico, DF, Mexico), and the ACC was determined
using an Ultra High Range Chlorine photometer model HI96771C (Hanna Instruments, Melrose,
MA, USA). The concentrations of HOCl (the main available chlorine form in NEW) and OCl− were
further determined using a diode-array system spectrophotometer Cary-8454 (Agilent Technologies,
Santa Clara, CA, USA). Ultraviolet spectra was collected in the range of 200–400 nm at room
temperature in 1-cm quartz cell and the absorbance at 237 nm and 293 nm was used to determine the
concentration using Lambert-Beer’s law equation with 100 1/M·cm and 350 1/M·cm as the molar
absorption coefficients for HOCl and OCl−, respectively [34].
3.5. Maize Grain
White maize grains of the commercial hybrid AS-900 provided by Aspros Comercial SA de CV
(Cortazar, Mexico) were used. The aflatoxin content of the grain was below the immunoaffinity column
minimum detection limit (0.5 ng/g). Contents of T-2/HT-2 toxins and total fumonisins (FB1, FB2 and
FB3) were also determined using monoclonal antibody columns [35]. Moisture content was determined
by drying replicate portions of 5 to 10 g each of whole grain at 103 ◦C for 72 h, with percentages
calculated on a wet-weight basis.
3.6. Fungal Isolate
The Aspergillus flavus Link strain UNIGRAS-1231 (Culture Collection of the Grain and Seed
Research Unit of the National Autonomous University of Mexico) was plated into Petri dishes
containing MSA medium (%: malt extract, 2; sodium chloride, 6; and agar, 2) for 7 days at 25 ◦C.
This strain has high ability to produce AFB1 and AFB2 [36].
3.7. Aflatoxins Production
Aflatoxins were produced according to the technique proposed by Méndez-Albores et al. [36].
The inoculated maize was incubated during 37 days to obtain an approximate aflatoxin content
of 13,500 ng/g. The aflatoxin-contaminated maize was stored at 4 ◦C prior to treatment.
3.8. Aflatoxin Analyses
3.8.1. Using Immunoaffinity Columns (IACs)
The aflatoxin content was determined according to the 991.31 AOAC method [37] using
antibody-based IACs for AFB1 and AFB2. Samples (50 g) were extracted by blending with 100 mL
methanol-water (80:20, v/v) and 5 g of NaCl using a laboratory blender model 51BL30 (Waring,
CT, USA). The mixture was filtered through a Whatman 1 filter paper and a portion of 5 mL was
diluted with 20 mL of distilled water. The diluted preparation was filtered through a micro-fiber filter,
and 10 mL were passed through the IACs (Afla B, VICAM Science Technology, Watertown, MA, USA).
Subsequently, the column was washed twice with 10 mL of distilled water and dried with sterile air
flow. The toxins were then eluted with 1 mL of HPLC grade methanol and quantified in a fluorometer
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VICAM Series-4EX (VICAM Source Scientific, Irvine, CA, USA) after reaction with 1 mL of 0.002%
aqueous bromine. The detection limit for aflatoxins via fluorescence measurement is approximately
0.5 ng/g.
3.8.2. Using Ultra Performance Liquid Chromatography (UPLC)
The aflatoxin identification was carried out according to the technique proposed by
Jardon-Xicontencatl et al. [20], using a Waters ACQUITY UPLC H-Class System equipped with a
quaternary solvent manager and an ACQUITY UPLC BEH C18 phase reverse column (2.1 × 100 mm,
1.7 μm). Standards, as well as samples collected from the IACs (1 μL), were injected and eluted with
a single ternary mixture of 64:18:18 water/methanol/acetonitrile (all HPLC grade) at a flow rate
of 400 μL/min. Aflatoxins were fluorometrically detected and identified using a UPLC-optimized
fluorescence detector (Waters, Milford, MA, USA). The excitation and emission wavelengths were
365 and 429 nm, respectively. Aflatoxins were identified by their Rt and compared with those of a
pure aflatoxin standard solution. The estimated detection limits are 0.58 and 2.01 ng/kg for AFB2 and
AFB1, respectively.
3.9. Detoxification of the Aflatoxin-Contaminated Maize with NEW and Diet Formulation
Batches of the aflatoxin-contaminated maize (1 kg) were milled (Molinos Pulvex, Mexico, DF,
Mexico) using a hammer head and a 0.5 mm mesh screen, and subjected to detoxification treatment
using standardized conditions previously outlined by Jardon-Xicotencatl et al. [20]. Subsequently,
the aflatoxin-detoxified material was placed into flat stainless steel pans for 2 h in a sterile air flow
chamber. The ground maize was mixed in a commercial turkey feed procured from Nutricion Tecnica
Animal SA de CV (Queretaro, Mexico) containing 26% protein, 12.64 MJ/kg (metabolizable energy)
and met or exceeded levels of other nutrients recommended by the National Research Council [38]. The
commercial feed was free of any detectable mycotoxins (aflatoxins, T-2/HT-2 toxins and fumonisins)
and contained no antibiotic, nor anticoccidial drugs or even growth promoters. Feed batches (25 kg)
were artificially contaminated with B-aflatoxins (430 ng/g) using 27 g of the milled maize per kilogram
of feed. In order to assure the proper distribution of the aflatoxins, the contaminated feed was mixed
for 20 min in a Ribbon Blender Mixer model MH-7050 (Molinos Pulvex, Mexico, DF, Mexico).
3.10. Birds and Housing
For the experiment, 240 6-day-old female large white Nicholas-700 turkey poults (obtained from a
commercial hatchery) were individually weighed at placement and randomly distributed in four pens
at the Poultry Research Station of the National Autonomous University of Mexico. Six replicates of ten
poults (n = 60 per treatment) were grouped based on the following four dietary treatments: (1) control
feed containing aflatoxin-free maize (CONTROL); (2) feed containing the aflatoxin-contaminated maize
(AF); (3) feed containing the aflatoxin-contaminated maize detoxified with NEW (AF + NEW); and (4)
control feed containing aflatoxin-free maize treated with NEW (NEW). The temperature, lighting and
ventilation programs were followed according to standard recommendations of the supplier. Feed and
water were provided ad libitum during the whole period of the experiment (2 weeks).
3.11. Collection of Samples and Measurements
Poults were individually weighed (on a weekly basis) and feed consumption for each replicate
was measured weekly until the end of the experiment (2 weeks). Body weight gain, feed intake,
feed conversion ratio (FCR) and mortality rate (MR) were calculated. Feed intake and FCR were
adjusted for mortalities when necessary. At 20 days of age, blood was drawn by cardiac puncture
under anesthesia (the turkey was exposed for 1 minute to 40% carbon dioxide, 30% oxygen, and 30%
nitrogen) from 18 randomly selected birds from each treatment (3 birds per replicate), and serum
was prepared. The following analyses were performed spectrophotometrically using commercially
available kits (BioSystems, Barcelona, Spain): total protein (545 nm), albumin (630 nm), total bilirubin
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(540 nm), creatinine (500 nm), and uric acid (520 nm). The serum aspartate aminotransferase (AST),
alanine aminotransferase (ALT), gamma glutamiltranspeptidase (GGT), and alkaline phosphathase
(AP) activities were also determined spectrophotometrically at 340 nm, 340 nm, 410 nm and 405 nm,
respectively. The bled poults were then exposed to 80% carbon dioxide, 5% oxygen, and 15% nitrogen
for euthanasia [39]. All efforts were made to minimize unnecessary pain and suffering. Liver plus
gall bladder, kidney, spleen, and bursa of Fabricius were excised and washed in cold saline and their
relative percentages estimated. For histopathological examination, all specimens were fixed in 10%
neutral-buffered formalin for 48 h, routinely embedded in paraffin, cut into 4 μm thick sections and
processed for hematoxylin and eosin (H & E) staining.
3.12. Statistical Analysis
Data were subjected to analysis of variance (ANOVA) using the General Linear Model (GLM)
procedure in Statistical Analysis System software version 8.0 [40], and means were separated by the
Dunnett procedure and judged to be significantly different if p < 0.05.
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Abstract: Patulin is a mycotoxin of food safety concern. It is produced by numerous species of
fungi growing on fruits and vegetables. Exposure to the toxin is connected to issues neurological,
immunological, and gastrointestinal in nature. Regulatory agencies worldwide have established
maximum allowable levels of 50 μg/kg in foods. Despite regulations, surveys continue to find patulin
in commercial food and beverage products, in some cases, to exceed the maximum limits. Patulin
content in food can be mitigated throughout the food processing chain. Proper handling, storage,
and transportation of food can limit fungal growth and patulin production. Common processing
techniques including pasteurisation, filtration, and fermentation all have an effect on patulin content
in food but individually are not sufficient safety measures. Novel methods to remove or detoxify
patulin have been reviewed. Non-thermal processing techniques such as high hydrostatic pressure,
UV radiation, enzymatic degradation, binding to microorganisms, and chemical degradation all
have potential but have not been optimised. Until further refinement of these methods, the hurdle
approach to processing should be used where food safety is concerned. Future development should
focus on determining the nature and safety of chemicals produced from the breakdown of patulin in
treatment techniques.
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1. Introduction
Mycotoxins are toxic secondary metabolites produced by fungi that present a potential hazard
regrading food safety. Patulin is a mycotoxin and is known to be produced by more than 60 species of
fungi belonging to greater than 30 genera [1,2]. Although typically associated with Penicillium expansum,
patulin is also known to be produced by other fungi, including P. claviforme, P. urticae, P. patulum,
Aspergillus clavatus, A. giganteus, Byssoclamys fulva, B. nivea, and Alternaria alternata [3]. Chemically
speaking, patulin (4-hydroxy-4-H-furo[3,2-c]pyran-2[6H]-one) is an unsaturated heterocyclic lactone
with a molecular weight of 154 (Figure 1) [4,5]. Discovered in the 1940s, patulin was initially
investigated for its potential as an antibiotic due to its strong activity against gram-positive and
gram-negative bacteria such as Mycobacterium tuberculosis [6] and more than 75 other different bacterial
species [7]. In the 1960s, it was found to be toxic not only to bacterial cells but to animal and plant cells
as well and was subsequently reclassified as a mycotoxin [8].
Toxins 2017, 9, 157 224 www.mdpi.com/journal/toxins
Toxins 2017, 9, 157
 
Figure 1. Chemical structure of patulin.
Patulin has a broad spectrum of toxicities that include both acute and chronic effects. Some
examples include congestion and edema of blood vessels and tissues [9]. Formation of sarcomas has
been observed when large doses of the mycotoxin were injected into animals, causing concerns of
carcinogenicity in humans [10]. Other effects seen in animals include teratogenicity, liver, spleen and
kidney damage, lung and brain edema, and immune system toxicity [11]. In humans, the primary
reported acute symptoms include gastrointestinal issues, nausea, and vomiting, but there is no
conclusive evidence as to the nature of the chronic effects [3]. The LD50 of patulin ranges from 15 to
25 mg/kg and is dependent on the characteristics of exposure as well as the route of ingestion [5].
Patulin is a highly reactive molecule, able to interact with proteins to form intramolecular and
intermolecular crosslinks with specific amino acids, causing it to behave as an enzyme inhibitor [12,13].
It has also been shown that patulin can form intermolecular links with DNA molecules [14]. These
properties may explain the reported teratogenic and carcinogenic effects. No reports are available
on the possible toxicity of patulin due to inhalation of the toxin in powdered form [15]. Children are
more at risk for toxicities from patulin as they often consume more potentially contaminated products.
Information taken from a study by the USDA has shown that children have a very high consumption
of apple products as compared to adults [16]. During the first year of life, children were found to
consume on average 6.4 g/kg body weight/day of apples while adults consumed only 0.4 g/kg body
weight/day [16]. This means that it is of particular importance to be cautious of the potential danger
that patulin and other mycotoxins present in baby foods.
Due to the potential negative health effects of consuming patulin, regulatory agencies from around
the world have instituted limits regarding the maximum amount of patulin that can be in food products.
Many organizations such as Health Canada, The United States Food and Drug Administration, and the
Codex Committee on Food Additives and Contaminants have all set limits of 50 μg/kg patulin [17–19].
The World Health Organization has suggested a limit of 0.4 μg/kg body weight and the European
Union has set a much lower maximum limit of 25 μg/kg for solid products and 10 μg/kg for any food
marketed towards infants [20,21].
Despite the presence of these regulations, patulin continues to be found in food products around
the world. Table 1 summarizes the patulin contamination that has been quantified in various food
products. Patulin is typically associated with apples and apples products; however it has also been
found in other fruits such as pears, figs, and tomatoes [22–24]. Scientific surveys have also discovered
patulin contamination in vegetables such as bell peppers, grains like wheat, rice and corn, and some
cheeses [25–27].
In some cases patulin has been found in commercial food products exceeding regulatory limits.
An examination of apple and pear products in Tunisia for patulin contamination found that 50% of
samples were contaminated [28]. The level of patulin ranged from 2 μg/kg to 889 μg/kg, with 22% of
contaminated samples exceeding the limit for the toxin set by the European Union. Another study
based in Turkey found that dried figs contained patulin in levels as high as 151 μg/kg [23].
Other studies have surveyed food products for the presence of spores of patulin producing fungi.
The concern is that, should fungi capable of producing mycotoxins survive processing, they may under
the right circumstances continue to produce patulin later. Fungi such as P. expansum, B. nivea, and
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A. terreus have been isolated from cereals and a variety of fruits [29]. Strains of patulin producing fungi
have been found in other products such as peanuts, pecans, and hazelnuts [30].
The presence of fungi does not necessarily indicate the presence of patulin within a food. Likewise
the absence of visible fungal growth is not a guarantee of safety. The mycotoxin has been shown to
diffuse away from mold in food products. In apples, patulin has been found 1–2 cm away from the
infected flesh [31,32]. Similar diffusion was seen in pears in a later study [33]. In tomatoes, likely due
to the lower viscosity of their interiors, patulin can diffuse throughout the entirety of the fruit [31].
The same study also found that patulin can diffuse through wheat based products by as much as 3–4 cm.
Given the potential toxicity of patulin and the continued occurrence of it in commercial
food products, there has been research done to look at the effect of different treatments on
patulin. This review will examine the methods used to mitigate the threat of patulin in food
through the commercial food chain with a focus on techniques devised for the specific function
of mycotoxin reduction.
Table 1. Recent surveys of the occurrence of patulin in food commodities.
Food Commodity Location Range (μg/kg) Positive (%) Reference
Apples Spain 0 0 [34]
Apples Portugal 1–70.6 ND [24]
Apples United States of America 8.8–417.6 40.8 [35]
Figs Turkey 39.3–151.6 ND [23]
Tomatoes Portugal 21.29 ND [24]
Tomatoes Belgium ND 10.8 [25]
Bell Peppers Belgium ND 11.4 [25]
Hazelnuts Turkey 16.6–92.4 ND [36]
Cereal Based Foods Portugal 0–4.5 75 [26]
Apple Juice Italy 1.6–55.4 47 [37]
Apple Juice Turkey 7–376 100 [38]
Apple Juice Brazil 3–7 3 [39]
Apple Juice Tunisia 2–889 64 [28]
Apple Juice Portugal 1.2–42 41 [40]
Apple Juice Belgium 2.5–39 81 [41]
Apple Juice Spain 0–36.5 45 [42]
Apple Juice South Korea 9.9–30.9 12.5 [43]
Apple Juice Spain 2.5–6 7.1 [30]
Apple Juice South Africa 5–45 24 [44]
Apple Juice United States of America 8.8–2700.4 22.7 [35]
Apple Puree Argentina 22–221 50 [22]
Apple Puree Portugal 1.2–5.7 7 [40]
Apple Puree Spain 0–50.3 13 [42]
Apple Puree Italy 1.92 - [45]
Apple Puree South Africa 5–20 35 [44]
Apple Products Argentina 17–39 16 [22]
Apple Products China 1.2–94.7 12.6 [46]
Pear Products Argentina 25 17 [22]
Pear Products Italy 0.79 ND [45]
Tomato Products Italy 7.15 ND [45]
Fruit Jam Tunisia 2–554 20 [28]
Pear Juice Tunisia 5–231 47.6 [28]
Orange Juice South Korea 9.9–30.9 8 [43]
Grape Juice South Korea 5.2–14.5 17 [43]
Semi-hard cheese Italy 15–460 28 [27]
ND = No data available.
2. Pre-Processing Control of Patulin
The degree of patulin contamination in a food product can be managed at all levels in the food
processing chain. There are common pre-processing steps that are completed regardless of the end
product. These can have a significant effect on the patulin content of the finished food. These steps
include storage, removal of the fungi from fresh fruit and vegetables, and the application of fungicides.
226
Toxins 2017, 9, 157
2.1. Storage
Prevention of fungal growth is the first step in the mitigation of mycotoxins. The conditions that
foods face directly after harvest and before processing can have a large effect on the final quality of the
produce. P. expansum is known to possess psychrotrophic characteristics; it is able to grow and produce
patulin under refrigeration temperatures [47]. This fungus is able to produce patulin between 4 and
25 ◦C for 20 to 90 days [48]. The implication is that refrigerated storage is only suitable for relatively
short periods of storage. The Food and Agriculture Organization of the United Nations (FAO) suggests
keeping storage to <10 ◦C or to store fresh produce for <48 h in order to prevent the risk of patulin.
Another study determined that the 48 h mark is only important for produce stored at 20 ◦C or higher
(open deck storage); it found that in refrigerated storage the 48 h mark was not a critical time slot [49].
The use of a modified atmosphere is a second control option used for the storage of food products.
The application of a high carbon dioxide and/or nitrogen atmosphere with low oxygen content has
been shown to be a potential means of controlling mold growth and rot in apples [50,51]. Apples
packaged in polyethylene have shown high degrees of inhibition of fungal growth and patulin
production, while polypropylene is not an effective inhibiting material [52]. Without the use of a
modified atmosphere, polyethylene limited growth by 68% and toxin production by 99.5%. Inhibition
was further increased with the use of a modified atmosphere with CO2 in a dose dependent manner
on both patulin production and fungal growth.
2.2. Fungicides
Another means for controlling mold growth and mycotoxins in the field and in storage is the
application of fungicides. There are a large number of fungicides that have been shown to possess
varying levels of effectiveness. Benzimidazole fungicides used to be a common form of post-harvest
treatment for fruit to deter fungal growth but have seen a steep decline in use due to increased fungal
resistance [53]. Ripening makes fruits more sensitive to contamination by mold; ripened fruit put
into storage had a higher risk of contamination in the absence of fungicide use. In contrast, when
treated with fungicide, the more ripened fruit had smaller amounts of fungal contamination than
the unripened ones, suggesting that the efficacy of fungicides is dependent on the characteristics of
the fruit and the degree of ripening at the onset of storage [54]. Fludioxonil is another conventional
fungicide that has been found to be effective in controlling Penicillium growth in apples [55]. While
the use of conventional fungicides is an effective control measure, increased regulatory and health
concerns and fungal resistance to the fungicides have led to research into finding alternative control
agents [47]. A naturally occurring volatile compound trans-2-hexenal has been shown to be an effective
fumigant in controlling P. expansum growth and patulin reduction in apples during storage [56]. A 3%
solution of sodium hypochlorite (NaOCl) also effectively inhibited the growth of a number of fungi,
including P. expansum, A. alaternata, and Fusarium sp., on apples [57]. Essential oils such as lemon and
orange oils were also tested in the same study, and it was found that the production of patulin by
P. expansum in apples was completely inhibited by a 0.2% solution of lemon oil and by >90% with the
use of 0.05% lemon oil and 0.2% orange oil solutions.
2.3. Physical Removal of Fungi and Infected Tissue
The overall quality of food products is highly dependent on the quality of the raw ingredients.
Ingredients with a high concentration of mycotoxin contamination will inherently cause a high level
of contamination in the finished product. It is a recommended practice to sort out any damaged
produce prior to processing and storage [58]. This not only decreases the patulin content in the finished
product but also helps to reduce the possibility of cross contamination. Unfortunately the highest
quality produce are typically sorted out for sale as fresh produce, whereas it is common to use bruised
damaged fruit or even windfalls for the creation of juices or purees [59,60]. While this is purely a
choice to lower the cost and make use of lower quality fruits, it can decrease the safety of food products.
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There are other steps that can be taken in order to reduce the final patulin content and increase product
quality other than sorting out infected fruit. These will typically either take the form of a washing or
trimming process.
Washing typically involves either immersion into a tumbling water tank/bath or application
of a high pressure water stream [61]. The primary purpose of the washing step is to remove debris,
including dirt, plant matter, bugs, and mold/fungi [60]. Patulin is a water soluble molecule, and,
by including a washing step, a portion of the patulin content in produce can be solubilized and
removed [62]. Studies on the effects of washing treatments on the patulin level in apples found that
this was one of the most critical stages of processing and could remove up to 54% of patulin from
infected apples [61,63]. Researchers found that use of a high pressure water spray was more effective
than a rotary wash tub as the spray would also aid in the physical removal of infected tissue for an
improved reduction of both patulin and pathogenic fungi. The efficacy of washing can vary, ranging
from 10% to 100% reductions [64].
Research has also been done into examining whether a chemical wash solution would be more
effective than water at reducing patulin. Both the United States Food and Drug Administration
(USFDA) and the Canadian Food Inspection Agency (CFIA) have recommended the use of a
100–150 ppm chlorine wash solution for processed fruit and vegetable products [65,66]. The use
of a chlorine solution is primarily for the purpose of reducing microbial levels and not for the
destruction of patulin. The effectiveness of chlorine as an antimicrobial is highly dependent on
pH [67]. Research has been conducted to compare the use of a chlorine solution as opposed to pure
water to reduce patulin content in apples [64], but, other than a larger impact on mold/fungi counts,
no significant difference was found in patulin reduction by chlorine treatment. Chlorine levels need
to be closely monitored as chlorine may cause the possible formation of chemical by-products and
increased wear and corrosion of the equipment [68]. Other options for treating fruit include chlorine
dioxide [68], hydrogen peroxide [69], acetic acid vapour [70], ozonated water [58,71], calcium salts [72],
and electrolyzed oxidizing water [73]. A 200 ppm NaOCl solution inhibited the growth of P. expansum
but was not able to completely prevent the production of patulin [67]. The same study found that the
use of an acetic acid solution of 2–5% for >1 min was able to completely inhibit the growth of mold
and prevent the production of patulin.
While an effective technique for removing patulin, a washing step alone is not sufficient to
guarantee the safety of fresh food products. There is also the potential for the wash water to spread
the patulin and cause cross contamination. Moreover, if not properly handled and disposed of, the
wash solution containing patulin becomes a potential source of contamination for the entire processing
facility. Washing is not a sufficient standalone mitigation technique and should be applied as a carefully
monitored critical control point with other patulin reduction methods following it.
Another means of patulin reduction by fungi removal is the trimming of tissue from produce
that is infected with fungi or is otherwise damaged. Regarding apples, patulin has been shown to
concentrate around the area of infection and thus the removal of just this section of the apple will
significantly reduce its patulin content [47]. Trimming damaged tissue was found to be capable of
removing more than 93–99% of the total patulin content from apples [74].
Trimming of the fruit is an economically useful means of patulin reduction as, unlike sorting,
only small portions of the material is discarded. The danger of this method is that the contaminated
material must be handled properly and disposed of following its removal from the apple. This allows
for possible cross contamination as well as a potential increased cost to processors. The other limitation
is that, as previously discussed, patulin can diffuse from the infected area to other areas of the
food products [31]. For products such as tomatoes, trimming will have no significant effect on
patulin reduction.
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3. Effect of Processing Steps on Patulin
Commercially sold food products have been found to contain patulin, in some cases exceeding
the regulatory limit. As has been discussed, pre-processing methods can have a significant impact on
the reduction of the patulin content. There is a limit to the efficacy of such techniques, and in instances
of high patulin contents these methods are not able to reduce patulin to the regulatory limit. Studies
have been conducted to determine the effect of conventional processing on patulin, with the intention
of combining these techniques with pre-processing methods in an integrated system to increase safety.
3.1. Clarification/Filtration
Clarification or filtration techniques are commonly used in the manufacture of fruit juices.
The purpose of these steps is primarily to remove solid particles such as pectins or proteins from
solution [61]. This category of processing techniques has been studied for their potential to also reduce
the patulin content from liquid apple products.
A system of depectinisation, clarification (with gelatine and bentonite), and filtration using a
rotary vacuum pre-coat filter could reduce patulin content by 39% [61]. The depectinisation step
caused negligible change to the patulin content, and the clarification step was found to be responsible
for the majority of the reduction in patulin. A different study examining filtration media found that
bentonite gave a patulin reduction of 8.5% and diatomaceous earth only 3.4% [75]. This same study also
examined the use of centrifugation either alone or combined with other filtration methods. This type
of separation works based on the difference in force applied to substances as determined by their
individual masses [76]. Centrifugation alone reduced patulin content by 20.5% [75].
The removal of patulin by activated carbon/charcoal as a filtration medium has been extensively
studied [77–80]. An early work compared stirring powdered activated carbon in the juice with using
an activated carbon filter screen [77] and found that both methods were equally effective in reducing
patulin in apple juice by 98.15–100%. It should to be noted that follow up studies did not find such
high levels of reduction by activated carbon [78]. Nevertheless, activated carbon was found to be the
most effective clarification means to reduce patulin, although it was also found to cause the highest
reduction in pH, colour, sugar content, and possibly other nutrients. Different types of activated
carbon showed different effects on patulin removal. Steam activated carbon was more effective than
chemically activated carbon [44]. The same study also suggested that more activated carbon was
required to reduce patulin in juices with higher solids contents.
Enzymatic depectinisation is a common juice/concentrate clarification method that uses pectinase
enzymes to break down the pectin that surrounds protein particles in the solution, causing the protein
to sediment out [60]. Depectinisation has been studied for its potential to also remove patulin from
apple juice with varying results. Enzyme treatment only reduced patulin content by <5% in previous
studies [61,75,80]; however, a study using apple juice samples from an industrial processing facility
found that the use of enzymatic depectinisation removed 28% of the patulin content [81]. It is theorized
that the patulin removal ability of this method is due to patulin binding to the solid particles that are
removed from the solution [75]. Given these varying results, enzyme treatment does not appear to be
a practical means of controlling patulin contamination.
Microfiltration and ultrafiltration have been used in recent years as an additional means of liquid
product clarification. Membrane filtration separates molecules based on the molecular weight of
solutes suspended in a solution [82]. Microfiltration typically filters out molecules in the size range of
0.1–2 μm, and ultrafiltration in the range of 0.001–0.1 μm. These types of systems are advantageous
over conventional clarifying methods in that they cut down on enzyme consumption and the use of
other filtering aids and are readily adapted to a continuous flow process [81]. The two methods are
distinguished primarily by difference in membrane pore size; thus the maximum molecular weights
they will let through [76]. Both have been studied for their ability to filter out patulin from apple
juice [61,78]. Microfiltration could reduce the patulin content by 20.1% at different stages of apple
juice processing [81]. Ultrafiltration was less effective in patulin removal from apple juice, with a
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3–12% reduction [61,78]. The ability of membrane filtration to remove patulin is likely dependent on
its binding to larger molecules that can be removed by the membranes rather than filtering out patulin
itself [81]. This could explain the disparity of results, as the individual experimental parameters and
particular composition of the apple juices used may have had a greater effect on the results than the
difference in filter size.
3.2. Heat Treatment
Heat treatments such as pasteurization and distillation are common preservation methods in food
processing [76]. Pasteurization is a mild heat treatment used to extend the shelf life and increase the
safety of foods by destroying detrimental microorganisms. Evaporation and distillation are processes
that use heat to remove water and/or volatile components from liquid foods.
The use of thermal treatments to reduce the risk of patulin has been questioned due to its resistance
to heat [74,83–85]. Pasteurization has historically shown differing and contrasting results with regard
to patulin reduction. These are summarized briefly in Table 2. Pasteurization for 20 min at 80 ◦C of
apple juice spiked with patulin was found to cause a reduction of up to 50% [86]; however a later
study reported that patulin was stable at 80 ◦C for 30 min in apple juice, and a more severe treatment
of 120 ◦C for 30 min was required in order to achieve patulin reduction [87]. A high temperature
short time (HTST) system was found to cause greater reduction in patulin (18.8% reduction at 90 ◦C)
compared to a batch pasteurization treatment [88]. Re-examination of the two methods found that
longer time pasteurization of 20 min at 90◦C and 100 ◦C could lead to 18.81% and 25.99% patulin
reduction, respectively [89]. Conflicting results continue to be generated by different investigators
when comparing HTST and batch pasteurization [81,89].
Distillation, on the other hand, was found to reduce patulin by 24% in apple juice; however this
was likely due to the degradation of patulin into breakdown products by heat as opposed to removal
as a volatile phase [87]. This was confirmed in a later study [90].
The ability of heat treatments to remove patulin is highly dependent on the treatment parameters
as well as the characteristics of the apple product. It has been indicated that, for a juice that has an
initial patulin level equal to or greater than 200 μg/kg, no variation of heat treatment can reduce the
patulin to below the regulated level of 50 μg/kg [89]. Other components of the food matrices may also
play a role in how patulin is affected. As in filtration, it is possible that the presence of other large
molecules such as fibre, protein, or sugars may cause binding to patulin and an increased resistance to
destruction [81]. The pH of the product may also have had an effect on patulin reduction. Patulin is
stable in acidic conditions; it has shown resistance to heat at a pH range of 3.5–5.5 at 125 ◦C [85].









80 20 4 55 [86]
80 30 ND NS [87]
90 0.17 96.5 13.4 [80]
90 0.17 20 19 [88]
90 0.5 433 39.6 [81]
90 7 1500 60 [32]
90 10 140 12.1 [91]
90 20 220 18.8 [89]
90 20 1000 NS [92]
100 20 220 26 [89]
NS = No significant reduction in patulin found; ND = No data available; PAT = patulin.
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3.3. Fermentation
Fermentation is a process in which yeast converts sugars into alcohols, gases, and/or acids [76].
Numerous studies have been reported on the contamination of unfermented apple juice by patulin;
however few surveys have documented patulin contamination in alcoholic cider [93,94]. Yeast
fermentation was found to be able to reduce patulin by up to 90% [95]. Another study used eight
strains of yeast and three different types of fermentation processes to assess the effect on patulin in
apple juice spiked with 15 mg/L patulin and found that all treatments were able to reduce the patulin
content by 99% over a two week fermentation period [96]. Similarly, in an examination of the ability
of three different strains of Saccharomyces cerevisiae to degrade patulin in apple juice, it was found
that all three were effective at reducing the patulin content during fermentation but were ineffective
during periods of aerobic growth [94]. This suggests that the reduction of patulin seen is a result of
degradation by fermentation as opposed to adsorbing to the yeast cells themselves. This study also
examined the breakdown products of patulin by fermentation and whether they were adsorbed by the
yeast cells [94]. They found that numerous decomposition products were generated by fermentation
and that they remained in the juice after fermentation. Of note, one of these products was E-ascadiol,
which is a mycotoxin itself, though considered to be less toxic than patulin [97].
4. Patulin Reduction Techniques
Conventional processing has been shown to have an effect on patulin content in food products [47,61].
The extent to which the patulin content can be reduced by these means is unclear, with results
dependent on the parameters and the initial patulin content [22,37]. This suggests that further treatment
may be required to reduce the mycotoxin content. Methods of processing specifically for the reduction
of patulin have been proposed to replace traditional methods or for inclusion in the production process
as part of a hurdle approach. These include biological, chemical, and physical methods to either bind
patulin or degrade it.
4.1. Biological Control Agents
Biological control of patulin refers to any method which uses microorganisms to reduce the patulin
content in a product or to prevent the production of patulin. These methods differ from fermentation
in that they do not necessarily contribute to the characteristics or chemical properties of the food;
they are studied for the purpose of patulin reduction. This control method falls under two general
categories based on the mode of patulin reduction; detoxification and adsorption. Detoxification refers
to processes that chemically modify the mycotoxin to inactivate or reduce toxicity, while adsorption
refers to the means by which the mycotoxin is bound and removed from solution. Similar to the
fermentative removal of patulin by the yeast S. cerevisiae, microorganisms such as lactic acid bacteria
(LAB), other yeasts, and fungi have been investigated for their ability to degrade patulin in aqueous
solution [98–102]. Microorganisms, including LAB and yeast cells have also been found to be capable of
patulin reduction in food products through the mechanism of adsorption onto their cell walls [103–108].
LAB are microorganisms of significance due to their high usage in the food industry as both a
means to process food and as additives. They are used as probiotics in maintaining gastrointestinal
health and have been shown to offer protection against some toxic compounds [109]. Research has
found that significant amounts of patulin were removed by 10 strains of LAB, resulting in a 47 to 80%
reduction of patulin [106]. The result also suggests that this reduction of patulin by LAB is highly
strain specific. The increased surface area and cell wall volume of the bacteria showed a higher ability
to adsorb patulin from aqueous solution [108]. Functional groups including C-O, OH, and NH were
found to be involved in adsorbing patulin, suggesting that polysaccharides and proteins that are rich in
these groups may play important roles. The effect of cell viability on degree of patulin removal has also
been assed [107]. The highest reduction of patulin was achieved by a strain of Bifidobacterium bifidum at
51.1% for viable cells and 54.1% for nonviable cells.
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Yeast cells or cell wall components have also been studied for their ability to bind patulin.
Two types of inactivated yeast powder were examined for their capacity to adsorb the mycotoxin [105].
Patulin was reduced to below 4.6 μg/kg after 36 h. Cell powders of eight or 10 yeast strains were
shown to be able to reduce patulin by greater than 50% over a 24 h period [104]. The ability of two
Enterococcus faecium strains to remove patulin from aqueous solution has also been investigated [103].
The strains were able to remove between 15% and 45% of the patulin over a 48 h period. The viability
of the strains did not have a significant effect on the ability to remove patulin. It was also found that
patulin forms a stable complex with the bacteria, and the patulin-bacteria complexes could reasonably
be maintained through further processing.
Microorganisms have also been studied for their ability to detoxify patulin. Two strains of
Metschnikowia pulcherrima yeast were able to degrade patulin in a liquid media spiked with 5, 7.5, 10,
and 15 μg/mL patulin [101]. It was found that one of the yeast strains was able to reduce patulin levels
by 100% within 48 h and the other within 72 h at all concentrations. No patulin was found in the cell
walls after degradation, suggesting that the ability of these yeast strains to remove patulin is unrelated
to cell wall binding, as was the case in the other form of biological control of patulin. Researchers also
noted that the presence of patulin did not influence the concentration of yeast cells during growth,
suggesting that the yeast was immune to the toxic effects of the mycotoxin. It has not been determined
whether all yeast strains possess patulin resistance. However, using a pre-treatment of low amounts
of patulin prior to fermentation, it was found that patulin resistance and degradation abilities could
be induced in Sporobolomyces sp. cells [102]. A variety of yeast strains have been examined for their
ability to degrade patulin. The yeast P. ohmeri was able to degrade more than 83% of patulin after two
days at 25 ◦C, and after 15 days patulin was degraded below the detectable limit [99]. S. cerevisiae
degraded 96% of patulin in apple juice that had an initial concentration of 4.5 μg/mL after 6 d at 25 ◦C.
However only 90% was degraded when the initial patulin content was 7.0 μg/mL, suggesting that
the rate of degradation is concentration dependent. A strain of marine yeast, Kodameae ohmeri, has
been reported to have a high tolerance to patulin and to have the ability to significantly reduce patulin
content in apple juice. It has been suggested that the ability of yeast to detoxify patulin is enzymatic
in nature [110]. It was found that the yeast Rhodosporidium paludignum could significantly reduce the
patulin content in apples and pears. A potential hazard concerning the use of R. paludignum has also
been noted; however the application of this yeast in high concentrations actually increased the patulin
concentration in infected fruits [111]. This is possibly caused by a triggering of stress responses of
patulin-producing fungi. Another concern with patulin degradation is the potential toxicity of the
breakdown products. While not all of the degradation products have been assessed, some have been
identified as E-ascladiol, Z-ascladiol, and deoxypatulinic acid [98,100,112]. E-ascladiol and Z-ascladiol
have been found to exhibit no signs of toxicity towards human cell lines derived from the intestinal
tract, kidney, liver, and immune system [113].
4.2. Chemical Additives
Several methods of chemical degradation of patulin have been proposed. Some of these are
novel methods, while others are additives used for other purposes in apple production but that have
found subsequent use as patulin reducers. Of the variety of chemicals studied, the most promising
include ascorbic acid, ammonia, potassium permanganate, sulfur dioxide, ozone, and some of the
B vitamins [95,114–117].
Ascorbic acid and ascorbate (Vitamin C) have been studied to reduce patulin in apple products.
Slight reductions of patulin by ascorbic acid have been reported, with one study noting only 5% losses
after 3 h and 36% after 44 h [115]. Similarly, the degradation of patulin during storage was observed;
the patulin content of apple juice with ascorbic acid added was decreased by 70% but only by 30% in
juice without added ascorbic acid after a 34 d period [118].
The degradation of patulin by ammoniation and by oxidation with potassium permanganate in an
acidic and a basic environment has also been studied as a control measure [115]. Both treatments were
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effective and able to reduce patulin by more than 99.9% in a standard aqueous solution. Under acidic
conditions, treatment with potassium permanganate was found to produce potentially mutagenic and
harmful compounds, limiting its potential for use in foodstuffs.
Patulin has been shown to be unstable in the presence of sulfur containing compounds [119].
For this reason there has been study on the effect of sulfur dioxide to degrade patulin in solution.
One study found that a solution with 200 ppm of sulfur dioxide was able to reduce patulin by 12% after
24 h and 90% after two days [95]. A later study found that just 100 ppm sulfur dioxide could reduce
patulin content by 50% in 15 min. The differences noted here could be attributed to differences in the
composition of the sample solutions, as interfering components may have been present. Patulin is also
thought to react with a number of other sulfur compounds to produce less toxic compounds [9,120].
It has been shown that patulin will form adducts with a number of sulfur containing compounds such
as cysteine, N-acetylcysteine, and glutathione [12]. This is because patulin has a strong affinity for
binding covalently to sulfhydryl groups as well as amino, thiol, and NH2 groups [121]. While still
possessing some toxicity, it has been determined that these adducts are 100 times less toxic than patulin
itself [122].
Ozone is a strong oxidant, capable of reacting with numerous chemical groups and is thought to
be able to detoxify patulin [116,121,123]. Patulin treated with a 10% solution of ozone degraded from
5 ppm to below detectable levels in 15 s [116]. Metal ions in general did not affect patulin degradation
by ozone oxidation although iron and manganese both significantly reduced the effect. Ozone alone
was able to degrade patulin by up to 98% in 1 min [123]. Ozone treatment is highly effective and it
does not have a significant effect on the quality parameters of food products [121].
Among thiamine hydrochloride, pyridoxine hydrochloride, and calcium D-pantothenate, the
latter i.e. calcium D-pantothenate was the most effective at reducing patulin, being able to reduce it by
up to 94.3% over six months with no significant loss in quality characteristics, compared to 35.8% with
no addition of any substance [117]. While effective, this length of time may be impractical for many
products and the toxicity of the adducts formed requires further study.
4.3. Physical Treatments
Patulin is known to be resistant to degradation by heat treatment [85]. Furthermore some of the
treatments used in apple processing that have been suggested as possibilities for the reduction of
patulin are known to have a negative effect on some of the quality characteristics of the food product
such as pH, clarity, colour, sugars, and ◦Brix [78,79,91]. Development in the field of non-thermal food
processing techniques has opened up the potential for unconventional processing methods to play a
role in apple processing and the reduction of patulin.
4.3.1. Ultraviolet Radiation
Ultraviolet (UV) radiation is an approved non-thermal method for the preservation of fruit juices
in both Canada and the United States [124,125]. Typically used for the destruction of microorganisms,
it has also been studied as a means of degrading patulin [126,127]. UV radiation with an exposure
range of 14.2–99.4 mJ/cm2 on apple cider was able to cause reductions ranging from 9.4 to 43.4%
with higher exposures causing higher patulin reductions [128]. No loss of chemical components or
sensory properties was found including pH, ◦Brix, and total acids. A later study on the effect of UV
radiation (253.7 nm) on patulin in apple juice, apple cider, and a model aqueous solution showed
that it was highly effective in all but apple cider [127,129]. It was suggested that apple cider might
contain components that are interfering with the breakdown reaction. The increased turbidity of apple
cider is considered to hamper the action of UV. The use of filtration/clarification processes therefore
can increase the effectiveness of this technique on apple cider. Other studies have shown that the
effect of UV radiation can be significantly hindered by the presence of large amounts of ascorbic
acid [126]. Ascorbic acid is a common additive to apple juice for its anti-browning and antioxidant
properties [130]. In order for UV radiation to be an effective treatment, any addition of ascorbic acid
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would have to occur afterwards. The particular wavelength of UV light used was also shown to affect
patulin reduction [131]. It was determined that patulin reduction in apple juice or cider was most
effective at 222 nm as opposed to 254 and 282 nm. No significant changes to pH, soluble solids, or the
colour of the apple juice were found during this treatment. Despite this apparent lack of change to
other components of apple juice, a trained sensory panel found that UV radiation treated juice was
significantly different from conventionally treated juice [126]. Further research should examine not
only the effect of UV on patulin but also on flavour compounds.
4.3.2. Pulsed Light
The use of pulsed light is another processing technique that has been proposed for the destruction
of patulin in food products [132]. Pulsed light is a non-thermal food preservation technique that
involves the use of short (1 μs–0.1 s) bursts of broad spectrum light with wavelengths ranging from
200 to 1100 nm [133]. Patulin was degraded by pulsed light in MclIvaine buffer, apple juice, and apple
puree [132]. Treatment with pulsed light was able to reduce the patulin content by 85–95% in the
buffer, 22% in the juice, and 51% in the apple puree. The effectiveness was not dependent on the initial
patulin content.
4.3.3. High Hydrostatic Pressure
High hydrostatic pressure processing (HPP) is a non-thermal food processing method originally
designed for the reduction of microorganisms that has also been studied as a means of reducing
mycotoxins in foods [134]. HPP is a food preservation treatment that uses high pressure to inactivate
microorganisms and proteins [135,136]. HPP treatment has been found to reduce up to 56.24% of
patulin in apple juice contaminated with 100 ppb of the mycotoxin, depending on the operating
conditions [134]. Pressures ranged from 30 to 500 Mpa, and temperatures ranged from (30–50 ◦C).
No clear trend as to the optimal pressure/temperature combination has been concluded, suggesting
that further study is required to refine this technology. A higher pressure at 600 MPa for 300 s was
found to reduce patulin in juice by 31% [137]. It has been shown that HPP primarily works on
hydrophobic and electrostatic interactions, not the covalent ones found in patulin molecules [138].
The reductions in patulin content have been attributed to the formation of adducts with compounds
containing sulphhydryl groups such as glutathione or cysteine [134,139]. These adducts have been
shown to be 100 times less toxic than patulin itself [122].
5. Conclusions
Patulin is a mycotoxin of threat to human health. While the precise nature of the long term effects
in humans are uncertain, the evidence from animal cases is sufficient to justify concern. A number
of regulatory agencies have laid out limitations as to the allowable patulin content in food products.
Despite these regulations, patulin maintains a presence in foods produced around the world. Means
of removing or detoxifying patulin in food are necessary considerations in the processing chain to
increase safety.
A combination of temperature control, the use of modified atmosphere storage, and the application
of fungicides can significantly decrease fungal growth and the production of patulin in fresh fruits.
However not every storage facility has access to all of these technologies, and there are issues with
the over use of chemical fungicides. Improving the quality of the fruit to be processed by means of
washing, trimming, and sorting are all very useful means for controlling patulin. These processes
may not be economically feasible for all producers as they also significantly increase raw material
waste. The waste itself presents a contamination issue and requires special consideration for handling
and disposal. Typical pre-processing techniques are not sufficient and further patulin reduction is
necessary. Conventional processing methods using heat, fermentation, and/or chemical binders have
similarly been shown to have an effect on patulin. However the evidence is inconclusive as to the
actual efficacy of these techniques and so cannot be relied upon to guarantee safety. Furthermore, there
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is concern with the potential toxicity of compounds produced by the degradation of patulin by some
of these methods. Most of these products have yet to be identified, and some that have been identified
are known to be toxic.
Due to the resistance of patulin to acidic conditions and heat treatment, alternative methods
have been proposed for the removal or detoxification of patulin using modified or novel processing
techniques. For these methods to be considered for this purpose they must be safe and effective.
The FAO has requirements for a decontamination process that state that the method must do
the following:
1. Destroy, inactivate, or otherwise remove the mycotoxins.
2. Not leave or create any products that possess toxic/mutagenic/carcinogenic properties.
3. Be practical in so far as it is technologically and economically feasible.
4. Prevent the re-occurrence of mycotoxins by destroying any fungal spores or mycelium.
The development of non-thermal physical processing techniques has led to some promising
possibilities for techniques to reduce the patulin content of food products. UV and pulsed light
radiation can effectively remove patulin from solution; however they may also destroy beneficial
components of the food. HPP can be an effective means of patulin degradation; however the optimal
conditions have yet to be determined and may depend in part on the properties of the food product.
Regarding the FAO requirements, the primary concern for any of these treatments is that current
research is inadequate to fully explain the mechanism of action and the potential toxicity of the
breakdown products. These methods would also require highly specialized equipment, which
represents a major cost factor and may not be allowed for use in food products.
Chemical degradation of patulin is another potential solution, given that the method is easily
accommodated into traditional processing streams. However, the use of chemical agents solely for the
purpose of mycotoxin reduction is currently not permitted, though many of the chemicals listed here
can also serve other purposes; for example, ascorbic acid (Vitamin C) is commonly used to prevent
oxidation or browning [60,140]. Despite this potential, further research is still required to validate
some of the inconsistencies found and to determine the optimal processing conditions. The exact
nature of the reactions and, more importantly, the reaction products for many of these cases are still
unknown, which provides some health and safety concerns.
Biologically based methods can eliminate or reduce the patulin content in food products.
Both enzymatic degradation and the adsorptive removal of patulin by microorganisms like LAB or
yeast have a significant impact on patulin content. Furthermore, it has been found that the application
of biological control methods causes no significant impact to the juice quality characteristics of ◦Brix,
acidity, colour, and clarity [104]. Various microorganisms have the ability to either detoxify or bind
to patulin in an aqueous environment, though it is unclear what the optimal processing conditions
are. It has been shown that strain, pH, temperature, incubation time, concentration of microorganisms,
and patulin level all play an important role, but further study is required [106]. Some breakdown
products have been identified, but not all are known [98,100,112]. More work is required to more fully
understand the processes involved and to determine how to safely incorporate these methods into
food processing.
There are numerous methods that have an effect on fungi and patulin; however there does not
appear to be any singular method that can reliably prevent patulin in food products. Instead the most
practical course of action appears to be the application of the hurdle approach to food safety. That is to
say that multiple safety checks and measures should be implemented throughout the entire growth,
harvest, and production cycle. Work on the refinement of these techniques to determine the optimal
processing conditions is necessary to increase the practicality of usage. The main concern at this point
and the area to which future research focus must be turned is in understanding and controlling the
degradation compounds that are produced by a number of these methods.
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Abstract: Deoxynivalenol (DON) is a secondary fungal metabolite and contaminant mycotoxin that is
widely detected in wheat and corn products cultivated around the world. Bio-remediation methods
have been extensively studied in the past two decades and promising ways to reduce DON-associated
toxicities have been reported. Bacterial epimerization of DON at the C3 carbon was recently reported
to induce a significant loss in the bio-toxicity of the resulting stereoisomer (3-epi-DON) in comparison
to the parental compound, DON. In an earlier study, we confirmed the diminished bio-potency of
3-epi-DON using different mammalian cell lines and mouse models and mechanistically attributed it
to the reduced binding of 3-epi-DON within the ribosomal peptidyl transferase center (PTC). In the
current study and by inspecting the chromatographic behavior of 3-epi-DON and its molecular
interactions with a well-characterized enzyme, Fusarium graminearum Tri101 acetyltransferase, we
provide the evidence that the C3 carbon epimerization of DON influences its molecular interactions
beyond the abrogated PTC binding.
Keywords: deoxynivalenol; epimer; polarity; Tri101; molecular; interactions
1. Introduction
Deoxynivalenol (DON) is a secondary fungal metabolite and contaminant mycotoxin that is
wildly detected in wheat and corn products cultivated around the world. It is estimated that more than
four billion people are exposed to high levels of this metabolite especially in developing countries [1].
In mono-gastric animals, DON presence within feed is associated with adverse effects ranging from low
animal-productivity, feed-refusal, to decreased weight-gain [2–4]. Similarly, DON causes both chronic
and acute symptoms in humans with changes observed at the molecular and cellular levels [5,6].
Intestinal inflammations, increased susceptibility to infections, negative effects on the active transport
of many nutrients [2,7], and brain homeostasis [8] are among the reported outcomes of DON exposure.
Finally, DON is considered a major factor in the pathogenicity of Fusarium species against plants [9].
DON initial toxicity emerges from its ability to bind eukaryotic ribosomes hence inhibits protein
biosynthesis [2,5,10]. DON binds to the 60S subunit and inside the A-site of the peptidyl transferase
center (PTC) of the wildtype ribosome forming three hydrogen bonds: (a) The first is between the
hydrogen of the uracil U2873 sugar and the oxygen of the epoxy group on C12 in DON; (b) The
second is between the hydrogen of the guanine G2403 and the oxygen of the C15 group CH2OH in
DON; (c) Finally, the oxygen of uracil U2869 interacts with hydrogen of the C3 group in DON [11,12].
The attenuation or abrogation of such interactions as in the case of ribosomal protein L3 (RPL3) mutants
lead to a semi-dominant resistance toward this toxin in plants and yeast [13–15].
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The chemical structure of DON influences both its potency and the associated sensitivity-levels
endured in different animal species [2]. Changes to DON structure (such as de-epoxidation, acetylation,
and hydroxylation) can substantially influence its toxicity [2,16]. For example, the C15 carbon
acetylation is report to increase the toxicological potency of DON in Caco-2 cells while modifications
that take place at the C3 carbon are reported to decrease its toxicity by a number of orders of
magnitude [2].
Many microorganisms isolated in the past two decades including bacteria, filamentary fungi,
and yeasts were shown to reduce DON toxicity [17–19] either by physically binding DON (hence
reducing its absorption) or through introducing enzymatic/chemical modifications at specific side
groups [20–22]. Recently, a soil bacterium identified as Devosia mutans Strain 17-2-E-8, was reported to
epimerize the -OH group at the C3 carbon within DON leading to a significant abrogation of DON
cellular toxicity [23,24]. The diminished toxicity of this epimer, 3-epi-DON, was confirmed in different
cell lines including Caco-2 and 3T3 fibroblasts in addition to B6C3F1 mouse model [25]. Other teams
have reported similar results for 3-epi-DON [26,27].
In spite of the confirmed reduction of toxicity for 3-epi-DON using different in vivo models, a
clear mechanistic explanation for the drastic reduction in potency connected with just one (-OH)
group rotation is lacking. A recent study compared the toxicological profiles of DON, 3-epi-DON,
and deepoxy-deoxynivalenol (DOM-1) and confirmed the toxicity reduction for both 3-epi-DON and
DOM-1 attributing the reduction of 3-epi-DON cellular toxicity to the reduced hydrogen bonding of
3-epi-DON within the ribosomal peptidyl transferase center [12].
In this study, we first compare the chromatographic behavior of DON and 3-epi-DON and later
explore the ability of both compounds to interact with a recombinant Fusarium graminearum Tri101
acetyltransferase [28] by tracking acetyl-groups transfer as an indicative marker of such interactions.
While the reduced toxicity of 3-epi-DON can be plausibly attributed to the attenuated binding of
3-epi-DON to ribosomal peptidyl transferase centers, the obtained data show that the increased polarity
of 3-epi-DON in addition to its aberrant molecular interactions are indeed factors that can contribute to
the overall toxicity reduction possibly in a synergistic fashion.
2. Results
2.1. Fusarium graminearum Tri101 Acetyltransferase Expression and Purification
Expression levels of His-tagged FgTri101 in E. coli whole cell lysates are shown in Figure 1a.
A clear band of the induced enzyme with the expected molecular weight (52 kDa) was present in the
third lane after 0.5 mM IPTG addition overnight.
It was critical to start the induction within the OD600 = 0.6–0.8 range as higher values led to
protein degradation and much lower yields. The induction took place also at 16 ◦C overnight even
though such low temperatures were not always necessary and the induction could possibly proceed at
37 ◦C. The outcome of His-FgTri101 purification is shown in Figure 1b. The second elution led to the
least contaminated yet highest enzyme yield. Final protein preparations were subdivided in aliquots
(10–20 μL) and stored at −20 ◦C until usage.
2.2. Chromatographic Elution Patterns Suggested the Increased Polarity of 3-epi-DON
The epimerization of DON at the C3 group rendered 3-epi-DON to a higher polarity spectrum
compared to the parental compound, DON. Under the same isocratic separation conditions (buffer
composition, temperature, reverse phase column), DON was originally eluting at 13.2 min. (Figure 2A)
however after the bacterial epimerization, 3-epi-DON shifted to the 8.9 min. (Figure 2B). The noted
change in elution time, despite the similarity in structures/molecular weights/ionization status, was
an indicative of changes of the polarity index associated with electron rearrangements. Figure 2C
evidently presents DON and 3-epi-DON separation patterns for Devosia mutans 17-2-E-8 LB broth
sample under the same analytical conditions (isocratic) and using a reverse-phase C12 Jupiter 4μ
Proteo 90A HPLC column (commonly used for the purification of peptide mixtures) which reflected
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an altered interactions of 3-epi-DON with the column matrix. While chromatographic separations are
not conventionally used to draw conclusions about polarity changes of mycotoxins, the data presented
here collectively supported the notions that the observed changes in elution times are due to the
increased polarity of 3-epi-DON. Our experimental approach was similar to the one that was suggested
earlier by Namjesnik-Dejanovic and Cabaniss [29].
Figure 1. The induction and purification of His-FgTri101 expressed in E. coli BL21(DE3) cells.
(a) His-FgTri101 from Fusarium graminearum was induced and overexpressed in BL21(DE3) cells;
(b) The enzyme was purified with Clontech’s His-TALON gravity columns by overnight incubation at
4 ◦C. All washes and subsequent elution steps were conducted at room temperature.
Figure 2. Chromatographic separation of DON and 3-epi-DON. Both DON and 3-epi-DON were
injected on Jupiter 4μ Proteo 90A HPLC column. The results indicated that DON (less-polar) eluted in
a longer time frame (A) in comparison to 3-epi-DON (B) under the same isocratic separation conditions.
Section (C) represents the injection of both compounds at the same run.
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2.3. Fusarium graminearum Tri101 Carried DON Acetylation Both in Vitro and in Vivo but Not 3-epi-DON
As mentioned below in the Materials and Methods section, FgTri101 was used to track the
molecular interactions of DON and 3-epi-DON as it provides means of measuring such interactions
indirectly and quantitatively. Both in vivo and in vitro models were used to minimize any aberrant
interpretations resulting from DON and 3-epi-DON abilities to adsorb to bacterial cell walls/proteins
hence reduce their availability within cellular matrixes/reaction mixes.
In short, FgTri101 was able to interact with DON both in vivo and in vitro as indicated by the
C3 carbon acetylation. The in vivo interactions between DON and E. coli BL21(DE3) cells expressing
His-FgTri101 led to a significant decrease of DON recovery (Figure 3a) in test tubes in comparison to
the tubes that harbored only the LB broth supplemented with 50 μg/mL DON (control) or the empty
pET-28a(+) vector (negative control) (Figure 3a).
Figure 3. Changes in DON concentrations in E. coli BL21(DE3) cells overexpressing Fusarium graminearum
Tri101. (a) A significant decrease in DON recovery was noted for the construct that encoded for the
Tri101 enzyme in comparison to the control or the empty vector. The noted decrease in DON was
confirmed to be due to the acetylation of DON by His-FgTri101 (b). The above tendency was observed
in two separate experiments, each with three replications, and the different letters signify significant
differences between the means according to Fisher’s Least Significant Difference (LSD) test (p < 0.005).
Furthermore, FgTri101 presence with DON led to the accumulation of the 3ADON metabolite as
shown in Figure 3b. No 3ADON was detected in tubes harboring LB broth (with 50 μg/mL DON) nor
the empty pET-28a(+) vector (negative control) alone indicating that the accumulation was the result
of specific DON/FgTri101 interactions (acetylation).
On the other hand, incubation of 3-epi-DON with either E. coli BL21(DE3) cells expressing
His-FgTri101 or BL21(DE3) cells with empty pET-28a(+) vector did not lead to any changes in 3-epi-DON
recovery levels after methanol-extractions (Figure 4a) or to the detection of 3ADON presence in these
reactions (data not shown) as a result of 3-epi-DON and FgTri101 interactions.
In order to assure that E. coli BL21(DE3) cells incubated with both DON and 3-epi-DON were all
expressing FgTri101, a SDS-PAGE separation of total cell-lysates was conducted and the results are
shown in Figure 4b. The three triplicates of DON/BL21(DE3)-FgTri101 cells expressed His-tagged
FgTri101 in an equal fashion to 3-epi-DON/BL21(DE3)-FgTri101 cells offering the chance for both
metabolites to interact with FgTri101 equally and forming 3ADON (if possible).
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Figure 4. Changes in 3-epi-DON concentrations in E. coli BL21(DE3) cells overexpressing Fusarium
graminearum Tri101. (a) No changes in 3-epi-DON recoveries were noticed for the construct that
encoded the Tri101 enzyme in comparison to the control or empty vector. The above tendency was
observed in two separate experiments, each with three replications, and the different letters signify
significant differences between the means according to Fisher’s Least Significant Difference (LSD)
test (p < 0.005); (b) To confirm that the above cells where all over-expressing His-FgTri101, bacterial
pellets were collected, lysed, and ran on SDS-PAGE gels (4%–20%) before Coomassie Blue staining.
The overexpression levels of His-FgTri101 were all evident in both DON and 3-epi-DON treatments.
In an identical fashion, the in vitro reactions assembled as stated later within the Materials and
Methods section yielded parallel observations (Table 1). No 3ADON was detected using LC-MS/MS
analytical method when 3-epi-DON was incubated with purified his-tagged FgTri101 (tube #6) nor
when either DON or 3-epi-DON were incubated with FgTri101 in the absence of acetyl-CoA (tubes #2
and #5). The 3ADON metabolite was only detectable in the presence of DON, FgTri101, and acetyl-CoA
(tube #3).
Table 1. The in vitro testing of FgTri101 ability to interact with DON and 3-epi-DON, respectively.
Reaction mixes were assembled in triplicates as mentioned under the Materials and Methods section.
Methanol-extracted aliquots were analyzed for 3ADON using the LC-MS/MS approach. Tri101
supported the acetylation of DON but not 3-epi-DON.
Component/Tube (1) (2) (3) (4) (5) (6)
DON + + + − − −
3-epi-DON − − − + + +
recombinant His-FgTri101 − + + − + +
acetyl-CoA − − + − − +
3ADON
formation/detection No No Yes No No No
2.4. 3-epi-DON Cross-Reactivity with DON-Monoclonal Antibodies Suggested Similar Structural
Configurations/Side-Group Rearrangements of Both Compounds
A commercial monoclonal antibody that was generated against DON and is widely used to
specifically capture this toxin from complex food matrixes/biological samples was tested for its
ability to interact with 3-epi-DON. The assumption was that, if both compounds were captured and
retained equally on the DONtest immunoaffinity column, then it is plausible to hypothesize that the
two metabolites display similar epitopes and share close structural configurations needed for such
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monoclonal antibody recognition/interactions. In other words, despite the structural stress induced
by the C3 carbon epimerization of DON (and the correlated electrons rearrangements to stabilize
the resulting isoform), the two chemicals can be assumed to endure a similar epitope/3D chemical
configuration in case they were both recognized/bound by the same monoclonal antibodies.
Satisfyingly enough, the DONtest immunoaffinity column showed the ability to bind 3-epi-DON
in a comparable fashion to DON. When the methanol eluted compounds were analyzed using HPLC
methods described below, both metabolites were detectable as indicated in Figure 5.
Figure 5. Both DON and 3-epi-DON interacted with the same conjugated commercial DON-monoclonal
antibody in a similar fashion. The chromatographic separation of DON and 3-epi-DON after the affinity
column purification step (DONtest) and injection on Jupiter 4μ Proteo 90A HPLC column is shown.
The results indicated that DON (a) was captured in a similar fashion to 3-epi-DON (b).
The obtained results suggested that most of the 3D structural features of DON were still indeed
conserved after carbon C3 epimerization. Such conserved features were responsible for the observed
affinity between the tested DON-monoclonal antibody and 3-epi-DON in a similar fashion to the ones
noticed earlier between DON with that exact monoclonal antibody.
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2.5. Molecular Visualization of FgTri101/DON Interactions Highlighted the Role of Some Non-Polar
Amino Acids
As mentioned in the Materials and Methods section, the FgTri101 enzyme crystal structure was
solved by Garvey et al. [28] showing the key amino acids that occupy the active pocket of the enzyme.
Among these amino acids are: Leu16, TRP380, SER378, SER379, and the catalytic His156 (Figure 6).
Figure 6. The molecular visualization of DON within F. graminearum Tri101 binding pocket. The C3
carbon (and attached -OH group) in DON (less-polar) is facing a non-polar amino acid (Leu16). In the
case of 3-epi-DON (higher-polarity), the same group will be facing a matrix of non-polar (Leu16) and
neutral (Trp380) amino acid residues.
When DON occupies the enzyme’s active pocket (and taking the steric hindrance in consideration),
the C3-O3 group extends to establish the interactions with the nearby Leu16 and His156 and shows
higher affinity toward the non-polar Leu16 residue (Figure 6). In contrast, when 3-epi-DON occupied
the same space: (a) first, it elicited a reduce affinity toward Leu16 (an extension to the previously
observed chromatographic behavior on the reverse phase column) and (b) second, the C3-O3 bond was
slightly leaning away in the opposite direction. Altogether, this leads to decreased dwelling/interaction
times between FgTri101 and 3-epi-DON in comparisons with the original interactions noticed for
FgTri101 and DON. Such reduced interactions between 3-epi-DON and other molecular targets
(including ribosomal binding sites) were reported to be the force that dictates 3-epi-DON reduced
toxicity [12].
Furthermore, the molecular modeling and visualization of 3-epi-DON and FgTri101 interactions
indicated while this metabolite do indeed fit within the Tri101 active site without any major
conformational perturbations, the 3-OH group in 3-epi-DON is sufficiently disoriented to prevent the
acetylation reaction from proceeding.
3. Discussion
Food and feed research is driven nowadays by a strong support from current consumers to adapt
green biotechnological solutions [21,30]. The field is increasingly exploring new avenues within the
bioremediation arena to mitigate the growing problems of mycotoxin contamination. DON presence
in the food/feed chain is still considered as a challenging task to address as no effective biological
means of control are optimized yet. Most recently, a number of research teams have reported the
use of bacterial isolates to bio-transform DON to other metabolites with a significant reduction in
the associated toxicity [2,18,31–34]. Among the reported bacterial metabolites within this regard
were DOM-1, 16-hydroxy-deoxynivalenol, and 3-epi-DON. A clear mechanistic understanding of
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the phenomena behind the diminished toxicity of such metabolites is a must in order to avoid any
unpredicted scenarios such as the case of previously reported masked mycotoxins [35].
To fully comprehend the reduction of DON toxicity upon C3 carbon epimerization [24,26,33],
we tested the ability of 3-epi-DON to adapted/interact with the active pocket of a recombinant
Tri101 enzyme cloned from F. graminearum. The Tri101 enzyme which represents a large group of
acetyltransferases that naturally interact with DON, was expressed and purified in an exogenous host,
namely E. coli BL21(DE3). The ability of the recombinant FgTri101 enzyme to transfer acetyl groups
from acetyl-CoA to DON was used in this study as an indicative of such interactions while the absence
of acetylated by-products, judged by LC-MS/MS analysis, hinted toward aberrant enzyme-substrate
interactions. Other parameters including substrate polarity and 3D structural rearrangements were
investigated too.
The obtained observations here collectively supported the highlighted role of C3 carbon in
establishing the molecular interactions of DON with different cellular targets. This carbon plays a
pivotal role in DON toxicity which emerges mainly from DON’s ability to bind to ribosomal RNA
hence inhibiting protein bio-synthesis and suppressing host-defense mechanisms. A decent amount
of scientific literature was dedicated for understanding the multifaceted relations between DON
interactions with cellular targets including ribosomes, and overall bio-toxicity [2,9]. The conserved role
of C3 carbon (modification and orientation) in DON bio-potency is not surprising. In fact, some of the
mitigation approaches that were suggested earlier to reduce DON efficacy as plant immuno-inhibitor
where to enzymatically modify this group through acetylation and/or glycosylation [27,36,37].
By far the most prominent interaction between DON and the PTC is mediated by the 3-OH group,
which coordinates a structural Mg-Ion. Modeling 3-epi-DON/PTC shows that the epimerized 3-OH
group is not in place to form reasonable interactions, and the strongest interaction (with the Mg-Ion)
is broken. While the epoxide group is still in close contact with U2873 of the rRNA but due to the
isomeric changes, 3-epi-DON cannot establish any bonds with U2869 [12].
In Tri101, 3-epi-DON could be modelled quite convincingly into the DON binding site, and there
were no obvious clashes. The epimerized 3-OH group was out of reach for acetylation. This in addition
to the increased polarity clearly shows why Tri101 cannot work with 3-epi-DON as a substrate.
Furthermore, the obtained data indicated that 3-epi-DON was still capable of interacting with
a commercial DON-specific monoclonal antibody rolling out the assumption that a mere steric
hindrance/global 3D structural rearrangements are the base for the observed reduced interactivity
(and toxicity) associated with C3 epimerization. Collectively, the provided data suggested that the
reduced toxicity of 3-epi-DON is due to a combination of reduced interactions and increased polarity
index which both affect the observed interactions of 3-epi-DON at the molecular level as noted also by
Pierron et al. [12].
The reported differences in polarity can be advantageous from the analytical point of view as
they allow to validly distinguish between the two stereoisomers based on their separation patterns.
The interactions of DON and 3-epi-DON with reverse phase HPLC columns packed with non-polar
stationary phases clearly can be utilized to analyze both metabolites under isocratic conditions.
The retention times of less-polar eluents (DON in this case) are substantially longer than the more-polar
molecules (such as 3-epi-DON).
Since chemical modifications do in some cases affect the ability of certain chemicals of crossing
cellular membranes as in the case of 15-acetyldeoxynivalenol (15ADON) which shows a higher
permeability in human Caco-2 intestinal cells in comparison to DON or 3ADON [38] and in order
to minimize the chances of aberrant interpretations, we used both in vitro and in vivo approaches to
address the molecular intractability questions with Tri101. Both models yielded identical outcomes.
In conclusion, the presented work here provides the base for a better understanding of
the correlations between DON, 3-epi-DON, role of C3 carbon epimerization, and host-toxicity at
the molecular level. Further studies that securitize the effect of C3 carbon epimerization on the
transport/absorbability of 3-epi-DON in polarized eukaryotic cells (such as Caco-2) can also provide
great insights about the kinetics of this microbial metabolite in animal/human gastrointestinal tracts.
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4. Materials and Methods
4.1. Bacterial Strains, Plasmids, and Chemicals
LB broth (Cat. #244620) was obtained from BD (Franklin Lakes, NJ, USA). Kanamycin (Cat. #60615)
and acetyl coenzyme A sodium salt (Cat. #A2056) were ordered from Sigma-Aldrich (Oakville, ON,
Canada). Deoxynivalenol (Cat. #51481-10-8) was obtained from TripleBond (Guelph, ON, Canada) and
stored at −20 ◦C freezer until usage. 3-epi-DON was prepared and purified as described earlier [39].
BL21(DE3) competent cells (Cat. #69450-3) and pET-28a(+) vector (Cat. #69864-3) were both purchased
from Novagen-EMD Millipore (Etobicoke, ON, Canada).
4.2. Recombinant F. graminearum Tri101 Acetyltransferase Cloning, Expression, and Purification
Fusarium graminearum Tri101 acetyltransferase (FgTri101) (GenBank # AB000874, 1356 bp) was
selected to investigate DON and 3-epi-DON interactions for multiple reasons: (a) first, substrate-enzyme
interactions can be measured indirectly through the determination of the acetylated-C3-DON in
proportion to the un-modified original toxin; (b) second, the enzyme crystal structure was solved
earlier by Garvey et al. [28] and clear insights about DON-binding site and the catalytic mechanism are
already established; (c) third, the reported FgTri101 enzyme shows structural plasticity, particularly
related to substrate-binding within the catalytic pocket. This plasticity is manifested by the ability
of T-2 toxin to bind to the same site where DON was shown to bind [28]. Based on the bulkiness of
T-2 structure (Figure 7a) (type A trichothecene) in comparison to DON or 3-epi-DON (Figure 7b,c), it
can be logically assumed with confidence that steric hindrance that results from DON to 3-epi-DON
epimerization should not be the sole factor that dictates 3-epi-DON interactions with FgTri101.
Figure 7. T-2 (a) and Deoxynivalenol (DON) (b) toxins were both reported to complex with FgTri101
despite the bulkiness of T-2 toxin in comparison to DON [28]. Due to the noted plasticity of FgTri101
active pocket, it is logical to assume that 3-epi-DON (c) can also bind within the enzyme’s catalytic
cavity without any major structural restrain.
FgTri101 was cloned in pET-28a(+) vector after linearizing the vector with NdeI and BamHI
restriction digests. gBlock fragments encoding FgTri101 sequence (optimized for E. coli expression)
were ordered from IDT-DNA (Integrated DNA Technologies, Inc.; Coralville, IA, USA) and In-Fusion
cloning reactions (In-Fusion HD Cloning Plus CE; Cat. #638916; TaKaRa-Clontech; Mountain View,
CA, USA) were used to assemble the fragments according to the supplier’s protocol. His-tag was fused
to the enzyme’s N-terminus. The resulting pET-28a(+)-His-FgTri101 kanamycin resistant vector was
transformed into TOP10 competent cells (Life Technologies Inc., Burlington, ON, Canada) and selected
on Kan+ plates before sending for sequencing at the University of Guelph Laboratory Services.
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The sequence-verified plasmid, pET-28a(+)-His-FgTri101, was transformed into E. coli BL21(DE3)
competent cells which were grown at 37 ◦C for 5 h (OD600= 0.6–0.8) then transferred to 300 mL
LB broth supplemented with kanamycin before inducing overnight with 0.5 mM IPTG (as final
concentration). The induced culture was kept at 16 ◦C and 150 rpm until harvesting by spinning
at 4500 rpm in swing-bucket type centrifuge. Collected pellets were subjected to a gentle protein
extraction protocol using Qproteome bacterial protein preparation kit (Cat. #37900; Qiagen, Toronto,
ON, Canada) according to the supplier’s recommendations. The His-tagged enzyme was purified
by binding overnight to HisTALON Gravity columns (Cat. #ST0165; TaKaRa-Clontech), washing,
and elution in 1 mL buffer increments. The purified enzyme was sub-aliquoted and stored at −20 ◦C
until usage.
4.3. The in Vivo Acetyl-Transfer Assays
In the in vivo assays, E. coli BL21(DE3) cells either harboring empty pET-28a(+) or
pET-28a(+)-His-FgTri101 vectors were incubated with either DON or 3-epi-DON separately. The
resulting 3-acetyl-DON (3ADON) formation (if any) and reductions of DON/3-epi-DON concentrations
were tracked using LC-MS/MS approach as described later. In short, tubes (in triplicates) containing LB
broth supplemented with 50 ppm DON or 50 ppm 3-epi-DON were inoculated with 50 μL of overnight
cultures of E. coli BL21(DE3) cells either harboring empty pET-28a(+) or pET-28a(+)-His-FgTri101.
The cultures were kept growing on an orbital shaker (150 rpm) at 37 ◦C for 5 h (culture OD600 = 0.6–0.8)
then were induced using IPTG (0.5 mM as final concentration) at 16 ◦C for another 16–20 h before
spinning at 10,000 rpm and collecting the depleted broth and bacterial pellets for later analysis.
Bacterial pellets were subject to SDS-PAGE analysis and Coomassie Brilliant Blue staining to confirm
protein induction/expression while the depleted culture broth was extracted with 95% HPLC-grade
methanol, filter-sterilized, and used as described later for DON, 3-epi-DON, and 3ADON analysis.
4.4. The in Vitro Acetyltransferase Enzymatic Assay
The purified His-FgTri101 enzyme prepared as described above was used as a model cellular
target to investigate DON and 3-epi-DON in vitro interactions. In essence, working reaction mixes
were prepared as suggested by Garvey et al. [28] through combining acetyl-CoA (0.62 mM as final
concentration), 100 μg/mL DON or 3-epi-DON, 3.25 μg of His-FgTri101 enzyme in 50 mM Tris-HCl
buffer (pH = 8). Mixes (n = 5) were kept at 28 ◦C overnight and reactions were terminated by adding
absolute methanol in an equal volume. DON, 3-epi-DON, and 3ADON concentrations were measured
using LC-MS/MS as described below. Both DON and 3-epi-DON recovery percentages were calculated
in addition to 3ADON accumulation (if any).
4.5. Using Immunoaffinity Binding to Delineate DON and 3-epi-DON Structural Overlaps
Monoclonal antibodies can characteristically recognize a single, specific epitope that is displayed
on a protein or a chemical. Such highly specific antibodies can be used generally speaking to track
structural changes [40]. In the following approach we made use of this concept to tentatively test
the ability of 3-epi-DON to bind to the same commercial monoclonal antibody generated against
DON in order to gain insights about any structural changes associated with the epimerization of
C3 carbon. An immunoaffinity column, DONtest HPLC obtained from VICAM (Cat. #G1005; MA,
USA), packed with a DON-specific proprietary monoclonal antibody was tested for the ability to bind
3-epi-DON. In short, 1 mL of DON standard (1 μg/mL), 3-epi-DON (1 μg/mL), or combinations were
loaded onto the pre-set columns and pressure was applied to achieve 1–2 drops/second flow rates.
Columns were then washed with 5 mL of pure water and eluted with 1 mL of HPLC-grade methanol
according to the supplier’s recommendations. The eluted DON and 3-epi-DON were dried either
under nitrogen-streams or by using a SpeedVac concentrator (SPD2010, Thermo Scientific, Waltham,
MA, USA) to be re-suspended later in 0.5 mL of 10% acetonitrile in water. Finally, samples were passed
through 0.45 μm filters (Whatman, Florham Park, NJ, USA; Cat. #6765-1304) and analyzed using HPLC
as described later.
251
Toxins 2016, 8, 261
4.6. HPLC Analysis
An Agilent HPLC system (1200 Series; Palo Alto, CA, USA) equipped with a quaternary pump,
an inline degasser, an auto-sampler, and a diode array detector (DAD) was used in this study. A C12
reverse phase Phenomenex Jupiter 4μ Proteo 90A column (250 × 4.6 mm, Cat. #00G-4396-E0) coupled
with a C18 guard column (Torrance, CA, USA) was used for the reported separation. A mobile phase
consisting of two solvents (A: acetonitrile and B: H2O) mixed in 1:9 ratio by volume was used for elution.
Isocratic conditions with flow rates controlled at 1 mL/min. were utilized with an injection volumes
set to 50 μL. The total running time was 15 minutes while the detection wavelength was set at 218 nm.
4.7. LC-MS/MS Determination of DON and 3-epi-DON
Since mass spectrometry (MS) detectors have much better sensitivity levels, it was the
preferred method to track DON, 3-epi-DON, and their acetylated products (if any). Liquid
chromatography-tandem mass spectrometry (LC-MS/MS) was used to simultaneously determine
DON and 3-epi-DON in methanol-extracted samples similar to what was described earlier by
Young et al. [19]. In short, the system was composed of a Shimadzu HPLC system (Shimadzu, Kyoto,
Japan) equipped with an UV/VIS photodiode array detector connected to a triple quadrupole IONICS
3Q Molecular Analyzer (IONICS, Bolton, ON, Canada). An Agilent (Agilent Technologies, Santa Clara,
CA, USA) ZORBAX SB-C18 column (2.1 × 100 mm, 3.5 μm) was used for separation. Two mobile
phases, solvent A (99.9% H2O + 0.1% formic acid) and solvent B (99.9% MeOH + 0.1% formic acid)
were used. The chromatographic elution conditions were as the following: 0−1 min, isocratic 10%
B; 1–10 min, gradient 10% to 80% B; 10–12 min, isocratic 80% B; 12–13 min gradient 80% to 10% B;
13–18 min, isocratic 10% B. The column temperature was set to 25 ◦C, the flow rate was controlled at
0.4 mL/min, and the injection volume was 10 μL, respectively. The ESI positive mode was used for
data collection. Before carrying out the actual analyses, the system was optimized using standards at
very low concentrations. Quantification was accomplished at multiple reaction monitoring (MRM)
mode by monitoring the transition pairs of m/z 296.52 (molecular ion)/ 249.13 (fragment ion) for DON
and 3-epi-DON and 338.83/231.13 for 3ADON. The fragment ion of each compound was selected based
on the ion which has the highest sensitivity among the fragment ions of that compound. The dwelling
time for MRM data collection was 200 ms. Peak areas obtained at the MRM mode were used to
establish the calibration curves through least-squares regressions with R2 values ≥ 0.99.
4.8. Statistical Analysis and Molecular Visualization
All statistical analyses were conducted using SigmaPlot (version 12.5, Systat Software, Inc.;
San Jose, CA, USA). One-way analysis of variance (ANOVA) was applied to the reported results
followed by Fisher’s Least Significant Difference (LSD) test. Crystal structures of F. graminearum TRI101
complexed with Coenzyme A, Deoxynivalenol (#3B2S) and T-2 mycotoxin (#2RKV) were obtained
from RCSB-Protein Data Bank. Both PyMOL (The PyMOL Molecular Graphics System, Version 1.7.4;
Schrödinger LLC; Cambridge, MA, USA) and JSmol (https://sourceforge.net/projects/jsmol/) were
used to visualize and manipulate the 3D structure of the reported complexes.
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Abstract: Of all the food-contaminating mycotoxins, aflatoxins, and most notably aflatoxin B1 (AFB1),
are found to be the most toxic and economically costly. Green farming is striving to replace fungicides
and develop natural preventive strategies to minimize crop contamination by these toxic fungal
metabolites. In this study, we demonstrated that an aqueous extract of the medicinal plant Micromeria
graeca—known as hyssop—completely inhibits aflatoxin production by Aspergillus flavus without
reducing fungal growth. The molecular inhibitory mechanism was explored by analyzing the
expression of 61 genes, including 27 aflatoxin biosynthesis cluster genes and 34 secondary metabolism
regulatory genes. This analysis revealed a three-fold down-regulation of aflR and aflS encoding the
two internal cluster co-activators, resulting in a drastic repression of all aflatoxin biosynthesis genes.
Hyssop also targeted fifteen regulatory genes, including veA and mtfA, two major global-regulating
transcription factors. The effect of this extract is also linked to a transcriptomic variation of several
genes required for the response to oxidative stress such as msnA, srrA, catA, cat2, sod1, mnsod, and
stuA. In conclusion, hyssop inhibits AFB1 synthesis at the transcriptomic level. This aqueous extract
is a promising natural-based solution to control AFB1 contamination.
Keywords: Aflatoxin B1; Aspergillus flavus; hyssop; inhibition; oxidative stress
1. Introduction
Aspergillus flavus, a saprophytic fungus that develops on many crops including maize, oilseed,
dried fruit, and spices [1], is the main producer of aflatoxin B1 (AFB1), the most potent naturally
occurring carcinogen. AFB1 is associated with several pathologies mainly targeting the liver [2]. This
mycotoxin also has major economic impacts as it contributes to considerable amounts of crop and
livestock losses occur [3], endangering food and feed security. Globalization of food trade and global
climate changes have further exacerbated the situation [4,5].
Many methodologies have been developed to limit AFB1 contamination in crops. First, the
implementation of good agricultural practices is undoubtedly a key factor to reduce undesirable
growth of fungi. Fungal growth and mycotoxin production closely depend on temperature and
humidity [6] and since these meteorological parameters are impossible to control, contamination
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cannot be completely avoided. The massive use of fungicides in crops over the last decades led to an
accumulation of toxic chemical residues in food products but also in water and soil and resulted in the
development of resistant pathogen populations [7].
Recent studies have pointed out the use of physio-chemical approaches to counteract aflatoxin
contamination [8,9] while others were based on the detoxification properties or the protective
physiological effect of bacterial metabolites or natural extracts used as feed supplements [10–13].
Although proven to be efficient, these approaches remain strictly restricted to animal feed. Nonetheless,
such alternative strategies could be used at a much earlier phase, postharvest, to prevent aflatoxin
production in crops. As an example, several bio-control approaches were developed relying on
the use of microorganisms, such as lactic acid bacteria strains [14] or atoxinogenic fungi [15,16].
These strains displayed the ability to inhibit aflatoxin production or fungal growth to a certain
extent [17,18]. Prevention strategies could also rely on the use of natural substances like plant extracts
or essential oils. As plants grow, they produce many metabolites that serve as a defense against a
number of environmental stresses. Therefore, plant extracts have long been studied as protective
bioactive agents and it was demonstrated that some of them have antifungal or anti-toxinogenic
properties [19,20].
Micromeria graeca, commonly known as hyssop, is an herbaceous plant belonging to the Lamiaceae
family. It is a widespread species in the Mediterranean basin and is frequently used for medicinal
purposes and as a condiment [21]. The composition of essential oil, the toxicity, and the antimicrobial
effect of different species of hyssop were previously described [22–27], but there is little data on
the composition and toxicity of the aqueous extract of hyssop [21,28], and none on its antifungal or
anti-mycotoxinogenic effect. The purpose of this study was to test the aqueous extract of M. graeca
for its ability to prevent aflatoxin’s biosynthesis. We observed that it inhibits AFB1’s production by
A. flavus strains without interfering with fungal growth. The molecular mechanism of action of this
extract involved down-regulation of all the AFB1 biosynthetic cluster as well as modulation in the
expression of 15 secondary metabolite regulating genes.
2. Results
2.1. Effect of Aqueous Extract of Hyssop on the Production of AFB1 and the Development of A. flavus
When A. flavus strain NRRL 62477 was grown in a hyssop-supplemented medium,
a dose-dependent decrease in AFB1 production was observed. The downward trend started at the
lowest concentration (0.0195 mg/mL) and was statistically significant (28.5%, p-value 0.0032) starting at
0.078 mg/mL. Inhibition reached 99.2% at 10 mg/mL and AFB1 was no longer detectable at 15 mg/mL
(Figure 1). Further experiments were then conducted supplementing the culture medium with
10 mg/mL of hyssop extract, this being the lowest to present a quasi-total inhibition of AFB1 synthesis.
At 10 mg/mL, aflatoxin inhibition by hyssop was accompanied by a mild increase of the colony
diameter (4.4 ± 0.03 vs. 4.25 ± 0.03 cm for treated and control respectively, p-value 0.0213). However,
no significant increase in the total spore count or in the spore density was observed following
the addition of hyssop. Besides, no further change was observed in mycelium weights or for the
germination delay in the presence of hyssop in the medium (Table 1).
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Figure 1. Aflatoxin B1 (AFB1) production as a function of hyssop concentration. Malt extract agar
(MEA) medium was supplemented with increasing concentrations of hyssop extract ranging from
0.0195 to 15 mg/mL and cultivated at 27 ◦C, in the dark, for 8 days. AFB1 concentrations were
quantified through HPLC/FLD. Results are expressed as mean % ± SEM (n = 3). ns = no significant
changes; nd = not detectable; * p-value < 0.05; ** p-value < 0.01; *** p-value < 0.001.
Table 1. The effect of the addition of 10 mg/mL hyssop to the culture medium on the development
of A. flavus (i) colony diameter was measured in length and width; (ii) weight was measured after a
48 h-drying at 60 ◦C; (iii) germinating conidia were counted by observation under stereo-microscope
after 16 h incubation at 27 ◦C; (iv) total spore count is estimated following a complete wash of conidia
and a Malassez-cell count of proper dilutions and (v) spore density was calculated based on the total





Colony diameter (cm) 4.25 ± 0.03 4.4 ± 0.03
Mycelium dry weight (g) 0.16 ± 0.03 0.15 ± 0.02
Sporulation
Germinating conidia after 16 h (%) 96.5 ± 8.5% 101.5 ± 4%
Total spore count 8.1 × 108 ± 4.5 × 107 1.1 × 109 ± 9.9 × 107
Spore density (conidia/cm2) 5.7 × 107 ± 2.6 × 106 7 × 107 ± 5.6 × 106
Following addition of hyssop in medium, A. flavus colonies presented numerous macro and
microscopic modifications. The major noticeable macroscopic morphological change was the
development of an abundant aerial mycelium covering the entire surface of the colony. This latter also
displayed fasciculation on the edge. The presence of these numerous floccose tufts also increased the
depth of the colony (Figure 2).
Under microscope, classic A. flavus structures were present in the basal mycelium of
hyssop-treated cultures: long, coarse, un-branched conidiophores and radiate biseriate conidial
heads. However, in the aerial mycelium, conidiophores, vesicles, and conidia presented an atypical
morphology and organization: (1) an increased number of short conidiophores bearing small columnar
heads in relation with the abundant aerial mycelium; (2) phialides developing anarchically on hyphae
and on conidiophores in the absence of a vesicle; (3) and the presence of conidiophores with two, and
less frequently three, sporulated vesicles (Figure 3).
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Figure 2. Phenotype of A. flavus strain NRRL62477 after four days of culture at 27 ◦C in MEA medium
or MEA medium supplemented with 10 mg/mL of hyssop aqueous solution. (a) Control culture grown
on a regular MEA medium; (b) MEA medium was supplemented with 10 mg/mL of aqueous solution
of hyssop; (c) Magnification of the aerial mycelium covering the hyssop treated culture.
Figure 3. Microscopic views (x400) of A. flavus NRRL 62477 conidiophores in the (I) basal mycelium on
(a) MEA medium and (b) MEA supplemented with 10 mg/mL of hyssop extract, and the (II) aerial
mycelium showing the development of anarchic philalides when strain was grown on a hyssop-treated
MEA medium; (c) and (d) development of anarchic philalides; (e) conidiophore bearing two vesicles
and (f) presence of short conidiophores with columnar heads.
At the dose of 10 mg/mL, we observed a 77.7% and 70.8% inhibition of the production of AFB1
in two other A. flavus strains (E28 and E71respectively), without alteration of fungal growth. Similar
morphological changes were also observed for these two strains (data not shown).
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2.2. Aqueous Extract of Hyssop Down-Regulated the Expression of AFB1 Cluster Genes
The biosynthesis of AFB1 is the result of a well-described cascade of more than 20 enzymatic
reactions. This cascade is governed by 27 clustered genes encoding the corresponding enzymes
as well as two internal regulators, AflR encoding a Gal4 zinc finger transcription factor and its
co-activator AflS. The expression of all of these genes was analyzed in order to determine whether
the inhibition of AFB1 synthesis occurred at a transcriptomic level. Inhibition of AFB1 production in
hyssop-supplemented media was accompanied by a decrease in the expression of both of aflR and aflS
genes by 3.2 and 2.8 times respectively (p-value < 0.0001). Apart from aflT (encoding a MFS-family
transporter), which is not regulated by the AflR/AflS complex [29] and was down regulated only
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Figure 4. Expression of genes belonging to AFB1 cluster genes in the presence of 10 mg/mL of hyssop
aqueous extract; (A) internal cluster regulators (B) genes involved in the earlier steps of AFB1 enzymatic
cascade leading to the formation of norsolorinic acid (C) genes involved in the middle steps of the
AFB1 enzymatic cascade converting norsolorinic acid into sterigmatocystin (D) genes involved in the
final steps of the cascade leading to AFB1 synthesis (E) genes with uncharacterized functions. Black
line represents the expression level of control. ** p-value < 0.01; *** p-value < 0.001.
Genes undergoing the most drastic inhibitions were hypC, aflI, and aflO, encoding enzymes
respectively intervening at the beginning, middle, and end of the biosynthetic pathway and with
corresponding fold-changes of 167.2, 60.7, and 468.8 with p-values < 0.001. For the genes encoding
enzymes involved in the first steps of the cascade leading to the polyketide structure, aflA, aflB, and aflC,
expression was decreased by 12.2, 12.3, and 14.7 respectively. The least impacted genes were aflM, aflG,
and hypD with expression levels decreased by 8.4, 9.3, and 9.4 times respectively. For the remaining
AFB1 cluster genes, the same downward trend was observed with expression levels decreased by 14 to
50 folds (Supplementary Material Table S1). This repression of the entire aflatoxin gene cluster could
then be directly linked to the inhibition of the production of this mycotoxin.
259
Toxins 2017, 9, 87
2.3. Transcriptomic Effect of Hyssop Extract on the Expression of Genes Coding for Regulators of
Secondary Metabolites
The expression of AFB1 cluster genes is subjected to the control exerted by regulatory factors
encoded by genes outside of the cluster. In order to investigate a possible genetic relationship between
those regulators and the transcriptional inhibition of AFB1 cluster genes after the addition of hyssop
extract, we conducted a study on the regulatory network affecting secondary metabolism that includes
34 genes involved in several fungal functional pathways. Among these, a total of 15 genes involved
in diverse cellular mechanisms were modulated by adding hyssop to the culture medium (Figure 5).
The modulated genes could be grouped in five categories based on their cellular functions in other
ascomycetes [30]. The first one includes global regulating factors such as veA, mtfA, nsdC that were
affected with expression levels respectively increased by 3.8, 1.9, and 1.5 folds (p-values < 0.0001, 0.0001
and 0.0122). Secondly, genes encoding enzymes involved in cellular protection from oxidative stress
such as superoxide dismutases (sod1 and mnsod) and catalases (catA and cat2) had their expression
decreased by 1.6, 2, 2.2, and 3 folds respectively (p-values 0.013, 0.0007, 0.004, and < 0.0001). Other
genes intervening in the oxidative stress response and encoding transcription factors, notably msnA
and srrA, had their expression levels increased by 3.2 and 1.4 times with p-values of 0.0126 and 0.0017,
respectively. The third category involves gprK and gprH, encoding G-protein receptors involved
in relaying external signals with gprK expression increased by 2 folds (p-value < 0.0001) and gprH
decreased by 2.1 folds (p-value 0.0006). Moreover, ppoC encoding a fatty acid dioxygenase involved in
oxylipin production also presented an expression decreasing by 1.5 times (p-value 0.003). The conidial
developmental factor stuA whose expression increased by 1.8 times (p-value 0.0012) constitutes the
fourth category. Finally, two genes encoding environmentally influenced transcription factors whose
expression is respectively modulated by nitrogen and medium pH, areA and pacC were also triggered
by the addition of hyssop in the medium and their expression levels were respectively increased by
1.7 and 1.6 folds with p-values of 0.0215 and < 0.0001.
Figure 5. Schematic representation of gene expression ratios of the different regulatory genes
affected upon 10 mg/mL hyssop supplementation of MEA media. Genes are grouped into the five
categories described above. The black line represents the expression level of genes in control cultures.
* p-value < 0.05; ** p-value < 0.01; *** p-value < 0.001.
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3. Discussion
3.1. Hyssop Leads to an Inhibition of AFB1 Synthesis in A. flavus by a Transcriptomic Regulation of AFB1
Cluster Genes
The inhibition of AFB1 synthesis was dose-dependent (Figure 1) and the same impact was
observed using several strains of A. flavus. Another recent study by Omidpanah et al. (2015) [31]
pointed out that some aqueous extracts including thyme and mint had fungicidal effect on A. flavus
at concentrations of 0.2 and 0.8 mg/mL respectively, yet without determining aflatoxin inhibition at
any of the concentration range used. At a comparable concentration of 0.625 mg/mL, hyssop’s extract
was able to inhibit the production of aflatoxin by 52% without restraining the growth of A. flavus.
A slight trend for an increase in total spore count and density was observed upon addition of hyssop,
but these results remain statistically non-significant and do not affect the anti-aflatoxinogenic property
of the extract.
AFB1 biosynthesis in aflatoxinogenic fungi is the result of a coordinated cascade of enzymatic
reactions. The enzymes catalyzing these reactions are encoded by 27 genes and grouped into a cluster
located in the telomeric region of the 3rd chromosome of aflatoxinogenic species [32]. The function of
almost all of these genes was elucidated and described in previous works [33–35]. We demonstrated
that AFB1 inhibition in A. flavus by M. graeca extract is consistent with a drastic repression of all
AFB1 cluster genes following a significant decrease in the expression levels of the two internal cluster
regulators aflR and aflS (previously annotated as aflJ) (Figure 4). Furthermore, the down-regulation of
these two latter genes in AF-repressive conditions has been previously described as associated with
the repression of the entire AF cluster genes [36]. It could also be noted that the inhibition level of the
cluster genes does not depend on their chronological intervention in the enzymatic cascade leading
to AFB1 synthesis, contrary to what has been described for other anti-aflatoxinogenic agents such as
eugenol [30].
3.2. The Implication of VeA and MtfA: Two Leading Transcriptional Regulators
VeA is a global regulating transcription factor involved in primary and secondary metabolism [37]
and recruiting other factors such as LaeA and VelB to form the trimeric velvet complex.
The activity of this complex affects fungal development, conidiation, and secondary metabolism [38].
In hyssop-treated cultures, transcripts of laeA, velB, and vosA, the latter being an interacting partner
of velB [39], were not affected (Table S1). This result further highlights the independent role of VeA
in multiple other cellular mechanisms [40]. The presence of VeA is necessary for the expression of
secondary metabolite genes; however, it can also act as a repressor of some of these genes and thus
inhibit the production of the concerned metabolite. VeA is essential for the transcription of AF cluster
genes, including the transcription factor aflR and others (aflD, aflM, and aflP) regulating production
of aflatoxin. Deletion of the veA gene led to the repression of AFB1 cluster genes in A. flavus [41].
However, according to our current study and to another recent one [30], a repression of all AFB1 cluster
genes can also coincide with a veA-over-expression profile (Figure 5). Such is the case of penicillin,
produced by A. nidulans where an OE:veA led to the repression of acvA, the penicillin biosynthesis
gene and subsequent inhibition of penicillin production [42].
VeA can also interact with another conserved global transcription factor, MtfA. The latter has
a major role in regulating the development and the secondary metabolism in filamentous fungi [43]
and it is linked to AFB1’s biosynthesis as well as to aflR’s expression. An over-expression of mtfA in
A. flavus has drastically inhibited the production of AFB1 following a down-regulation of aflR, whereas
the effect of an mtfA deletion was less important [44]. The concurring over-expression of mtfA and veA
in our conditions (Figure 5), which further highlights the interaction between these two factors, could
then be responsible for down-regulating AF-cluster genes and inhibiting the production of aflatoxin.
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3.3. Implication of Other Regulatory Factors in AF Inhibition by M. graeca—Hyssop Extract
Stressful environmental conditions may lead fungi to establish several defense lines to limit
cellular damage. For example, when subjected to oxidative stress, fungi might respond by producing
secondary metabolites such as aflatoxins. The oxidative stress generated by enhanced lipid
peroxidation and the free radical generation was proven to be a prerequisite for aflatoxin production
in A. parasiticus [45]. Moreover, the anti-aflatoxinogenic effect of antioxidant agents, such as eugenol,
seems to be linked to an alleviation of oxidative stress and lipid peroxidation as well as a modulation
of the expression of a number of genes involved in the oxidative stress response [30,46].
It has been demonstrated that VeA contributes to a positive transcriptomic modulation of
stress-tolerance genes such as msnA and srrA under induced oxidative stress conditions [39].
The expression of these two transcription factors is then highly dependent on that of veA. Therefore,
their over-expression in a hyssop-treated medium might be the outcome of an over-expressed veA
(Figure 5). The developmental factor StuA has also been associated to stress-response in fungi, yet
there isn’t a clear view on its contribution [47]. However, its dependence on msnA was shown since
its expression levels were modulated in A. flavus as well as in A. parasiticus msnA-deleted strains [48].
MsnA is also known for regulating the expression of the catalases (CAT)- and superoxide dismutases
(SOD)-encoding genes [48]. Those antioxidant enzymes along with aflatoxin formation are suggested as
part of the fungus defense mechanism against reactive oxygen species (ROS) damages [49]. When the
medium was supplemented with M. graeca extract, A. flavus responded by decreasing the expression
of SOD- and CAT-encoding genes such as sod1, mnsod, catA and cat2 as levels of msnA increased
thus resulting in an AF-biosynthesis repression, possibly related to an alleviation of environmental
oxidative stress.
Two other regulatory factors that were not linked to oxidative stress were also modulated by
hyssop’s addition to medium. The first regulator is PacC, which is a pH-dependent factor whose
over-expression in aflatoxin-repressive conditions is to be investigated. In fact, PacC is usually activated
under alkaline conditions [50] whereas hyssop addition does not change the pH of the medium (data
not shown).
The second regulatory factor is NsdC, known to be a developmental regulator whose alteration
causes several morphological aberrances such as shorter-stipe conidiophores presenting abnormal
conidial-head formations. Similar to VeA, NsdC modulation could participate to the morphological
modifications observed in hyssop-treated cultures (Figure 3). It has also been linked to aflatoxin
cluster-gene expression [51] as well as being a global regulator of secondary metabolism [52]. More
data is yet to be collected on the individual and possibly collaborative roles of both of these factors in
the regulation of secondary metabolism.
3.4. Morphological Modifications of Conidiophores and Vesicles of A. flavus in Hyssop-Supplemented Media
Besides its role in secondary metabolite regulation, VeA is also a developmental factor
in regulating morphogenesis as alterations in its expression levels can result in morphological
abnormalities. For example, a reduction in fungal aerial hyphae was noted in both A. flavus and
Fusarium graminaerum veA deleted strains [41,53]. Therefore, the modulation of veA expression could
contribute to morphological abnormalities observed upon hyssop exposure (Figure 3).
Furthermore, a single previous study has described the modification of the aerial hyphae in an
AF-inhibiting profile in A. parasiticus in the presence of n-decyl aldehyde, a corn-derived volatile
compound [54]. However, another study conducted on A. flavus mutant strains described the
appearance of morphological abnormalities, notably on phialide formation, associated to a cessation of
AFB1 production [51].
Alterations in morphology, such as the development of aerial hyphae, were also associated to
an imbalance in the G-protein signal transduction pathway [55,56]. This pathway is governed by
the binding of signaling molecule to G-protein coupled receptors (GPCR) such as those encoded
by gprK and gprH, both affected by the addition of hyssop to the media (Figure 5), and tuned by
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regulators of the G-protein signaling cascade (RGS), whose roles and implication in AFB1 synthesis
are being investigated in A. flavus [57]. G-protein signaling pathway is also linked to oxylipins
that are hormonal-like signaling molecules [58] produced by fatty-acid-oxygenases such as PpoC.
Moreover, oxylipins regulation has also been described as VeA-dependent [37]. However, fungal signal
perception and transduction pathways are a very complex loop due to the diversity of signals that
might initiate them and most importantly to the numerous acting factors involved downstream. Since
M. graeca extract is a complex extract containing many signal-provoking agents such as polysaccharides,
amino acids, minerals, phenolic compounds and many others, it remains possible that morphological
modifications have no direct link to AFB1’s inhibition.
4. Conclusions
This study demonstrates the efficiency of M. graeca aqueous extract in limiting AFB1 contamination
without altering fungal growth. Such an effect could ensure food safety without affecting biodiversity.
Indeed, A. flavus is a very competitive crop-contaminating agent; therefore, the use of fungistatic
agents could favor the emergence of other, possibly uncontrollable microorganisms. According
to our results, inhibition by hyssop extract occurs at a transcriptomic level as expression ratios
of all of aflatoxin cluster-genes were severely decreased. Nonetheless, hyssop extract triggered a
response in several fungal cellular mechanisms including cellular signaling, global transcription
factors, and conidial development, as well as factors acting in the oxidative stress response. Massive
transcriptomic analyses, such as RNAseq or Microarray assays, would be a good complement to
this study since they could provide a broader vision of cellular functions affected by the addition of
hyssop to the medium. Nonetheless, being as complex as it is, this extract may shelter several bioactive
compounds [59] contributing in a complementary way to its anti-aflatoxinogenic activity. To ascertain
more accurately the inhibitory mechanism of action, the content of this extract needs to be deciphered
in order to determine and purify its active molecules as well as the inhibition extent of each of the
isolated compounds.
5. Materials and Methods
5.1. Solvents and Standards
All solvents were HPLC grade and purchased from ThermoScientific Fisher (Villebon-Sur-Yvette,
France). Lyophilized aflatoxin B1 standard was purchased from Sigma Aldrich (St. Louis, MO, USA).
Stock solutions of each of the standards were prepared in methanol and stored at 4 ◦C in the dark.
Calibration curves were prepared beforehand by diluting stock solutions with mobile phase used for
HPLC analysis.
5.2. Preparation of the Aqueous Solution of Hyssop
Dried hyssop (M. graeca) was commercially purchased from Tyr, Lebanon. Hyssop species was
kindly confirmed by Prof. Marc Beyrouthy (Department of Agricultural Sciences, USEK—Lebanon).
Leaves were ground with an electrical grinder and ten grams of ground hyssop were added to 80 mL
of bi-distilled water and placed on a horizontal shaking table at 220 rpm for 24 h. Extracts were
then filtered through cotton gauze before being centrifuged for 10 min at 3500 rpm. Filtrates were
centrifuged once again, at 4700 rpm for 30 min and autoclaved at 121 ◦C for 15 min. Final sterile
extracts were stored at +4 ◦C until their use.
5.3. Fungal Strains and Growth Conditions
A referenced toxinogenic Aspergillus flavus strain NRRL 62477 isolated from paprika samples
harvested from a Moroccan market [59] was used to evaluate aflatoxin inhibition by aqueous solution of
hyssop as well as the molecular mechanism of inhibition. Further analysis of total aflatoxin inhibition
by the aqueous hyssop solution was conducted on two other A. flavus strains (E28 and E71) that
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were previously isolated from white pepper and paprika samples from Morocco [60]. Strains were
cultivated on a malt extract agar (MEA) medium (30 g malt extract and 15 g agar-agar per liter)
(Biokar Diagnostics, Allone, France), supplemented at 2% v/v with the autoclaved aqueous hyssop
solution, whereas 2% v/v water-supplemented media were used for control cultures. The media
for RNA isolation and dry weight measurement were layered with 8.5 cm diameter cellophane
disks (Hutchinson, Chalette-sur-Loing, France) before inoculation in order to allow separation of
mycelium from the culture medium. Spore suspensions were prepared in Tween 80 (0.05% in water)
from a one-week-old MEA culture. Spores were counted on a Malassez cell and 103 spores were
inoculated in the center of the medium. Cultures destined for RNA isolation were incubated in
6 replicates per condition for 4 days. For AFB1 quantification assays, cultures were incubated for
8 days and were in triplicates. All cultures were incubated at 27 ◦C. The media pH was measured
before and after inoculation and after incubation using a H199161 food pH-meter (Hanna Instruments,
Tanneries, France).
5.4. Examination of Cultural Parameters
5.4.1. Effect on Growth
The final growth mean was estimated by the measurement of culture diameters in length and
width at day 4.
5.4.2. Mycelium Dry Weight
Following a four-day incubation period, cellophane disks were peeled off and placed in new petri
dishes that were incubated for 48 h at 60 ◦C. Dried mycelium films were allowed to cool in a desiccator
before being weighed on an analytical balance. Final weight was calculated by subtracting the mean
weight of four desiccated control cellophane disks.
5.4.3. Total Spore Quantification
Colonies were cut out of MEA media, 1 mm beyond the mycelium border, placed in a stomacher
bag with 50 mL of Tween 0.05% and spores were gently manually scraped off of culture without tearing
the media. The bag was then placed in a stomacher for 90 s. The supernatant was filtered through
cotton gauze that was then rinsed with 3 × 20 mL Tween 0.05%. Spore solutions were homogenized
by thorough vortex and subsequent dilutions were prepared in Tween 0.05% for counting on a
Malassez cell in order to determine the total spore count (SC). Spore density (SD) was calculated as
SD = SC/(πr2), r = average colony radius.
5.4.4. Delay to Germination
Two hundred spores were inoculated in the center of the media and germinating spores were
counted after a 16-h incubation period at 27 ◦C by stereo-microscopic examination.
5.4.5. Fungal Morphological Features
Macroscopic (e.g., color of conidial areas, thallus margin and texture, aspect of conidial heads and
colony reverse) and microscopic (e.g., conidiophore, shape of vesicles, number of sterigmata, shape
of conidia and ornamentation) characters were observed under stereomicroscope SZX9—X12-120
(Olympus, Rungis, France) and optical microscope CX41—X400 and X1000 (Olympus, Rungis,
France) respectively.
5.5. RNA Isolation and Reverse Transcription
Cellophane disks along with the four-day mycelium were peeled off from the medium, finely
grinded with liquid nitrogen and a maximum of 100 mg were used for total RNA purification
through a RNeasy Plus Minikit (Qiagen, Hilden, Germany), which includes an on-column genomic
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DNA clean-up, following the manufacturer’s instructions. RNA integrity and purity were checked
with agarose gel electrophoresis and a NanoDrop ND1000 (Labtech, Palaiseau, France) that also
determined its concentration. First-strand cDNA synthesis reaction was primed using RevertAid
Reverse Transcriptase (MBI Fermentas, UK), RNase Inhibitor (Applied Biosystems, Warrington, UK)
and an anchored oligo(dT) Bys 3′ Primer (5′-GCTGTCAACGATACGCTAACGTAACGGCATGAC
AGTGTTTTTTTTTTTTTTTTT-3′). An RT minus sample, where no reverse transcriptase reaction takes
place, and a sterile water sample were added as negative controls in order to verify the absence of
undesirable genomic DNA contamination and primer complementation, respectively.
5.6. Real-Time PCR Expression Profile Analysis of Genes Regulating AFB1 Biosynthesis in A. flavus
The genome of A. flavus strain NRRL 3357 (GenBank accession number EQ963478) served as
a matrix for all of the primer used in this study. Gene selection and the corresponding primer
pair sequences were adapted from a previous work [29] and primer sequences of the stuA gene
(AFLA_046990) were added in this study (stuA_F: GATAAACGGAACCAAACTGCTCAA; stuA_R:
CACGCTCAAATGGGATCCAA ). In total, the expression of 61 genes was simultaneously analyzed,
27 of which corresponded to the AFB1 cluster and 34 to regulatory factors. Regulatory factors were
grouped into 6 categories: (1) environmental transcription factors (Area, CreA, MeaB and PacC);
(2) oxidative stress response factors (AtfA, AP-1, CatA, Cat2, MnSOD, MsnA, and SrrA); (3) the
velvet complex (LaeA, VeA, VelB and VosA); (4) factors belonging to different cellular signaling
families such as the Ras-family (RasA), the G-protein signaling family (FadA and FlbA) as well
as the G-protein receptors (GprK, GprA, GprH, GprP, and GprG) and oxylipin enzymes (PpoA,
PpoB, and PpoC); (5) regulators of development and conidiation (FluG, BrlA, StuA, and AbaA) and
(6) global secondary-metabolism-regulating transcription factors (NsdC, MtfA, and Fcr3). Primer
pairs design was based on the coding sequence of the corresponding genes, with at least one of
the primers extending on an exon/exon junction in order to avoid undesirable genomic DNA
amplification. Primer-dimers or self-complementarities were evaluated using the PrimerExpress 2.0
software (Applied Biosystems, Courtaboeuf, France). All primers were synthesized by Sigma Aldrich
(Saint-Quentin Fallavier, France). Following RNA extractions and reverse transcriptase reactions,
real-time PCR assays were performed on 15 ng cDNA in a 5 μL reaction volume per well, using
Power SYBR® Green PCR Master Mix (Applied Biosystems, Warrington, UK) as a fluorescent dye for
cDNA quantification. Master mixes and diluted cDNA samples were prepared separately on 96-well
Framestar Jupe plates (Dominique Dutscher, Issy-les-Moulineaux, France) and mixed in 384-well
plates by an Agilent Bravo Automated Liquid Handling Platform (Agilent Technologies, Santa Clara,
CA, USA). All real time amplification reactions were carried out on a ViiA7 Real-Time PCR System
(Applied Biosystems, Warrington, UK), as described by Tannous et al. [61].
5.7. Aflatoxin Extraction and HPLC Quantification
Media of four- and eight-day cultures were entirely retrieved and their AFB1 content determined
after extraction with 25 and 40 mL chloroform respectively. Extracts were held for 2 h on a horizontal
shaking table at 200 rpm and were then filtered through a Whatman 1PS phase separator filter (GE
Healthcare Life Sciences, Vélizy-Villacoublay, France, 150 mm diameter). Filtrates were evaporated to
dryness and dissolved in 1 mL of a water-acetonitrile-methanol mixture (65:17.5:17.5; v/v/v). Extracts
were filtered using 0.45 μm porosity disks (Thermo Scientific Fisher, Villebon-Sur-Yvette, France) before
analysis. HPLC analysis was performed using a Dionex Ultimate 3000 UHPLC (Thermo Scientific,
France) using a 125 × 2 mm, 5 μm, 100 Å, Luna® C18(2) LC column (Phenomenex, Torrance, CA,
USA). Aflatoxins were separated using the program described by Fu, Huang, & Min, 2008, with
minor modifications [62]. A mixture of water (acidified with 0.2% acetic acid)-acetonitrile (79:21,
v/v) is eluent A and methanol is eluent B. Separation program consists of a 30 min A:B (82.5:17.5)
isocratic flow at 0.2 mL/min. Aflatoxins were detected using a fluorescent detector at wavelengths
of 365/430 nm (excitation/emission). UV Spectra were confirmed by an additional diode array
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detector (DAD) coupled to the apparatus. Sample concentrations were calculated based on a standard
calibration curve.
5.8. Statistics
All experiments were performed in triplicate. For gene expression assays, six biological replicates
were used each time for each gene. Data presented for the dose-dependent effect of hyssop extract were
analyzed using a One-way ANOVA followed by a post hoc Dunnett’s test (α = 0.05) and conducted
with XLSTAT (Addinsoft, Paris). Gene expression and growth and sporulation data were analyzed
using Student’s t-test in Excel statistics. Differences were considered statistically significant when
p-value was lower than 0.05.
Supplementary Materials: The following are available online at www.mdpi.com/2072-6651/9/3/87/s1, Table S1:
Gene expression ratios of AFB1 cluster genes upon hyssop addition. Ratios are obtained in comparison to
control values.
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23. Michalczyk, M.; Macura, R.; Tesarowicz, I.; Banaś, J. Effect of adding essential oils of coriander (Coriandrum
sativum L.) and hyssop (Hyssopus officinalis L.) on the shelf life of ground beef. Meat Sci. 2012, 90, 842–850.
[CrossRef] [PubMed]
24. Soylu, E.M.; Kurt, S.; Soylu, S. In vitro and in vivo antifungal activities of the essential oils of various plants
against tomato grey mould disease agent Botrytis cinerea. Int. J. Food Microbiol. 2010, 143, 183–189. [CrossRef]
[PubMed]
25. Tisserand, R. Essential oil safety II. metabolism, neurotoxicity, reproductive toxicity. Int. J. Aromather. 1996, 7,
26–29. [CrossRef]
26. Alwan, S.; El Omari, K.; Soufi, H.; Zreika, S.; Sukarieh, I.; Chihib, N.-E.; Jama, C.; Hamze, M. Evaluation
of the antibacterial activity of Micromeria barbata in Lebanon. J. Essent. Oil Bear. Plants 2016, 19, 321–327.
[CrossRef]
27. Formisano, C.; Oliviero, F.; Rigano, D.; Saab, A.M.; Senatore, F. Chemical composition of essential oils
and in vitro antioxidant properties of extracts and essential oils of Calamintha origanifolia and Micromeria
myrtifolia, two Lamiaceae from the Lebanon flora. Ind. Crops Prod. 2014, 62, 405–411. [CrossRef]
28. Skotti, E.; Anastasaki, E.; Kanellou, G.; Polissiou, M.; Tarantilis, P.A. Total phenolic content, antioxidant
activity and toxicity of aqueous extracts from selected Greek medicinal and aromatic plants. Ind. Crops Prod.
2014, 53, 46–54. [CrossRef]
29. Chang, P.-K.; Yu, J.; Yu, J.-H. aflT, a MFS transporter-encoding gene located in the aflatoxin gene cluster, does
not have a significant role in aflatoxin secretion. Fungal Genet. Biol. 2004, 41, 911–920. [CrossRef] [PubMed]
267
Toxins 2017, 9, 87
30. Caceres, I.; El Khoury, R.; Medina, Á.; Lippi, Y.; Naylies, C.; Atoui, A.; El Khoury, A.; Oswald, I.P.; Bailly, J.-D.;
Puel, O. Deciphering the anti-aflatoxinogenic properties of eugenol using a large-scale q-PCR approach.
Toxins (Basel) 2016, 8, 123. [CrossRef] [PubMed]
31. Omidpanah, S.; Sadeghi, H.; Mohamadian, M.; Manayi, A. Evaluation of antifungal activity of aqueous
extracts of some medicinal plants against Aspergillus flavus, pistachio aflatoxin producing fungus in vitro.
Drug Dev. Ther. 2015, 6, 66–69.
32. Georgianna, D.R.; Payne, G.A. Genetic regulation of aflatoxin biosynthesis: From gene to genome.
Fungal Genet. Biol. 2009, 46, 113–125. [CrossRef] [PubMed]
33. Yu, J.; Chang, P.-K.; Ehrlich, K.C.; Bhatnagar, D.; Cleveland, T.E.; Payne, G.A.; Linz, J.E.; Woloshuk, C.P.;
Bennett, J.W. Clustered pathway genes in aflatoxin biosynthesis. Appl. Environ. Microbiol. 2004, 70, 1253–1262.
[CrossRef] [PubMed]
34. Ehrlich, K.C. Predicted roles of the uncharacterized clustered genes in aflatoxin biosynthesis. Toxins (Basel)
2009, 1, 37–58. [CrossRef] [PubMed]
35. Ehrlich, K.C.; Yu, J.; Cotty, P.J. Aflatoxin biosynthesis gene clusters and flanking regions. J. Appl. Microbiol.
2005, 99, 518–527. [CrossRef] [PubMed]
36. Holmes, R.A.; Boston, R.S.; Payne, G.A. Diverse inhibitors of aflatoxin biosynthesis. Appl. Microbiol.
Biotechnol. 2008, 78, 559–572. [CrossRef] [PubMed]
37. Calvo, A.M. The VeA regulatory system and its role in morphological and chemical development in fungi.
Fungal Genet. Biol. 2008, 45, 1053–1061. [CrossRef] [PubMed]
38. Bayram, O.; Braus, G.H. Coordination of secondary metabolism and development in fungi: The velvet family
of regulatory proteins. FEMS Microbiol. Rev. 2012, 36, 1–24. [CrossRef] [PubMed]
39. Bayram, O.; Krappmann, S.; Ni, M.; Bok, J.W.; Helmstaedt, K.; Valerius, O.; Braus-Stromeyer, S.; Kwon, N.-J.;
Keller, N.P.; Yu, J.-H.; et al. VelB/VeA/LaeA complex coordinates light signal with fungal development and
secondary metabolism. Science 2008, 320, 1504–1506. [CrossRef] [PubMed]
40. Baidya, S.; Duran, R.M.; Lohmar, J.M.; Harris-Coward, P.Y.; Cary, J.W.; Hong, S.-Y.; Roze, L.V.; Linz, J.E.;
Calvo, A.M. VeA is associated with the response to oxidative stress in the aflatoxin producer Aspergillus
flavus. Eukaryot. Cell 2014, 13, 1095–1103. [CrossRef] [PubMed]
41. Duran, R.M.; Cary, J.W.; Calvo, A.M. Production of cyclopiazonic acid, aflatrem, and aflatoxin by Aspergillus
flavus is regulated by veA, a gene necessary for sclerotial formation. Appl. Microbiol. Biotechnol. 2007, 73,
1158–1168. [CrossRef] [PubMed]
42. Sprote, P.; Brakhage, A.A. The light-dependent regulator velvet A of Aspergillus nidulans acts as a repressor of
the penicillin biosynthesis. Arch. Microbiol 2007, 188, 69–79. [CrossRef] [PubMed]
43. Ramamoorthy, V.; Dhingra, S.; Kincaid, A.; Shantappa, S.; Feng, X.; Calvo, A.M. The putative
C2H2 transcription factor MtfA is a novel regulator of secondary metabolism and morphogenesis in
Aspergillus nidulans. PLoS ONE 2013, 8, e74122. [CrossRef] [PubMed]
44. Zhuang, Z.; Lohmar, J.M.; Satterlee, T.; Cary, J.W.; Calvo, A.M. The master transcription factor mtfA
governs aflatoxin production, morphological development and pathogenicity in the fungus Aspergillus flavus.
Toxins (Basel) 2016, 8, 29. [CrossRef] [PubMed]
45. Jayashree, T.; Subramanyam, C. Oxidative stress as a prerequisite for aflatoxin production by Aspergillus
parasiticus. Free Radic. Biol. Med. 2000, 29, 981–985. [CrossRef]
46. Jayashree, T.; Subramanyam, C. Antiaflatoxigenic activity of eugenol is due to inhibition of lipid peroxidation.
Lett. Appl. Microbiol. 1999, 28, 179–183. [CrossRef] [PubMed]
47. Hong, S.-Y.; Roze, L.V.; Linz, J.E. Oxidative stress-related transcription factors in the regulation of secondary
metabolism. Toxins (Basel) 2013, 5, 683–702. [CrossRef] [PubMed]
48. Chang, P.-K.P.; Scharfenstein, L.L.L.; Luo, M.; Mahoney, N.; Molyneux, R.J.; Yu, J.; Brown, R.L.; Campbell, B.C.
Loss of msnA, a putative stress regulatory gene, in Aspergillus parasiticus and Aspergillus flavus increased
production of conidia, aflatoxins and kojic acid. Toxins (Basel) 2011, 3, 82–104. [CrossRef]
49. Hong, S.-Y.; Roze, L.V.; Wee, J.; Linz, J.E. Evidence that a transcription factor regulatory network coordinates
oxidative stress response and secondary metabolism in aspergilli. Microbiologyopen 2013, 2, 144–160.
[CrossRef] [PubMed]
50. Ke, R.; Haynes, K.; Stark, J. Modelling the activation of alkaline pH response transcription factor PacC in
Aspergillus nidulans: Involvement of a negative feedback loop. J. Theor. Biol. 2013, 326, 11–20. [CrossRef]
[PubMed]
268
Toxins 2017, 9, 87
51. Cary, J.W.; Harris-Coward, P.Y.; Ehrlich, K.C.; Mack, B.M.; Kale, S.P.; Larey, C.; Calvo, A.M. NsdC and
NsdD affect Aspergillus flavus morphogenesis and aflatoxin production. Eukaryot. Cell 2012, 11, 1104–1111.
[CrossRef] [PubMed]
52. Gilbert, M.K.; Mack, B.M.; Wei, Q.; Bland, J.M.; Bhatnagar, D.; Cary, J.W. RNA sequencing of an nsdC mutant
reveals global regulation of secondary metabolic gene clusters in Aspergillus flavus. Microbiol. Res. 2015, 182,
150–161. [CrossRef] [PubMed]
53. Jiang, J.; Liu, X.; Yin, Y.; Ma, Z. Involvement of a velvet protein FgVeA in the regulation of asexual
development, lipid and secondary metabolisms and virulence in Fusarium graminearum. PLoS ONE 2011, 6,
e28291. [CrossRef] [PubMed]
54. Wright, M.S.; Greene-Mcdowelle, D.M.; Zeringue, H.J.; Bhatnagar, D.; Cleveland, T.E. Effects of volatile
aldehydes from Aspergillus-resistant varieties of corn on Aspergillus parasiticus growth and aflatoxin
biosynthesis. Toxicon 2000, 38, 1215–1223. [CrossRef]
55. Yang, Q.; Borkovich, K.A. Mutational activation of a Gα(i) causes uncontrolled proliferation of aerial hyphae
and increased sensitivity to heat and oxidative stress in Neurospora crassa. Genetics 1999, 151, 107–117.
[PubMed]
56. Han, K.H.; Seo, J.A.; Yu, J.H. Regulators of G-protein signalling in Aspergillus nidulans: RgsA downregulates
stress response and stimulates asexual sporulation through attentuation of GanB (Gα) signalling.
Mol. Microbiol. 2004, 53, 529–540. [CrossRef] [PubMed]
57. Affeldt, K.; Carrig, J.; Amare, M.G.; Keller, N. Global survey of canonical Aspergillus flavus G protein-coupled
receptors. MBio 2014, 5, 1501–1514. [CrossRef] [PubMed]
58. Brodhagen, M.; Keller, N.P. Signalling pathways connecting mycotoxin production and sporulation.
Mol. Plant Pathol. 2006, 7, 285–301. [CrossRef] [PubMed]
59. Atoui, A.K.; Mansouri, A.; Boskou, G.; Kefalas, P. Tea and herbal infusions: Their antioxidant activity and
phenolic profile. Food Chem. 2005, 89, 27–36. [CrossRef]
60. EL Mahgubi, A.; Bailly, S.; Tadrist, S.; Querin, A.; Ouadia, A.; Oswald, I.P.; Bailly, J.-D. Distribution and
toxigenicity of Aspergillus section Flavi in spices marketed in Morocco. Food Control 2013, 32, 143–148.
[CrossRef]
61. Tannous, J.; El Khoury, R.; Snini, S.P.; Lippi, Y.; El Khoury, A.; Atoui, A.; Lteif, R.; Oswald, I.P.; Puel, O.
Sequencing, physical organization and kinetic expression of the patulin biosynthetic gene cluster from
Penicillium expansum. Int. J. Food Microbiol. 2014, 189, 51–60. [CrossRef] [PubMed]
62. Fu, Z.; Huang, X.; Min, S. Rapid determination of aflatoxins in corn and peanuts. J. Chromatogr. A 2008, 1209,
271–274. [CrossRef] [PubMed]
© 2017 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access
article distributed under the terms and conditions of the Creative Commons Attribution




Protective Effects of Sporoderm-Broken Spores of
Ganderma lucidum on Growth Performance,
Antioxidant Capacity and Immune Function of Broiler
Chickens Exposed to Low Level of Aflatoxin B1
Tao Liu 1, Qiugang Ma 1,*, Lihong Zhao 1, Ru Jia 2, Jianyun Zhang 1, Cheng Ji 1 and
Xinyue Wang 1
1 State Key Laboratory of Animal Nutrition, College of Animal Science and Technology,
China Agricultural University, Beijing 100193, China; liuyitao2004@126.com (T.L.);
lihongzhao100@126.com (L.Z.); jyzhang@cau.edu.cn (J.Z.); jicheng@cau.edu.cn (C.J.);
xinyuewang2016@126.com (X.W.)
2 College of Life Science, Shanxi University, Taiyuan 030006, Shanxi, China; jiaru.bjdk071@163.com
* Correspondence: maqiugang@cau.edu.cn; Tel.: +86-10-62731998; Fax: +86-10-62732774
Academic Editor: Ting Zhou
Received: 16 August 2016; Accepted: 21 September 2016; Published: 24 September 2016
Abstract: This study was conducted to investigate the toxic effects of aflatoxin B1 (AFB1) and evaluate
the effects of sporoderm-broken spores of Ganoderma lucidum (SSGL) in relieving aflatoxicosis in
broilers. A total of 300 one-day-old male Arbor Acre broiler chickens were randomly divided into four
dietary treatments; the treatment diets were: Control (a basal diet containing normal peanut meal);
AFB1 (the basal diet containing AFB1-contaminated peanut meal); SSGL (basal diet with 200 mg/kg
of SSGL); AFB1+SSGL (supplementation of 200 mg/kg of SSGL in AFB1 diet). The contents of AFB1
in AFB1 and AFB1+SSGL diets were 25.0 μg/kg in the starter period and 22.5 μg/kg in the finisher
period. The results showed that diet contaminated with a low level of AFB1 significantly decreased
(p < 0.05) the average daily feed intake and average daily gain during the entire experiment and
reduced (p < 0.05) serum contents of total protein IgA and IgG. Furthermore, a dietary low level
of AFB1 not only increased (p < 0.05) levels of hydrogen peroxide and lipid peroxidation, but also
decreased (p < 0.05) total antioxidant capability, catalase, glutathione peroxidase, and hydroxyl
radical scavenger activity in the liver and spleen of broilers. Moreover, the addition of SSGL to
AFB1-contaminated diet counteracted these negative effects, indicating that SSGL has a protective
effect against aflatoxicosis.
Keywords: spores of Ganoderma lucidum; oxidative stress; aflatoxins; antioxidant capability
1. Introduction
Aflatoxins (AFBs) are the most common mycotoxins and are mainly produced by
Aspergillus flavus and Aspergillus parasiticus [1]. Among all the AFBs, aflatoxin B1 (AFB1) is the most
highly toxic contaminant in foods and feedstuffs, and is classified by the International Agency of
Research on Cancer (IARC) as a Group 1 carcinogen. In poultry, consumption of AFB1 can cause huge
economic losses by retarding animal growth, increasing feed efficiency and the incidence of disease,
and inducing damage to organs such as the liver and spleen [2,3]. Moreover, the carry-over of AFB1
through animal-derived products into the human food chain is a potential threat to human health due
to its hepatotoxicity, carcinogenicity, mutagenicity, teratogenicity, and immunosuppression [4,5]. AFB1
is the most widespread oxidative agent of the AFBs [6], and it was reported that the toxic effects of
AFB1 were intimately linked with its pro-oxidant which could induce the generation of reactive oxygen
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species (ROS) and lead to the impairment of DNA, RNA, proteins, lipids, and other molecules [7,8].
Therefore, some studies suggested that the addition of antioxidants to diets could protect animals
against AFB1-induced toxicity by enhancing the antioxidant system and immunity [9,10].
Ganoderma lucidum (G. lucidum), a traditional folk medicinal mushroom, has been used
as an important longevity and health-promoting herb for more than 2000 years in China [11].
The spores of Ganoderma lucidum (SGL), ejected from the pileus of G. lucidum in the mature phase,
are tiny and mist-like particles of about 6.5–8.0 × 9.6–12.6 μm enwrapped with an outer bilayer
of sporoderm [12]. During the past two decades, because the spores could be collected on a large
scale, SGL has attracted extensive interest as studies revealed that the spores possess many bioactive
substances, including polysaccharides, unsaturated fatty acids, triterpenoids, nucleotides, ergostero
and other bioactive ingredients [13,14]. In vitro, the polysaccharides of SGL had strong bioactivity in
scavenging 1,1-Diphenyl-2-picrylhydrazyl and oxygen radicals [15]. In addition, antioxidant activities
of polysaccharides from SGL were also demonstrated in rats [16]. Furthermore, the polysaccharides
from SGL had potent stimulating effects on spleen mass, lymphocyte proliferation and antibody
production in mice [17,18]. Fatty acids are another kind of potential active ingredient of SGL,
which showed high bioactivities in antitumor and immunomodulation in rats [19,20]. However,
the bioactivities of spores are closely related to the status of the sporoderm; the intact sporoderm can
inhibit the release and absorption of bioactive substances in the spores [21]. Yue et al. [22] observed
that dietary sporoderm-broken spores of Ganoderma lucidum (SSGL) were more effective in stimulating
the production of interferon-γ, interleukin-2, interleukin-4 and interleukin-6 in mice than dietary
sporoderm-unbroken spores of G. lucidum. Therefore, we speculated that supplementation of SSGL
to AFB1-contaminated diets might alleviate aflatoxicosis through decreasing the oxidative status and
elevating the antioxidant defense system.
Our previous study showed that different levels of SSGL (100, 200 and 500 mg/kg) improved
the average daily gain, decreased the feed:gain ratio, and enhanced the antioxidant capacity in the
liver and spleen of broilers. In this study, SSGL was chosen to evaluate its protective effects on growth
performance, antioxidant function and serum immunoglobulins of male Arbor Acre broilers exposed
to a low level of AFB1.
2. Results
2.1. Effects of SSGL on Growth Performance of Male Arbor Acre Broiler Chickens Exposed to Low
Level of AFB1
In 0–21 d, broilers fed a diet contaminated with AFB1 resulted in a significant decrease (p < 0.05) in
average daily feed intake (ADFI) as compared to the control group (Table 1). The addition of SSGL into
the diet contaminated with AFB1 significantly increased (p < 0.05) the ADFI of broilers as compared
to the AFB1 group. The ADFI of broilers among control, SSGL and AFB1+SSGL groups showed no
significant differences (p > 0.05). The average daily gain (ADG) and feed:gain ratio (F:G) were not
significantly affected (p > 0.05) by a low level of AFB1 or dietary SSGL in broilers.
In 22–44 d, broilers in the AFB1 group had significantly lower (p < 0.05) ADFI and ADG than those
in the control group. However, supplementation of SSGL to the AFB1-contaminated diet obviously
increased (p < 0.05) ADFI, ADG and decreased (p < 0.05) F:G as compared with the AFB1 group.
In addition, broilers in the SSGL and AFB1+SSGL groups had significantly higher (p < 0.05) ADG than
those in the control group, but ADFI, ADG and F:G between the SSGL and AFB1+SSGL groups showed
no significant differences (p > 0.05). Similar effects of SSGL on the growth performance (ADG, ADFI
and F:G) of broilers exposed to a low level of AFB1 were also observed during the entire experiment
(0–44 d).
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Table 1. Effects of SSGL on growth performance of male Arbor Acre broiler chickens exposed to a low
level of AFB1.
Index 1 Control AFB1 SSGL AFB1+SSGL SEM p-Value
0–21 d
ADFI (g/d) 53.0 a 51.0 b 52.2 ab 53.0 a 0.296 0.039
ADG (g/d) 33.5 32.9 33.3 33.1 0.141 0.441
F:G 1.58 1.55 1.57 1.60 0.011 0.425
22–44 d
ADFI (g/d) 135.7 a 132.0 b 138.0 a 137.9 a 0.776 0.008
ADG (g/d) 70.4 b 67.8 c 74.0 a 73.8 a 0.632 <0.001
F:G 1.93 ab 1.95 a 1.87 b 1.87 b 0.012 0.011
0–44 d
ADFI (g/d) 98.1 a 95.2 b 99.0 a 99.4 a 0.515 0.006
ADG (g/d) 53.6 b 51.9 c 55.5 a 55.3 a 0.360 <0.001
F:G 1.83 a 1.84 a 1.78 b 1.80 ab 0.008 0.069
1 Data are expressed as group mean values; ADFI, average daily feed intake; ADG, average daily gain;
F:G, feed:gain ratio, equal to ADFI/ ADG; SEM, standard error of the mean; a–c Means within the same row
with different superscripts are significantly different (p < 0.05).
2.2. Effects of SSGL on Oxidative Status in Liver and Spleen of Male Arbor Acre Broiler Chickens Exposed to
Low Level of AFB1
The data in Table 2 showed that the hepatic levels of H2O2, MDA and LPO of broilers in the AFB1
group were significantly higher (p < 0.05) than those in the control group, but these indexes were
markedly decreased (p < 0.05) by the supplementation of SSGL into the diet contaminated with AFB1.
Moreover, broilers in the SSGL group had significantly lower (p < 0.05) hepatic levels of H2O2 and
MDA than those in the control group. A higher (p < 0.05) hepatic H2O2 level and lower (p < 0.05)
hepatic MDA level of broilers were observed in the AFB1 group as compared to the control group,
but the hepatic LPO level of broilers showed no difference (p > 0.05) among the control, SSGL and
AFB1+SSGL groups.
Table 2. Effects of SSGL on oxidative status in liver and spleen of male Arbor Acre broiler chickens
exposed to a low level of AFB1.




c 15.06 a 9.60 d 12.38 b 0.540 <0.001
MDA (nmol/g prot) 2.57 b 3.10 a 2.07 d 2.26 c 0.102 <0.001




b 16.19 a 14.18 b 14.23 b 0.252 0.001
MDA (nmol/g prot) 1.87 ab 1.95 a 1.80 b 1.84 ab 0.019 0.046
LPO (μmol/g prot) 4.20 b 5.08 a 3.34 c 3.04 d 0.207 <0.001
1 Data are expressed as group mean values; H2O2, hydrogen peroxide; MDA, malondiadehyde; LPO, lipid
peroxidation. SEM, standard error of the mean; a–d Means within the same row with different superscripts are
significantly different (p < 0.05).
Similar to the liver, the splenic levels of H2O2 and LPO of broilers in the AFB1 group were
significantly increased (p < 0.05) as compared with those in the control group (Table 2). However, the
addition of SSGL in the diet contaminated with AFB1 significantly reduced (p < 0.05) H2O2 and LPO
272
Toxins 2016, 8, 278
levels in the spleen compared with the AFB1 group. In addition, the splenic level of LPO in the SSGL
and AFB1+SSGL groups was significantly lower (p < 0.05) than that in the control group, and broilers
in the SSGL group had a lower (p < 0.05) MDA level than those in AFB1 group. These results showed
that diets contaminated with AFB1 could aggravate the oxidative status of broilers, which could be
relieved by the supplementation of SSGL.
2.3. Effects of SSGL on Antioxidant Defense System in Liver and Spleen of Male Arbor Acre Broiler Chickens
Exposed to Low Level of AFB
Broilers fed a diet contaminated with AFB1 had significantly decreased (p < 0.05) T-AOC, CAT,
GR, GSH-Px and HRSA levels in the liver as compared with those in the control group (Table 3), while
the addition of SSGL into the diet contaminated AFB1 significantly enhanced (p < 0.05) the levels of
T-AOC, CAT, GR, HRSA and GSH in the liver. When compared to the control group, hepatic enzyme
activities (T-AOC, CAT, GR) and the GSH level of broilers were significantly increased (p < 0.05) in
the SSGL group, whereas a significantly lower (p < 0.05) hepatic activity of GSH-Px and a higher
(p < 0.05) level of GSH were observed in broilers in the AFB1+SSGL group. The hepatic activity of
T-SOD of broilers exposed to AFB1 was not significantly affected (p > 0.05) by dietary supplementation
with SSGL.
Table 3. Effects of SSGL on antioxidant defense system in liver and spleen of male Arbor Acre broiler
chickens exposed to a low level of AFB1.
Index 1 Control AFB1 SSGL AFB1+SSGL SEM p-Value
Liver
T-AOC (U/mgprot) 2.19 b 2.04 c 2.32 a 2.28 ab 0.032 <0.001
CAT U/mgprot) 8.13 b 7.35 c 9.43 a 8.05 b 0.205 <0.001
T-SOD (U/mgprot) 16.95 16.78 16.12 16.58 0.227 0.647
GR (U/gprot) 4.47 b 3.74 c 6.74 a 4.84 b 0.297 <0.001
GSH-Px (U) 43.25 a 37.50 b 43.49 a 36.63 b 0.853 <0.001
GSH (mg/gprot) 2.03 b 2.07 b 2.43 a 2.44 a 0.058 0.001
HRSA (U/g prot) 2.42 a 1.98 b 2.58 a 2.45 a 0.062 <0.001
Spleen
T-AOC (U/mgprot) 2.46 b 1.78 c 3.28 a 2.52 b 0.139 <0.001
CAT (U/mgprot) 5.35 a 4.33 b 5.42 a 4.48 b 0.131 <0.001
T-SOD (U/mgprot) 22.22 a 19.27 b 22.11 a 21.64 a 0.363 0.001
GR (U/gprot) 6.34 c 6.02 c 9.25 a 7.52 b 0.346 <0.001
GSH-Px (U) 47.73 a 43.39 b 47.59 a 44.94 b 0.542 <0.001
GSH (mg/gprot) 3.92 b 3.64 c 4.32 a 4.36 a 0.079 <0.001
HRSA (U/g prot) 1.87 c 1.61 d 2.48 a 2.06 b 0.084 <0.001
1 Data are expressed as group mean values; T-AOC, total antioxidant capability; CAT, catalase; GR, glutathione
reductase; GSH-Px, glutathione peroxidase; GSH, reduced glutathione; HRSA, Hydroxyl radical scavenger
activity; SEM, standard error of the mean. a–d Means within the same row with different superscripts are
significantly different (p < 0.05).
Similar negative effects of AFB1 and ameliorative effects of dietary SSGL on the antioxidant
defense system were also found in the spleen (Table 3). The splenic levels of T-AOC, CAT, T-SOD,
GSH-Px, HRSA and GSH of broilers in the AFB1 group were lower (p < 0.05) than those in the control
group. However, supplementation of SSGL to the AFB1-contaminated diet significantly enhanced
(p < 0.05) splenic levels of T-AOC, T-SOD, GR, HRSA and GSH as compared to the AFB1 group. In
addition, broilers in the SSGL group had significantly higher T-AOC, GR, GSH, HRSA levels than
those in the control group, and significantly lower (p < 0.05) activities of CAT, GSH-Px, and higher
(p < 0.05) activities of GR, HRSA and GSH were observed in the AFB1+SSGL group as compared to
the control group. The splenic activities of T-AOC, CAT, GR, GSH-Px, HRSA in the SSGL group were
higher (p < 0.05) than those in the AFB1+SSGL group.
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2.4. Effects of SSGL on Serum Total Protein and Immunoglobulins of Male Arbor Acre Broiler Chickens
Exposed to Low Level of AFB1
The contents of serum TP, IgA and IgG of broilers exposed to a low level of AFB1 were significantly
lower (p < 0.05) than those in the control group (Table 4), while these indexes were significantly
improved by the addition of SSGL to the diet contaminated with AFB1. However, the contents of
serum TP, IgA and IgG of broilers among the control, SSCL and AFB1+SSGL groups showed no
significant differences (p > 0.05). There was no significant difference (p > 0.05) in the serum IgM of
broilers among all the groups.
Table 4. Effects of SSGL serum immunoglobulins of male Arbor Acre broiler chickens exposed to a low
level of AFB1.
Index 1 Control AFB1 SSGL AFB1+SSGL SEM p-Value
TP (g/L) 24.82 a 22.73 b 25.94 a 25.07 a 0.374 0.007
IgA (g/L) 0.291 a 0.284 b 0.298 a 0.295 a 0.002 0.003
IgG (g/L) 0.266 a 0.232 b 0.273 a 0.257 a 0.005 <0.001
IgM (g/L) 0.224 0.225 0.229 0.236 0.002 0.288
1 Data are expressed as group mean values; TP, total protein; SEM, standard error of the mean; a,b Means within
the same row with different superscripts are significantly different (p < 0.05).
3. Discussion
3.1. Toxicity of AFB1 on Growth Performance
Feedstuffs are easily contaminated with AFB1 during harvesting, transportation and storage,
and it was reported that the detection rates of AFB1 were 50% in corn, 36% in soybean meal, 94%
in DDGS, respectively, in the Beijing region [23], and 15.39% in peanuts in the south of China [24].
Therefore, the presence of AFB1 in animals’ diets is hard to avoid, and it is increasingly recognized
that the long-term consumption of low levels of AFBs is detrimental to animals’ growth and health. In
this study, diet contaminated with AFB1 caused a significant decrease in the ADFI of broilers during
the starter period (0–21 d), and not only the ADFI but also the ADG of broilers during the finisher
period (22–44 d) were significantly reduced by dietary AFB1. Similar results had been observed in the
previous studies, in which an AFB1-containing diet (50–100 μg/kg) could significantly decrease the
body weight gain and feed consumption of broilers, causing economic loss [2,25]. Ducks fed diets
containing 20 μg/kg of AFB1 had a significantly lower ADG, ADF, and higher F:G [26]. These results
indicated that diets containing a low level of AFB1 (22.5–25.0 μg/kg) could inhibit broiler growth and
cause great financial losses.
3.2. Toxicity of AFB1 on Oxidative Stress of Broilers
Liver and immune system organs such as the spleen are considered to be sensitive to AFB1 [27,28].
It had been reported that the toxic effect elicited by AFB1 could be closely related to the generation
of reactive oxygen species (ROS), mainly including superoxide (O2−), hydrogen peroxide (H2O2),
and hydroxyl (OH·) [29]. H2O2 is released from the mitochondria; hydroxyl radicals (OH·) are also
an extremely reactive free radical. Biosynthesis and accumulation of ROS are central to oxidative
stress-related metabolism [30]. The exceeded ROS could enhance lipid peroxidation, which will impair
membrane function by decreasing membrane fluidity and changing the activities of membrane-bound
enzymes and receptors [31]. MDA is formed at the end of lipid peroxidation, and reflects the degree
of the whole lipid oxidation in the body. In this study, the contents of H2O2, MDA and LPO in
the liver and spleen of broilers were significantly increased by dietary AFB1, indicating that a low
level of AFB1 (22.5–25.0 μg/kg) could increase the oxidative status in the liver and spleen of broilers.
Similar toxic effects of AFB1 on oxidative status were observed in the liver and spleen of rats [32], and
broilers [33,34].
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The levels of free radical molecules and lipid peroxidation are controlled by an antioxidant
defense system, consisting of enzymatic components such as SOD, CAT, and GR, and non-enzymatic
components such as GSH and vitamin E [35]. When oxidative stress arises as a pathologic event,
the defense system will promote the regulation and expression of enzymatic and non-enzymatic
components [36]. SOD can detoxicate O2− to H2O2, and then GSH-Px and CAT catalyze H2O2
directly to water and oxygen at the expense of GSH [37,38]. Many studies observed that dietary AFB1
could decrease the activities of antioxidant enzymes and levels of non-enzymatic antioxidants in
broilers [9,39,40]. In the present study, the antioxidant enzyme activities and GSH level in the liver
and spleen of broilers fed a diet contaminated with AFB1 were significantly lower than those in the
control group, suggesting that the diet contaminated with a low level of AFB1 (22.5–25.0 μg/kg) could
suppress the antioxidant capacity of broilers.
3.3. Toxicity of AFB1 on Serum Total Protein and Immunoglobulins of Broilers
Except for the toxic effects of AFB1 on the liver and spleen, the immunosuppression in animals
is also a matter of concern, because it may predispose farm animals to infectious diseases and result
in economic losses [41]. Immunoglobulins, secreted by B cells, are the main antibody isotypes of
the serum and extracellular fluid immune system, thereby allowing them to control the infection of
body tissues. AFB1 is known to be immunosuppressive in birds, and it has been reported that diets
containing 300 μg/kg of AFB1 significantly reduced the serum IgA, IgG and IgM of broilers [42]. In
addition, chickens fed aflatoxin at a concentration of 2500 μg/kg had lower serum total protein (TP),
albumin and IgG, but serum IgM was not affected by AFBs [43]. Serum TP is the indicator of protein
synthesis, and the decreased serum TP induced by dietary AFB1 may contribute to the decreased
contents of immunoglobulins [44,45]. In the present study, broilers fed diets contaminated with a low
level of AFB1 (22.5–25.0 μg/kg) had significantly lower serum TP, IgA and IgG, while serum IgM was
not significantly affected by dietary AFB1. One mechanism of action of AFBs is related to the inhibition
of protein synthesis, which may be responsible for the decrease in serum IgA and IgG in this study.
3.4. Effects of SSGL
Seeking effective ways to alleviate the negative effects of AFB1 has attracted more and more
attention. Nowadays, researchers found that different feed additives had the ability to relieve
aflatoxicosis. Alpha-lipoic acid, known as an “ideal antioxidant”, could prevent hepatic oxidative
stress and down-regulate the expression of hepatic pro-inflammatory cytokines of broilers exposed
to a low level of AFB1 [46]. Selenium, playing important roles in immune function, could protect
chickens from AFB1-induced impairment of humoral and cellular immune function by reducing bursal
histopathological lesions and percentages of apoptotic bursal cells [47]. Vitamin E, as an antioxidant,
could ameliorate AFB1-induced toxicity in rats [9] and in ducks [48]. Moreover, some plants or
their extracts, such as Chinese cabbage powder [49] and tinospora cordifolia root extract [50], were
demonstrated to counteract the detrimental toxic effects of AFBs. Although SGL, as a traditional
Chinese herb, is characterized as having antioxidation, immunomodulation and hepatoprotection
activities, there is no study to assess the protective effects of SGL or its extracts on AFB1-induced
toxins in broiler chickens. In the present study, the results showed that the addition of SSGL to an
AFB1-contaminated diet relieved the negative effects of AFB1 on the growth performance of broilers.
SGL has strong bioactivities in antioxidation, and polysaccharides from SGL had been reported to
have the ability to scavenge DPPH radicals, increase reducing power and inhibit lipid peroxidation
in vitro [51]. Moreover, SGL was effective in protection against Cd(II)-induced hepatotoxicity
through reducing the increase in serum AST, ALT and hepatic MDA of mice [52]. Supplementation
with 4 or 8 g/kg of SGL significantly increased the activities of GSH and GR, and decreased the MDA
content in the hippocampus of rats [15]. In type 2 diabetic rats, the serum level of MDA was 13.9%
lower, and serum levels of GSH-Px and SOD were 25.9% and 38.0% higher at four weeks in the SGL
group [53]. Some antioxidants such as vitamin E and alpha-lipoic acid are reported to be effective
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in protecting animals from oxidative damage induced by AFB1, so SSGL may have similar abilities.
Indeed, lower oxidative status and higher antioxidant capacity were observed in broilers fed on a diet
supplemented with SSGL in the present study, indicating that dietary SSGL could protect broilers from
oxidative damage induced by AFB1.
In the present study, the results showed that dietary SSGL significantly increased the
contents of serum TP, IgA and IgG, and decreased the AFB1-induced toxins to serum immunity.
Mohan et al. [54] observed that dietary polysaccharides of G. lucidum significantly increased the
muscle TP of Macrobrachium rosenbergii. Finisher pigs fed diets that received polysaccharides of
G. lucidum had higher contents of serum TP, globulin and IgG [55]. These results suggested that
G. lucidum may have the ability to increase the protein synthesis of animals. Di et al. [56] found
that the high-performance thin-layer chromatography fingerprint profiles of carbohydrate and acid
hydrolyzates of polysaccharides from G. lucidum and the spores were quite similar, indicating that
they may have similar bioactivities. The (1 → 3)-α-D-glucan of SGL enhanced the T and B lymphocyte
proliferation and antibody production of rats [17]. Thus, the mechanism of SSGL improving serum
IgA and IgG in this study could be partially due to the decrease in the inhibition of protein synthesis
induced by AFB1.
4. Conclusions
The results from this study demonstrated that diets contaminated with AFB1 (22.5–25.0 μg/kg)
suppressed the growth performance, antioxidant capacity and immune action of broilers. However, the
addition of SSGL significantly counteracted the adverse effects of AFB1, effectively improving growth
performance and reducing the oxidative stress and immunosuppression of broilers; so SSGL, as a feed
additive for inhibiting aflatoxicosis, may have promising potential in feed industrial applications.
5. Materials and Method
5.1. Sporoderm-Broken Spores of Ganoderma lucidum
SGL in present study was supplied by Riverside Ganoderma Lucidum Planting Co. Ltd.
(Xiuyan Manchu Autonomous County, Anshan, Liaoning Province, China). The spores was dried
at 55 ◦C for 24 h, and then broken by supercritical fluid extraction device (Nantong Hua′an Co. Ltd.,
Nantong, China). Briefly, approximately 150 g of spores was loaded into a steel cylinder equipped
with mesh filters (6.5 μm) on both ends. Liquefied CO2 was pumped into the vessel and the pressure
was raised to 35 MPa consequently. The process was last for 4 h and the temperature was set at 25 ◦C
by the temperature controller. At the end of process, the pressure was quickly released within 1 min,
and the spores was broken due to rapid depressurization. The SSGL were removed and stored
at −20 ◦C before adding into the diets [12,57].
5.2. Birds, Diets and Management
This study was approved by the Animal Care and Use Committee of the China Agricultural
University (ethical approval code: CAU20151028-2; Date: 28 October 2015). A total of 300 one-day-old
male Arbor Acre broiler chickens were obtained from a commercial company (Beijing Huadu Yukou
Poultry Co., Ltd., Beijing, China). Birds with similar body weights (40.0 ± 1.0 g) were randomly
assigned to four treatments with five replicate pens of 15 birds per pen. The diets for treatments
were: Control (the basal diets containing 20% normal peanut meal in the starter and 18% in the
finisher period, without any mycotoxins); AFB1 (moldy peanut meal naturally contaminated with
121.7 μg/kg AFB1 substituting for all the normal peanut meal in the basal diet); SSGL (basal diet
received 200 mg/kg of SSGL); AFB1+SSGL (AFB1 diet supplemented with 200 mg/kg of SSGL).
The contents of mycotoxins (AFB1, AFB2, AFG1, AFG2, deoxynivalenol (DON), zearalenone (ZEA)
and ochratoxin (OTA)) in basal diet and AFB1-contaiminated diets were tested with HPLC (Shimadzu
LC-10 AT, Shimadzu, Tokyo, Japan) method [25,58]. Briefly, 25 g of the milled samples were mixed
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with 80 mL of methanol-water (80:20 v/v) for aflatoxins; water for DON; acetonitrile-water (70:30 v/v)
for ZEA; methanol-water (60:40 v/v) for OTA, the mixtures were shaken for 2 h. The extracts were
filtered, and the filtrate was cleaned up through an immunoaffinity column (Vicam, Milford, MA, USA)
before HPLC determination. The limits of detection (LOD) and quantification (LOQ) were: 0.10 and
0.50 μg/kg for AFB1; 0.08 and 0.25 μg/kg for AFB2; 0.15 and 0.50 μg/kg for AFG1; 0.10 and 0.50 μg/kg
for AFG2; 1.00 and 5.00 μg/kg for ZEA; 10.00 and 50.00 μg/kg for DON; 0.21 and 0.60 μg/kg for OTA,
respectively. The final contents of AFB1 in diets received moldy peanut meal (AFB1 and AFB1+SSGL
groups) were 25.0 ± 1.2 μg/kg in starter period and 22.5 ± 1.1 μg/kg in finisher period; the other
mycotoxins were determined to be at concentrations below detection limits. Hardly any aflatoxins or
other mycotoxins were found (below detection limits) in basal diets.
The formulation of the basal diets are presented in Table 5, all essential nutrients in the basal diet
met NRC (1994) [59]. The feeding trial period lasted for 44 days.
Table 5. Ingredients and nutrient composition of the basal diet.
Ingredient (%) Starter Period (0–21 d) Finisher Period (22–44 d)
Corn 57.95 60.79
Soybean meal 14.20 13.30
Peanut meal 20.00 18.00
Limestone 1.30 1.00
Dicalcium phosphate 1.80 1.50
Salt 0.30 0.30
Soybean oil 3.00 4.00
Lysine [98.5%] 0.46 0.34
DL-Methionine 0.37 0.20
Threonine 0.19 0.14
Choline chloride 0.10 0.10
Vitamin premix 1 0.03 0.03






Total phosphorus 0.67 0.61
Lys 1.15 1.01
Met 0.63 0.45
1 Provided per kilogram of diet: vitamin A, 15,000 IU; cholecalciferol, 3000 IU; vitamin E, 20 IU;
vitamin K 3, 2.18 mg; thiamine, 2.15 mg; riboflavin, 8.00 mg; pyridoxine, 4.40 mg; vitamin B 12, 0.02 mg;
Calcium pantothenate, 25.60 mg; nicotinic acid, 65.80 mg; folic acid, 0.96 mg; biotin, 0.20 mg. 2 Provided per
kilogram of diet: Fe, 100.0 mg; Cu, 8.0 mg; Zn, 78.0 mg; Mn, 105.0 mg; I, 0.5 mg; Se, 0.3 mg.
The trial was conducted in two periods consisting of a starter period from day 1 to 21 and a
finisher period from day 22 to 44. The rearing system was designed as flooring rearing. All birds
were raised in weird-floored pens (100 × 100 × 60 cm) in an environmentally controlled room with
continuous light. The temperature was maintained at 35–37 ◦C (65% relative humidity) for the first
two days, and 33–35 ◦C for day 3–7. The room temperature was gradually decreased by 2 ◦C per week
until to 24 ◦C, and then maintained unchanged. Water and diets were provided ad libitum. All birds
were inoculated with Newcastle disease vaccine on day 7 and day 21 and inoculated with infectious
bursa disease vaccine on day 14 and day 21.
5.3. Sample Collection
At 44 days of age, one bird close to the average weight was selected from each pen. After the
birds were fasted for 12 h, blood sample was collected in tubes (without anticoagulant) from a wing
vein with a 5 mL syringe. The samples were centrifuged at 1000× g for 10 min, and the serum was
277
Toxins 2016, 8, 278
separated and then stored at −20 ◦C until analysis. The chickens were then sacrificed; the liver and
spleen were removed immediately. A portion of the liver and the whole spleen were snap frozen in
liquid nitrogen and stored at −70 ◦C.
5.4. Oxidative Stress Indices in Liver and Spleen
Liver and spleen tissues (about 1 g) were cut into small pieces and homogenized in ice-cold saline
buffer (1:9, wt/v) using an Ultra-turrax (T8, IKA-labortechnik, Staufen, Germany) to form homogenate
at a concentration of 0.1 g/mL for further analysis. The homogenate was centrifuged at 1000× g
for 10 min at 4 ◦C, and the supernatant was collected and stored in freezer for assays of T-AOC,
CAT, GR, GSH-PX, GSH, MDA, LPO, H2O2, hydroxyl radical scavenger activity (HRSA) and TP.
All the assays were measured with commercial assay kits (Nanjing Jiancheng Bioengineering Institute,
Nanjing, China) and the procedures accordingly.
5.5. Serum Concentrations of Total Protein and Immunoglobulins
The contents of serum TP, IgA, IgM and IgG were measured using commercial kits from Nanjing
Jiancheng Bioengineering Institute. The measurements were performed according to the detection
kit instructions.
5.6. Statistical Analyses
All data were subjected to analysis by one-way ANOVA using SAS (Version 8e, SAS Institute,
Cary, NC, USA). Duncan’s multiple range test was used for multiple comparisons when a significant
difference was detected. Means were considered significantly different at p < 0.05.
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Abstract: Bacillus subtilis ANSB060 isolated from fish gut is very effective in detoxifying aflatoxins in
feed and feed ingredients. The purpose of this research was to investigate the effects of B. subtilis
ANSB060 on growth performance, body antioxidant functions, and aflatoxin residues in ducks fed
moldy maize naturally contaminated with aflatoxins. A total of 1500 18-d-old male Cherry Valley
ducks with similar body weight were randomly assigned to five treatments with six replicates of
50 ducks per repeat. The experiment design consisted of five dietary treatments labeled as C0
(basal diet containing 60% normal maize), M0 (basal diet containing 60% moldy maize contaminated
with aflatoxins substituted for normal maize), M500, M1000, and M2000 (M0 +500, 1000 or 2000 g/t
aflatoxin biodegradation preparation mainly consisted of B. subtilis ANSB060). The results showed
that ducks fed 22.44 ± 2.46 μg/kg of AFB1 (M0) exhibited a decreasing tendency in average daily
gain (ADG) and total superoxide dismutase (T-SOD) activity in serum, and T-SOD and glutathione
peroxidase (GSH-Px) activities in the liver significantly decreased along with the appearance of
AFB1 and AFM1 compared with those in Group C0. The supplementation of B. subtilis ANSB060
into aflatoxin-contaminated diets increased the ADG of ducks (p > 0.05), significantly improved
antioxidant enzyme activities, and reduced aflatoxin accumulation in duck liver. In conclusion,
Bacillus subtilis ANSB060 in diets showed an ameliorating effect to duck aflatoxicosis and may be a
promising feed additive.
Keywords: aflatoxin B1; aflatoxin biodegradation preparation; Bacillus subtilis ANSB060; ameliorating
effects; growth performance; antioxidant function; residue
1. Introduction
Aflatoxins (AF) are secondary toxic metabolites produced by certain fungi belonging to the genus
Aspergillus and can occur as natural contaminants of poultry food [1–5]. The principal aflatoxins
commonly found in feedstuffs are aflatoxin B1 (AFB1), aflatoxin B2 (AFB2), aflatoxin G1 (AFG1),
and aflatoxin G2 (AFG2) [6]. AFB1 has the highest toxic potency and is classified as a Group I
carcinogen by the International Agency for Research on Cancer (IARC, International Agency for
Research on Cancer, 1993). After being ingested by animals, AFB1 is converted to AFB1-8, 9-epoxide in
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the liver with a reaction catalyzed by cytochrome P-450 isozymes, forming adducts with the guanine
base of DNA, thus resulting in the toxicity of AFB1 [7,8].
Feeds contaminated with AFB1 can result in aflatoxicosis in poultry [9,10]. Many studies have
found that feeding grains contaminated with AFB1, either naturally or purified, can reduce growth
performance and immunity ability, alter intestinal morphology and blood biochemistry parameters,
and damage liver and kidney tissues in broilers [11,12]. Additionally, residues of aflatoxins and their
metabolites may be present in meat and other products of animals fed rations contaminated with
aflatoxins and potentially result in health problems in human.
It is known that aflatoxins are difficult or impossible to be removed completely from plants
and living organisms, as they can alter the chemical structure of mycotoxins as part of their
defense against xenobiotics [13]. Researchers have tried for decades to find effective strategies
regarding mycotoxin detoxification. The multifaceted approaches in previous reports could simply be
categorized into physical, chemical, and biological methods. A physical method is using non-nutritive
absorptive materials in animal diets to reduce the toxin absorption from the gastrointestinal tract of
chickens [14,15]. A study showed that Blasticidin A (BcA), an antibiotic produced by Streptomyces, can
control aflatoxin production by inhibiting protein synthesis [16]. Recently, the interest of researchers has
turned to the biological detoxification of mycotoxins using microorganisms or enzymatic preparation
for their specificity, efficiency, and simplicity [17–21]. Some microbes such as Armillariella tabescens [22],
Rhodococcus erythropolis [23], and Myxococcus fulvus [24] have been reported to possess the ability to
degrade aflatoxins. However, most of the microorganisms are not allowed to be applied in animal
feed under the supervision of the U.S. Food and Drug Administration (FDA), the Association of
American Feed Control Officials (AAFCO), and the Direct of Ministry of Agriculture, People’s Republic
of China. Based on this concern, we have isolated a strain of Bacillus subtilis ANSB060 from fish gut
that possesses a strong ability to detoxify aflatoxins. We also have confirmed that this strain can inhibit
the growth of pathogens and resist unfavorable conditions within simulated gut environments [25].
Since the nutritional and pharmaceutical use of Bacillus subtilis is generally recognized as safe (GRAS),
the Ministry of Agriculture of the People’s Republic of China has permitted B. subtilis for use in animal
feed. Ma et al. (2012) have shown that the addition of B. subtilis ANSB060 can enhance the activity of
antioxidant enzymes and recover the protein synthesis in the livers of laying hens [26], and Fan et al.
(2013, 2015) verified its positive effects of detoxifying aflatoxins on broilers [27,28].
Ducks are considered to be highly susceptible because they are unable to efficiently metabolize
aflatoxins [10]. A study examining the effects of AFB1 on liver lesions in poultry reported that ducks
generated hepatic lesions on alternate days per os 15 μg AFB1 [29]. Other literature on ducks fed diets
naturally contaminated with AFB1 is also available [30,31]. However, to the best of our knowledge,
little information on biological detoxification methods dealing with duck diets contaminated with
AFB1 has been found. China has a large consumer of duck products in the world (FAO, 2003), so it
is of great importance to study the effects of aflatoxins on ducks and develop solutions to detoxify
aflatoxins to ensure the qualities of duck products. We have investigated the toxic effects of aflatoxins
and the efficacy of Bacillus subtilis ANSB060 for the amelioration of aflatoxicosis in broiler chickens.
Whether low levels of aflatoxins can affect the growth and antioxidant functions of ducks and which
level of aflatoxins in diets can result in residues in duck tissues is still under consideration. Thus,
certifying the effects of low levels of aflatoxins on ducks and finding a reasonable method to degrade
aflatoxins in diets is important. Therefore, the objective of this study was to investigate the protective
effects of aflatoxin biodegradation preparation (B. subtilis ANSB060) on growth performance, body
antioxidant functions, and aflatoxin residues in ducks fed maize naturally contaminated with AFB1.
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2. Results
2.1. Growth Performance
The effects of B. subtilis ANSB060 on growth performance of Cherry Valley ducks fed moldy
maize naturally contaminated with aflatoxins are presented in Table 1. There were no significant
difference on ADG and ADFI among ducks fed basal diet without AFB1 (C0), a moldy diet naturally
contaminated with AFB1 (M0), and diets (M500, M1000, and M2000) naturally contaminated with
AFB1 mixed with B. subtilis ANSB060 during the experimental phase (p > 0.05). However, birds fed a
diet with 22.44 ± 2.46 μg/kg of AFB1 (M0) had a relatively smaller ADG (p > 0.05) compared to those
fed the basal diet without AFB1 (C0), while ducks fed 22.44 ± 2.46 μg/kg of AFB1 with B. subtilis
ANSB060 exhibited relatively higher ADG (p > 0.05) compared to those in Group M0. The feed/gain
ratio (F:G) of ducks was significantly affected by the dietary aflatoxins and B. subtilis ANSB060 during
the experimental phase (p < 0.05). The F:G of birds in Group M1000 was markedly decreased compared
with that in Group M0 (p < 0.05), implying that B. subtilis ANSB060 in diets might relieve the negative
effects of aflatoxion on birds and improve the feed efficiency of ducks.
Table 1. Effects of B. subtilis ANSB060 on the growth performance of ducks fed moldy maize naturally
contaminated with aflatoxins during the experiment.
Item Initial BW, g Final BW, g ADG, g/bird d ADFI, g/bird d F:G, g/g
C0 759.75 ± 7.13 3159.73 ± 19.62 109.09 ± 0.78 235.28 ± 1.79 2.17 ± 0.02 a
M0 758.15 ± 6.02 3120.93 ± 8.43 107.40 ± 0.53 234.28 ± 0.61 2.18 ± 0.01 a
M500 754.92 ± 3.61 3193.96 ± 22.20 110.86 ± 1.05 237.23 ± 3.08 2.14 ± 0.02 a
M1000 758.47 ± 5.26 3195.05 ± 11.78 110.75 ± 0.46 230.38 ± 2.21 2.08 ± 0.02 b
M2000 759.60 ± 7.01 3186.97 ± 23.95 110.33 ± 1.31 237.32 ± 2.44 2.17 ± 0.03 a
p Value 0.967 0.067 0.075 0.332 0.014
Each value is a mean ± SD from 6 replicates of 50 ducks each; a,b Means values with different superscripts in
each column are significantly different (p < 0.05).
2.2. Serum Antioxidant Indices
The effects of B. subtilis ANSB060 on the serum antioxidant indices of ducks exposed to aflatoxins
are shown in Table 2. The total superoxide dismutase (T-SOD) activity of the M0 group was decreased
by the dietary aflatoxins compared to that in Group C0 during the experimental phase (p < 0.05).
However, the addition of B. subtilis ANSB060 into moldy diets significantly improved the activity
of serum T-SOD in the Group M500, M1000 and M2000 (p < 0.05), maintaining it in a normal status
showed in Group C0. Though the glutathione peroxidase (GSH-Px) activity and malondiadehyde
(MDA) content were not different among all groups (p > 0.05), Group M0 had the lowest GSH-Px
activity and the highest MDA content, and the dietary B. subtilis ANSB060 could raise the activity of
GSH-Px and decrease MDA concentration, keeping them to the normal level.
Table 2. The effects of B. subtilis ANSB060 on the serum antioxidant indexes of ducks fed moldy maize
naturally contaminated with aflatoxins during the experiment.
Item T-SOD, U/mL GSH-Px, U/mL MDA, nmol/mL
C0 112.41 ± 4.32 a,b 1718.89 ± 141.66 2.55 ± 0.16
M0 107.36 ± 2.70 a 1508.71 ± 184.24 2.83 ± 0.32
M500 121.50 ± 2.13 b 1601.39 ± 81.31 2.62 ± 0.16
M1000 121.34 ± 4.12 b 1818.50 ± 96.85 2.58 ± 0.28
M2000 120.30 ± 3.99 b 1818.50 ± 264.37 2.45 ± 0.20
p Value 0.029 0.581 0.810
Each value is a mean ± SD from 6 replicates of 2 ducks each; a,b Means values with different superscripts in
each column are significantly different (p < 0.05).
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2.3. Liver Antioxidant Indices
The effects of B. subtilis ANSB060 on liver antioxidant indices of ducks exposed to aflatoxins
are presented in Table 3. The result indicated that a low dose of aflatoxins in diets (Group M0) can
decrease the activities of liver T-SOD and GSH-Px in ducks during the experimental period (p < 0.05);
however, the presence of B. subtilis ANSB060 in some diets (Group M500, M1000 and M2000) exhibited
a powerful capability of recovering T-SOD and GSH-Px activities in duck livers. The MDA level in
liver was detected as the index of lipid peroxidation, and there were no significant effects of dietary
aflatoxins and B. subtilis ANSB060 on MDA levels in duck livers in all groups (p > 0.05).
Table 3. The effects of B. subtilis ANSB060 on the liver antioxidant indices of ducks fed moldy maize
naturally contaminated with aflatoxins during the experiment.
Item T-SOD, U/mgprot GSH-Px, U/mgprot MDA, nmol/mgprot
C0 111.10 ± 5.73 c 116.45 ± 6.12 a 0.55 ± 0.05
M0 85.21 ± 3.44 a 87.11 ± 5.28 b 0.90 ± 0.29
M500 104.83 ± 3.50 b,c 109.96 ± 3.31 a 0.79 ± 0.08
M1000 98.37 ± 3.00 b 106.58 ± 3.82 a 0.56 ± 0.05
M2000 105.80 ± 3.92 b,c 104.44 ± 5.86 a 0.64 ± 0.06
p-value 0.001 0.007 0.398
Each value is a mean ± SD from 6 replicates of 2 ducks each; a–c Means values with different superscripts in
each column are significantly different (p < 0.05).
2.4. Aflatoxin Residues in Liver
The aflatoxin residues in the livers of ducks fed moldy diet naturally contaminated with
22.44 ± 2.46 μg/kg AFB1 with or without B. subtilis ANSB060 are given in Table 4. Aflatoxins were
not detected in the livers of ducks consuming a normal diet (Group C0). The AFB1 and AFM1 residues
in Group M0 were the highest, being 0.12 and 0.10 ng/g, respectively. B. subtilis ANSB060 in diets
could degrade aflatoxins into nontoxic products in the duck intestinal tract such that AFB1 and AFM1
residues in the liver were decreased. The AFB1 residues was significantly decreased by 41.7%, 50.0%,
and 58.3% respectively in Groups M500, M1000, and M2000 compared to those in Group M0 (p < 0.05).
Similarly, the AFM1 residues were significantly reduced by 40.0% in Groups M500, M1000, and M2000,
respectively. The AFB2, AFG1, and AFG2 residues in liver were not detected in all treatments.
Table 4. The effects of B. subtilis ANSB060 on aflatoxin residues (ng/g) in livers from ducks fed moldy
maize naturally contaminated with aflatoxins during the experiment.
Item AFB1 AFB2 AFG1 AFG2 AFM1
C0 ND * ND ND ND ND
M0 0.12 ± 0.01 a ND ND ND 0.10 ± 0.02 a
M500 0.07 ± 0.01 b ND ND ND 0.06 ± 0.00 b
M1000 0.06 ± 0.01 c ND ND ND 0.06 ± 0.01 b
M2000 0.05 ± 0.01 d ND ND ND 0.05 ± 0.01 b
Each value is a mean ± SD from 6 replicates of 1 duck each; a–c Means values with different superscripts in
each column are significantly different (p < 0.05); * ND = Not detected.
3. Discussion
3.1. Growth Performance
Aflatoxins are mycotoxins produced by Aspergillus spp. that contaminate animal feed and human
food. Aflatoxins can lead to growth reduction, immunity suppression, and oxidative damage, along
with residues in animal tissues [9,32–34], and it has become a threat to human health. B. subtilis
ANSB060 has shown a strong ability to detoxify aflatoxins in vitro; the degradation percentages of
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aflatoxins B1, M1, and G1 in this strain are 81.5%, 60%, and 80.7%, respectively [25]; meanwhile,
their protective effects on the performance and antioxidant function in layers [26] and the reduced
accumulation of aflatoxin residues in livers of broilers [27] have also been verified.
In this study, ducks fed diets contaminated with 22.44 ± 2.46 μg/kg of AFB1 show a tendency to
decline in body weight, ADG, and feed efficiency compared with ones in the control group, illustrating
a toxic effect of aflatoxins on the growth performance of ducks, which is consistent with previous
research. A significant decrease in ADG and ADFI in ducks fed a diet containing 200 ppm AFB1
for three weeks were observed in the research conducted by Cheng et al. (2001) [35]. Meanwhile,
Fowler et al. (2015) reported a reduced body weight (BW) from the first week to the third week in
broilers fed aflatoxin-contaminated diets, and this reduction grew greater along with the increase
of aflatoxin concentrations in diets from 0 to 1800 μg/kg; the percentages of body weight reduction
ranged from 8.8% to 24.5% during Week 2, and from 15.6% to 41.3% during Week 3. Additionally,
a negative effect of aflatoxins on the cumulative F:G ratio of broiler chicks was also shown [36].
However, the deleterious effect on the ADG of ducks in our study was not significant during the
trial phase. This may be due to lower concentration of aflatoxins and the inadequate duration of the
experiment. Previous results indicate that a decrease in ADG was due to anorexia, reluctance, and an
inhibition of protein synthesis and lipogenesis [37–39]. This growth inhibition in ducks suggests that
diets naturally contaminated with aflatoxins at a low level (22.44 ± 2.46 μg/kg) appear to have a toxic
effect on the growth performance of ducks in vivo. This result indicates that aflatoxin degradation
preparation mainly consisting of B. subtilis ANSB060 has a great ability to ameliorate the toxic effects
of aflatoxins on the growth performance of ducks. The basic mechanism seems to be one in which the
spores of B. subtilis ANSB060 can survive and colonize in an animal’s intestinal tract and secrete active
substances to degrade aflatoxins in diets so that the adsorption of aflatoxins declines [27]. Some studies
have suggested that microbial enzymes cleave the lactone ring of the AFB1 molecule in vitro to lower
its toxicity [40,41]. Nevertheless, the specific biotransformation mechanism of B. subtilis ANSB060
detoxifying aflatoxins in the animal’s intestinal tract is unclear, and further studies should be performed
with this strain [28].
3.2. Serum and Liver Antioxidant Indices
The inability to protect against reactive oxygen species (ROS) is the origin of oxidative stress.
ROS are produced during the procedure of normal metabolism, and do much harm to the animal body.
ROS mainly contain hydrogen peroxide (H2O2), a superoxide anion radical (O2•−), and a hydroxyl
radical (•OH). •OH is one of the most toxic oxygen-based radicals and wreaks havoc within cells,
particularly with macromolecules. There is a dynamic equilibrium between oxidant and antioxidant
systems and is vital for cell function, regulation, and adaptation to diverse growth conditions to remain
healthy in animal bodies [42], and oxidant stress can be induced subsequently if the balance is broken
down and the generation of ROS in a system exceed the system’s ability to neutralize and eliminate
them [43]. Oxidant stress can cause biological membrane lipid oxidation, denaturation of intracellular
protein and enzymes, DNA damage, pain, and ultimately various diseases. Enzymes such as SOD and
GSH-Px are crucial components of the antioxidant system and play a key role in removing ROS and
relieving oxidative damage [42]. MDA is the main product of lipid peroxidation that can bring about
protein damage and inactivation of membrane-bound enzymes [44]; thus, the level of MDA can be an
important index reflecting the body’s antioxidant ability [45].
One of our aims is to study the effects of adding B. subtilis ANSB060 to diets contaminated with
a concentration of 22.44 ± 2.46 μg/kg aflatoxins on the antioxidant function in ducks. Our findings
related to body antioxidant ability indicate that feeding diets contaminated with 22.44 ± 2.46 μg/kg
aflatoxins can result in a significant decrease in T-SOD activity and an increase in the MDA level both
in serum and the liver, while the activity of GSH-Px in duck livers is markedly decreased compared
with that in the control group from Day 18 to Day 39. These results are in accordance with previous
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studies [46–49], demonstrating that lipid peroxidation took place in the ducks fed diet contaminated
with aflatoxins.
While the activity of T-SOD is significantly increased and the MDA level is relatively decreased
both in serum and liver, the activity of GSH-Px has a tendency to increase in serum but markedly
increase in liver when ducks ingest aflatoxin-contaminated diets containing B. subtilis ANSB060 during
the experiment compared with those fed no B. subtilis ANSB060 (M0). SOD and GSH-Px take part
in lipid peroxidation by catalyzing the conversion of lipid hydroperoxide to hydroxy acids in the
presence of GSH [50]. Liver is shown to be the major target organ for aflatoxins [51], and the increase
in SOD and GSH-Px activities as well as the decrease in MDA level in serum and liver reflect that
B. subtilis ANSB060 contributes to the inhibition of lipid peroxidation and relieve the harm produced
by lipid peroxidation in ducks.
As a cause of liver degeneration and cancer, the elimination of these toxins from feedstuffs and
foodstuffs bears great importance. In poultry, several nonnutritive adsorbents have been tested and
have made some progress [46,52]; now, B. subtilis ANSB060 has been shown to have the capacity to
inhibit lipid peroxidation, providing another biological method to alleviating oxidative damage to
ducks caused by aflatoxins.
3.3. Aflatoxin Residues in Liver
The residue of aflatoxins and their metabolites in animal products have caused wide public
concern. Liver is the main detoxifying organ that removes wastes and xenobiotics by metabolic
conversion and biliary excretion [53]. Among the metabolites of AFB1, the toxicity of AFM1
in animals seems to be comparable to or slightly less than that of AFB1 [12]. In our study,
low levels (0.12 and 0.10 ng/g) of AFB1 and AFM1 are retained in the livers of ducks fed the
aflatoxin-contaminated diet for 21 days. Residue levels of AFB1 (0.05 and 0.13 μg/kg) and AFM1
(0.10 and 0.32 μg/kg) were also observed in the livers of broilers given diets contain 50 and 100 μg of
AFB1/kg for 42 days [15]. AFB1 residue was found in the livers of laying hens fed 2.5 mg/kg AFB1
diet for four weeks [54]. Residue levels may be different because of the type of bird and diet, the
concentrations of AFB1, and the duration, and enhanced tolerance to aflatoxins. In many countries,
the maximum tolerance level of AFB1 in human food products is 2 ng/g. AFB1 residues in liver not
only affect the performance and health of poultry, but also impair the health of the poultry product
consumers as aflatoxins accumulate in edible parts of poultry, so it is necessary to control the quality
of poultry products and analyze aflatoxin residues in different tissues of birds considering public
health and safety. The results of our study show significantly decreased residue levels of AFB1- and
AFM1-incorporated B. subtilis ANSB060 in ducks exposed to aflatoxins. The protective effects of
B. subtilis ANSB060 from aflatoxins may be due to their specific biotransformation of aflatoxins in
the intestinal tract, which leads to the reduction of aflatoxins absorbed by the intestinal tract and,
consequently, a decrease in aflatoxin residues in the liver. However, the specific mechanism has not
been tested, and more research should be done to determine this.
4. Conclusions
In conclusion, this study clearly indicates that aflatoxins in diets at a level of 22.44 μg/kg resulted
in depressed growth performance and antioxidant capacity in liver and serum, as well as aflatoxin
liver residues in ducks. Adding aflatoxin biodegradation preparation B. subtilis ANSB060 into moldy
diets significantly recovers the growth performance of ducks and reduces the accumulation of aflatoxin
residues in liver, effectively improving the antioxidant capacity to some extent. These results suggest
that B. subtilis ANSB060 counteract the adverse effects of aflatoxins in animal diets, and thus is believed
to be a very promising feed additive to detoxify aflatoxins in feed.
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5. Materials and Methods
5.1. Ducks, Diets, and Management
One-day-old Cherry Valley ducks were obtained from a commercial hatchery and fed a commercial
rearing diet for 17 days to adapt to the surroundings. On Day 18, 1500 male ducks were randomly
assigned into 5 treatment groups with 6 replicates of 50 birds each. Five dietary treatment groups were
composed as follows: Group C0 (the negative control), consisting of the basal diet with 60% normal
maize; Group M0 (the positive control), containing 60% moldy maize taking the place of normal
maize; and Groups M500, M1000, and M2000, containing an added 500 g/t, 1000 g/t and 2000 g/t
of aflatoxin biodegradation preparation in the diet of Group M0, respectively. In this experiment,
aflatoxin biodegradation preparation was mainly composed of industrially fermented and dried
B. subtilis ANSB060 products via certain processing technology. The viable count of B. subtilis ANSB060
was more than 1 × 109 CFU/g in the aflatoxin biodegradation preparation. The composition of the
basal diet was presented in Table 5.
Table 5. Basal diet formulations and nutritional contents.
Ingredients Percentage (%) Nutrition Component Content
Maize 60.00 Crude protein, % 16.50
Soybean meal 13.64 Metabolizable energy, MJ/kg 12.39
Wheat 4.75 Calcium, % 1.00
Flour 3.50 Total phosphorus, % 0.67
Peanut meal 4.20 Available phosphorus, % 0.42
Zein meal 3.50 Methionine, % 0.46
Calcium hydrophosphate 1.36 Methionine + Cystine, % 0.76




Rice bran meal 2.00
Premix 1 1.30
Total 100.00
1 Provided per kilogram of diet: vitamin A: 15,000 IU; cholecalciferol: 4000 IU; vitamin E: 40 IU; vitamin K3:
5.0 mg; thiamine: 3.0 mg; riboflavin: 3.0 mg; pyridoxine: 4.6 mg; vitamin B12: 0.08 mg; folic acid: 1.6 mg; niacin:
50 mg; pantothenic acid: 15 mg; choline chloride: 1000 mg; biotin: 0.25 mg; manganese: 100 mg; zinc: 100 mg;
selenium: 0.3 mg; iodine: 0.3 mg; iron: 50 mg; copper: 15 mg.
This study was approved by the Animal Care and Use Committee of the China Agricultural
University (ethical approval code: CAU20131028-2; Date: 28 October 2013). All ducks were reared
on floor in an environmentally controlled house equipped with central heating and temperature
controllers. The size of barrier was 8 m × 2 m. Animals were cared for in accordance with the
guidelines for the care and use of laboratory animals presented in the guide issued by the National
Institute of Health and China’s Ministry of Agriculture. Body weight (BW), average daily gain (ADG),
average daily feed intake (ADFI), and feed/gain ratio (F:G) were measured on a replicate basis at the
end of the experiment (39 day old).
5.2. Analysis of Dietary Mycotoxin
The contents of mycotoxins (AFB1, AFB2, AFG1, AFG2, deoxynivalenol, zearalenone,
and ochratoxin A) in feed ingredients and formulated diets in the study were determined using high
performance liquid chromatography (HPLC) according to appropriate methods [55]. After these five
diets were prepared, the final contents of mycotoxins for each diet were determined. The concentration
of AFB1, AFB2, AFG1, AFG2, and zearalenone of the diets fluctuated at 22.44 ± 2.46 μg/kg,
6.69 ± 1.32 μg/kg, 1.65 ± 0.65 μg/kg, 0.00 μg/kg, and 5.20 ± 0.68 μg/kg in Groups M0, M500,
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M1000, and M2000, respectively. Only AFB1 was found in diet of Group C0, but the concentration of
AFB1 was less than 0.20 μg/kg in this group.
5.3. Sampling of Antioxidant Indices and Measurements
At 39 day of age, 12 ducks (2 birds for each replicate) close to the average weight of treatment
were slaughtered by dislocation of the neck vertebrae and bleeding after fasting for 12 h. Blood
samples were collected by puncture of wing vein; after being centrifuged at 1000× g at 4 ◦C for
10 min, the serum was separated and transferred into 1.5 mL plastic centrifuge tubes for analysis of
antioxidant indices including superoxide dismutase (SOD), glutathione peroxidase (GSH-Px) activity,
and malondiadehyde (MDA) content.
The liver tissue samples were washed with ice-cold sterilized saline (0.85%), snap frozen in liquid
nitrogen, and stored at −80 ◦C for further analysis of liver antioxidant indices. Liver tissue (1 g) was
cut into small pieces and homogenized in ice-cold saline buffer (0.85%, pH = 7.4) (1:9, w/v) with an
Ultra-Turrax (T8, IKA-labortechnik, Staufen, Germany) to form homogenates at a concentration of
0.1 g/mL for further analysis. Liver homogenates were centrifuged at 1000 g for 15 min at 4 ◦C, and the
supernatants were collected. The supernatants were used for the assays of SOD and GSH-Px activity,
and MDA content.
These parameters were determined with the clinical chemistry analyzer (Commercial Kit,
Nanjing Jiancheng Bioengineering Institute, Nanjing, China) according to the manufacturer’s
recommended procedure.
5.4. Analysis of Aflatoxin Residues in Liver
Livers samples from the pectoralis major of the right side of the duck were excised and frozen
at −20 ◦C to analyze the residues of the aflatoxins. For this analysis, liver samples of six birds from
each treatment (one for each replicate) were selected. Analysis of AFB1, AFB2, AFG1, AFG2, and AFM1
residues in the tissues was performed according to Fan et al. [27].
The ground defrosted liver sample (25 g), when 5 g of NaCl was added, was blended in 100 mL
of methanol–water (80:20) for 3 min. Through a paper filter, an aliquot of 10 mL of filtrate was diluted
with 40 mL of PBS/0.1% Tween-20 Wash Buffer and applied to an immunoaffinity column. Aflatoxins
were eluted with 1.0 mL of methanol in a glass vial and dried near to dryness under a gentle stream of
nitrogen and dissolved in a HPLC mobile phase. AFB1, AFB2, AFG1, and AFG2 were determined by
the HPLC system (Shimadzu LC-10 AT) equipped with reverse phase column (Diamonsil, C18, 5 μm,
15 cm × 4.6 cm ID) and post-column photochemical derivatization (AURA, New York, NY, USA) and
fluorescence monitor (Shimadzu RF-20A), with excitation at 360 nm and emission at 440 nm, with
methanol/water (45:55) as the mobile phase, at a flow rate of 1 mL/min. For the determination of
AFM1, HPLC was performed with a fluorescence monitor at 365 nm for excitation and 425 nm for
emission, and water/acetonitrile/methanol (68:24:8) as the mobile phase at a flow rate of 1 mL/min.
5.5. Statistical Analyses
Data were analyzed using the GLM procedure of SAS software (version 9; SAS Institute, Inc.,
Cary, NC, USA). Duncan’s multiple range tests were used for multiple comparisons when the analysis
indicated significant differences among treatments. All statements of statistical significance were based
on probability (p < 0.05). All data were expressed as means ± SD.
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Abstract: This study was designed to establish if Curcumin (CM) alleviates Aflatoxin B1
(AFB1)-induced hepatotoxic effects and to determine whether alteration of the expression of
cytochrome P450 (CYP450) isozymes is involved in the regulation of these effects in chick liver.
One-day-old male broilers (n = 120) were divided into four groups and used in a two by two factorial
trial in which the main factors included supplementing AFB1 (< 5 vs. 100 μg/kg) and CM (0 vs.
150 mg/kg) in a corn/soybean-based diet. Administration of AFB1 induced liver injury, significantly
decreasing albumin and total protein concentrations and increasing alanine aminotransferase
and aspartate aminotransferase activities in serum, and induced hepatic histological lesions at
week 2. AFB1 also significantly decreased hepatic glutathione peroxidase, catalase, and glutathione
levels, while increasing malondialdehyde, 8-hydroxydeoxyguanosine, and exo-AFB1-8,9-epoxide
(AFBO)-DNA concentrations. In addition, the mRNA and/or activity of enzymes responsible for
the bioactivation of AFB1 into AFBO—including CYP1A1, CYP1A2, CYP2A6, and CYP3A4—were
significantly induced in liver microsomes after 2-week exposure to AFB1. These alterations induced
by AFB1 were prevented by CM supplementation. Conclusively, dietary CM protected chicks
from AFB1-induced liver injury, potentially through the synergistic actions of increased antioxidant
capacities and inhibition of the pivotal CYP450 isozyme-mediated activation of AFB1 to toxic AFBO.
Keywords: curcumin; aflatoxin B1; CYP450; AFBO–DNA; chicks
1. Introduction
Aflatoxins (AF) are secondary fungal metabolites that are largely produced by the fungi Aspergillus
flavus and Aspergillus parasiticus [1,2]. Among the various dangerous AF and their metabolites, aflatoxin
B1 (AFB1) is the most toxic, exhibiting harmful hepatotoxic, teratogenic, mutagenic, and carcinogenic
effects on humans and many species of livestock [3–6]. It is also classified as a Group I carcinogen [7].
Human or animal consumption of the food or feed contaminated by AFB1 can pose serious problems
to their health and productivity, and thus result in significant economic losses [8,9]. The toxic effects of
AFB1 are associated with its toxification and detoxification biotransformation pathways. Upon being
delivered to the liver, AFB1 is bioactivated by cytochrome P450 (CYP450)—a member of the phase I
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metabolizing enzymes—into the highly reactive exo-AFB1-8,9-epoxide (AFBO) [3,10]. AFBO can form
adducts with DNA and other critical macromolecules, causing toxicity, mutations, and cancer [10].
Meanwhile, AFB1 can induce the generation of reactive oxygen species (ROS), which can lead to
oxidative stress, potentially mediated via CYP450 activity [11,12]. On the other hand, AFBO can be
detoxified via conjugation with glutathione (GSH) to form a non-toxic adduct, which can be catalyzed
by glutathione-S transferases (GSTs), the phase II detoxification enzymes [10].
Curcumin (CM) is a natural polyphenolic compound extracted from rhizomes of Curcuma longa
Linn (turmeric), widely used as household spice, natural food colorant, and herbal medicine in
many Asian countries for thousands of years [13]. It possesses antioxidant, anti-inflammatory,
radio-protective, chemotherapeutic, anti-cancer, and detoxification abilities in laboratory animals
and humans [14–17]. Previous publications have described that CM can effectively mitigate
AFB1-induced adverse effects in several animal species [6,15,18–20]. Moreover, the protective
action of CM against AFB1-induecd adverse effects was further demonstrated by improving the
antioxidant capacity [18,19,21,22]. Notably, as different CYP450 isozymes catalyze AFB1 to various
metabolites, including the highly toxic AFBO and the less- or non-toxic aflatoxicol, AFM1, AFP1,
and AFQ1, examination of the regulation of the proportions of CYP450 isozymes by CM would be
valuable [10,23]. Previous studies have described that CM can alter various CYP450 isozymes in vivo
and in vitro [24–27]. Moreover, CM inhibition of AFB1 toxicity has been reported by modulating
CYP450 function [14], while the knowledge of which crucial CYP450 isozymes are involved in this
process remains unknown. Chicken orthologs of human CYP1A, 2A, and 3A families are the main
CYP450 enzymes responsible for the bioactivation of AFB1 into the highly toxic AFBO in chicken [23].
However, there is limited information on the effect of CM on these pivotal CYP450 isozymes that
are involved in AFB1 metabolism. Therefore, we selected chickens to investigate whether dietary
supplementation of CM mitigated AFB1-induced hepatotoxic effects though the regulation of these
key CYP450 isozymes.
2. Results
2.1. Growth Performance, Serum Biochemistry, and Liver Histology
Non-significant differences in average daily feed intake, average daily gain, and feed/gain ratio
were observed among the four groups throughout the experiment (Table S1). Serum biochemical
parameters were significantly affected by either supplementation of AFB1 or CM at week 2
(Table 1). Compared to the control, the activities of alanine aminotransferase (ALT) and aspartate
aminotransferase (AST) increased (p < 0.05) by 33.3% and 43.8% respectively, while the concentrations
of albumin (ALB) and total protein (TP) decreased (p < 0.05) by 33.8% and 26.0%, respectively, in
the serum of chicks by AFB1 supplementation. Notably, the serum biochemical parameter changes
observed in the AFB1 group were prevented in the AFB1 + CM group. However, no significant
differences in these serum biochemical parameters were observed among the four groups at week 4
(Table 1). Since the serological results indicated AFB1 only induced liver injury at week 2, we selected
samples from week 2 to explore the mechanism. Furthermore, dietary AFB1 exposure induced liver
injury as shown through bile duct hyperplasia and necrosis at week 2. Strikingly, the AFB1 + CM
group prevented the hepatic injury observed in the AFB1 group (Figure 1).
2.2. Hepatic Antioxidant Parameters and CYP450 Isozyme Activities
After 2 weeks of experimental treatments, the antioxidant parameters and CYP450 isozyme
activities were significantly altered by either supplementation of AFB1 or CM (Tables 2 and 3).
Compared to the control, supplementation of dietary AFB1 led to a decrease (0.05) in the
activities of glutathione peroxidase (GPX, 13.1%), catalase (CAT, 16.2%), and GSH concentration
(30.9%), along with increase (p < 0.05) in concentrations of malondialdehyde (MDA, 100.0%) and
8-hydroxydeoxyguanosine (8-OHdG, 17.9%) in the liver of chicks at week 2, respectively. Interestingly,
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the antioxidant parameter changes observed in the AFB1 group were prevented in the AFB1 + CM
group (Table 2). In addition, supplementation of CM alone increased (p < 0.05) activity of GPX
(25%), while it did not affect the other antioxidant parameters, when compared with the control.
Meanwhile, the dietary AFB1 supplementation led to an increase (p < 0.05) in the activity of CYP1A1
(270.6%), CYP1A2 (99.4%), CYP2A6 (184.5%), and CYP3A4 (29.2%) in the liver microsomes of chickens,
respectively (Table 3). Strikingly, the increased CYP450 isozyme activities observed in the AFB1 group
were reduced in the AFB1 + CM group.
Table 1. Effects of dietary AFB1 and CM concentrations on serum biochemical parameters in chicks 1.
Item Control AFB1 CM AFB1 + CM
Week 2
ALT, U/L 1.2 ± 0.1 a 1.6 ± 0.4 b 1.2 ± 0.3 a,b 1.3 ± 0.2 a,b
AST, U/L 176.7 ± 27.0 a 254.2 ± 53.9 b 178.4 ± 38.1 a 193.5 ± 39.4 a,b
TP, g/L 17.7 ± 1.1 b 13.1 ± 2.3 a 17.3 ± 1.8 b 19.1 ± 2.0 b
ALB, g/L 7.4 ± 0.3 b 4.9 ± 1.0 a 7.1 ± 1.2 b 8.1 ± 1.0 b
Week 4
ALT, U/L 1.0 ± 0.1 1.2 ± 0.3 1.4 ± 0.4 1.6 ± 0.5
AST, U/L 217.4 ± 26.8 211.2 ± 22.0 223.6 ± 37.5 245.9 ± 83.4
TP, g/L 22.8 ± 3.9 23.3 ± 2.7 21.8 ± 4.4 26.3 ± 7.8
ALB, g/L 9.9 ± 2.1 9.8 ± 1.9 9.3 ± 2.4 11.6 ± 3.7
1 Values are expressed as means ± SD (n = 5), and means with different superscript letters differ (p < 0.05).
AFB1, aflatoxin B1; ALB, albumin; ALT, alanine aminotransferase; AST, aspartate aminotransferase; CM,
curcumin; TP, total protein. Experimental details of Control and AFB1 groups are given in Sun et al. (2016) [12].
Figure 1. Photomicrographs of hepatic sections stained with hematoxylin and eosin (400× magnification)
of chicks from different treatment groups at week 2. AFB1, aflatoxin B1; CM, curcumin. Experimental
details of Control and AFB1 groups are given in Sun et al. (2016) [12].
Table 2. Effects of dietary AFB1 and CM concentrations on hepatic antioxidant parameters in chicks at
week 2 1.
Item Control AFB1 CM AFB1 + CM
GPX, U/mg 127.8 ± 5.1 b 111.1 ± 10.3 a 159.9 ± 15.1 c 159.7 ± 8.9 c
SOD, U/mg 156.8 ± 5.2 a,b 149.9 ± 9.7 a 170.2 ± 6.7 b 162.5 ± 8.7 a,b
CAT, U/mg 13.6 ± 0.9 b 11.4 ± 1.6 a 15.4 ± 1.2 b,c 16.7 ± 1.0 c
GST, U/mg 61.5 ± 1.1 60.6 ± 1.9 62.3 ± 5.1 62.0 ± 2.4
GSH, μmol/g 48.5 ± 10.1 b 33.5 ± 3.9 a 62.8 ± 17.6 b 53.4 ± 15.6 b
MDA, μmol/g 3.2 ± 0.4 a 6.4 ± 1.3 b 2.9 ± 0.5 a 3.2 ± 0.6 a
8-OHdG, nmol/mg 152.2 ± 8.1 a 179.5 ± 5.4 b 157.9 ± 2.9 a 156.8 ± 4.7 a
1 Values are expressed as means ± SD (n = 5), and means with different superscript letters differ (p < 0.05). AFB1,
aflatoxin B1; CAT, catalase; CM, curcumin; GPX, glutathione peroxidase; GSH, glutathione; GST, glutathione-S
transferases; MDA, malondialdehyde; SOD, superoxide dismutase; 8-OHdG, 8-hydroxydeoxyguanosine.
Experimental details of Control and AFB1 groups are given in Sun et al. (2016) [12].
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Table 3. Effects of dietary AFB1 and CM concentrations on the activities of chicken cytochrome P450
(CYP450) orthologs in the liver at week 2 1.
Item Control AFB1 CM AFB1 + CM
CYP1A1, nmol/(mgprotein·min) 0.34 ± 0.13 a 1.26 ± 0.17 c 0.83 ± 0.15 b 0.79 ± 0.16 b
CYP1A2, nmol/(mgprotein·min) 1.71 ± 0.45 a 3.41 ± 0.49 b 2.45 ± 0.63 a,b 1.95 ± 0.55 a
CYP2A6, nmol/(mgprotein·min) 2.07 ± 0.30 a 5.89 ± 1.37 b 3.00 ± 1.18 a 3.08 ± 0.63 a
CYP3A4, nmol/(mgprotein·min) 26.93 ± 2.22 a 34.79 ± 3.06 b 24.86 ± 1.51 a 22.60 ± 2.26 a
1 Values are expressed as means ± SD (n = 5), and means with different superscript letters differ (p < 0.05).
AFB1, aflatoxin B1; CM, curcumin; CYP1A1, Cytochrome P450 1A1; CYP1A2, Cytochrome P450 1A2; CYP2A6,
Cytochrome P450 2A6; CYP3A4, Cytochrome P450 3A4. Experimental details of Control and AFB1 groups are
given in Sun et al. (2016) [12].
2.3. Hepatic AFBO–DNA Adduct Contents
The concentrations of AFBO–DNA adducts in the liver were significantly affected by either
supplementation of AFB1 or CM at week 2 (Figure 2). Compared to the control, the hepatic AFBO–DNA
adduct content was increased (p < 0.05) 12 times by AFB1 supplementation. Interestingly, the
AFB1 + CM group decreased (p < 0.05) the concentration of AFBO–DNA adduct (63.7%) in the
liver when compared to the AFB1 group.
Figure 2. Effects of dietary AFB1 and CM concentrations on the contents of AFBO–DNA adducts in
the liver of chicks at week 2. Values are expressed as means ± SD (n = 5), and means with different
superscript letters differ (p < 0.05). AFB1, aflatoxin B1; AFBO, exo-AFB1-8,9-epoxide; CM, curcumin.
Experimental details of Control and AFB1 groups are given in Sun et al. (2016) [12].
2.4. Hepatic CYP450 Isozyme Activities and Gene Expression
The mRNA levels of CYP1A1, CYP1A2, and CYP3A4 in the liver were significantly altered by
either supplementation of AFB1 or CM (Figure 3). Specifically, dietary AFB1 supplementation led to
upregulated (p < 0.05) mRNA levels of CYP1A1, CYP1A2, and CYP3A4 in liver microsomes. Strikingly,
the increased hepatic CYP450 isozyme mRNA levels observed in the AFB1 group were suppressed in
the AFB1 + CM group. It is fascinating to find that the effects of AFB1 and CM on changes in hepatic
CYP450 isozyme mRNA levels were in parallel with their activities.
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Figure 3. Effects of dietary AFB1 and CM concentrations on relative mRNA abundance of CYP450
isozyme genes in liver of chicks at week 2. Values are expressed as means ± SD (n = 5), and means with
different superscript letters differ (p < 0.05). AFB1, aflatoxin B1; CM, curcumin; CYP1A1, Cytochrome
P450 1A1; CYP1A2, Cytochrome P450 1A2; CYP3A4, Cytochrome P450 3A4. Experimental details of
Control and AFB1 groups are given in Sun et al. (2016) [12].
3. Discussion
Protection against AFB1-induced hepatotoxic effects was successfully replicated in broiler chicks
fed an AFB1-contaminated corn–soybean diet with CM supplementation. Although the dietary AFB1
had no significant effect on growth performance in chicks, it induced the typical clinical signs of
hepatic injury, including increased activities of AST and ALT, decreased concentrations of ALB and
TP in serum, as well as bile duct hyperplasia and necrosis in the liver of chicks at week 2 [28,29].
However, the serological results indicated that AFB1-induced liver injury disappeared at week 4.
The reasons for this might be that older poultry was more resistant to aflatoxicosis than young
poultry [30], and the AFBO–DNA adducts could be repaired by the nucleotide excision repair system
in liver [31]. Intriguingly, dietary supplementation of CM mitigated serum and histopathological
parameter alterations that were induced by dietary supplementation of AFB1 at week 2. These
outcomes were consistent with previous studies, which provided evidence that hepatic injury was
induced by dietary AFB1 as well as that dietary CM supplementation displayed protective effects
against its negative effects [15,19–21]. Moreover, the present study displayed AFB1-induced oxidative
stress in chickens as evidenced by decreased antioxidant ability (GPX, CAT, and GSH), increased lipid
peroxidation (MDA), and DNA damage (8-OHdG). On the other hand, dietary CM supplementation
inhibited these changes. Meanwhile, dietary supplementation of CM alone improved the hepatic GPX
activity, which was consistent with previous studies in which CM increased GPX activity, probably by
activating the Nrf2–keap1 pathway [32,33]. A previous study showed that dietary supplementation
of 5000 mg/kg CM increased hepatic phase II detoxification enzyme (GST) activity in rats that were
exposed to AFB1 [34], while GST activity was not affected by CM in this study. The divergence
between these reports could be attributed to the different animal species and ingestion dose. Taken
together, these outcomes are similar to former studies, which reported that oxidative stress could be
due to the direct effects of AFB1, its metabolites, and/or the generation of free radicals [11,35]. Dietary
supplementation of CM, however, showed protective actions against AFB1-induced hepatic injury,
which were associated with the enhancement of antioxidant capacities [18,19,21,22].
The most interesting finding from the present study was that the four major CYP450 isozymes
were significantly inhibited to a large extent by dietary supplementation of CM upon exposure to
dietary AFB1. The hepatic mRNA levels and/or enzyme activities of CYP1A1, CYP1A2, CYP2A6,
and CYP3A4 were significantly increased when chicks were exposed to dietary AFB1, while dietary
supplementation of CM inhibited these changes. Because a previous study reported that CYP2A6 and
(to a lesser extent) CYP1A1 are responsible for the bioactivation of AFB1 into AFBO in chicken hepatic
microsomes, and that CYP1A2 and CYP3A4 are the most important enzymes capable of bioactivating
AFB1 into AFBO in mammals [23,36], inhibition of the activities of these enzymes could decrease
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the production of AFBO. Indeed, as a major toxic adduct of AFBO [10,36], the AFBO–DNA was
sharply decreased by the dietary supplementation of CM when chicks were exposed to dietary AFB1.
These findings suggest that the protective actions of CM may be mediated through inhibited activities
of these crucial CYP450 isozymes, which could decrease the production of the highly toxic AFBO.
These outcomes are in agreement with previous studies, which showed that CM-mediated inhibition
of AFB1 toxicity was associated with a reduction of the formation of AFBO–DNA by modulating
CYP450 function, including CYP1A1 activity [14,20], while the activities of CYP1A2, CYP2A6, and
CYP3A4 inhibited by CM in this process are described, to our knowledge, for the first time in the
current study. Similarly, CM has been shown to inhibit tumorigenesis induced by benzo(a)pyrene
and 2,3,7,8-tetrachlorodibenzo-p-dioxin through the inhibition of CYP1A1, CYP1B1, and/or CYP1A2
enzyme on mRNA, protein, and/or activities levels [25,37].
The CYP450s are important metabolizing enzymes, most of which are mainly expressed in the
liver. Clinically, these enzymes play vital roles in drug metabolism and are required for the efficient
clearance of xenobiotics from the body [38,39]. On the other hand, these enzymes can also bioactivate
biologically inert carcinogens and toxins, such as 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone [40],
N-nitrosonornicotine [41], hexamethylphosphoramide [42], benzo(a)pyrene [25], AFB1 [10], and
2,6-dichlorobenzonitrile [43] to electrophilic metabolites that can cause toxicity, cell death, and
sometimes cellular transformation that results in cancer. Given that CM is a strong inhibitor of
CYP450 isozymes, it could be a potentially promising chemopreventive agent for many carcinogens
and toxins, even though its mechanism of action remains to be clarified.
In summary, the present study successfully confirmed that dietary CM supplementation could
alleviate AFB1-induced liver injury, with regard to the suppression of serum biochemistry changes
and histopathological lesions in the liver of broilers. The protective mechanism of CM against
AFB1-induced adverse effects may be associated with: (1) the common mechanism that CM could
reduce AFB1-induced oxidative stress by increasing antioxidant capacities; and (2) the novel finding
that CM could effectively inhibit the regulatory role of CYP450 isozymes that are crucial for the
activation of AFB1 to highly toxic AFBO. Further validation of the potential mechanisms of the
interactions between CM and the CYP450 isozymes would be beneficial to gain a better understanding
of the detoxification mechanism of CM and applications of CM to control chemical carcinogenesis.
4. Materials and Methods
4.1. Chicks, Treatments, and Samples Collection
Our animal protocol was approved by the Scientific Ethic Committee of Huazhong Agricultural
University on 8 August 2015. The project identification code is HZAUCH-2015-007. In total,
120 one-day-old male avian broilers were randomly divided into four treatment groups with five
replicates of six chicks per pen. All chicks were allowed free access to a corn/soybean-based diet (BD)
formulated to meet the nutritional requirements of broilers’ diets (Table S2) as reported previously [12],
and distilled water. After three days of acclimation, the four experimental groups were arranged in
a two by two factorial design trial that included BD diet supplemented with AFB1 (Sigma-Aldrich,
St. Louis, MO, USA) and CM (China National Medicines Corp. Ltd., Beijing, China), as follows:
Control; AFB1 (100 μg AFB1/kg); CM (150 mg CM/kg); and AFB1 + CM (100 μg AFB1/kg with
150 mg CM/kg). The experiment lasted for four weeks. The doses were chosen based on previous
studies, which reported that dietary consumption of approximately 100 μg AFB1/kg induced adverse
effects [44], while dietary supplementation of 74–222 mg CM/kg displayed a protective effect on
AFB1 in broilers [19]. Individual body weights and feed intake of broilers were measured biweekly.
Meanwhile, chicks (n = 5/group) were euthanized by decapitation to collect blood and livers for the
preparation of serum and liver histological tissue samples as previously described [29].
298
Toxins 2016, 8, 327
4.2. Dietary AFB1 Analysis, and Feed Preparation
Twenty grams of moldy corn was extracted with 100 mL of methanol (Fisher, Pittsburgh, PA,
USA):water (70:30, v/v) for AFB1 detection. After shaking for 3 min, the supernatant of the extract was
filtered through a Whatman filter (Whatman, Clifton, NJ, USA), and the filtrate was collected. Then,
the concentration of AFB1 in filtrate was measured followed the protocol of the ELISA kit (AgraQuant®
Aflatoxin B1 Assay, Romer, Singapore). The powdered feed was mixed with a vertical mixer.
4.3. Serum Biochemical and Histological Analysis
The serum activities of aspartate aminotransferase (AST) and alanine aminotransferase (ALT),
along with concentrations of albumin (ALB) and total protein (TP) were determined in serum samples.
Analysis of the serum samples was measured by an automatic biochemistry analyzer (Beckman
Synchron CX4 PRO, Fullerton, CA, USA). The liver tissues were fixed in 10% neutral buffered formalin
and processed for paraffin embedding, sectioned at 5 μm, and then stained with hematoxylin and
eosin, by standard procedure [29]. Liver sections from all broilers were microscopically examined.
4.4. Antioxidant Enzyme Activities Analysis
Liver samples (0.5 g) were thawed in 4.5 mL isotonic saline on ice and homogenized as previously
described [33]. The supernatants were then prepared by centrifugation at 12,000 × g for 15 min
at 4 ◦C. Activities of superoxide dismutase (SOD), glutathione peroxidase (GPX), catalase (CAT),
and GST, as well as concentrations of GSH and malondialdehyde (MDA) were determined using the
colorimetric method through the specific assay kits (A001, A005, A007-1, A004 A006-1 and A003), which
were purchased from the Nanjing Jiancheng Bioengineering Institute of China. The concentration of
8-hydroxydeoxyguanosine (8-OHdG) in serum was measured using the ELISA kit (H165, Nanjing
Jiancheng Bioengineering Institute, Nanjing, China). Concentrations of protein were determined using
the bicinchoninic acid assay [45].
4.5. Hepatic AFBO–DNA Adduct Analysis
Liver genomic DNA was extracted using the DNA extraction kit following the manufacturer’s
instructions (Qiagen, Shanghai, China). The DNA concentrations were quantified by the 260/280 nm
absorbance ratio by an Agilent Bioanalyzer 2100 (Agilent Technologies, Amstelveen, The Netherlands).
Genomic DNA (15 μg) was used to determine the AFBO–DNA adduct amount using a competitive
ELISA method, according to the manufacturer’s instructions (Cell Biolabs, Inc., San Diego, CA, USA).
4.6. Hepatic Microsomal CYP450 Isozyme Activities Analysis
The liver microsomes and cytosolic fractions were prepared as described previously [46].
The microsomal activities of 7-ethoxyresorufin-O-deethylase, methoxyresorufin-O-demethylase,
coumarin 7-hydroxylase, and nifedipine oxidation were determined to assess chicken orthologs
of human CYP1A1, CYP1A2, CYP2A6, and CYP3A4 activities, respectively [23]. The concentrations of
protein were measured as described above [45].
4.7. Real-Time Quantitative Polymerase Chain Reaction (qPCR)
Total RNA was extracted from liver samples by using Trizol (Invitrogen, Carlsbad, CA, USA)
following the manufacturer’s instructions. The quality and quantity of the RNA samples were analyzed
by an Agilent Bioanalyzer 2100 using an RNA 6000 Labchip kit (Agilent Technologies, Amstelveen,
The Netherlands). The cDNA was synthesized from 1.0 μg total RNA by using Super Script III reverse
transcriptase (Invitrogen). The mRNA levels of CYP450 isozyme genes were determined by qPCR
(7900 HT; Applied Biosystems, Foster City, CA, USA). The primers of CYP450 isozymes and reference
gene glyceraldehyde-3-phosphate dehydrogenase were reported previously [12]. The 2−ddCt method
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was used for the quantification, with glyceraldehyde 3-phosphate dehydrogenase (GAPDH) as a
housekeeping gene and the relative abundance normalized to the control (as 1) [47].
4.8. Statistical Analysis
One-way ANOVA followed by Fisher’s least significant difference (LSD) test was used to compare
the effects between groups on each variable within the same tissue. Data are presented as means ± SD,
and significance level was set at p < 0.05. All analyses were conducted using SAS 8.2 (SAS Institute,
Cary, NC, USA).
Supplementary Materials: The following are available online at www.mdpi.com/2072-6651/8/11/327/s1,
Table S1: Effects of dietary AFB1 and CM concentrations on growth performance in chicks, Table S2: Basal
diet formulations and nutritional contents.
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